
<html lang="en"     class="pb-page"  data-request-id="72e16240-6cf2-444b-a046-e82eb8edb16d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm5016846;issue:issue:10.1021/jmcmar.2015.58.issue-13;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Clostridium difficile Drug Pipeline: Challenges in Discovery and Development of New Agents" /></meta><meta name="dc.Creator" content="Angie M.  Jarrad" /></meta><meta name="dc.Creator" content="Tomislav  Karoli" /></meta><meta name="dc.Creator" content="Mark A. T.  Blaskovich" /></meta><meta name="dc.Creator" content="Dena  Lyras" /></meta><meta name="dc.Creator" content="Matthew A.  Cooper" /></meta><meta name="dc.Description" content="In the past decade Clostridium difficile has become a bacterial pathogen of global significance. Epidemic strains have spread throughout hospitals, while community acquired infections and other sou..." /></meta><meta name="Description" content="In the past decade Clostridium difficile has become a bacterial pathogen of global significance. Epidemic strains have spread throughout hospitals, while community acquired infections and other sou..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 30, 2015" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm5016846" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm5016846" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm5016846" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm5016846" /></link>
        
    
    

<title>Clostridium difficile Drug Pipeline: Challenges in Discovery and Development of New Agents | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm5016846" /></meta><meta property="og:title" content="Clostridium difficile Drug Pipeline: Challenges in Discovery and Development of New Agents" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0017.jpeg" /></meta><meta property="og:description" content="In the past decade Clostridium difficile has become a bacterial pathogen of global significance. Epidemic strains have spread throughout hospitals, while community acquired infections and other sources ensure a constant inoculation of spores into hospitals. In response to the increasing medical burden, a new C. difficile antibiotic, fidaxomicin, was approved in 2011 for the treatment of C. difficile-associated diarrhea. Rudimentary fecal transplants are also being trialed as effective treatments. Despite these advances, therapies that are more effective against C. difficile spores and less damaging to the resident gastrointestinal microbiome and that reduce recurrent disease are still desperately needed. However, bringing a new treatment for C. difficile infection to market involves particular challenges. This review covers the current drug discovery pipeline, including both small molecule and biologic therapies, and highlights the challenges associated with in vitro and in vivo models of C. difficile infection for drug screening and lead optimization." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm5016846"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm5016846">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm5016846&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm5016846&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm5016846&amp;href=/doi/10.1021/jm5016846" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 5164-5185</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm5014133" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.5b00918" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title"><i>Clostridium difficile</i> Drug Pipeline: Challenges in Discovery and Development of New Agents</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angie+M.++Jarrad">Angie M. Jarrad</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tomislav++Karoli">Tomislav Karoli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+A.+T.++Blaskovich">Mark A. T. Blaskovich</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dena++Lyras">Dena Lyras</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+A.++Cooper">Matthew A. Cooper</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">The Institute for Molecular Bioscience, University of Queensland, St. Lucia, Queensland 4072, Australia</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">School of Biomedical Sciences, Monash University, Clayton, Victoria 3800, Australia</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#1d70337e72726d786f5d686c33787968337c68"><span class="__cf_email__" data-cfemail="2e43004d41415e4b5c6e5b5f004b4a5b004f5b">[email protected]</span></a>. Telephone: +61 7 3346 2045.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm5016846&amp;href=/doi/10.1021%2Fjm5016846" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 5164–5185</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 11, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>31 October 2014</li><li><span class="item_label"><b>Published</b> online</span>30 March 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 July 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm5016846" title="DOI URL">https://doi.org/10.1021/jm5016846</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by text">with CC-BY<a href="/page/policy/authorchoice_ccby_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm5016846"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">6561</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">50</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm5016846" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Clostridium difficile Drug Pipeline: Challenges in Discovery and Development of New Agents&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Angie&quot;,&quot;last_name&quot;:&quot;M. Jarrad&quot;},{&quot;first_name&quot;:&quot;Tomislav&quot;,&quot;last_name&quot;:&quot;Karoli&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;A. T. Blaskovich&quot;},{&quot;first_name&quot;:&quot;Dena&quot;,&quot;last_name&quot;:&quot;Lyras&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;A. Cooper&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;5164-5185&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm5016846&quot;},&quot;abstract&quot;:&quot;In the past decade Clostridium difficile has become a bacterial pathogen of global significance. Epidemic strains have spread throughout hospitals, while community acquired infections and other sources ensure a constant inoculation of spores into hospitals. In response to the increasing medical burden, a new C. difficile antibiotic, fidaxomicin, was approved in 2011 for the treatment of C. difficile-associated diarrhea. Rudimentary fecal transplants are also being trialed as effective treatments. Despite these advances, therapies that are more effective against C. difficile spores and less damaging to the resident gastrointestinal microbiome and that reduce recurrent disease are still desperately needed. However, bringing a new treatment for C. difficile infection to market involves particular challenges. This review covers the current drug discovery pipeline, including both small molecule and biologic therapies, and highlights the challenges associated with in vitro and in vivo models of C. difficile infecti&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5016846&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5016846" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5016846&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5016846" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5016846&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5016846" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm5016846&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5016846&amp;href=/doi/10.1021/jm5016846" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm5016846" /></input><a href="/doi/pdf/10.1021/jm5016846" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm5016846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm5016846%26sid%3Dliteratum%253Aachs%26pmid%3D25760275%26genre%3Darticle%26aulast%3DJarrad%26date%3D2015%26atitle%3DClostridium%2Bdifficile%2BDrug%2BPipeline%253A%2BChallenges%2Bin%2BDiscovery%2Band%2BDevelopment%2Bof%2BNew%2BAgents%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D13%26spage%3D5164%26epage%3D5185%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291430" title="Infectious diseases">Infectious diseases</a>,</li><li><a href="/action/doSearch?ConceptID=292016" title="Therapeutics">Therapeutics</a>,</li><li><a href="/action/doSearch?ConceptID=291362" title="Antimicrobial agents">Antimicrobial agents</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=291214" title="Bacteria">Bacteria</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jmcmar.2015.58.issue-13/20150709/jmcmar.2015.58.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In the past decade <i>Clostridium difficile</i> has become a bacterial pathogen of global significance. Epidemic strains have spread throughout hospitals, while community acquired infections and other sources ensure a constant inoculation of spores into hospitals. In response to the increasing medical burden, a new <i>C. difficile</i> antibiotic, fidaxomicin, was approved in 2011 for the treatment of <i>C. difficile</i>-associated diarrhea. Rudimentary fecal transplants are also being trialed as effective treatments. Despite these advances, therapies that are more effective against <i>C. difficile</i> spores and less damaging to the resident gastrointestinal microbiome and that reduce recurrent disease are still desperately needed. However, bringing a new treatment for <i>C. difficile</i> infection to market involves particular challenges. This review covers the current drug discovery pipeline, including both small molecule and biologic therapies, and highlights the challenges associated with in vitro and in vivo models of <i>C. difficile</i> infection for drug screening and lead optimization.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35226" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35226" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i2" class="anchor-spacer"></div><h3 class="article-section__title" id="_i2">1.1 Epidemiology</h3><div class="NLM_p"><i>Clostridium difficile</i> is a Gram-positive spore forming anaerobic bacterium that has become a significant problem in health care settings and in the community in recent years. It was recognized as an urgent threat to human health in a 2013 CDC report on antibiotic resistance.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Patients are susceptible to infection when there is a disturbance in the healthy gut microbiome, often due to prior oral antibiotic use, which permits <i>C. difficile</i> to colonize and cause disease in the gastrointestinal tract. <i>C. difficile</i> infection (CDI) severity varies from self-limiting mild diarrhea to severe life-threatening pseudomembranous colitis and toxic megacolon (inflamed colon with abdominal distension). The <i>C. difficile</i> glycosylating toxins, toxin A (TcdA) and toxin B (TcdB), are important virulence factors that promote epithelial tissue damage and inflammation in the infected host, resulting in rapid fluid loss into the intestinal epithelium and diarrhea.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Some strains produce an additional toxin, binary toxin or CDT. CDT is prevalent in strains commonly associated with severe disease, such as BI/NAP1/027 and ribotype 078 isolates, although the role of this toxin in disease remains undefined (review Gerding et al.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a>).</div><div class="NLM_p last"><i>C. difficile</i> spores are an ideal vehicle for transmission between patients because they persist in the environment for long periods and are resistant to heat and typical disinfectants such as alcohol based hand washes.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> Spores are ingested from the environment and germinate in response to bile salts in the small intestine. The resulting vegetative cells colonize the colon and produce toxins that cause disease symptoms.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> An epidemic fluoroquinolone-resistant group of strains, belonging to the BI/NAP1/027 class, is associated with more severe disease and increased death rates<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and has spread rapidly throughout hospitals and community care facilities at a global scale.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7-9)</a> Community acquired <i>C. difficile</i> infection (CA-CDI) rates have also increased with 40% of CA-CDI patients requiring hospitalization, providing a recurrent source of spores in hospitals and making complete eradication of the disease in hospitals a challenging task.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3">1.2 Current Antibiotic Therapies</h3><div class="NLM_p">The first line treatment for <i>C. difficile</i> infection is antibiotics, either metronidazole <b>1</b> for mild to moderate infection or oral vancomycin <b>2</b> for moderate to severe infection (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Both of these drugs are generic and have been on the market for over 40 years.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> Unfortunately in 14–27% of cases they do not effectively treat the infection or prevent relapsing infection.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Rifaximin <b>3</b> is sometimes used as a “chaser therapy”, following initial treatment.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Fidaxomicin <b>4</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) is the first new drug on the market specifically designed to treat <i>C. difficile</i> and has been available since 2011. It offers improvements on relapse rates<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> by reducing collateral damage to the resident gut microbiota because it is more selective for <i>C. difficile</i><a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> over potentially beneficial bacteria, thereby encouraging the suppression of <i>C. difficile</i> colonization and proliferation, as well as purportedly inhibiting spore formation.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Current antibiotic treatments primarily used to treat for <i>C. difficile</i> infection: metronidazole <b>1</b>, vancomycin <b>2</b>, rifaximin <b>3</b> (sometimes used as a chaser therapy), and fidaxomicin <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec1_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i4" class="anchor-spacer"></div><h4 class="article-section__title" id="_i4">1.2.1 Metronidazole</h4><div class="NLM_p last">Metronidazole, a nitroimidazole, is active against a wide spectrum of anaerobic bacteria and parasites. Reduction of the nitro functional group in metronidazole initiates decomposition to toxic radical species. The nitro functional group scavenges electrons from electron carriers, such as reduced ferredoxin, which are at a lower reduction potential than their respective protein homologues in facultative anaerobic bacteria. Reduction forms an unstable nitro radical anion, which in most cases decomposes rapidly to nitrite.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> This reduction consumes the compound and drives further uptake into the cell.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The nitrite and the radical imidazole that form cause damage to bacterial DNA leading to cell death.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> An alternative nitro group reduction pathway via nitroso and hydroxylamine intermediates to the amine is less likely because of the high energy barrier of this process.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Oral metronidazole is essentially 100% bioavailable, with the systemic absorption resulting in reduced concentrations in the colon that approach the minimal inhibition concentration (MIC) in the colon.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The relatively low concentration of compound at the site of infection due to systemic absorption is thought to contribute to reduced efficacy in moderate to severe cases of CDI and toward the development of resistance.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div></div><div id="sec1_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i5" class="anchor-spacer"></div><h4 class="article-section__title" id="_i5">1.2.2 Vancomycin</h4><div class="NLM_p last">Vancomycin, a glycopeptide antibiotic, inhibits cell wall synthesis in Gram-positive bacteria by binding to cell wall building blocks. Specifically, vancomycin binds to the C-terminus of polypeptide intermediates terminating in <span class="smallcaps smallerCapital">d</span>-alanyl <span class="smallcaps smallerCapital">d</span>-alanine (<span class="smallcaps smallerCapital">d</span>-Ala-<span class="smallcaps smallerCapital">d</span>-Ala), particularly the peptidoglycan precursor lipid II.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> This binding blocks transglycosylase enzymes from transferring the pentapeptide of lipid II to a polyglycan chain. Vancomycin can also bind to the pentapeptide on the polyglycan, inhibiting transpeptidases from linking adjacent pentapeptides to create the cross-linked framework of peptidoglycan.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Vancomycin is known to dimerize which increases the affinity to the <span class="smallcaps smallerCapital">d</span>-Ala-<span class="smallcaps smallerCapital">d</span>-Ala terminated pentapeptide.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Vancomycin is given orally and is minimally systemically absorbed, resulting in high concentrations achieved in the colon.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The broad-spectrum activity of vancomycin against Gram-positive bacteria contributes to a reduction in microbiome diversity compared to fidaxomicin treatment.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div></div><div id="sec1_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i6" class="anchor-spacer"></div><h4 class="article-section__title" id="_i6">1.2.3 Rifaximin</h4><div class="NLM_p last">The RNA synthesis inhibitor rifaximin is most commonly used to treat CDI as a chaser antimicrobial therapy after an initial dose of vancomycin. It is nonabsorbable and has minimal systemic effects. It is relatively selective on the gastrointestinal microbiota, although the concentrations of administered compound achieved in the gut are likely to cause inhibition of bacteria other than <i>C. difficile</i>.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a></div></div><div id="sec1_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i7" class="anchor-spacer"></div><h4 class="article-section__title" id="_i7">1.2.4 Fidaxomicin</h4><div class="NLM_p last">The macrolide fidaxomicin inhibits RNA synthesis by RNA polymerase. Unlike the broad-spectrum mechanisms of action of metronidazole and vancomycin, fidaxomicin shows a narrower spectrum of activity selective for <i>C. difficile</i> over other gut microbes.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Fidaxomicin also inhibits spore production,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> with both effects believed to account for reduced relapse rates observed clinically. For example, in comparison to vancomycin, fidaxomicin had 52% fewer second occurrence relapse rates by 28 days after infection in patients with no prior episode of CDI (22.6% of vancomycin treated patients relapsed vs 11.7% of fidaxomicin treated patients).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> A second meta-analysis reported a 40% reduction in persistent diarrhea, recurrence, or death over 40 days.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> These figures demonstrate the improvement in clinical outcomes that can occur with a treatment specifically developed to target <i>C. difficile</i>. Nevertheless, there is still room for further improvement as fidaxomicin fails in 12% of treatments (in contrast to 14–27% treatment failures with vancomycin and metronidazole).<a onclick="showRef(event, 'ref13 ref28'); return false;" href="javascript:void(0);" class="ref ref13 ref28">(13, 28)</a> Fidaxomicin is minimally absorbed, which means systemic side effects are avoided despite its cytotoxicity, which is similar to tamoxifen against breast cancer cell lines.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div></div></div><div id="sec1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">1.3 Drug Resistance</h3><div class="NLM_p last">Metronidazole, vancomycin, and fidaxomicin drug resistance in <i>C. difficile</i> is not widespread at this time. However, resistance has been observed and is of concern given the increased prevalence of <i>C. difficile</i> infections over the past decade and the subsequent requirement for antibiotics now and in the future.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30-32)</a> Metronidazole resistance of >32 μg/mL has been reported, but resistance is unstable and is often lost on passaging or freeze–thawing of bacteria.<a onclick="showRef(event, 'ref30 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref30 ref33 ref34">(30, 33, 34)</a> The MIC values observed of >32 μg/mL are likely outside the therapeutic concentrations achieved in the colon, since the concentration of metronidazole in the feces of patients with CDI has been found to be 0.8–24.2 μg/g of stool.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Reduced susceptibility to vancomycin has been seen, with <i>C. difficile</i> isolates with a MIC of 4 μg/mL reported (compared to sensitive strains with MIC range of ≤0.5–2 μg/mL).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> In clinical trials fidaxomicin resistance up to 16 μg/mL was observed, a significant increase over the normal MIC range of 0.003–1 μg/mL.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The MIC of fidaxomicin increased to 2 μg/mL against <i>C. difficile</i> in a 13-generation forced resistance study.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> For fidaxomicin, like the rifamycin antibiotics, single amino acid substitutions in the protein targets cause high resistance (MIC > 256 μg/mL), rendering the antibiotic ineffective.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The clinical relevance of elevated MICs to vancomycin and fidaxomicin is unclear given the high concentrations (generally >1000 μg/g) achieved in the feces.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> However, considering the relative ease that <i>C. difficile</i> strains have spread globally, any development of resistance is of concern, particularly if no other new drugs are approved for <i>C. difficile</i>. Therefore, continued investment into the development of new antimicrobials is important to mitigate the potential for development and spread of resistance to the current arsenal of antibiotics.</div></div><div id="sec1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">1.4 Alternative Treatments for Severe CDI: Fecal Bacteriotherapy</h3><div class="NLM_p">Fecal bacteriotherapy is used to treat relapsing or severe CDI that is refractory to treatment with antibiotics and acts to restore balance to the gut microbiota in order to suppress <i>C. difficile</i> outgrowth. Typically patients are given antibiotics to reduce the load of actively growing <i>C. difficile</i>, with antibiotic treatment withheld 2–3 days prior to transplant of homogenized donor feces into the colon through a nasogastric intubation, enema, or colonoscope.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> This therapy is psychologically unappealing and also poses risks in terms of infection from the donor and from the irrigation and colonoscopy procedures performed prior to the transplant.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Despite these drawbacks, fecal bacteriotherapy is gaining popularity because of the reported success rate of 92% (systematic review by Gough et al.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a>). In light of the potential benefits, patient acceptance is high with 94% of patients surveyed indicating that they would accept treatment over antibiotics if recommended by a doctor.<a onclick="showRef(event, 'ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44">(42-44)</a></div><div class="NLM_p">Despite evidence of fecal bacteriotherapy being performed since the 4th century during the Dong-Jin dynasty in China,<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45, 46)</a> the first randomized controlled clinical trial for treatment of <i>C. difficile</i> was only reported in 2013.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> This rudimentary treatment is moving toward a refined, standardized practice supported by a hospital based prescreened donor system, with ongoing investigations into frozen fecal preparations and case studies of “designer” synthetic fecal transplants incorporating 33 strains of laboratory cultured bacteria.<a onclick="showRef(event, 'ref41 ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref41 ref47 ref48 ref49">(41, 47-49)</a> A standardized laboratory preparation is considerably more palatable, controllable, safer, and marketable, since strains can be sequenced and antibiotic resistant strains or other pathogenic organisms avoided. However, further research is required to ensure longevity of treatment and that laboratory passage does not reduce strain efficacy.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p last">Medical protocols are reported in the literature,<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51, 52)</a> but do-it-yourself guides<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> and YouTube “how to” videos are directly accessible to patients online. In response to this, in April 2013 the FDA moved to regulate fecal bacteriotherapy as a biological therapy and thus require that physicians file an IND before performing fecal transplant.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> However, acknowledgment that this would potentially deny patients a life-saving cure saw an update on this ruling in July 2013, with fecal transplants to treat CDI permitted on compassionate grounds without an IND under an “enforcement discretion” as long as informed consent is obtained with appropriate acknowledgment of risks of the investigational therapy.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> In March 2014 these guidelines were tightened so that the donor must be known to the physician or the provider and that the donor sample be screened under the direction of the provider.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Fecal bacteriotherapy also faces further regulatory issues, with recent debate over whether the treatment should be classified as an investigational new drug or tissue.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56, 57)</a></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">2 Clinical Development</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13883" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13883" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The clinical pipeline for new <i>C. difficile</i> treatments is characterized by traditional antibiotic molecules and nonantibiotic biological therapeutics (recently reviewed by Tsutsumi<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a>) at various stages of development (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Antibiotics in clinical trials to treat CDI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Clinical Pipeline for <i>C. difficile</i> Treatment Includes Antibiotics and Nonantibiotic Therapies at Each Phase of Development</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">phase</th><th class="colsep0 rowsep0" align="center">developer</th><th class="colsep0 rowsep0" align="center">class</th><th class="colsep0 rowsep0" align="center">ref</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="center"><b>Antibiotic therapies</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CRS3123, <b>5</b></td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">National Institute of Allergy and Infectious Diseases (NIAID)</td><td class="colsep0 rowsep0" align="left">methionyl-tRNA synthetase inhibitor</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">59</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NVB302, <b>6</b></td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">Novacta Biosystems Limited</td><td class="colsep0 rowsep0" align="left">lantibiotic</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">60</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SMT19969, <b>7</b></td><td class="colsep0 rowsep0" align="left">II</td><td class="colsep0 rowsep0" align="left">Summit Corporation Plc./Wellcome Trust</td><td class="colsep0 rowsep0" align="left">bis-benzimidazole</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">63</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LFF571, <b>8</b></td><td class="colsep0 rowsep0" align="left">II</td><td class="colsep0 rowsep0" align="left">Novartis Pharmaceuticals</td><td class="colsep0 rowsep0" align="left">4-aminothiazolyl macrocycle</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">62</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cadazolid, <b>9</b></td><td class="colsep0 rowsep0" align="left">III</td><td class="colsep0 rowsep0" align="left">Actelion</td><td class="colsep0 rowsep0" align="left">quinolonyloxazolidinone</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">64</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ramoplanin, <b>10</b></td><td class="colsep0 rowsep0" align="left">II (previously completed phase III)</td><td class="colsep0 rowsep0" align="left">Nanotherapeutics, Inc.</td><td class="colsep0 rowsep0" align="left">lipoglycodepsipeptide</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">65</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rifaximin, <b>3</b></td><td class="colsep0 rowsep0" align="left">III</td><td class="colsep0 rowsep0" align="left">Salix Pharmaceuticals</td><td class="colsep0 rowsep0" align="left">rifamycin</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">166</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CB-183,315, <b>11</b></td><td class="colsep0 rowsep0" align="left">III</td><td class="colsep0 rowsep0" align="left">Cubist Pharmaceuticals</td><td class="colsep0 rowsep0" align="left">lipopeptide</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref67 ref68">67, 68</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">nitazoxanide, <b>13</b></td><td class="colsep0 rowsep0" align="left">III</td><td class="colsep0 rowsep0" align="left">VA Medical Center, Houston/Baylor College of Medicine</td><td class="colsep0 rowsep0" align="left">nitrothiazolide</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">70</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="center"><b>Nonantibiotic therapies</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IC84</td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">Valneva Austria GmbH</td><td class="colsep0 rowsep0" align="left">vaccine</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">72</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">frozen encapsulated FMT</td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">Massachusetts General Hospital</td><td class="colsep0 rowsep0" align="left">microbiota restoration</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">167</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">frozen FMT</td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">Massachusetts General Hospital</td><td class="colsep0 rowsep0" align="left">microbiota restoration</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">168</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">defined FMT</td><td class="colsep0 rowsep0" align="left">I</td><td class="colsep0 rowsep0" align="left">Baylor College of Medicine/Michael Debakey Veterans Affairs Medical Center</td><td class="colsep0 rowsep0" align="left">microbiota restoration</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">169</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PF-06425090</td><td class="colsep0 rowsep0" align="left">II</td><td class="colsep0 rowsep0" align="left">Pfizer</td><td class="colsep0 rowsep0" align="left">vaccine</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">170</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VP20621</td><td class="colsep0 rowsep0" align="left">II</td><td class="colsep0 rowsep0" align="left">Shire</td><td class="colsep0 rowsep0" align="left">nontoxigenic <i>C. difficile</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">75</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GS-CDA1, MDX-1388</td><td class="colsep0 rowsep0" align="left">II</td><td class="colsep0 rowsep0" align="left">University of Massachusetts, Worcester/Medarex</td><td class="colsep0 rowsep0" align="left">human monoclonal antibodies</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">171</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FMT</td><td class="colsep0 rowsep0" align="left">II</td><td class="colsep0 rowsep0" align="left">NorthShore University HealthSystem</td><td class="colsep0 rowsep0" align="left">microbiota restoration</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">172</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FMT in pediatric patients</td><td class="colsep0 rowsep0" align="left">II</td><td class="colsep0 rowsep0" align="left">MemorialCare Health System</td><td class="colsep0 rowsep0" align="left">microbiota restoration</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">173</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FMT</td><td class="colsep0 rowsep0" align="left">II</td><td class="colsep0 rowsep0" align="left">Colleen Kelly, The Miriam Hospital</td><td class="colsep0 rowsep0" align="left">microbiota restoration</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">174</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FMT by colonoscopy</td><td class="colsep0 rowsep0" align="left">II</td><td class="colsep0 rowsep0" align="left">Catholic University of the Sacred Heart</td><td class="colsep0 rowsep0" align="left">microbiota restoration</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">175</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RBX2660</td><td class="colsep0 rowsep0" align="left">II</td><td class="colsep0 rowsep0" align="left">Rebiotix Inc.</td><td class="colsep0 rowsep0" align="left">microbiota restoration</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">80</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tolevamer (GT267-004)</td><td class="colsep0 rowsep0" align="left">III</td><td class="colsep0 rowsep0" align="left">Genzyme</td><td class="colsep0 rowsep0" align="left">toxin binder</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">73</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MK-3415, MK-6072, and MK-3415A</td><td class="colsep0 rowsep0" align="left">III</td><td class="colsep0 rowsep0" align="left">Merck</td><td class="colsep0 rowsep0" align="left">human monoclonal antibodies</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">74</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ACAM-CDIFF</td><td class="colsep0 rowsep0" align="left">III</td><td class="colsep0 rowsep0" align="left">Sanofi-Pasteur</td><td class="colsep0 rowsep0" align="left">vaccine</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">71</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Bio-K+ CL-1285</td><td class="colsep0 rowsep0" align="left">III</td><td class="colsep0 rowsep0" align="left">Bio-K Plus International Inc.</td><td class="colsep0 rowsep0" align="left">microbiota restoration</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">79</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FMT by capsule versus colonoscopy</td><td class="colsep0 rowsep0" align="left">II/III</td><td class="colsep0 rowsep0" align="left">University of Alberta/University of Calgary</td><td class="colsep0 rowsep0" align="left">microbiota restoration</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">176</a></td></tr></tbody></table></div></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">2.1 Traditional Antibiotics in the Clinical Pipeline</h3><div class="NLM_p last">Several new antibiotics have entered the first stage of human clinical testing, phase I, including <b>5</b> (CRS3123, previously known as REP3123), a methionyl-tRNA synthetase inhibitor being developed by the National Institute of Allergy and Infectious Diseases.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> A type B lantibiotic deoxyactagardine B, <b>6</b> (NVB302), under development by Novacta Biosystems has completed phase I.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Summit Corporation is recruiting for proof of efficacy phase II clinical trials of their bis-benzimidazole <b>7</b> (SMT19969),<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> while Novartis has completed phase II trials of their 4-aminothiazolyl macrocycle <b>8</b> (LFF571).<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62, 63)</a> Acetlion’s cadazolid <b>9</b>, a quinolonyloxazolidinone chimeric antibiotic, is recruiting for pivotal phase III testing.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Ramoplanin <b>10</b>, a lipoglycodepsipeptide antibiotic acquired from Oscient Pharmaceuticals by Nanotherapeutics<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> has completed a phase III trial for CDI and will be conducting a phase IIb study for relapse prevention.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> A lipopeptide analogue of daptomycin, <b>11</b> (CB-183,315) under development by Cubist, is currently recruiting for phase III.<a onclick="showRef(event, 'ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref67 ref68">(67, 68)</a> Two existing drugs are undergoing repurposement trials: the glycycline antibiotic tigecycline <b>12</b> (phase unknown)<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> and nitazoxanide <b>13</b> (phase II),<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> a drug currently used to treat protozoan infections.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">2.2 Nonantibiotic Therapies in the Clinical Pipeline</h3><div class="NLM_p">In addition to new antibiotic drug candidates for treatment of <i>C. difficile</i> infection, there are numerous biotherapeutic approaches at each phase of the clinical pipeline. Unlike antibiotic-based therapies, several of these approaches target the <i>C. difficile</i> major toxins, TcdA and TcdB, and include active and passive vaccine treatments to boost the immune response. A Sanofi-Pasteur ACAM-CDIFF TcdA- and TcdB-toxoid vaccine in phase III is the most advanced in the clinical pipeline.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Pfizer and Intercell (IC84) both have vaccine candidates in phase I, both utilizing recombinant toxin-based approaches.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Another treatment approach tested the ability of polymers to bind the disease-causing toxins secreted during <i>C. difficile</i> vegetative growth, thereby reducing inflammation and severe disease symptoms. Unfortunately, the polymer tolevamer failed to meet efficacy end points in phase III trials and was inferior to metronidazole and vancomycin antibiotic treatment.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Merck’s human monoclonal antibodies (MK-3415, MK-6072, and MK-3415A), for use in a passive immunotherapeutic approach by inactivating the toxins, are in phase III trials.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></div><div class="NLM_p">CDI is considered a secondary infection resulting from an initial disruption in the healthy microbial gut microbiota, often caused by antibiotic use. Therefore, another therapeutic approach aims to correct or prevent dysbiosis by manipulating the microbial niche. Treatment with nontoxigenic <i>C. difficile</i> strains, which aims to outcompete toxigenic strains and prevent their colonization, is in phase II trials, by ViroPharma (acquired by Shire in 2013).<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> However, the <i>C. difficile</i> toxin-encoding PaLoc region from a toxigenic strain was recently shown to be mobilized to nontoxigenic isolates, supporting the hypothesis that nontoxigenic strains can become toxigenic through horizontal gene transfer events.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> This raises concerns that the use of live nontoxigenic strains in therapeutic approaches is risky, especially since a number of placebo patients were also found to be infected with nontoxigenic <i>C. difficile</i> strains during the clinical trials, apparently because of spore contamination of communal living areas.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> There are also ethical considerations surrounding the use of this approach, since carriers may transmit the strain to nonconsenting individuals. An alternative approach in the future could be the use of <i>Clostridium scindens</i>, since it has recently been shown to promote resistance to <i>C. difficile</i> infection in mouse CDI models in a manner associated with increased production of <i>C. difficile</i>-inhibiting secondary bile metabolites.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></div><div class="NLM_p">Another option under consideration is the use of probiotic therapies to prevent CDI. Bio-K+ CL-1285 is an encapsulated probiotic propriety mixture of <i>Lactobacillus acidophilus</i> and <i>Lactobacillus casei</i> that has completed phase III clinical trials for prevention of antibiotic-associated diarrhea, including CDI.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Patients at high-risk of developing CDI (50–70 years age, receiving penicillin, cephalosporin, or clindamycin antibiotic therapy), administered two capsules of Bio-K+ CL-1285 daily, were significantly less likely to develop CDI (23.8% placebo vs 1.2% twice daily capsule treatment, <i>P</i> = 0.002), suggesting that this approach may be efficacious.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a></div><div class="NLM_p">As discussed earlier, microbiota transplantation also aims to restore an imbalanced microbiota using a holistic strategy. Fecal transplant therapies or artificial microbial preparations containing a diverse microbial ecosystem are used in this approach. Clinical trials are currently evaluating issues such as whether frozen and thawed or encapsulated preparations are as effective as the fresh, unprocessed material, since many bacteria, particularly anaerobes, would not survive the treatment and storage phase, perhaps reducing product efficacy compared with the starting material. The aim is to make this therapy easier to distribute, as set donations can be processed, tested for pathogens, prepared ahead of time, and made more palatable by encapsulation of the transplant. A recent 2014 study indicates that frozen capsules are indeed a viable form of administration.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Rebiotix have focused on developing an off the shelf product for transplant that is consistent and easy to administer. Their product, RBX2660, is a microbial suspension, which has completed enrollment in phase II, and Rebiotix is in discussions with the FDA on design of the phase III trial.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Monarch Labs in collaboration with BioTherapeutics, Education and Research Foundation is also seeking to develop a fecal transplant therapy, Medical Microbiota, which is a prescreened, cGMP processed product for transplantation. They are also developing a cGMP processing and banking service for autologous transplantation.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></div><div class="NLM_p last">An important factor that may influence the efficacy of microbiota-restoration strategies is the treatment of patients with broad-acting antibiotics such as vancomycin to control CDI, although antibiotics are generally halted shortly prior to administration of microbiota therapy.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Antibiotic therapy reduces the load of vegetative <i>C. difficile</i> cells in the host prior to infusion of the microbial suspension, which may contribute to the subsequent success of microbiota restoration strategies. However, the necessity of this antibiotic therapy prior to the application of microbial restoration therapies is not known.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> It is clear that the need for antibiotics for the treatment of CDI will continue and that their adjunct use in microbial restoration therapies may be highly beneficial. For this reason, there is a continued market for investment into the development of new antimicrobials against CDI, which will be the focus of the remainder of this review.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">3 Early Drug Discovery Research and Preclinical Development Pipeline</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41300" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41300" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have undertaken a chemoinformatic approach to understand the historical and recently explored chemical space for compounds with antimicrobial activity against <i>C. difficile</i> at the preclinical stages of drug research and discovery. Compounds with reported antimicrobial activity against <i>C. difficile</i> were abstracted from the ChEMBL<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> database. The data were then separated into either known, marketed antibiotics or compounds at the early discovery research phase and preclinical stages of development. The compounds in the early preclinical drug discovery phase were clustered using Pipeline Pilot into antimicrobial classes (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, methods in <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). Analysis of the data from ChEMBL showed that the results only contained compounds published in four scientific journals over selected years: <i>Antimicrobial Agents and Chemotherapy</i> (2007–2010), <i>Bioorganic Medicinal Chemistry</i> (one article from 2008), <i>Bioorganic Medicinal Chemistry Letters</i> (1998–2012), and <i>Journal of Medicinal Chemistry</i> (1984–2009). Therefore, the search was widened to include all bioactivities against <i>C. difficile</i> catalogued in the Reaxys Medicinal Chemistry Public Beta as well as manual searches of the literature.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compounds in early and preclinical drug discovery phase with antimicrobial activity against <i>C. difficile</i> in the scientific literature from the analysis of compounds with antimicrobial activity against <i>C. difficile</i> curated by ChEMBL. Antibiotics on the market and agents in clinical trials were excluded from analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The majority of studies are 10–20 years old and predate the <i>C. difficile</i> crisis of the past decade. However, the more recent studies that include <i>C. difficile</i> as a greater focus demonstrate the renewed drug discovery efforts for this pathogen. Notably, few of the older studies are focused on medicinal chemistry efforts to specifically optimize compounds for activity against <i>C. difficile</i>. However, the tiacumicin family of antibiotics, including fidaxomicin, was initially discovered in 1975 but the development of this class remained largely unexplored until the late 1990s when Optimer Pharmaceuticals initiated the commercial development of fidaxomicin for CDI.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Therefore, examining the past can offer direction for future investigations, especially since most of the older research was not conducted in the context of the requirements for a <i>C. difficile</i>-specific antibiotic.</div><div class="NLM_p">The majority of the reports describe investigations of traditional antibiotic chemotypes with screening against <i>C. difficile</i> performed in parallel to testing against other bacterial pathogens that form the focus of these studies. These studies are summarized in <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information Table 1">Supporting Information Table 1</a>. Of note is the importance of testing drug candidates against a number of strains, since there is a wide range of MIC results for some drug candidates. The MIC<sub>50</sub> and MIC<sub>90</sub> values are important to the interpretation of the MIC ranges obtained from testing against multiple strains and thus determining the efficacy against a population of strains. The discussion here focuses on studies where a number of analogs were synthesized and on studies of unique chemotypes tested against <i>C. difficile</i>.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">3.1 Nitroheterocycles</h3><div class="NLM_p">Ballard et al. have explored analogs of the nitrothiazole drug, nitazoxanide <b>13</b>, for activity against <i>C. difficile</i> as part of a broader study for compounds with activity against <i>Helicobacter pylori</i> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A).<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Variations to the thiophene and thiazole “head” groups <b>14</b>–<b>16</b> and amide “tail” <b>a</b>–<b>e</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A)<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> were found to influence activity with MICs varying from 0.4 to >28 μM. The headgroup <b>15</b> found in nitazoxanide was generally favored, with <b>15c</b> and <b>15d</b> the most potent against <i>C. difficile</i> (MICs of 0.4 and 1 μM, respectively). A follow-up study explored tail group <b>f</b>–<b>l</b> and headgroup <b>15</b> to give MICs ranging from 0.8 to 5.9 μM (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A).<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Four furylthiazoles (no nitro group) <b>17</b>–<b>22</b> and two phenylthiazoles <b>21</b>–<b>22</b> also developed for <i>H. pylori</i> by Fujisawa Pharmaceutical Co. were tested for activity against <i>C. difficile</i> but were not active at 100 μg/mL (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B).<a onclick="showRef(event, 'ref85 ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref85 ref86 ref87">(85-87)</a> In contrast, two of five thiazolides, <b>23</b> and <b>24</b>, only those with a nitrothiazole ring similar to nitazoxanide, displayed potent activity (0.06–0.5 and 0.06–0.25 μg/mL, respectively) against 10 strains of <i>C. difficile</i>.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> The three inactive compounds <b>25</b>–<b>27</b> (MIC > 32 μg/mL) either contained no nitro group (denitrotizoxanide) <b>25</b> or a bromine in place of the nitro group (<b>26</b> and <b>28</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C).<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Nitroheterocycles: (A) analogs of nitazoxanide <b>14</b>–<b>16</b>;<a onclick="showRef(event, 'ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref83 ref84">(83, 84)</a> (B) furanyl thiazoles <b>17</b>–<b>20</b> and phenylthiazoles <b>21</b> and <b>22</b> (inactive against <i>C. difficile</i>, MIC > 100 μg/mL);<a onclick="showRef(event, 'ref85 ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref85 ref86 ref87">(85-87)</a> (C) thiazolides with a nitrothiazole ring, similar to nitazoxanide;<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> (D) nitrofuranylsemicarbazone <b>28</b>;<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> (E) the six 5-nitroimidazole scaffolds <b>29</b>–<b>34</b> in the library of metronidazole triazole conjugates (crude, >85% purity);<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> (F) quinoxalines <b>35</b>–<b>36</b>.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A series of nitrofuranylsemicarbazones were investigated for MIC activity against <i>C. difficile</i>, <i>Staphylococcus epidermis</i>, <i>Staphylococcus aureus</i>, methicillin resistant <i>S. aureus</i>, and <i>Propionibacterium acnes</i> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>D).<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Only compound <b>28</b> had reasonable activity against four strains of <i>C. difficile</i>, in the range of 0.25–8 μg/mL, with the other 11 compounds in the range of 32 to >256 μg/mL. While the mechanism of action of nitrofuryls is typically attributed to toxicity caused by reduction of the nitro group,<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> the role of this mechanism in this case is unclear as several matched pairs with R<sub>2</sub> = H or NO<sub>2</sub> did not show large differences in activity. The R<sub>1</sub> groups (methyl, isopropyl, and <i>tert</i>-butyl) are likely too far from the nitrofuranyl to affect the reduction process electronically, so they should not cause changes in activity based on a reduction mechanism. Additionally the active compound shows similar activity against the other bacteria assayed, presumably under aerobic conditions, further supporting an alternative mechanism of action for this compound.</div><div class="NLM_p">The chemical space for nitroheterocyclic compounds with a reduction-based mode of action similar to metronidazole remained relatively unexplored for <i>C. difficile</i> until a series of metronidazole triazole conjugates was published in 2013 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>E).<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> This group synthesized six 5-nitroimidazole azido cores and reacted each core with a library of 63 structurally diverse alkynes to make 378 5-nitroimidazole triazole conjugates <b>29</b>–<b>34</b>.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> These compounds were tested as crude mixtures (purity of >85% by LCMS) against <i>C. difficile</i>, <i>H. pylori</i>, <i>Trichomonas vaginalis</i>, <i>Giardia lamblia</i>, and <i>Bacteroides fragilis</i>. A second follow-on series of 47 different alkynes reacted with the six cores gave a further 281 compounds, but these were not tested against <i>C. difficile</i>.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Interestingly, a high proportion of the compounds in the initial series were active against metronidazole resistant <i>G. lamblia</i> (100% of compounds tested) and <i>T. vaginalis</i> (47% of compounds tested) parasite strains. However, the compounds generally lost activity against the microaerophilic bacterium <i>H. pylori</i> containing mutations in both the <i>frxA</i> and <i>rdxA</i> genes that encode reductases involved in the clinical resistance to metronidazole (only 1.4% of compounds active).<a onclick="showRef(event, 'ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref90 ref91">(90, 91)</a> This suggests that some metronidazole triazole conjugates may be active against metronidazole resistant <i>C. difficile</i>. However, the effectiveness of these compounds at inhibiting spore formation, germination, and spore outgrowth is not currently known.</div><div class="NLM_p last">The quinoxalines <b>35</b> (SC44914) and <b>36</b> (SC-44942-A) have a similar spectrum of action as metronidazole, with the mode of action postulated to be similar because of similar reduction potentials (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>F).<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Both quinoxalines were potent against <i>C. difficile</i> with MICs against 20 isolates of ≤0.06 μg/mL for <b>35</b> and ≤0.06 to 0.5 μg/mL for <b>36</b> (the metronidazole control was ≤0.06 to 2 μg/mL).<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">3.2 Glycopeptides</h3><div class="NLM_p">Zhang et al.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> made a series of desmethyl vancomycin analogs <b>37</b>–<b>53</b> inspired by telavancin and oritavancin, glycopeptides approved for treatment of complicated skin infections (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). This series of compounds contained desmethyl vancomycin in which the methyl group on the amino group of the <i>N</i>-terminal residue of vancomycin was absent. Various hydrophobic groups were appended via the amine on the vancosamine sugar (R<sub>1</sub> of Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), in a fashion similar to the hydrophobic chains on oritavancin and telavancin. When tested for potency against <i>Enterococcus faecium</i> and <i>C. difficile,</i> the compounds were generally within one dilution of the MICs for the controls (vancomycin and desmethyl vancomycin) for four strains of <i>C. difficile</i>, indicating that variations at these positions do not play a key role in determining activity for <i>C. difficile</i>. This was in contrast to variation observed in the structure–activity relationships for <i>E. faecium.</i></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Desmethyl vancomycin derivatives <b>37</b>–<b>53</b> with lipophilic variations at R<sub>1</sub> on the vancosamine sugar.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">3.3 Macrolides</h3><div class="NLM_p">Kirst et al. reported on macrolide antibiotics related to tylosin natural products and synthetically modified derivatives from Eli Lilly Research Laboratories (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> The compounds were tested against a wide range of aerobic and anaerobic bacteria. Fifteen of these compounds <b>54</b>–<b>68</b> were tested for activity against <i>C. difficile</i>.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Six compounds of the desmyocosin scaffold <b>58</b>–<b>64</b> showed a MIC of ≤0.5 μg/mL compared with the desmycosin <b>57</b> MIC of 0.25 μg/mL. These compounds were also active against a range of anaerobic bacterial strains including <i>B. fragilis</i>, <i>Fusobacterium symbiosum</i>, <i>Peptococcus prevoti</i>, and <i>Peptostreptococcus anaerobius</i>, as well as aerobic bacterial strains including <i>S. aureus</i> and <i>Streptococcus</i> group B, C, and D strains. Three tylosin derived macrocycles also showed good activity at ≤0.5 μg/mL compared to 1 μg/mL for tylosin <b>54</b>.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Tylosin derived macrolides <b>54</b>–<b>69</b>.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The 23-demycinosyltylosin (DMT) derivative <b>68</b> also showed good activity against <i>C. difficile</i> (1 μg/mL) with the 5-<i>O</i>-myc-aminosyltylonolide (OMT) <b>65</b> and OMT derivatives <b>66</b> and <b>67</b> showing weaker activity at 2–4 μg/mL (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> The majority of these compounds were tested using in vivo models, against either <i>Streptococcus pyogenes</i> or <i>S. aureus</i>. The goal of this study was to improve the oral availability of these compounds by chemical modifications. The compounds were dosed subcutaneously and orally. Several compounds lost activity when dosed orally compared to subcutaneous dosing. Peripheral plasma compound levels measured in mice and rats supported the varied oral bioavailability. This study is an example where drug candidates that failed in the past because of properties such as poor oral availability may now be useful in the treatment of <i>C. difficile</i>, where compounds with poor oral availability are desirable for <i>C. difficile</i> treatment because a high concentration of compound remains at the site of infection, with low systemic exposure.</div><div class="NLM_p last">A more recently developed tylosin macrolide <b>69</b> (YM133) exhibited potent activity against 21 <i>C. difficile</i> strains with MICs ranging from ≤0.05 to 0.39 μg/mL (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Compound <b>69</b> was also active against macrolide-resistant <i>S. aureus</i> but was less active against strains with 14- and 16-membered macrolide resistance compared to 14-membered macrolide resistant or erythromycin resistant strains.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18">3.4 Fluoroquinolones</h3><div class="NLM_p">A large number of fluoroquinolones <b>70a</b>–<b>m</b>, <b>71a</b>–<b>f</b>, <b>72a</b>–<b>g</b>, and <b>73a</b>–<b>c</b> were synthesized and investigated for antibacterial activity by Sanchez et al. from Parke-Davis as a division of Warner-Lambert Pharmaceuticals (now acquired by Pfizer) (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> As a part of this study, 27 compounds were tested against several anaerobic bacteria including <i>C. difficile</i>. The compounds ranged in activity from 0.2 to 12.5 μg/mL, with the most potent series <b>70a</b>–<b>m</b> containing R<sub>1</sub> = H, R<sub>2</sub> = OMe, and R<sub>3</sub> = variety of piperazine, pyrrolidine, and piperidine groups (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> While <i>C. difficile</i> potency was good, the compounds possessed poor specificity, with broad spectrum activity against Gram-negative and Gram-positive facultative anaerobic bacteria and obligately anaerobic bacteria.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Fluoroquinolones <b>70</b>–<b>73</b>.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">3.5 Tetramic and Tetronic Acids</h3><div class="NLM_p">Tetramic acids have been shown to have activity against <i>C. difficile</i> (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). Aromatic dienoyltetramic acids <b>74</b>–<b>77</b> formed the basis of a study by Rosen et al. of Abbott Laboratories.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> The compounds’ activity ranged from 125 to ≤0.5 μg/mL. The derivatives active at ≤0.5 μg/mL generally contained a longer C<sub>10</sub>H<sub>7</sub> lipophilic tail. More recently, Ueda et al. examined tetramic acids, derived from bacterial autoinducers, for their bactericidal activity against <i>C. difficile</i>.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Compound <b>78</b> at 10 μM (2.5 μg/mL) reduced <i>C. difficile</i> numbers to the limit of detection of 2 log CFU/mL after overnight incubation.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> The other tetramic acids tested <b>79</b>–<b>82</b> with lower activity (13–15 μg/mL) showed that the keto–enol form with the free hydroxyl group and a longer acyl side chain is important to maintain activity against <i>C. difficile</i>, since tetramic acids lacking these features were inactive at 100 μM (21–31 μg/mL).<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> The tetramic acids, tirandalydigin <b>83</b> (MIC = 32 μg/mL), streptolydigin <b>84</b> (8 μg/mL), and tirandamycin <b>85</b> (16 μg/mL), were weakly active against one strain of <i>C. difficile</i>.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> The agglomerins A, B, C, and D <b>86</b>–<b>89</b>, tetronic acids structurally related to tetramic acids, were reported by Shoji et al. at Shionogi & Co. with activity against <i>C. difficile</i> from 0.78 to 3.13 μg/mL.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> The structures were solved in 1990 by Terui et al.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A–C) Tetramic acids <b>74</b>–<b>85</b> investigated for activity against <i>C. difficile</i><a onclick="showRef(event, 'ref87 ref97 ref98'); return false;" href="javascript:void(0);" class="ref ref87 ref97 ref98">(87, 97, 98)</a> and (D) structurally related tetronic acids <b>86</b>–<b>89</b>.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">3.6 Bis-Indoles</h3><div class="NLM_p">The bis-indoles <b>90</b> (MBX 1066) and analogue <b>91</b> (MBX 1162) (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>) investigated by Microbiotix Inc. have broad spectrum activity against Gram-positive and Gram-negative aerobic and anaerobic bacteria including 18 isolates of <i>C. difficile</i> (MIC<sub>90</sub> for both compounds was 0.12 μg/mL).<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> The compounds inhibit DNA synthesis and are proposed to bind in the minor groove of the DNA duplex because of their similarity to DNA binding agents.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> The bisindole structure is important for activity against <i>C. difficile</i> since a 2-phenyl-1<i>H</i>-indole <b>92</b> tested against three <i>C. difficile</i> strains was inactive at the highest concentration tested (100 μg/mL).<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Bis-indoles <b>90</b> and <b>91</b> with potent activity against <i>C. difficile</i> compared to the 2-phenyl-1<i>H</i>-indole <b>92</b> not active at 100 μg/mL.<a onclick="showRef(event, 'ref102 ref104'); return false;" href="javascript:void(0);" class="ref ref102 ref104">(102, 104)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">3.7 Hybrids</h3><div class="NLM_p">Hybrid-like 1-carba-3-thiathiazole cephalosporins were investigated by Eli Lilly for their activity against anaerobic bacteria (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>A).<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Five compounds <b>93</b>–<b>97</b> were reported with thiazoles at the 3-thia positions and either a methyloxime <b>94</b>–<b>97</b> or fluoroethyloxime <b>93</b> side chain.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> The compound derivatives with a nitrothiazole and a methyloxime <b>94</b> or fluoroethyloxime side chain <b>93</b> exhibited broad spectrum activity against the panel of anaerobes tested which was generally equivalent to or better than cefoxitin and cefotetan controls. They were active at 2 and 4 μg/mL against <i>C. difficile</i> (cefoxitin, 32 μg/mL; cefotetan, 16 and 32 μg/mL). Thiazole ring substitutions <b>95</b>–<b>97</b> were tolerated, and the compounds had similar activity against the aerobic organisms: <i>S. aureus</i>, <i>S. epidermis</i>, <i>Streptococcus pneumoniae</i>, <i>Haemophilus influenza</i>, <i>Escherichia coli</i>, and <i>Enterobacter aerogenes</i>.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (A) Hybrid 1-carba-3-thiathiazole cephalosporins<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a><b>93</b>–<b>97</b> and (B) hybrid penem and carbapenems linked to quinolones <b>98</b>–<b>101</b>.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Attempts were made to replace the nitro group on the thiazole because of observed mutagenicity. Methyl sulfoxide <b>95</b>, nitrile <b>96</b>, or trifluoromethyl <b>97</b> groups increased the activity against <i>C. difficile</i> (MICs of 0.06–0.125 μg/mL). However, loss of the nitro-substituted thiazole resulted in loss of activity against <i>Bacteroides</i> spp. and <i>F. symbiosum</i>, which the researchers deemed as a negative feature in their search for a broad-spectrum agent. Given that <i>C. difficile</i> infection is exacerbated by damage to the gut microbiota, selective agents are now considered desirable. This illustrates the potential value of re-examining drug candidates abandoned in the past because of their lack of broad-spectrum action, as this selectivity is now considered an advantage.</div><div class="NLM_p last">Another example of hybrid compounds is the Hoffmann-La Roche study by Corraz et al. into penems and carbapenems linked at the 2′ position to quinolones (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>B).<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Four hybrid compounds <b>98</b>–<b>101</b> were tested against either one or in some instances two strains of <i>C. difficile</i>. The hybrid compounds showed superior MIC activity (0.5–8 μg/mL) against <i>C. difficile</i> when compared to the single antibiotic counterparts (fleroxacin, ciprofloxacin, or imipenem, 4–16 μg/mL). However, in general the hybrid compounds had superior MICs against a broad range of other Gram-negative and Gram-positive bacteria, indicating that these are not good leads to pursue for new selective agents against <i>C. difficile</i>.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22">3.8 Other DNA Topoisomerase and Gyrase Inhibitors</h3><div class="NLM_p">Both synthetic inhibitors and natural products that target topoisomerase II, inhibiting DNA synthesis, have been reported (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>). Dual acting inhibitors of bacterial DNA gyrase and topoisomerase IV, based on an aminobenzimidazole urea core, have been extensively explored by Vertex Pharma as new leads against a range of Gram-positive pathogens (staphylococci, streptococci, and enterococci) and the respiratory Gram-negative pathogen <i>H. influenzae</i>.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Two lead compounds, <b>102</b> (VRT-125853) and <b>103</b> (VRT-752586), showed relatively low frequencies of spontaneous resistance.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Compound <b>103</b> was active in <i>S. aureus</i> and <i>S. pneumoniae</i> animal infection models.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> When tested for in vitro activity against <i>C. difficile</i>, <b>102</b> displayed a range of potencies against 11 strains of <i>C. difficile</i> (1–16 μg/mL), while <b>103</b> was found to be even more potent (0.06–4 μg/mL).<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Further development of the aminobenzimidazole urea compound class by Vertex has alleviated deficiencies identified for <b>103</b> such as CYP3A4 inhibition, reactive metabolite formation, short half-life, and poor physicochemical properties, and <b>104</b> has been selected as a preclinical candidate.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> However, the activities of <b>104</b> and other analogs against <i>C. difficile</i> have not been reported. The Vertex library of aminobenzimidazoles (>330 compounds)<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> prepared could be reinvestigated to potentially identify alternative lead compounds with potent, more selective activity against <i>C. difficile</i> and poor oral availability.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Aminobenzimidazole urea inhibitors of bacterial DNA gyrase and topoisomerase IV <b>102</b>–<b>104</b>,<a onclick="showRef(event, 'ref107 ref109'); return false;" href="javascript:void(0);" class="ref ref107 ref109">(107, 109)</a> topoisomerase II ATPase inhibitor kibdelomycin <b>107</b>,<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> and benzothiazole ethyl urea inhibitors of DNA gyrase GyrB and topoisomerase IV ParE ATPase <b>105</b> and <b>106</b>.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Dual action benzothiazole ethyl urea based compounds have been explored by Biota, inhibiting the DNA gyrase GyrB and topoisomerase IV ParE ATPase.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Two compounds, <b>105</b> and <b>106</b>, inhibited <i>C. difficile</i> 630 (ATCC 9689) at 0.03 and 0.015 μg/mL, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>).<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Kibdelomycin, <b>107</b>, is a natural product with broad-spectrum antimicrobial activity by inhibiting topoisomerase II ATPase. A 2014 study by Miesel et al. from Merck Research Laboratories examined <b>107</b> for in vitro activity against a panel of 168 <i>C. difficile</i> clinical isolates (MIC<sub>90</sub> = 0.25 μg/mL) and other commensal anaerobic organisms.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> The compound was not orally absorbed and exhibited in vivo efficacy in a hamster model of infection using the toxigenic B1 <i>C. difficile</i> strain SM8-6865 (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>).<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a></div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23">3.9 Peptidic Antimicrobials</h3><div class="NLM_p">Pexiganan <b>108</b> (Cytolex, MSI-78, Locilex) (structure in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) is a 22-amino-acid antimicrobial peptide with broad-spectrum antimicrobial activity that has recently entered phase III clinical trials under a special protocol assessment as a topically applied treatment of mild infections of diabetic foot ulcers.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> During development this compound was evaluated for activity against <i>C. difficile</i> and was active against four strains of <i>C. difficile</i> from 0.5 to 4 μg/mL<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> and again at 4 μg/mL against one other strain of <i>C. difficile</i>.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> A range of 16 cecropin–melittin hybrid peptides (CAMEL analogs) <b>109</b>–<b>124</b> were also tested against anaerobic bacteria including 10 <i>C. difficile</i> strains and were active between 1 and 4 μg/mL (structures in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> However, peptidic antibiotics such as pexiganan <b>108</b> and the cecropin–melittin hybrid peptides <b>109</b>–<b>124</b> are unlikely to survive passage through the gastrointestinal tract.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Pexiganan and Cecropin-Melittin Hybrid Peptides<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> with Antimicrobial Activity against <i>C. difficile</i></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">peptide</th><th class="colsep0 rowsep0" align="center">amino acid sequence<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pexiganan, <b>108</b></td><td class="colsep0 rowsep0" align="left">GIGKFLKKAKKFGKAFVKILKK-NH<sub>2</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CAMEL0, <b>109</b></td><td class="colsep0 rowsep0" align="left">KWKLFKKIGAVLKVL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CAMEL9, <b>110</b></td><td class="colsep0 rowsep0" align="left">KW<i><b>R</b></i>LFK<i><b>N</b></i>IGAVLKVL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CAMEL24, <b>111</b></td><td class="colsep0 rowsep0" align="left">KWKLFK<i><b>H</b></i>IGAVLKVL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CAMEL42, <b>112</b></td><td class="colsep0 rowsep0" align="left"><i><b>H</b></i>WKLFKKIGAVLKVL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CAMEL46, <b>113</b></td><td class="colsep0 rowsep0" align="left">KWKLFK<i><b>G</b></i>I<i><b>R</b></i>AVLKVL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CAMEL48, <b>114</b></td><td class="colsep0 rowsep0" align="left">KWKL<i><b>G</b></i>KKI<i><b>L</b></i>AVLKVL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CAMEL48D, <b>115</b></td><td class="colsep0 rowsep0" align="left">KWKL<i><b>G</b></i>KKI<i><b>L</b></i>AVLKVL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CAMEL101, <b>116</b></td><td class="colsep0 rowsep0" align="left">KWKL<i><b>G</b></i>KKI<i><b>LR</b></i>VLKVL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CAMEL102, <b>117</b></td><td class="colsep0 rowsep0" align="left"><i><b>G</b></i>WKL<i><b>G</b></i>KKI<i><b>LR</b></i>VLKVL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CAMEL108, <b>118</b></td><td class="colsep0 rowsep0" align="left">KWKL<i><b>G</b></i>KKI<i><b>LN</b></i>VLKVL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CAMEL109, <b>119</b></td><td class="colsep0 rowsep0" align="left"><i><b>G</b></i>W<i><b>R</b></i>L<i><b>G</b></i>KKI<i><b>LR</b></i>VLKVL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CAMEL110, <b>120</b></td><td class="colsep0 rowsep0" align="left"><i><b>G</b></i>WKL<i><b>G</b></i>KKI<i><b>LN</b></i>VLKVL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CAMEL123, <b>121</b></td><td class="colsep0 rowsep0" align="left"><i><b>L</b></i>WKLFKKI<i><b>RR</b></i>VL<i><b>R</b></i>VL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CAMEL129, <b>122</b></td><td class="colsep0 rowsep0" align="left"><i><b>L</b></i>WKLFKKI<i><b>NR</b></i>VLKVL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CAMEL135, <b>123</b></td><td class="colsep0 rowsep0" align="left"><i><b>G</b></i>WRL<i><b>I</b></i>KKI<i><b>LR</b></i>V<i><b>F</b></i>K<i><b>GL</b></i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CAMEL136, <b>124</b></td><td class="colsep0 rowsep0" align="left"><i><b>V</b></i>W<i><b>R</b></i>L<i><b>I</b></i>KKI<i><b>LR</b></i>V<i><b>F</b></i>K<i><b>G</b></i>L</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Adapted from Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> from OH et al.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a></p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Bold italicized letters in cecropin–melittin hybrid peptides indicate sites of mutation compared with the CAMEL0 sequence.</p></div></div></div><div class="NLM_p">Recently, synthetic nylon-3 polymers (poly-β-peptides) <b>125</b>–<b>127</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>) designed to mimic host-defense peptides were shown to inhibit <i>C. difficile</i> growth (MICs of 12.5–25 μg/mL) and importantly also blocked spore outgrowth in two strains of <i>C. difficile</i> (MIC of spore outgrowth of 3.13–12.5 μg/mL).<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> Compared to host-defense peptides, synthetic polymer mimics also offer potential advantages for the relative ease of synthesis and stability to proteolytic degradation.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Nylon-3 polymers <b>125</b>–<b>127</b>.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25">3.10 Natural Products</h3><div class="NLM_p">Natural products have a history of use as antibiotics and treatment for <i>C. difficile</i> is no exception, with metronidazole, vancomycin, and fidaxomicin all having origins as natural products. A number of more recent, novel natural products investigated for antimicrobial activity against <i>C. difficile</i> are described in this subsection.</div><div class="NLM_p">Ziracin <b>128</b> (SCH27899), an oligosaccharide antibiotic derivative of everninomicin, had potent activity against 27 strains of <i>C. difficile</i> with MICs ranging from 0.05 to 0.2 μg/mL (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>).<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> The MIC<sub>50</sub> was 0.1 μg/mL, and MIC<sub>90</sub> was 0.2 μg/mL.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Compound <b>128</b> was subsequently tested for activity against a further 25 <i>C. difficile</i> strains, with the MIC ranging from 0.06 to 0.125 μg/mL.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> Although <b>128</b> was in development as an iv antibiotic for Gram-positive infections, Schering-Plough suspended development because of failure of efficacy versus safety end points. The two ortho ester linkages in <b>128</b> are unlikely to be stable under the acidic conditions of the stomach. Therefore, <b>128</b> in itself is not a good lead for oral treatment of CDI without additional measures such as enteric coated capsules.</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Structures of ziracin <b>128</b>,<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> hydramycin <b>129</b>,<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> clerocidin <b>130</b>,<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> echinosporamicin-type antibiotics <b>131</b> and <b>132</b>,<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> merochlorin A <b>133</b>,<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> and olympicin A <b>134</b>,<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> and analogs <b>135</b>–<b>138</b><a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> with activity against <i>C. difficile</i>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Hydramycin <b>129</b>, a pyranoanthraquinone isolated from <i>Streptomyces violaceus</i>, was shown to have antibiotic and antitumor properties by Bristol Myers Squibb (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>).<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> The activity against one strain of <i>C. difficile</i> was 0.4 μg/mL. The cytotoxicity of this antibiotic limits the likelihood of further development, although fidaxomicin also exhibits cytotoxicity.</div><div class="NLM_p">The natural product clerocidin <b>130</b>, a terpenoid antibiotic, displayed potent activity against one <i>C. difficile</i> strain with MIC = 0.2 μg/mL.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> Compound <b>130</b> was initially thought to be a DNA gyrase inhibitor,<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> but it has since been shown to act as a DNA alkylating agent that targets single stranded DNA.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> This mechanism of action limits further use of <b>130</b> as an antimicrobial agent.</div><div class="NLM_p">Two polycyclic antibiotics consisting of a backbone of six fused rings, <b>131</b> (TLN-05220) and <b>132</b> (TLN-05223), were isolated from <i>Micromonospora echinospora</i> ssp. <i>challisensis</i> (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>).<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> The echinosporamicin-type antibiotics were potent against various tumor cell lines (IC<sub>50</sub> of <0.1 to 9.7 μM depending on the cell line), although <b>131</b> failed to show efficacy in an in vivo mouse human prostate tumor model.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Both <b>131</b> and <b>132</b> were active against Gram-positive bacteria <i>C. difficile</i>, <i>S. aureus</i>, <i>S. pneumoniae</i>, and <i>Enterococcus faecalis</i>. Compound <b>131</b> with a free carboxylic acid was active at 0.06 μg/mL against <i>C. difficile</i>, while the methyl ester analogue <b>132</b> was less potent with MIC = 2 μg/mL.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> This compound class would only have use as an anti-<i>C. difficile</i> agent if the cytotoxic effects were avoided by poor oral bioavailability.</div><div class="NLM_p">Merochlorin A <b>133</b>, a meroterpenoid, has been investigated for antistaphylococcal and anticlostridial activity (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>).<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Compound <b>133</b> was active at 0.3 and 0.15 μg/mL against two <i>C. difficile</i> strains, more potent than the activity against <i>S. pneumoniae</i>, multidrug resistant MRSA, and VRE (MICs of 1–4).<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> No activity was observed (MIC of >64 μg/mL) against Gram-negative strains including <i>Pseudomonas aeruginosa</i>, <i>E. coli</i>, <i>Enterobacter cloacae</i>, <i>Acinetobacter baumannii</i>, and <i>Klebsiella pneumoniae</i>. However, <b>133</b> was cytotoxic against HeLa cells at close to the staphylococcal MIC after extended incubation (IC<sub>50</sub> = 64 μg/mL at 24 h, IC<sub>50</sub> = 2 μg/mL at 72 h) and also was inactivated by the presence of 20% human serum (<i>S. aureus</i> MIC > 64 μg/mL).<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> A gram scale synthesis was recently completed, opening up the path for further studies.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a></div><div class="NLM_p">A collection of natural product flavonoid and related phytochemicals was assessed for their inhibitory action against <i>C. difficile</i> in 2014.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Olympicin A, <b>134</b>, was active at 1 μg/mL against a BI/NAP1/027 <i>C. difficile</i> strain, equivalent to vancomycin activity against this strain (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>).<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Several analogs of <b>134</b>, <b>135</b>–<b>138</b>, containing the natural product chalcone motif, <b>135</b>–<b>137</b>, or an alternative flavonone core, <b>138</b>, were 1–2 dilutions less active against <i>C. difficile</i> (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>).<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Mode of action studies in <i>S. aureus</i> showed that <b>135</b>–<b>137</b> disrupted membrane potential and also inhibited the macromolecular synthesis of proteins, RNA, and DNA.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> Further analogs have now been reported and evaluated for activity against <i>Mycobacterium tuberculosis</i>, <i>E. faecalis</i>, <i>S. aureus</i>, and <i>E. coli</i> but not <i>C. difficile</i>.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a></div><div class="NLM_p">The cyclic thiazolyl derivative <b>139</b> (BMS-249524), part of the nocathiacin family, was potent against five strains of <i>C. difficile</i> with the MIC activity ranging from 0.06 to 1 μg/mL (Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>).<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> Nine analogs of the related thiomuracin A <b>140</b>, a thiazolyl actinomycetales metabolite, were also active against <i>C. difficile</i> with MICs from 0.003 to ≤0.008 μg/mL (Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>).<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> Notably, these compounds are structurally related to <b>8</b>, which is in phase II clinical trials as a treatment for <i>C. difficile</i> infection.<a onclick="showRef(event, 'ref65 ref129'); return false;" href="javascript:void(0);" class="ref ref65 ref129">(65, 129)</a></div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Cyclic thiazolyl peptidic antimicrobial compounds <b>139</b> and <b>140</b> similar to <b>8</b>, which is in phase II clinical trials.<a onclick="showRef(event, 'ref128 ref129'); return false;" href="javascript:void(0);" class="ref ref128 ref129">(128, 129)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26">3.11 <i>C. difficile</i> Specific Drug Targets and Inhibitors</h3><div class="NLM_p">Discovery of inhibitors with antimicrobial activity against new drug targets specific to <i>C. difficile</i> has so far been limited, in part because of historical difficulties in performing genetic manipulation. The development of the ClosTron gene-knockout system in 2007, which is used to inactive specific genes, has aided essential drug target validation.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> Potential drug targets for <i>C. difficile</i> have been compiled into a database by computational analysis of its genome, searching for choke point enzymes potentially necessary for cell survival, with exclusion of proteins found in human gut microbiota.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> More recently a curated <i>C. difficile</i> metabolic network has been established and used to predict essential targets and potential inhibitors.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> Validation of these predicted targets and inhibitors is still required. Despite <i>C. difficile</i> focused target based drug discovery being in the relative early stages, a number of studies have made progress in this area.</div><div class="NLM_p">Dang et al. used activity based chemical probes to identify new drug targets in <i>C. difficile</i>.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> They identified Cwp84 as a protease that mediates cleavage of SlpA, required for formation of the surface layer that coats the <i>C. difficile</i> cell and important for host–pathogen interactions.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> No inhibitors have been reported to date.</div><div class="NLM_p">Ratia et al. attempted to develop selective inhibitors of <i>C. difficile</i> by targeting the enzyme dehydroquinate dehydratase (DHQD), which is involved in the shikimate pathway for biosynthesis of chorismate, a precursor required for biosynthesis of three aromatic amino acids.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> The shikimate pathway is not present in humans, but as DHQD is present in bacteria in two different subtypes, selective inhibitors could potentially be obtained by a target based drug discovery approach. The type I DHDQ is present in <i>C. difficile</i>, while the type II DHQD is present in commensal bacterial species such as <i>Bacteroides thetaiotaomicron</i> and <i>Bifidobacterium longum</i>.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> The type I <i>C. difficile</i> DHQD (<i>cd</i>DHQD) was selectively inhibited compared to the type II <i>B. thetaiotaomicron</i> DHDQ (<i>bt</i>DHDQ) by three compounds <b>141</b>–<b>143</b> (<i>cd</i>DHQD IC<sub>50</sub> = 31–35 μM, cf. <i>bt</i>DHDQ IC<sub>50</sub> > 200 μM) identified from high throughput screening efforts (Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>).<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> However, the antimicrobial efficacy of the enzyme inhibitors has not yet been reported.</div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0016.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Inhibitors of type I dehydroquinate dehydratase <b>141</b>–<b>143</b> (IC<sub>50</sub> = 31–35 μM).<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Antimicrobial activity was not reported.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Inhibitors have been developed that inactivate the toxins TcdA and TcdB, but these do not possess antimicrobial activity.<a onclick="showRef(event, 'ref135 ref136'); return false;" href="javascript:void(0);" class="ref ref135 ref136">(135, 136)</a> Inhibitors of the enzymatic component of binary toxin, CDT, that is expressed by some strains of <i>C. difficile</i> have also been investigated.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> This approach potentially mitigates the disease symptoms, since CDI is a toxin-based disease but is not likely to kill the bacteria themselves. However, by not applying a harsh selection pressure, development of resistance might be prevented.</div><div class="NLM_p last"><i>C. difficile</i> spores are a dormant reservoir within the patient or environment that can cause relapsing infection cycles. The <i>C. difficile</i> spores sense host signals such as bile salts and amino acid nutrients and germinate into vegetative bacteria that produce toxins and cause disease. Therefore, one potential strategy to prevent relapse is to activate the spores and then eradicate them with an antimicrobial agent. Identification of agents that can promote germination of the entire population of spores, including those in a hyperdormant state, is challenging. This strategy has been explored in vitro whereby osmotic salts were used to activate spores and the antibiotic nisin then inhibited bacterial outgrowth.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> The identification of agonists of master regulator proteins for spore germination would facilitate this approach. Paradoxically, the opposite approach may also be useful, since blocking germination may prevent colonization and subsequent infection. CspC, a protease, may represent such a target, since it was identified as a bile acid-recognizing germinant receptor and was required for virulence in a hamster model of <i>C. difficile</i> infection.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a></div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27">3.12 Summary</h3><div class="NLM_p last">Antimicrobial agents that previously were considered to lack broad spectrum activity, had poor oral availability, or had systemic toxicity liabilities may be good starting points for further development of new treatments for CDI. In contrast, research into <i>C. difficile</i> focused target based drug discovery and therapeutic approaches directed at neutralizing the disease-causing toxins or preventing spore persistence offer new directions to explore. However, there are challenges and limitations associated with the spore-forming and anaerobic nature of <i>C. difficile</i> that hamper drug discovery efforts focused on this pathogen. These in vitro and in vivo challenges and limitations, discussed below, must be overcome to progress <i>C. difficile</i>-directed new drug discovery.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">4 Challenges and Limitations Facing New Drug Discovery</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70444" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70444" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29">4.1 In Vitro Assays and Challenges</h3><div class="NLM_p">Discovery of new drugs against <i>C. difficile</i> is difficult because of a number of challenges. First, there are technical barriers to general research, as <i>C. difficile</i> must be grown under strictly anaerobic conditions, usually in an anaerobic chamber. Specialist equipment and reagents are therefore required to meet these basic growth conditions, with the outright cost of these items, together with maintenance and consumable costs, being prohibitive to a nonspecialist laboratory. Anaerobic microbiology skills are also required, although stepwise protocols for laboratory maintenance of <i>C. difficile</i> and prevention of culture contamination with spores when handling multiple strains are available.<a onclick="showRef(event, 'ref140 ref141'); return false;" href="javascript:void(0);" class="ref ref140 ref141">(140, 141)</a> Industry–academic collaborations are providing a path for advancing compound development as difficulties, and costs associated with establishing the specialist infrastructure and in-house expertise can be overcome.</div><div class="NLM_p">The awkwardness of manipulating cultures inside an anaerobic chamber limits throughput, as does the size of the incubator compared to standard large shaker incubators available for bacteria grown aerobically. The agar dilution technique remains the gold standard for anaerobic susceptibility testing of anaerobes recommended by NCCLS.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> However, agar dilution has several limitations for <i>C. difficile</i>-specific drug discovery. First, it limits the number of compounds that can be tested at any one time because of the large amount of incubator space required when each compound is tested at numerous concentrations. Agar dilution also requires a larger amount of test compound for preparing the agar, compared to high throughput 96-well or 384-well broth microdilution assays. This can be prohibitive when the compound is only available in milligram quantities or when compound libraries or many analogs need to be tested. Therefore, the agar dilution method favors investigation of a limited number of lead compounds, which can be tested against multiple strains spotted on the same agar plate concurrently, rather than allowing large compound libraries or a large number of synthesized analogs to be screened. A better alternative for this purpose is microdilution susceptibility testing which only uses a fraction of the amount of compound required for the agar dilution method. Note that the disk diffusion method tends not to be used as often as agar dilution or broth microdilution.</div><div class="NLM_p"><i>C. difficile</i> spores are critical to <i>C. difficile</i> disease etiology, and the infection cycle and must be considered in the evaluation of potential of new drug candidates. It is reasonable to assume that to target vegetative and spore forms, different physicochemical properties for cellular entry and even different compound targets are likely to be required. During CDI, in an in vivo context, <i>C. difficile</i> exists as a mixed population of vegetative bacteria and spores. Therefore, testing that is confined to the vegetative bacterial form or isolated spores does not represent the situation in vivo. Adding to this complexity is the recent demonstration that <i>C. difficile</i> forms biofilms,<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> which adds a further hurdle to effective antibiotic treatment and therapeutic development. Spore formation, germination, and outgrowth are highly regulated processes that shift according to growth phase, nutrient availability, and other host-specific selection pressures such as antibiotic treatment and the presence of competing bacteria. To address the effectiveness of compounds at each stage of the <i>C. difficile</i> life cycle, separate assays studying sporulation, germination, and vegetative cell outgrowth are required.<a onclick="showRef(event, 'ref144 ref145 ref146'); return false;" href="javascript:void(0);" class="ref ref144 ref145 ref146">(144-146)</a> However, performing each of these assays in a high throughput manner to keep up with medicinal chemistry efforts is challenging. Adding to this difficulty is the unreliable sporulation of <i>C. difficile</i> in liquid media, with significant difficulties encountered in attempts to reproducibly synchronize sporulation during in vitro growth.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">Given the physiological limitations of standard in vitro testing of organisms in a single microbe culture system that does not contain competing microbiota, microbial fermentation products, or bile salts, all of which influence <i>C. difficile</i> growth, sporulation, and germination, alternative models have been developed that more closely resemble the host environment. These in vitro gut models involve a single continuous culture reactor, a more complex three-tier system, or a scaled down minibioreactor. The bioreactor is inoculated with a human fecal suspension, treated with antibiotic(s) to model the initial infection susceptibility disease stage, and then challenged with <i>C. difficile</i> spores or vegetative cells to initial infection. Culture samples can be taken over the course of the growth period, and <i>C. difficile</i> total cell counts and spore counts are enumerated using selective agar media. A metagenomic sequencing approach can be used to study changes in the diversity of the microbial populations, which overcomes the problem posed by the presence of uncultivable microbes in this type of analysis.</div><div class="NLM_p last">The three-tier system models the increasing alkalinity found through the gastrointestinal tract in three stages. The effectiveness of oritavancin,<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a><b>6</b>,<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> and cadazolid<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> has been evaluated in this system, showing the effect of antibiotic treatment on vegetative and spore <i>C. difficile</i> bacterial numbers as well as the relative numbers of the indigenous bacteria over time.<a onclick="showRef(event, 'ref147 ref148 ref150'); return false;" href="javascript:void(0);" class="ref ref147 ref148 ref150">(147, 148, 150)</a> More recently, the three-tier system model has been modified to study <i>C. difficile</i> biofilm formation in the context of the gut microbiota environment and antibiotic treatment.<a onclick="showRef(event, 'ref151 ref152'); return false;" href="javascript:void(0);" class="ref ref151 ref152">(151, 152)</a> One disadvantage of the three-tier model is the time required to complete experiments, which are of 6–8 weeks duration, thereby limiting compound throughput. Therefore, despite the potentially useful culture and microbiome information that this model can provide, this system is limited to the evaluation purposes conducted in the late stages of compound development and it is difficult to envision how it can be applied to high throughput screens of large numbers of analogs. The single reactor is a simplified version of the three-tier reactor, which may provide more utility for this purpose. Scaled down minibioreactors, located inside an anaerobic chamber, offer the advantage of being able to test multiple antibiotics at different concentrations at the same time. Once again, monitoring the microbiome community at the population level can be achieved using genome sequencing technologies.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30">4.2 Advantages and Limitations of Animal Infection Models</h3><div class="NLM_p">Animal infection models are critical for the assessment of drug candidate efficacy, since the contribution of many host factors to disease complexity, such as the immune response, simply cannot be reproduced in vitro. They also allow gross toxicities that may not be apparent through in vitro toxicity assays to be determined and are also essential for downstream regulatory body approval processes. The gold standard <i>C. difficile</i> infection model has been the hamster model (comprehensive review by Best et al).<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> However, one disadvantage of the hamster model is that disease takes place at a different site of infection (cecum compared to colon for humans). Furthermore, disease symptoms do not closely mimic those of humans, since the infection does not typically cause diarrhea and almost always leads to death in hamsters as a result of their exquisite sensitivity to the <i>C. difficile</i> toxins. The typical human CDI disease spectrum is not represented in this model, and antimicrobial efficacy can only be assessed in the context of prevention of death. Nevertheless, a wide range of antimicrobials and drug candidates have been evaluated and shown to be effective against <i>C. difficile</i> in the hamster model including rifaximin,<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> fidaxomicin,<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a><b>5</b>,<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> cadazolid,<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> ramoplanin,<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> nitazoxanide,<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> rifalazil,<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> and oritavancin.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a></div><div class="NLM_p">The more recently developed mouse CDI models appear to correlate more closely with human CDI (recently reviewed by Hutton et al.)<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> Importantly, mouse antibiotic treatment CDI induction regimes can be tailored to yield different disease outcomes. Treatment with single antibiotics, such as clindamycin, results in mice that reproducibly develop a mild, nonfatal disease upon infection. By contrast, mice treated with a mixture of broad-spectrum antibiotics develop a severe, often fatal disease following infection.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> The ability to modulate disease severity, presumably through differential effects on host microbiota depending on the antibiotic treatment regime, allows flexibility in the assessment of new therapeutics on disease stages representing the spectrum seen in human CDI. The smaller size of mice also means that less compound is required for testing, which is an important consideration in the early stages of compound development.</div><div class="NLM_p">Additional advantages of using mouse rather than hamster infection models include the greater ease of scoring disease symptoms such as weight loss and diarrhea as well as the ability to use the diverse range of mouse-specific reagents available for immunohistological tissue or other assessments. Furthermore, disease transmission<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> and relapse models<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> have been developed that allow these aspects of disease to be studied. Although the latter model does not allow relapse versus reinfection to be distinguished, both of which are likely to be important in recurrent human infection, it does provide a tool that can be used to determine how effective a treatment is in eradicating recurrent infection within the host following a primary infection. The variation between human and animal gut microbiomes must also be considered when animal models are used to test new antimicrobial compounds, since CDI susceptibility hinges on the host microbiome. However, next generation sequencing provides a powerful tool to evaluate these differences and the effect of treatments on microbial populations, providing unique opportunities that will lead to a better understanding of the complex host–microbial interactions that occur during CDI. Such efforts are also focused on understanding what microbiome community structures constitute “healthy”, “susceptible”, and “disease” states, which will also provide insights into our understanding of CDI.</div><div class="NLM_p last">Finally, it is important to consider which <i>C</i>. <i>difficile</i> strains are used in animal infection and CDI treatment studies. Recent epidemiological and genome sequencing studies have shown that <i>C</i>. <i>difficile</i> is a genetically heterogeneous species and that new variants are detected regularly, some of which cause epidemics.<a onclick="showRef(event, 'ref7 ref165'); return false;" href="javascript:void(0);" class="ref ref7 ref165">(7, 165)</a> For example, these studies demonstrated that the epidemic BI/NAP01/027 group comprises two independently arisen lineages of fluoroquinolone resistant strains that spread globally<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and that diverse strains of unknown origin cause CDI,<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> illustrating how new technologies can provide important insights into disease transmission and evolution on a population scale.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In the context of drug discovery, it is important to include a variety of strains in compound testing to assess their effectiveness across the range of <i>C</i>. <i>difficile</i> strain variants, especially at the lead optimization stage. These therapeutic agents must be effective against diverse strains, or selective forces will favor the proliferation and dissemination of strains against which the compound is least effective.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">5 Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74714" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74714" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In the past 10 years <i>C. difficile</i> has become a significant threat to human health. Even with the recent launch of the <i>C. difficile</i>-targeted antibiotic fidaxomicin, there is still no antibiotic available that can completely prevent recurrent disease. There remains an unmet need for better treatments that prevent relapse and reinfection, as well as transmission. To address this need, the scientific and medical communities are developing new treatment agents from both small molecule and biotherapeutic approaches. Selective antibiotics that do not destroy the diversity of microbiota associated with gut homeostasis and that <i>also</i> effectively inhibit spore formation are required. Nonorally absorbed agents, stable to passage through the stomach and small intestine, are desirable to maintain high concentrations of antibiotic at the site of infection, thus minimizing systemic toxicity and reducing the possibility of treatment failure due to MIC creep associated with antimicrobial resistance. Reinvestigation of abandoned antimicrobial lead candidates and analogs for their ability to fit the target product profile above, as occurred to bring the long ago discovered fidaxomicin out of the shadows and to market in 2011, offers one avenue toward the development of new drugs to fight CDI. Meanwhile, as <i>C. difficile</i> gains ground as a superbug to be reckoned with, further investment into understanding the biology of this organism and the subsequent identification of new drug targets will provide opportunities for medicinal chemists to develop first-in-class antimicrobials using target based drug discovery approaches. Other nonantibiotic treatment approaches such as vaccines and monoclonal antibiotics in clinical trials offer hope for another strategy to combat CDI and if successful could change the landscape of <i>C. difficile</i> research and development. The restoration of damaged gut microbiota using bacteriotherapy, whether fecal transplant or microbial ecosystem replacement, and as a treatment, adjunct therapy, or prophylactic offers great promise as a nonantibiotic therapy. The growing understanding of the complex gut microbe interactions and identification of which bacterial populations need to be maintained for good health will influence the development of new drugs. While concerns remain over the long-term health effects of bacteriotherapy, <i>C. difficile</i> drug discovery remains challenging because of the complex disease etiology and the technical challenges inherent with recurrence and relapse in predictive in vivo animal models. Looking forward, a combination of selective antibiotic <i>and</i> microbial restorative treatment may prove a winning formula.</div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32"><a href="/doi/suppl/10.1021/jm5016846">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50784" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50784" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Methods for clustering ChEMBL data and Table 1 listing summary of single drug candidates tested against <i>C. difficile</i>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5016846/suppl_file/jm5016846_si_001.pdf">jm5016846_si_001.pdf (217.69 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm5016846" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23115" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23115" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew A. Cooper</span> - <span class="hlFld-Affiliation affiliation">The
Institute for Molecular Bioscience, University
of Queensland, St. Lucia, Queensland 4072, Australia</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d6bbf8b5b9b9a6b3a496a3a7f8b3b2a3f8b7a3"><span class="__cf_email__" data-cfemail="9ef3b0fdf1f1eefbecdeebefb0fbfaebb0ffeb">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angie M. Jarrad</span> - <span class="hlFld-Affiliation affiliation">The
Institute for Molecular Bioscience, University
of Queensland, St. Lucia, Queensland 4072, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tomislav Karoli</span> - <span class="hlFld-Affiliation affiliation">The
Institute for Molecular Bioscience, University
of Queensland, St. Lucia, Queensland 4072, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark A. T. Blaskovich</span> - <span class="hlFld-Affiliation affiliation">The
Institute for Molecular Bioscience, University
of Queensland, St. Lucia, Queensland 4072, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dena Lyras</span> - <span class="hlFld-Affiliation affiliation">School
of Biomedical Sciences, Monash University, Clayton, Victoria 3800, Australia</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48260" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48260" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Angie M. Jarrad</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=BIO-d1809e3327-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Angie M. Jarrad</b> received her B.Sc. (Hons) from the University of Adelaide in 2011 and was awarded a University Medal. She is an Australian Postgraduate Award and Queensland Smart Futures Scholarship recipient at the University of Queensland. Her research is on the development of new antibiotics that are effective against <i>C. difficile</i>, focused on novel structural classes derived from existing vancomycin and metronidazole-based therapies. Ms. Jarrad has strong research interests in anti-infective agents and has expertise in medicinal chemistry, organic synthesis, and microbiology.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Tomislav Karoli</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=BIO-d1809e3335-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Tomislav Karoli</b> has over 16 years experience in medicinal and process chemistry working in antibacterial, antiviral, and oncology therapeutic areas in a variety of industrial and academic organisations. He spent 5 years at the University of Queensland working on a number of anti-infective drug discovery programs, including modified glycopeptide derivatives for Gram-positive infections and new antitubercular drugs. Dr. Karoli is currently the Head of Process Chemistry at Progen Pharmaceuticals and is an inventor of PG545, currently in clinical trials in advanced cancer patients.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Mark A. T. Blaskovich</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=BIO-d1809e3340-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Mark A. T. Blaskovich</b> has extensive medicinal chemistry expertise and over 15 years of industrial drug development experience, including research on peptidomimetic inhibitors of penicillin binding proteins (Molecumetics) and development of an melanocortin-5 receptor antagonist, currently in phase IIb trials for the treatment of acne (Mimetica). Since moving to the University of Queensland, Dr. Blaskovich has led programs focused on the development of vancomycin analogs for treating Gram-positive infections (including <i>C. difficile</i>), polymyxin analogs for Gram-negative infections, and derivatives of existing antibiotics as probes for mode of action studies.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Dena Lyras</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=BIO-d1809e3348-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Dena Lyras</b> is an Australian Research Council Future Fellow investigating the molecular pathogenesis of <i>C. difficile</i> infections. Her work couples the genetics of <i>C. difficile</i> (antibiotic resistance, colonization, and virulence factors) with the mouse model of <i>C. difficile</i> infection. Her laboratory is the only Australian facility currently using an animal model to investigate <i>C. difficile</i> infections and has optimized this model to enable the study of colonization, acute disease, transmission, and disease recurrence.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Matthew A. Cooper</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=BIO-d1809e3365-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Matthew A. Cooper</b> is a translational research scientist in anti-infective drug discovery with a solid track record of innovation and intellectual property generation and product launches with 21 patents issued or pending. He is the founder of Cambridge Medical Innovations and a cofounder of Akubio Ltd. Following 9 years working in industry in England, Prof. Cooper returned to Australia to pursue translational research in antibiotic discovery and drug design with research programs focused on novel glycopeptides for Gram-positive therapies (including <i>C. difficile</i> infections), lipopeptides for emergent NDM-1 and ESBL Gram-negative bacteria, and a new class of antibiotics to kill MDR- and XDR-tuberculosis.</p></figure></div><div class="ack" id="ACK-d1809e3382-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67742" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67742" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This paper was prepared with the support of NHMRC Grant APP1063214. A.M.J. is supported by an Australian Postgraduate Award (APA) Ph.D. scholarship and Queensland Government Smart Futures Scholarship. M.A.T.B. and T.K. were supported by Wellcome Trust Seeding Drug Discovery Award 094977/Z/10/Z. D.L. is supported by an ARC Future Fellowship (Grant FT120100779), and M.A.C. is supported by an NHMRC Principal Research Fellowship (Grant APP1059354).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i40" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i40"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i41" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i41"> Abbreviations Used</h2><tr><td class="NLM_term">CDI</td><td class="NLM_def"><p class="first last"><i>Clostridium difficile</i> infection</p></td></tr><tr><td class="NLM_term">CA-CDI</td><td class="NLM_def"><p class="first last">community acquired <i>C. difficile</i> infection</p></td></tr><tr><td class="NLM_term">FMT</td><td class="NLM_def"><p class="first last">fecal microbiota transplantation</p></td></tr><tr><td class="NLM_term">TcdA</td><td class="NLM_def"><p class="first last">toxin A</p></td></tr><tr><td class="NLM_term">TcdB</td><td class="NLM_def"><p class="first last">toxin B</p></td></tr><tr><td class="NLM_term">CDT</td><td class="NLM_def"><p class="first last">binary toxin</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22366" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22366" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 176 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span> </span><span class="NLM_article-title">Antibiotic Resistance Threats in the United States, 2013</span>. <span class="NLM_publisher-name">U.S. Department of Health and Human Services, Centers for Disease Control and Prevention</span>: <span class="NLM_publisher-loc">Atlanta, GA</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">114</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Antibiotic+Resistance+Threats+in+the+United+States%2C+2013.+U.S.+Department+of+Health+and+Human+Services%2C+Centers+for+Disease+Control+and+Prevention%3A+Atlanta%2C+GA%2C+2013%3B+pp+1%E2%80%93114."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DAntibiotic%2520Resistance%2520Threats%2520in%2520the%2520United%2520States%252C%25202013%26pub%3DU.S.%2520Department%2520of%2520Health%2520and%2520Human%2520Services%252C%2520Centers%2520for%2520Disease%2520Control%2520and%2520Prevention%26date%3D2013%26spage%3D1%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Carter, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rood, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyras, D.</span><span> </span><span class="NLM_article-title">The Role of Toxin A and Toxin B in the Virulence of <i>Clostridium difficile</i></span> <span class="citation_source-journal">Trends Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=21-29&author=G.+P.+Carterauthor=J.+I.+Roodauthor=D.+Lyras&title=The+Role+of+Toxin+A+and+Toxin+B+in+the+Virulence+of+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DG.%2BP.%26aulast%3DRood%26aufirst%3DJ.%2BI.%26aulast%3DLyras%26aufirst%3DD.%26atitle%3DThe%2520Role%2520of%2520Toxin%2520A%2520and%2520Toxin%2520B%2520in%2520the%2520Virulence%2520of%2520Clostridium%2520difficile%26jtitle%3DTrends%2520Microbiol.%26date%3D2012%26volume%3D20%26spage%3D21%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Gerding, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupnik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aktories, K.</span><span> </span><span class="NLM_article-title"><i>Clostridium difficile</i> Binary Toxin CDT: Mechanism, Epidemiology, and Potential Clinical Importance</span> <span class="citation_source-journal">Gut Microbes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=6-18&author=D.+N.+Gerdingauthor=S.+Johnsonauthor=M.+Rupnikauthor=K.+Aktories&title=Clostridium+difficile+Binary+Toxin+CDT%3A+Mechanism%2C+Epidemiology%2C+and+Potential+Clinical+Importance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGerding%26aufirst%3DD.%2BN.%26aulast%3DJohnson%26aufirst%3DS.%26aulast%3DRupnik%26aufirst%3DM.%26aulast%3DAktories%26aufirst%3DK.%26atitle%3DClostridium%2520difficile%2520Binary%2520Toxin%2520CDT%253A%2520Mechanism%252C%2520Epidemiology%252C%2520and%2520Potential%2520Clinical%2520Importance%26jtitle%3DGut%2520Microbes%26date%3D2014%26volume%3D5%26spage%3D6%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Edmonds, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zapka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasper, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormack, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macinga, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambol, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbogast, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerding, D. N.</span><span> </span><span class="NLM_article-title">Effectiveness of Hand Hygiene for Removal of <i>Clostridium difficile</i> Spores From Hands</span> <span class="citation_source-journal">Infect. Control Hosp. Epidemiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">302</span><span class="NLM_x">–</span> <span class="NLM_lpage">305</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1086%2F669521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=23388366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADC%252BC3szmt1ahsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=302-305&author=S.+L.+Edmondsauthor=C.+Zapkaauthor=D.+Kasperauthor=R.+Gerberauthor=R.+McCormackauthor=D.+Macingaauthor=S.+Johnsonauthor=S.+Sambolauthor=C.+Frickerauthor=J.+Arbogastauthor=D.+N.+Gerding&title=Effectiveness+of+Hand+Hygiene+for+Removal+of+Clostridium+difficile+Spores+From+Hands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Effectiveness of hand hygiene for removal of Clostridium difficile spores from hands</span></div><div class="casAuthors">Edmonds Sarah L; Zapka Carrie; Kasper Douglas; Gerber Robert; McCormack Robert; Macinga David; Johnson Stuart; Sambol Susan; Fricker Christopher; Arbogast James; Gerding Dale N</div><div class="citationInfo"><span class="NLM_cas:title">Infection control and hospital epidemiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">302-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This study determined whether surrogate organisms can predict activity against Clostridium difficile spores and compared the efficacy of hand hygiene preparations against C. difficile.  Our data suggest that surrogate organisms were not predictive of C. difficile spore removal.  Four preparations were significantly more effective than tap water at removing C. difficile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSoXdyRJzxK-fxQvRxYU81tfW6udTcc2ea7J6U62AEVAbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szmt1ahsw%253D%253D&md5=b454d130ea004f9414126bb72aced46f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1086%2F669521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F669521%26sid%3Dliteratum%253Aachs%26aulast%3DEdmonds%26aufirst%3DS.%2BL.%26aulast%3DZapka%26aufirst%3DC.%26aulast%3DKasper%26aufirst%3DD.%26aulast%3DGerber%26aufirst%3DR.%26aulast%3DMcCormack%26aufirst%3DR.%26aulast%3DMacinga%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DS.%26aulast%3DSambol%26aufirst%3DS.%26aulast%3DFricker%26aufirst%3DC.%26aulast%3DArbogast%26aufirst%3DJ.%26aulast%3DGerding%26aufirst%3DD.%2BN.%26atitle%3DEffectiveness%2520of%2520Hand%2520Hygiene%2520for%2520Removal%2520of%2520Clostridium%2520difficile%2520Spores%2520From%2520Hands%26jtitle%3DInfect.%2520Control%2520Hosp.%2520Epidemiol.%26date%3D2013%26volume%3D34%26spage%3D302%26epage%3D305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Sunkesula, V. C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kundrapu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jury, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshpande, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donskey, C. J.</span><span> </span><span class="NLM_article-title">Potential for Transmission of Spores by Patients Awaiting Laboratory Testing To Confirm Suspected <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">Infect. Control Hosp. Epidemiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1086%2F669510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=23388367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADC%252BC3szmt1ahsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=306-308&author=V.+C.+K.+Sunkesulaauthor=S.+Kundrapuauthor=L.+A.+Juryauthor=A.+Deshpandeauthor=A.+K.+Sethiauthor=C.+J.+Donskey&title=Potential+for+Transmission+of+Spores+by+Patients+Awaiting+Laboratory+Testing+To+Confirm+Suspected+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Potential for transmission of spores by patients awaiting laboratory testing to confirm suspected Clostridium difficile infection</span></div><div class="casAuthors">Sunkesula Venkata C K; Kundrapu Sirisha; Jury Lucy A; Deshpande Abhishek; Sethi Ajay K; Donskey Curtis J</div><div class="citationInfo"><span class="NLM_cas:title">Infection control and hospital epidemiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">306-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In a prospective study of inpatients tested for Clostridium difficile infection (CDI), skin and environmental contamination were common at the time of the order for CDI testing, and there were often delays in completion of testing.  Preemptive isolation of patients with suspected CDI may reduce the risk of transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSoXdyRJzxK-e_Q9URG6Dx8fW6udTcc2ea7J6U62AEVAbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szmt1ahsA%253D%253D&md5=32bd7eccb7bf5cb8c55de5b8580cada5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1086%2F669510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F669510%26sid%3Dliteratum%253Aachs%26aulast%3DSunkesula%26aufirst%3DV.%2BC.%2BK.%26aulast%3DKundrapu%26aufirst%3DS.%26aulast%3DJury%26aufirst%3DL.%2BA.%26aulast%3DDeshpande%26aufirst%3DA.%26aulast%3DSethi%26aufirst%3DA.%2BK.%26aulast%3DDonskey%26aufirst%3DC.%2BJ.%26atitle%3DPotential%2520for%2520Transmission%2520of%2520Spores%2520by%2520Patients%2520Awaiting%2520Laboratory%2520Testing%2520To%2520Confirm%2520Suspected%2520Clostridium%2520difficile%2520Infection%26jtitle%3DInfect.%2520Control%2520Hosp.%2520Epidemiol.%26date%3D2013%26volume%3D34%26spage%3D306%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Warny, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Killgore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brazier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, L. C.</span><span> </span><span class="NLM_article-title">Toxin Production by an Emerging Strain of <i>Clostridium difficile</i> Associated with Outbreaks of Severe Disease in North America and Europe</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">366</span><span class="NLM_x">, </span> <span class="NLM_fpage">1079</span><span class="NLM_x">–</span> <span class="NLM_lpage">1084</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1016%2FS0140-6736%2805%2967420-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=16182895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVartL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2005&pages=1079-1084&author=M.+Warnyauthor=J.+Pepinauthor=A.+Fangauthor=G.+Killgoreauthor=A.+Thompsonauthor=J.+Brazierauthor=E.+Frostauthor=L.+C.+McDonald&title=Toxin+Production+by+an+Emerging+Strain+of+Clostridium+difficile+Associated+with+Outbreaks+of+Severe+Disease+in+North+America+and+Europe"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe</span></div><div class="casAuthors">Warny, Michel; Pepin, Jacques; Fang, Aiqi; Killgore, George; Thompson, Angela; Brazier, Jon; Frost, Eric; McDonald, L. Clifford</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">9491</span>),
    <span class="NLM_cas:pages">1079-1084</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Toxins A and B are the primary virulence factors of Clostridium difficile.  Since 2002, an epidemic of C difficile-assocd. disease with increased morbidity and mortality has been present in Quebec province, Canada.  We characterized the dominant strain of this epidemic to det. whether it produces higher amts. of toxins A and B than those produced by non-epidemic strains.  We obtained isolates from 124 patients from Center Hospitalier Universitaire de Sherbrooke in Quebec.  Addnl. isolates from the USA, Canada, and the UK were included to increase the genetic diversity of the toxinotypes tested.  Isolate characterization included toxinotyping, pulsed-field gel electrophoresis (PFGE), PCR ribotyping, detection of a binary toxin gene, and detection of deletions in a putative neg. regulator for toxins A and B (tcdC).  By use of an enzyme-linked immunoassay, we measured the in-vitro prodn. of toxins A and B by epidemic strain and non-dominant strain isolates.  Findings: The epidemic strain was characterized as toxinotype III, North American PFGE type 1, and PCR-ribotype 027 (NAP1/027).  This strain carried the binary toxin gene cdtB and an 18-bp deletion in tcdC.  We isolated this strain from 72 patients with C difficile-assocd. disease (58 [67%] of 86 with health-care-assocd. disease; 14 [37%] of 38 with community-acquired disease).  Peak median (IQR) toxin A and toxin B concns. produced in vitro by NAP1/027 were 16 and 23 times higher, resp., than those measured in isolates representing 12 different PFGE types, known as toxinotype 0 (toxin A, median 848 μg/L [IQR 504-1022] vs 54 μg/L [23-203]; toxin B, 180 μg/L [137-210] vs 8 μg/L [5-25]; p<0·0001 for both toxins).  The severity of C difficile-assocd. disease caused by NAP1/027 could result from hyperprodn. of toxins A and B. Dissemination of this strain in North America and Europe could lead to important changes in the epidemiol. of C difficile-assocd. disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOf8zYIbBVarVg90H21EOLACvtfcHk0lhE9dHCCXZG8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVartL3E&md5=2e40f8346690972f4247c7857fcb027a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2805%2967420-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252805%252967420-X%26sid%3Dliteratum%253Aachs%26aulast%3DWarny%26aufirst%3DM.%26aulast%3DPepin%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DA.%26aulast%3DKillgore%26aufirst%3DG.%26aulast%3DThompson%26aufirst%3DA.%26aulast%3DBrazier%26aufirst%3DJ.%26aulast%3DFrost%26aufirst%3DE.%26aulast%3DMcDonald%26aufirst%3DL.%2BC.%26atitle%3DToxin%2520Production%2520by%2520an%2520Emerging%2520Strain%2520of%2520Clostridium%2520difficile%2520Associated%2520with%2520Outbreaks%2520of%2520Severe%2520Disease%2520in%2520North%2520America%2520and%2520Europe%26jtitle%3DLancet%26date%3D2005%26volume%3D366%26spage%3D1079%26epage%3D1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">He, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyajima, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellison, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connor, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamford, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arc, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brazier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douce, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerding, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koh, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senoh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peacock, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Songer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirmohamed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuijper, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wren, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkhill, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawley, T. D.</span><span> </span><span class="NLM_article-title">Emergence and Global Spread of Epidemic Healthcare-Associated <i>Clostridium difficile</i></span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1038%2Fng.2478" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=23222960" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2012&pages=109-113&author=M.+Heauthor=F.+Miyajimaauthor=P.+Robertsauthor=L.+Ellisonauthor=D.+J.+Pickardauthor=M.+J.+Martinauthor=T.+R.+Connorauthor=S.+R.+Harrisauthor=D.+Fairleyauthor=K.+B.+Bamfordauthor=S.+D%E2%80%99Arcauthor=J.+Brazierauthor=D.+Brownauthor=J.+E.+Coiaauthor=G.+Douceauthor=D.+Gerdingauthor=H.+J.+Kimauthor=T.+H.+Kohauthor=H.+Katoauthor=M.+Senohauthor=T.+Louieauthor=S.+Michellauthor=E.+Buttauthor=S.+J.+Peacockauthor=N.+M.+Brownauthor=T.+Rileyauthor=G.+Songerauthor=M.+Wilcoxauthor=M.+Pirmohamedauthor=E.+Kuijperauthor=P.+Hawkeyauthor=B.+W.+Wrenauthor=G.+Douganauthor=J.+Parkhillauthor=T.+D.+Lawley&title=Emergence+and+Global+Spread+of+Epidemic+Healthcare-Associated+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fng.2478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.2478%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DM.%26aulast%3DMiyajima%26aufirst%3DF.%26aulast%3DRoberts%26aufirst%3DP.%26aulast%3DEllison%26aufirst%3DL.%26aulast%3DPickard%26aufirst%3DD.%2BJ.%26aulast%3DMartin%26aufirst%3DM.%2BJ.%26aulast%3DConnor%26aufirst%3DT.%2BR.%26aulast%3DHarris%26aufirst%3DS.%2BR.%26aulast%3DFairley%26aufirst%3DD.%26aulast%3DBamford%26aufirst%3DK.%2BB.%26aulast%3DD%25E2%2580%2599Arc%26aufirst%3DS.%26aulast%3DBrazier%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DCoia%26aufirst%3DJ.%2BE.%26aulast%3DDouce%26aufirst%3DG.%26aulast%3DGerding%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DKoh%26aufirst%3DT.%2BH.%26aulast%3DKato%26aufirst%3DH.%26aulast%3DSenoh%26aufirst%3DM.%26aulast%3DLouie%26aufirst%3DT.%26aulast%3DMichell%26aufirst%3DS.%26aulast%3DButt%26aufirst%3DE.%26aulast%3DPeacock%26aufirst%3DS.%2BJ.%26aulast%3DBrown%26aufirst%3DN.%2BM.%26aulast%3DRiley%26aufirst%3DT.%26aulast%3DSonger%26aufirst%3DG.%26aulast%3DWilcox%26aufirst%3DM.%26aulast%3DPirmohamed%26aufirst%3DM.%26aulast%3DKuijper%26aufirst%3DE.%26aulast%3DHawkey%26aufirst%3DP.%26aulast%3DWren%26aufirst%3DB.%2BW.%26aulast%3DDougan%26aufirst%3DG.%26aulast%3DParkhill%26aufirst%3DJ.%26aulast%3DLawley%26aufirst%3DT.%2BD.%26atitle%3DEmergence%2520and%2520Global%2520Spread%2520of%2520Epidemic%2520Healthcare-Associated%2520Clostridium%2520difficile%26jtitle%3DNat.%2520Genet.%26date%3D2012%26volume%3D45%26spage%3D109%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">McDonald, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Killgore, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, R. C.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakova, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambol, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerding, D. N.</span><span> </span><span class="NLM_article-title">An Epidemic, Toxin Gene–Variant Strain of <i>Clostridium difficile</i></span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">2433</span><span class="NLM_x">–</span> <span class="NLM_lpage">2441</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1056%2FNEJMoa051590" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=16322603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlShurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=2433-2441&author=L.+C.+McDonaldauthor=G.+E.+Killgoreauthor=A.+Thompsonauthor=R.+C.+Owensauthor=S.+V.+Kazakovaauthor=S.+P.+Sambolauthor=S.+Johnsonauthor=D.+N.+Gerding&title=An+Epidemic%2C+Toxin+Gene%E2%80%93Variant+Strain+of+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">An epidemic, toxin gene-variant strain of Clostridium difficile</span></div><div class="casAuthors">McDonald, L. Clifford; Killgore, George E.; Thompson, Angela; Owens, Robert C., Jr.; Kazakova, Sophia V.; Sambol, Susan P.; Johnson, Stuart; Gerding, Dale N.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2433-2441</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Recent reports suggest that the rate and severity of C. difficile-assocd. disease in the United States are increasing and that the increase may be assocd. with the emergence of a new strain of C. difficile with increased virulence, resistance, or both.  A total of 187 C. difficile isolates were collected from 8 health care facilities in 6 states (Georgia, Illinois, Maine, New Jersey, Oregon, and Pennsylvania) in which outbreaks of C. difficile-assocd. disease had occurred between 2000 and 2003.  The isolates were characterized by restriction-endonuclease anal. (REA), pulsed-field gel electrophoresis (PFGE), and toxinotyping, and the results were compared with those from a database of >6000 isolates obtained before 2001.  PCR was used to detect the recently described binary toxin CDT and a deletion in the pathogenicity locus gene, tcdC, that might result in increased prodn. of toxins A and B.  Isolates that belonged to 1 REA group (BI) and had the same PFGE type (NAP1) were identified in specimens collected from patients at all 8 facilities and accounted for at least half of the isolates from 5 facilities.  REA group BI, which was 1st identified in 1984, was uncommon among isolates from the historic database (14 cases).  Both historic and current (obtained since 2001) BI/NAP1 isolates were of toxinotype III, were pos. for the binary toxin CDT, and contained an 18-bp tcdC deletion.  Resistance to gatifloxacin and moxifloxacin was more common in current BI/NAP1 isolates than in non-BI/NAP1 isolates (100% vs. 42%), whereas the rate of resistance to clindamycin was the same in the 2 groups (79%).  All of the current but none of the historic BI/NAP1 isolates were resistant to gatifloxacin and moxifloxacin.  A previously uncommon strain of C. difficile with variations in toxin genes has become more resistant to fluoroquinolones and has emerged as a cause of geog. dispersed outbreaks of C. difficile-assocd. disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9xi0s6sZPxrVg90H21EOLACvtfcHk0lhWVOQDDGHYRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlShurvP&md5=313fa0e669cc4edc29d63d9892e5ae37</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa051590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa051590%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonald%26aufirst%3DL.%2BC.%26aulast%3DKillgore%26aufirst%3DG.%2BE.%26aulast%3DThompson%26aufirst%3DA.%26aulast%3DOwens%26aufirst%3DR.%2BC.%26aulast%3DKazakova%26aufirst%3DS.%2BV.%26aulast%3DSambol%26aufirst%3DS.%2BP.%26aulast%3DJohnson%26aufirst%3DS.%26aulast%3DGerding%26aufirst%3DD.%2BN.%26atitle%3DAn%2520Epidemic%252C%2520Toxin%2520Gene%25E2%2580%2593Variant%2520Strain%2520of%2520Clostridium%2520difficile%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D353%26spage%3D2433%26epage%3D2441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Loo, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oughton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourgault, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frenette, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, M.</span><span> </span><span class="NLM_article-title">A Predominantly Clonal Multi-Institutional Outbreak of <i>Clostridium difficile</i>-Associated Diarrhea with High Morbidity and Mortality</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">2442</span><span class="NLM_x">–</span> <span class="NLM_lpage">2449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1056%2FNEJMoa051639" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=16322602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlShurvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=2442-2449&author=V.+G.+Looauthor=L.+Poirierauthor=M.+A.+Millerauthor=M.+Oughtonauthor=M.+D.+Libmanauthor=S.+Michaudauthor=A.-M.+Bourgaultauthor=T.+Nguyenauthor=C.+Frenetteauthor=M.+Kelly&title=A+Predominantly+Clonal+Multi-Institutional+Outbreak+of+Clostridium+difficile-Associated+Diarrhea+with+High+Morbidity+and+Mortality"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A predominantly clonal multi-institutional outbreak of clostridium difficile-associated diarrhea with high morbidity and mortality</span></div><div class="casAuthors">Loo, Vivian G.; Poirier, Louise; Miller, Mark A.; Oughton, Matthew; Libman, Michael D.; Michaud, Sophie; Bourgault, Anne-Marie; Nguyen, Tuyen; Frenette, Charles; Kelly, Mirabelle; Vibien, Anne; Brassard, Paul; Fenn, Susan; Dewar, Ken; Hudson, Thomas J.; Horn, Ruth; Rene, Piere; Monczak, Yuryy; Dascal, Andre</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2442-2449</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND In Mar. 2003, several hospitals in Quebec, Canada, noted a marked increase in the incidence of Clostridiumr difficile-assocd. diarrhea.  METHODS In 2004 we conducted a prospective study at 12 Quebec hospitals to det. the incidence of nosocomial C. difficile-assocd. diarrhea and its complications and a case-control study to identify risk factors for the disease.  Isolates of C. difficile were typed by pulsed-field gel electrophoresis and analyzed for binary toxin genes and partial deletions in the toxin A and B repressor gene tcdC.  Antimicrobial susceptibility was evaluated in a subgroup of isolates.  RESULTS A total of 1703 patients with 1719 episodes of nosocomial C. difficile-assocd. diarrhea were identified.  The incidence was 22.5 per 1000 admissions.  The 30-day attributable mortality rate was 6.9 percent.  Case patients were more likely than matched controls to have received fluoroquinolones (odds ratio, 3.9; 95 percent confidence interval, 2.3 to 6.6) or cephalosporins (odds ratio, 3.8; 95 percent confidence interval, 2.2 to 6.6). A predominant strain, resistant to fluoroquinolones, was found in 129 of 157 isolates (82.2 percent), and the binary toxin genes and partial deletions in the tcdC gene were present in 132 isolates (84.1 percent).  CONCLUSIONS A strain of C. difficile that was resistant to fluoroquinolones and had binary toxin and a partial deletion of the tcdC gene was responsible for this outbreak of C. difficile-assocd. diarrhea.  Exposure to fluoroquinolones or cephalosporins was a risk factor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrun2mbufmdVbVg90H21EOLACvtfcHk0lhWVOQDDGHYRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlShurvK&md5=7913e7008546a811107c1976bc772553</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa051639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa051639%26sid%3Dliteratum%253Aachs%26aulast%3DLoo%26aufirst%3DV.%2BG.%26aulast%3DPoirier%26aufirst%3DL.%26aulast%3DMiller%26aufirst%3DM.%2BA.%26aulast%3DOughton%26aufirst%3DM.%26aulast%3DLibman%26aufirst%3DM.%2BD.%26aulast%3DMichaud%26aufirst%3DS.%26aulast%3DBourgault%26aufirst%3DA.-M.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DFrenette%26aufirst%3DC.%26aulast%3DKelly%26aufirst%3DM.%26atitle%3DA%2520Predominantly%2520Clonal%2520Multi-Institutional%2520Outbreak%2520of%2520Clostridium%2520difficile-Associated%2520Diarrhea%2520with%2520High%2520Morbidity%2520and%2520Mortality%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D353%26spage%3D2442%26epage%3D2449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Khanna, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardi, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aronson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kammer, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baddour, L. M.</span><span> </span><span class="NLM_article-title">Outcomes in Community-Acquired <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">Aliment. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">618</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1111%2Fj.1365-2036.2011.04984.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=22229532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADC%252BC387pvFSlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2012&pages=613-618&author=S.+Khannaauthor=D.+S.+Pardiauthor=S.+L.+Aronsonauthor=P.+P.+Kammerauthor=L.+M.+Baddour&title=Outcomes+in+Community-Acquired+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Outcomes in community-acquired Clostridium difficile infection</span></div><div class="casAuthors">Khanna S; Pardi D S; Aronson S L; Kammer P P; Baddour L M</div><div class="citationInfo"><span class="NLM_cas:title">Alimentary pharmacology & therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">613-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Community-acquired Clostridium difficile infection (CA-CDI) is an increasingly appreciated condition.  It is being described in populations lacking traditional predisposing factors that have been previously considered at low-risk for this infection.  As most studies of CDI are hospital-based, outcomes in these patients are not well known.  AIM:  To examine outcomes and their predictors in patients with CA-CDI.  METHODS:  A sub-group analysis of a population-based epidemiological study of CDI in Olmsted county, Minnesota from 1991-2005 was performed.  Data regarding outcomes, including severity, treatment response, need for hospitalisation and recurrence were analysed.  RESULTS:  Of 157 CA-CDI cases, the median age was 50 years and 75.3% were female.  Among all CA-CDI cases, 40% required hospitalisation, 20% had severe and 4.4% had severe-complicated infection, 20% had treatment failure and 28% had recurrent CDI.  Patients who required hospitalisation were significantly older (64 years vs. 44 years, P < 0.001), more likely to have severe disease (33.3% vs. 11.7%, P = 0.001), and had higher mean Charlson comorbidity index scores (2.06 vs. 0.84, P = 0.001).  They had similar treatment failure and recurrence rates as patients who did not require hospitalisation.  CONCLUSIONS:  Community-acquired Clostridium difficile infection can be associated with complications and poor outcomes, including hospitalisation and severe Clostridium difficile infection.  As the incidence of community-acquired Clostridium difficile infection increases, clinicians should be aware of risk factors (increasing age, comorbid conditions and disease severity) that predict the need for hospitalisation and complications in patients with community-acquired Clostridium difficile infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXsjX1Yu5jIxFwe7cAcrfPfW6udTcc2ebQzBlUl-xYvbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC387pvFSlsw%253D%253D&md5=a8ab99baa06f149ee00852fa23aa3976</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2036.2011.04984.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2036.2011.04984.x%26sid%3Dliteratum%253Aachs%26aulast%3DKhanna%26aufirst%3DS.%26aulast%3DPardi%26aufirst%3DD.%2BS.%26aulast%3DAronson%26aufirst%3DS.%2BL.%26aulast%3DKammer%26aufirst%3DP.%2BP.%26aulast%3DBaddour%26aufirst%3DL.%2BM.%26atitle%3DOutcomes%2520in%2520Community-Acquired%2520Clostridium%2520difficile%2520Infection%26jtitle%3DAliment.%2520Pharmacol.%2520Ther.%26date%3D2012%26volume%3D35%26spage%3D613%26epage%3D618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Levine, D. P.</span><span> </span><span class="NLM_article-title">Vancomycin: a History</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">S5</span><span class="NLM_x">–</span> <span class="NLM_lpage">S12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1086%2F491709" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=16323120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsVagtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2006&pages=S5-S12&author=D.+P.+Levine&title=Vancomycin%3A+a+History"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Vancomycin: A history</span></div><div class="casAuthors">Levine, Donald P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S5-S12</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Vancomycin became available for clin. use > 50 years ago but was soon discarded in favor of other antibiotics that were deemed to be more efficacious and less toxic.  The advent of pseudomembranous enterocolitis, coupled with the spread of methicillin-resistant Staphylococcus aureus, led to a resurgence in the use of vancomycin.  Almost immediately, concerns arose with regard to its therapeutic utility.  In addn., resistance to vancomycin developed, first in enterococci and later in staphylococci.  Several types of resistance have now been identified, each with a unique effect on infections treated with vancomycin.  Recent studies have rekindled interest in the best way to administer the antibiotic.  The findings of future studies may result in a return to measuring levels of vancomycin in serum, to assure a successful therapeutic outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2_P2N2zwJHLVg90H21EOLACvtfcHk0litQZuNX8vgjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsVagtw%253D%253D&md5=8b516e40ed39bd3c3ec9e727dbbb048d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1086%2F491709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F491709%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DD.%2BP.%26atitle%3DVancomycin%253A%2520a%2520History%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2006%26volume%3D42%26spage%3DS5%26epage%3DS12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Baines, E. J.</span><span> </span><span class="NLM_article-title">Metronidazole: Its Past, Present and Future</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fjac%2F4.suppl_C.97" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=151090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADyaE1MXjtlKhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1978&pages=97-111&author=E.+J.+Baines&title=Metronidazole%3A+Its+Past%2C+Present+and+Future"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Metronidazole:  its past, present and future</span></div><div class="casAuthors">Baines, Eric J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">Suppl. C</span>),
    <span class="NLM_cas:pages">97-111</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    </div><div class="casAbstract">Metronidazole (I)  [443-48-1], introduced in 1960 as the first systemic antitrichomonal agent, was later shown to be effective in other infections caused by anaerobic protozoa; giardiasis (1961), amebiasis (1966) and balantidiasis (1969).  The drug's efficacy in cutaneous leishmaniasis and Chaga's disease is questionable but its widespread use for trichomoniasis led to clin. observations of benefit in other intercurrent conditions.  Some of these were substantiated clin. and can now be explained on the basis of (I)'s anaerobicidal activity.  Its specific action on anaerobic bacteria was not appreciated until 1972 when its clin. efficacy in Bacteroides fragilis infections was reported in the U.S.A.  Its successful uses in dracunculiasis and as a radiosensitizer for anoxic tumor cells were developed on the basis of chem. analogy.  There is substantial clin. evidence of the product's chemotherapeutic activity in the treatment and prevention of anaerobic sepsis, but its full potentialities as an antimicrobial agent and for the further investigation of disorders in which the actions of anaerobic micro-organisms might be involved, have still to be realized.  A review and discussion with many refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZn3BhiatKeLVg90H21EOLACvtfcHk0litQZuNX8vgjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXjtlKhtA%253D%253D&md5=251e0eb150f9e0ea756428d9a45827a7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1093%2Fjac%2F4.suppl_C.97&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252F4.suppl_C.97%26sid%3Dliteratum%253Aachs%26aulast%3DBaines%26aufirst%3DE.%2BJ.%26atitle%3DMetronidazole%253A%2520Its%2520Past%252C%2520Present%2520and%2520Future%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D1978%26volume%3D4%26spage%3D97%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Vardakas, K. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polyzos, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patouni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafailidis, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samonis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falagas, M. E.</span><span> </span><span class="NLM_article-title">Treatment Failure and Recurrence of <i>Clostridium difficile</i> Infection Following Treatment with Vancomycin or Metronidazole: A Systematic Review of the Evidence</span> <span class="citation_source-journal">Int. J. Antimicrob. Agents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1016%2Fj.ijantimicag.2012.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=22398198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtlOgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1-8&author=K.+Z.+Vardakasauthor=K.+A.+Polyzosauthor=K.+Patouniauthor=P.+I.+Rafailidisauthor=G.+Samonisauthor=M.+E.+Falagas&title=Treatment+Failure+and+Recurrence+of+Clostridium+difficile+Infection+Following+Treatment+with+Vancomycin+or+Metronidazole%3A+A+Systematic+Review+of+the+Evidence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence</span></div><div class="casAuthors">Vardakas, Konstantinos Z.; Polyzos, Konstantinos A.; Patouni, Konstantina; Rafailidis, Petros I.; Samonis, George; Falagas, Matthew E.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The objective of this review was to evaluate the frequency of treatment failure and recurrence of Clostridium difficile infection (CDI) following treatment with vancomycin or metronidazole in recently performed studies (last 10 years).  Searches in PubMed and Scopus were performed by two reviewers independently.  Data regarding treatment failure and recurrence following metronidazole and vancomycin treatment were extd. and analyzed.  In total, 39 articles (7005 patients) were selected for inclusion in the systematic review.  The reported treatment failure was 22.4% with metronidazole (16 studies) and 14.2% with vancomycin (8 studies).  Recurrence of CDI occurred in 27.1% of patients following metronidazole treatment (18 studies) and 24.0% of patients following vancomycin treatment (8 studies).  Mean treatment failure and recurrence in the selected studies was 22.3% (24 studies) and 22.1% (37 studies).  The reported outcomes depended on the study design (higher in prospective and retrospective cohort studies than in randomised controlled trials), geog. location of the study (higher in North America than in Europe and Asia), funding (higher in studies funded by non-profit organisations than pharmaceutical companies), mean age of the studied population (higher in older patients) and duration of follow-up (higher in studies with follow-up >1 mo).  In conclusion, infection with C. difficile is assocd. with 22.4% and 14.2% treatment failure and 27.1% and 24.0% recurrence after treatment with metronidazole and vancomycin, resp.  The variation in the reported outcomes amongst studies depends on the study design, location, funding, age and follow-up period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTT4SiLma897Vg90H21EOLACvtfcHk0litQZuNX8vgjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtlOgtbk%253D&md5=6addd564a3dce77eb24e4674e3559085</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.ijantimicag.2012.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijantimicag.2012.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DVardakas%26aufirst%3DK.%2BZ.%26aulast%3DPolyzos%26aufirst%3DK.%2BA.%26aulast%3DPatouni%26aufirst%3DK.%26aulast%3DRafailidis%26aufirst%3DP.%2BI.%26aulast%3DSamonis%26aufirst%3DG.%26aulast%3DFalagas%26aufirst%3DM.%2BE.%26atitle%3DTreatment%2520Failure%2520and%2520Recurrence%2520of%2520Clostridium%2520difficile%2520Infection%2520Following%2520Treatment%2520with%2520Vancomycin%2520or%2520Metronidazole%253A%2520A%2520Systematic%2520Review%2520of%2520the%2520Evidence%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2012%26volume%3D40%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Venugopal, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S.</span><span> </span><span class="NLM_article-title">Current State of <i>Clostridium difficile</i> Treatment Options</span> <span class="citation_source-journal">Clinical Infectious Diseases</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S71</span><span class="NLM_x">–</span> <span class="NLM_lpage">S76</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=S71-S76&issue=Suppl.+2&author=A.+A.+Venugopalauthor=S.+Johnson&title=Current+State+of+Clostridium+difficile+Treatment+Options"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVenugopal%26aufirst%3DA.%2BA.%26aulast%3DJohnson%26aufirst%3DS.%26atitle%3DCurrent%2520State%2520of%2520Clostridium%2520difficile%2520Treatment%2520Options%26jtitle%3DClinical%2520Infectious%2520Diseases%26date%3D2012%26volume%3D55%26issue%3DSuppl.%25202%26spage%3DS71%26epage%3DS76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Cornely, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crook, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorbach, S. L.</span><span> </span><span class="NLM_article-title">Treatment of First Recurrence of <i>Clostridium difficile</i> Infection: Fidaxomicin Versus Vancomycin</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S154</span><span class="NLM_x">–</span> <span class="NLM_lpage">S161</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=S154-S161&issue=Suppl.+2&author=O.+A.+Cornelyauthor=M.+A.+Millerauthor=T.+J.+Louieauthor=D.+W.+Crookauthor=S.+L.+Gorbach&title=Treatment+of+First+Recurrence+of+Clostridium+difficile+Infection%3A+Fidaxomicin+Versus+Vancomycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCornely%26aufirst%3DO.%2BA.%26aulast%3DMiller%26aufirst%3DM.%2BA.%26aulast%3DLouie%26aufirst%3DT.%2BJ.%26aulast%3DCrook%26aufirst%3DD.%2BW.%26aulast%3DGorbach%26aufirst%3DS.%2BL.%26atitle%3DTreatment%2520of%2520First%2520Recurrence%2520of%2520Clostridium%2520difficile%2520Infection%253A%2520Fidaxomicin%2520Versus%2520Vancomycin%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2012%26volume%3D55%26issue%3DSuppl.%25202%26spage%3DS154%26epage%3DS161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Louie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrne, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emery, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eyben, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krulicki, W.</span><span> </span><span class="NLM_article-title">Fidaxomicin Preserves the Intestinal Microbiome during and after Treatment of <i>Clostridium difficile</i> Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S132</span><span class="NLM_x">–</span> <span class="NLM_lpage">S142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=S132-S142&issue=Suppl.+2&author=T.+J.+Louieauthor=K.+Cannonauthor=B.+Byrneauthor=J.+Emeryauthor=L.+Wardauthor=M.+Eybenauthor=W.+Krulicki&title=Fidaxomicin+Preserves+the+Intestinal+Microbiome+during+and+after+Treatment+of+Clostridium+difficile+Infection+%28CDI%29+and+Reduces+Both+Toxin+Reexpression+and+Recurrence+of+CDI"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLouie%26aufirst%3DT.%2BJ.%26aulast%3DCannon%26aufirst%3DK.%26aulast%3DByrne%26aufirst%3DB.%26aulast%3DEmery%26aufirst%3DJ.%26aulast%3DWard%26aufirst%3DL.%26aulast%3DEyben%26aufirst%3DM.%26aulast%3DKrulicki%26aufirst%3DW.%26atitle%3DFidaxomicin%2520Preserves%2520the%2520Intestinal%2520Microbiome%2520during%2520and%2520after%2520Treatment%2520of%2520Clostridium%2520difficile%2520Infection%2520%2528CDI%2529%2520and%2520Reduces%2520Both%2520Toxin%2520Reexpression%2520and%2520Recurrence%2520of%2520CDI%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2012%26volume%3D55%26issue%3DSuppl.%25202%26spage%3DS132%26epage%3DS142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Finegold, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molitoris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaisanen, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolanos, M.</span><span> </span><span class="NLM_article-title">In Vitro Activities of OPT-80 and Comparator Drugs against Intestinal Bacteria</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4898</span><span class="NLM_x">–</span> <span class="NLM_lpage">4902</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=4898-4902&author=S.+M.+Finegoldauthor=D.+Molitorisauthor=M.+L.+Vaisanenauthor=Y.+Songauthor=C.+Liuauthor=M.+Bolanos&title=In+Vitro+Activities+of+OPT-80+and+Comparator+Drugs+against+Intestinal+Bacteria"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFinegold%26aufirst%3DS.%2BM.%26aulast%3DMolitoris%26aufirst%3DD.%26aulast%3DVaisanen%26aufirst%3DM.%2BL.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DBolanos%26aufirst%3DM.%26atitle%3DIn%2520Vitro%2520Activities%2520of%2520OPT-80%2520and%2520Comparator%2520Drugs%2520against%2520Intestinal%2520Bacteria%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D4898%26epage%3D4902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Babakhani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillaut, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sears, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonenshein, A. L.</span><span> </span><span class="NLM_article-title">Fidaxomicin Inhibits Spore Production in <i>Clostridium difficile</i></span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S162</span><span class="NLM_x">–</span> <span class="NLM_lpage">S169</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=S162-S169&issue=Suppl.+2&author=F.+Babakhaniauthor=L.+Bouillautauthor=A.+Gomezauthor=P.+Searsauthor=L.+Nguyenauthor=A.+L.+Sonenshein&title=Fidaxomicin+Inhibits+Spore+Production+in+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBabakhani%26aufirst%3DF.%26aulast%3DBouillaut%26aufirst%3DL.%26aulast%3DGomez%26aufirst%3DA.%26aulast%3DSears%26aufirst%3DP.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DSonenshein%26aufirst%3DA.%2BL.%26atitle%3DFidaxomicin%2520Inhibits%2520Spore%2520Production%2520in%2520Clostridium%2520difficile%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2012%26volume%3D55%26issue%3DSuppl.%25202%26spage%3DS162%26epage%3DS169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Müller, M.</span><span> </span><span class="NLM_article-title">Mode of Action of Metronidazole on Anaerobic Bacteria and Protozoa</span> <span class="citation_source-journal">Surgery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=6849201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADyaL3sXksVOgtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1983&pages=165-171&author=M.+M%C3%BCller&title=Mode+of+Action+of+Metronidazole+on+Anaerobic+Bacteria+and+Protozoa"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Mode of action of metronidazole on anaerobic bacteria and protozoa</span></div><div class="casAuthors">Mueller, Miklos</div><div class="citationInfo"><span class="NLM_cas:title">Surgery (St. Louis)</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">1, pt. 2</span>),
    <span class="NLM_cas:pages">165-71</span>CODEN:
                <span class="NLM_cas:coden">SURGAZ</span>;
        ISSN:<span class="NLM_cas:issn">0039-6060</span>.
    </div><div class="casAbstract">A review with 64 refs. of the antibacterial and protozoacidal activities of metronidazole (I)  [443-48-1].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor-3HRUQCoorVg90H21EOLACvtfcHk0liurIIwVl3HRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXksVOgtLk%253D&md5=f2ddd052469d34eb6779af4f38e0ff62</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26atitle%3DMode%2520of%2520Action%2520of%2520Metronidazole%2520on%2520Anaerobic%2520Bacteria%2520and%2520Protozoa%26jtitle%3DSurgery%26date%3D1983%26volume%3D93%26spage%3D165%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Edwards, D. I.</span><span> </span><span class="NLM_article-title">Nitroimidazole Drugs—Action and Resistance Mechanisms. II. Mechanisms of Resistance</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fjac%2F31.2.201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=8463167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADyaK3sXks1OgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1993&pages=201-210&author=D.+I.+Edwards&title=Nitroimidazole+Drugs%E2%80%94Action+and+Resistance+Mechanisms.+II.+Mechanisms+of+Resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Nitroimidazole drugs - action and resistance mechanisms. II. Mechanisms of resistance</span></div><div class="casAuthors">Edwards, David I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">201-10</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    </div><div class="casAbstract">A review with 57 refs. on drug resistance of nitroimidazole, esp. metronidazole, in bacteria and Trichomonas species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDufDmfbxSGbVg90H21EOLACvtfcHk0lg9A-CkPSt9qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXks1OgtLo%253D&md5=591df0019db20f5a8061322f1337ab11</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1093%2Fjac%2F31.2.201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252F31.2.201%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DD.%2BI.%26atitle%3DNitroimidazole%2520Drugs%25E2%2580%2594Action%2520and%2520Resistance%2520Mechanisms.%2520II.%2520Mechanisms%2520of%2520Resistance%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D1993%26volume%3D31%26spage%3D201%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Bolton, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culshaw, M. A.</span><span> </span><span class="NLM_article-title">Faecal Metronidazole Concentrations during Oral and Intravenous Therapy for Antibiotic Associated Colitis Due to <i>Clostridium difficile</i></span> <span class="citation_source-journal">Gut</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1169</span><span class="NLM_x">–</span> <span class="NLM_lpage">1172</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1986&pages=1169-1172&author=R.+P.+Boltonauthor=M.+A.+Culshaw&title=Faecal+Metronidazole+Concentrations+during+Oral+and+Intravenous+Therapy+for+Antibiotic+Associated+Colitis+Due+to+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBolton%26aufirst%3DR.%2BP.%26aulast%3DCulshaw%26aufirst%3DM.%2BA.%26atitle%3DFaecal%2520Metronidazole%2520Concentrations%2520during%2520Oral%2520and%2520Intravenous%2520Therapy%2520for%2520Antibiotic%2520Associated%2520Colitis%2520Due%2520to%2520Clostridium%2520difficile%26jtitle%3DGut%26date%3D1986%26volume%3D27%26spage%3D1169%26epage%3D1172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Pepin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alary, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valiquette, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raiche, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulop, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourassa, C.</span><span> </span><span class="NLM_article-title">Increasing Risk of Relapse after Treatment of <i>Clostridium difficile</i> Colitis in Quebec, Canada</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1591</span><span class="NLM_x">–</span> <span class="NLM_lpage">1597</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1086%2F430315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=15889355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlCltLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2005&pages=1591-1597&author=J.+Pepinauthor=M.+E.+Alaryauthor=L.+Valiquetteauthor=E.+Raicheauthor=J.+Ruelauthor=K.+Fulopauthor=D.+Godinauthor=C.+Bourassa&title=Increasing+Risk+of+Relapse+after+Treatment+of+Clostridium+difficile+Colitis+in+Quebec%2C+Canada"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada</span></div><div class="casAuthors">Pepin, Jacques; Alary, Marie-Eve; Valiquette, Louis; Raiche, Evelyne; Ruel, Joannie; Fulop, Katalin; Godin, Dominique; Bourassa, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1591-1597</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Background: Clinicians who treat patients with Clostridium difficile-assocd. diarrhea (CDAD) in Quebec, Canada, have noted an apparent increase in the proportion of patients who experience relapse.  Methods: To det. whether there was an increase in the frequency of treatment failure and of recurrence of CDAD after treatment, we reviewed data on cases that had been diagnosed in a hospital in the province of Quebec during the period 1991-2004.  The frequency of recurrences within 60 days after the initial diagnosis was measured using Kaplan-Meier anal., and Cox regression was used for multivariate anal.  Results: Among patients who had initially been treated with metronidazole, the proportion whose regimens were switched to vancomycin or for whom vancomycin was added because of a disappointing response did not vary between 1991 and 2002 (66 [9.6%] of 688 patients overall) but more than doubled in 2003-2004 (112 [25.7%] of 435; P < .001).  Among 845 patients treated with metronidazole only, the 60-day probability of recurrence increased dramatically in 2003-2004 (47.2%), compared with 1991-2002 (20.8%; P < .001).  During 1991-2002, the probabilities of recurrence were 20.0%, 13.8%, and 28.9% among individuals aged 0-17, 18-64, and ≥65 years, resp.; during 2003-2004, the probabilities were 25.0%, 27.1%, and 58.4%, resp.  Conclusion: In 2003-2004, there was an increase in the proportion of patients with CDAD believed, by their attending physicians, to have experienced metronidazole treatment failure, as well as an increase in the frequency of post-metronidazole therapy recurrences, esp. among elderly persons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreNFxjJULaRLVg90H21EOLACvtfcHk0lg9A-CkPSt9qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlCltLY%253D&md5=5be43d85e2da32190ef94434ac54a330</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1086%2F430315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F430315%26sid%3Dliteratum%253Aachs%26aulast%3DPepin%26aufirst%3DJ.%26aulast%3DAlary%26aufirst%3DM.%2BE.%26aulast%3DValiquette%26aufirst%3DL.%26aulast%3DRaiche%26aufirst%3DE.%26aulast%3DRuel%26aufirst%3DJ.%26aulast%3DFulop%26aufirst%3DK.%26aulast%3DGodin%26aufirst%3DD.%26aulast%3DBourassa%26aufirst%3DC.%26atitle%3DIncreasing%2520Risk%2520of%2520Relapse%2520after%2520Treatment%2520of%2520Clostridium%2520difficile%2520Colitis%2520in%2520Quebec%252C%2520Canada%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2005%26volume%3D40%26spage%3D1591%26epage%3D1597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Loll, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axelsen, P. H.</span><span> </span><span class="NLM_article-title">The Structural Biology of Molecular Recognition by Vancomycin</span> <span class="citation_source-journal">Annu. Rev. Biophys. Biomol. Struct.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2000&pages=265-289&author=P.+J.+Lollauthor=P.+H.+Axelsen&title=The+Structural+Biology+of+Molecular+Recognition+by+Vancomycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLoll%26aufirst%3DP.%2BJ.%26aulast%3DAxelsen%26aufirst%3DP.%2BH.%26atitle%3DThe%2520Structural%2520Biology%2520of%2520Molecular%2520Recognition%2520by%2520Vancomycin%26jtitle%3DAnnu.%2520Rev.%2520Biophys.%2520Biomol.%2520Struct.%26date%3D2000%26volume%3D29%26spage%3D265%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Beauregard, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwynn, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knowles, D. J.</span><span> </span><span class="NLM_article-title">Dimerization and Membrane Anchors in Extracellular Targeting of Vancomycin Group Antibiotics</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">785</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1995&pages=781-785&author=D.+A.+Beauregardauthor=D.+H.+Williamsauthor=M.+N.+Gwynnauthor=D.+J.+Knowles&title=Dimerization+and+Membrane+Anchors+in+Extracellular+Targeting+of+Vancomycin+Group+Antibiotics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeauregard%26aufirst%3DD.%2BA.%26aulast%3DWilliams%26aufirst%3DD.%2BH.%26aulast%3DGwynn%26aufirst%3DM.%2BN.%26aulast%3DKnowles%26aufirst%3DD.%2BJ.%26atitle%3DDimerization%2520and%2520Membrane%2520Anchors%2520in%2520Extracellular%2520Targeting%2520of%2520Vancomycin%2520Group%2520Antibiotics%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1995%26volume%3D39%26spage%3D781%26epage%3D785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Finegold, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molitoris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaisanen, M. L.</span><span> </span><span class="NLM_article-title">Study of the in Vitro Activities of Rifaximin and Comparator Agents against 536 Anaerobic Intestinal Bacteria from the Perspective of Potential Utility in Pathology Involving Bowel Flora</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2008&pages=281-286&author=S.+M.+Finegoldauthor=D.+Molitorisauthor=M.+L.+Vaisanen&title=Study+of+the+in+Vitro+Activities+of+Rifaximin+and+Comparator+Agents+against+536+Anaerobic+Intestinal+Bacteria+from+the+Perspective+of+Potential+Utility+in+Pathology+Involving+Bowel+Flora"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFinegold%26aufirst%3DS.%2BM.%26aulast%3DMolitoris%26aufirst%3DD.%26aulast%3DVaisanen%26aufirst%3DM.%2BL.%26atitle%3DStudy%2520of%2520the%2520in%2520Vitro%2520Activities%2520of%2520Rifaximin%2520and%2520Comparator%2520Agents%2520against%2520536%2520Anaerobic%2520Intestinal%2520Bacteria%2520from%2520the%2520Perspective%2520of%2520Potential%2520Utility%2520in%2520Pathology%2520Involving%2520Bowel%2520Flora%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D53%26spage%3D281%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Jiang, Z. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palazzini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riopel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupont, H.</span><span> </span><span class="NLM_article-title">In Vitro Activity and Fecal Concentration of Rifaximin after Oral Administration</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2205</span><span class="NLM_x">–</span> <span class="NLM_lpage">2206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2000&pages=2205-2206&author=Z.+D.+Jiangauthor=S.+Keauthor=E.+Palazziniauthor=L.+Riopelauthor=H.+Dupont&title=In+Vitro+Activity+and+Fecal+Concentration+of+Rifaximin+after+Oral+Administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%2BD.%26aulast%3DKe%26aufirst%3DS.%26aulast%3DPalazzini%26aufirst%3DE.%26aulast%3DRiopel%26aufirst%3DL.%26aulast%3DDupont%26aufirst%3DH.%26atitle%3DIn%2520Vitro%2520Activity%2520and%2520Fecal%2520Concentration%2520of%2520Rifaximin%2520after%2520Oral%2520Administration%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2000%26volume%3D44%26spage%3D2205%26epage%3D2206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span>New Drug To Fight Hospital Superbug Infection. <a href="http://www.specialisedtherapeutics.com.au/index.php?q=new-drug-to-fight-hospital-superbug-infection.html" class="extLink">http://www.specialisedtherapeutics.com.au/index.php?q=new-drug-to-fight-hospital-superbug-infection.html</a> (accessed Mar 20,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=New+Drug+To+Fight+Hospital+Superbug+Infection.+http%3A%2F%2Fwww.specialisedtherapeutics.com.au%2Findex.php%3Fq%3Dnew-drug-to-fight-hospital-superbug-infection.html+%28accessed+Mar+20%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Crook, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kean, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornely, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoesser, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angus, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorbach, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peto, T. E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Study 003/004 Teams.</span><span> </span><span class="NLM_article-title">Fidaxomicin Versus Vancomycin for <i>Clostridium difficile</i> Infection: Meta-Analysis of Pivotal Randomized Controlled Trials</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">S93</span><span class="NLM_x">–</span> <span class="NLM_lpage">S103</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=S93-S103&author=D.+W.+Crookauthor=A.+S.+Walkerauthor=Y.+Keanauthor=K.+Weissauthor=O.+A.+Cornelyauthor=M.+A.+Millerauthor=R.+Espositoauthor=T.+J.+Louieauthor=N.+E.+Stoesserauthor=B.+C.+Youngauthor=B.+J.+Angusauthor=S.+L.+Gorbachauthor=T.+E.+A.+Petoauthor=Study+003%2F004+Teams.&title=Fidaxomicin+Versus+Vancomycin+for+Clostridium+difficile+Infection%3A+Meta-Analysis+of+Pivotal+Randomized+Controlled+Trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrook%26aufirst%3DD.%2BW.%26aulast%3DWalker%26aufirst%3DA.%2BS.%26aulast%3DKean%26aufirst%3DY.%26aulast%3DWeiss%26aufirst%3DK.%26aulast%3DCornely%26aufirst%3DO.%2BA.%26aulast%3DMiller%26aufirst%3DM.%2BA.%26aulast%3DEsposito%26aufirst%3DR.%26aulast%3DLouie%26aufirst%3DT.%2BJ.%26aulast%3DStoesser%26aufirst%3DN.%2BE.%26aulast%3DYoung%26aufirst%3DB.%2BC.%26aulast%3DAngus%26aufirst%3DB.%2BJ.%26aulast%3DGorbach%26aufirst%3DS.%2BL.%26aulast%3DPeto%26aufirst%3DT.%2BE.%2BA.%26aulast%3D%26atitle%3DFidaxomicin%2520Versus%2520Vancomycin%2520for%2520Clostridium%2520difficile%2520Infection%253A%2520Meta-Analysis%2520of%2520Pivotal%2520Randomized%2520Controlled%2520Trials%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2012%26volume%3D55%26spage%3DS93%26epage%3DS103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Erb, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span> </span><span class="NLM_article-title">From Natural Product to Marketed Drug: the Tiacumicin Odyssey</span> <span class="citation_source-journal">Nat. Prod. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1039%2FC2NP20080E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=23111588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVWhtr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=161-174&author=W.+Erbauthor=J.+Zhu&title=From+Natural+Product+to+Marketed+Drug%3A+the+Tiacumicin+Odyssey"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">From natural product to marketed drug: the tiacumicin odyssey</span></div><div class="casAuthors">Erb, William; Zhu, Jieping</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">161-174</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Covering: 1975 to 2012The first members of the tiacumicin family of antibiotics, encompassing more than 40 compds., were isolated in 1975.  Structurally, the core aglycon is an 18-membered macrolactone having two conjugated diene units, one isolated double bond, 5 stereogenic centers and most often, at least one glycosidic linkage.  Tiacumicin B, a RNA synthesis inhibitor, is a narrow-spectrum antibiotic against clostridia.  For the treatment of Clostridium difficile infection (CDI), it has the same cure rate as vancomycin but with lower relapse rate and was approved by the FDA in May 2011.  The aim of this review is to present an overview of the chem. and biol. of tiacumicins since their discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcFIksUUNzBLVg90H21EOLACvtfcHk0ljYp1joVQV78A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVWhtr%252FE&md5=e81d026f6ed1e7534b787fd31eff05c8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2FC2NP20080E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2NP20080E%26sid%3Dliteratum%253Aachs%26aulast%3DErb%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DJ.%26atitle%3DFrom%2520Natural%2520Product%2520to%2520Marketed%2520Drug%253A%2520the%2520Tiacumicin%2520Odyssey%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2013%26volume%3D30%26spage%3D161%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Lynch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hizon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beniac, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kibsey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gravel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvey, M. R.</span><span> </span><span class="NLM_article-title">Canadian Nosocomial Infectious Surveillance Program (CNISP). Characterization of a Stable, Metronidazole-Resistant <i>Clostridium difficile</i> Clinical Isolate</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e53757</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e53757&author=T.+Lynchauthor=P.+Chongauthor=J.+Zhangauthor=R.+Hizonauthor=T.+Duauthor=M.+R.+Grahamauthor=D.+R.+Beniacauthor=T.+F.+Boothauthor=P.+Kibseyauthor=M.+Millerauthor=D.+Gravelauthor=M.+R.+Mulvey&title=Canadian+Nosocomial+Infectious+Surveillance+Program+%28CNISP%29.+Characterization+of+a+Stable%2C+Metronidazole-Resistant+Clostridium+difficile+Clinical+Isolate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DT.%26aulast%3DChong%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DHizon%26aufirst%3DR.%26aulast%3DDu%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DM.%2BR.%26aulast%3DBeniac%26aufirst%3DD.%2BR.%26aulast%3DBooth%26aufirst%3DT.%2BF.%26aulast%3DKibsey%26aufirst%3DP.%26aulast%3DMiller%26aufirst%3DM.%26aulast%3DGravel%26aufirst%3DD.%26aulast%3DMulvey%26aufirst%3DM.%2BR.%26atitle%3DCanadian%2520Nosocomial%2520Infectious%2520Surveillance%2520Program%2520%2528CNISP%2529.%2520Characterization%2520of%2520a%2520Stable%252C%2520Metronidazole-Resistant%2520Clostridium%2520difficile%2520Clinical%2520Isolate%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De53757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Snydman, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobus, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, L. A.</span><span> </span><span class="NLM_article-title">Activity of a Novel Cyclic Lipopeptide, CB-183,315, against Resistant <i>Clostridium difficile</i> and Other Gram-Positive Aerobic and Anaerobic Intestinal Pathogens</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3448</span><span class="NLM_x">–</span> <span class="NLM_lpage">3452</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=3448-3452&author=D.+R.+Snydmanauthor=N.+V.+Jacobusauthor=L.+A.+McDermott&title=Activity+of+a+Novel+Cyclic+Lipopeptide%2C+CB-183%2C315%2C+against+Resistant+Clostridium+difficile+and+Other+Gram-Positive+Aerobic+and+Anaerobic+Intestinal+Pathogens"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSnydman%26aufirst%3DD.%2BR.%26aulast%3DJacobus%26aufirst%3DN.%2BV.%26aulast%3DMcDermott%26aufirst%3DL.%2BA.%26atitle%3DActivity%2520of%2520a%2520Novel%2520Cyclic%2520Lipopeptide%252C%2520CB-183%252C315%252C%2520against%2520Resistant%2520Clostridium%2520difficile%2520and%2520Other%2520Gram-Positive%2520Aerobic%2520and%2520Anaerobic%2520Intestinal%2520Pathogens%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D3448%26epage%3D3452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baines, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corver, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawley, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goorhuis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuijper, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. H.</span><span> </span><span class="NLM_article-title">The Changing Epidemiology of <i>Clostridium difficile</i> Infections</span> <span class="citation_source-journal">Clin. Microbiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">549</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1128%2FCMR.00082-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=20610822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWgtLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=529-549&author=J.+Freemanauthor=M.+P.+Bauerauthor=S.+D.+Bainesauthor=J.+Corverauthor=W.+N.+Fawleyauthor=B.+Goorhuisauthor=E.+J.+Kuijperauthor=M.+H.+Wilcox&title=The+Changing+Epidemiology+of+Clostridium+difficile+Infections"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The changing epidemiology of Clostridium difficile infections</span></div><div class="casAuthors">Freeman, J.; Bauer, M. P.; Baines, S. D.; Corver, J.; Fawley, W. N.; Goorhuis, B.; Kuijper, E. J.; Wilcox, M. H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">529-549</span>CODEN:
                <span class="NLM_cas:coden">CMIREX</span>;
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  The epidemiol. of Clostridium difficile infection (CDI) has changed dramatically during this millennium.  Infection rates have increased markedly in most countries with detailed surveillance data.  There have been clear changes in the clin. presentation, response to treatment, and outcome of CDI.  These changes have been driven to a major degree by the emergence and epidemic spread of a novel strain, known as PCR ribotype 027 (sometimes referred to as BI/NAP1/027).  We review the evidence for the changing epidemiol., clin. virulence and outcome of treatment of CDI, and the similarities and differences between data from various countries and continents.  Community-acquired CDI has also emerged, although the evidence for this as a distinct new entity is less clear.  There are new data on the etiol. of and potential risk factors for CDI; controversial issues include specific antimicrobial agents, gastric acid suppressants, potential animal and food sources of C. difficile, and the effect of the use of alc.-based hand hygiene agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj5gUdmKNzDLVg90H21EOLACvtfcHk0ljSETU2N1Pxyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWgtLjI&md5=fcfd1a5f5ac00d61e03bcac78f21d84f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1128%2FCMR.00082-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.00082-09%26sid%3Dliteratum%253Aachs%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DBauer%26aufirst%3DM.%2BP.%26aulast%3DBaines%26aufirst%3DS.%2BD.%26aulast%3DCorver%26aufirst%3DJ.%26aulast%3DFawley%26aufirst%3DW.%2BN.%26aulast%3DGoorhuis%26aufirst%3DB.%26aulast%3DKuijper%26aufirst%3DE.%2BJ.%26aulast%3DWilcox%26aufirst%3DM.%2BH.%26atitle%3DThe%2520Changing%2520Epidemiology%2520of%2520Clostridium%2520difficile%2520Infections%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D2010%26volume%3D23%26spage%3D529%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weintraub, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nord, C. E.</span><span> </span><span class="NLM_article-title">Antimicrobial Resistance in <i>Clostridium difficile</i></span> <span class="citation_source-journal">Int. J. Antimicrob. Agents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">516</span><span class="NLM_x">–</span> <span class="NLM_lpage">522</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1016%2Fj.ijantimicag.2009.09.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=19828299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlGhs7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=516-522&author=H.+Huangauthor=A.+Weintraubauthor=H.+Fangauthor=C.+E.+Nord&title=Antimicrobial+Resistance+in+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial resistance in Clostridium difficile</span></div><div class="casAuthors">Huang, Haihui; Weintraub, Andrej; Fang, Hong; Nord, Carl Erik</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">516-522</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Clostridium difficile is the leading cause of hospital-acquired diarrhea, and the no. of outbreaks has risen markedly since 2003.  The emergence and spread of resistance in C. difficile has complicated treatment and prevention.  Most isolates are susceptible to vancomycin and metronidazole (MTZ); however, transient and heteroresistance to MTZ have been reported.  The prevalence of resistance to other antimicrobial agents is highly variable in different populations and in different countries, ranging from 0% to 100%.  Isolates of common PCR ribotypes are more resistant than uncommon ribotypes.  Most of the resistance mechanisms that have been identified in C. difficile are similar to those in other Gram-pos. bacteria, including mutation, selection, and acquisition of the genetic information that encodes resistance.  Better antibiotic stewardship and infection control are needed to prevent further spread of resistance in C. difficile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7gAYS41tNFbVg90H21EOLACvtfcHk0ljSETU2N1Pxyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlGhs7vL&md5=f3c925e9c1b6129c26d801a10f2e54d1</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.ijantimicag.2009.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijantimicag.2009.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DWeintraub%26aufirst%3DA.%26aulast%3DFang%26aufirst%3DH.%26aulast%3DNord%26aufirst%3DC.%2BE.%26atitle%3DAntimicrobial%2520Resistance%2520in%2520Clostridium%2520difficile%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2009%26volume%3D34%26spage%3D516%26epage%3D522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Peláez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cercenado, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcalá, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marín, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martín-López, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-Alarcón, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catalán, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez-Somolinos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouza, E.</span><span> </span><span class="NLM_article-title">Metronidazole Resistance in <i>Clostridium difficile</i> Is Heterogeneous</span> <span class="citation_source-journal">J. Clin. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3028</span><span class="NLM_x">–</span> <span class="NLM_lpage">3032</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1128%2FJCM.00524-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=18650353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFOku7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2008&pages=3028-3032&author=T.+Pel%C3%A1ezauthor=E.+Cercenadoauthor=L.+Alcal%C3%A1author=M.+Mar%C3%ADnauthor=A.+Mart%C3%ADn-L%C3%B3pezauthor=J.+Mart%C3%ADnez-Alarc%C3%B3nauthor=P.+Catal%C3%A1nauthor=M.+S%C3%A1nchez-Somolinosauthor=E.+Bouza&title=Metronidazole+Resistance+in+Clostridium+difficile+Is+Heterogeneous"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Metronidazole resistance in Clostridium difficile is heterogeneous</span></div><div class="casAuthors">Pelaez, T.; Cercenado, E.; Alcala, L.; Marin, M.; Martin-Lopez, A.; Martinez-Alarcon, J.; Catalan, P.; Sanchez-Somolinos, M.; Bouza, E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Microbiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3028-3032</span>CODEN:
                <span class="NLM_cas:coden">JCMIDW</span>;
        ISSN:<span class="NLM_cas:issn">0095-1137</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">At our institution, the prevalence of clin. isolates of Clostridium difficile with resistance to metronidazole is 6.3%.  We obsd. that initial metronidazole MICs of 16 to 64 mg/L against toxigenic, primary fresh C. difficile isolates, as detd. by agar diln., decreased to 0.125 mg/L after the isolates were thawed.  In this study, we examd. the possibility of heterogeneous or inducible resistance.  Totals of 14 metronidazole-resistant and 10 metronidazole-susceptible clin. isolates of toxigenic C. difficile were studied.  The isolates were investigated for the presence of nim genes by PCR.  After the isolates were thawed, susceptibility testing was done by agar diln., by disk diffusion using a 5-μg metronidazole disk, and by the Etest method.  An expt. for detg. the effect of prolonged exposure to metronidazole was applied to all resistant isolates and to susceptible control strains.  None of the isolates presented the nim genes.  All initially metronidazole-resistant C. difficile isolates became susceptible after thawing; however, they presented slow-growing subpopulations within the inhibition zones of both the disk and the Etest strip.  All metronidazole-susceptible isolates remained homogeneously susceptible by both methods.  After prolonged exposure in vitro to metronidazole, no zone of inhibition was found around the 5-μg disk in any of the metronidazole-resistant isolates, and the MICs as detd. by the Etest method ranged from 0.125 to >256 mg/L, with colonies growing inside the inhibition zone.  Our results indicate that (i) resistance to metronidazole was not due to the presence of nim genes, (ii) resistance to metronidazole in toxigenic C. difficile isolates is heterogeneous, and (iii) prolonged exposure to metronidazole can select for in vitro resistance.  We recommend routine performance of the disk diffusion method (5-μg metronidazole disk) with primary fresh C. difficile isolates in order to ensure that metronidazole-heteroresistant populations do not go undetected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp33HFIX6NNzrVg90H21EOLACvtfcHk0ljSETU2N1Pxyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFOku7vO&md5=2a91c7d8966298827704936bce32639b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1128%2FJCM.00524-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJCM.00524-08%26sid%3Dliteratum%253Aachs%26aulast%3DPel%25C3%25A1ez%26aufirst%3DT.%26aulast%3DCercenado%26aufirst%3DE.%26aulast%3DAlcal%25C3%25A1%26aufirst%3DL.%26aulast%3DMar%25C3%25ADn%26aufirst%3DM.%26aulast%3DMart%25C3%25ADn-L%25C3%25B3pez%26aufirst%3DA.%26aulast%3DMart%25C3%25ADnez-Alarc%25C3%25B3n%26aufirst%3DJ.%26aulast%3DCatal%25C3%25A1n%26aufirst%3DP.%26aulast%3DS%25C3%25A1nchez-Somolinos%26aufirst%3DM.%26aulast%3DBouza%26aufirst%3DE.%26atitle%3DMetronidazole%2520Resistance%2520in%2520Clostridium%2520difficile%2520Is%2520Heterogeneous%26jtitle%3DJ.%2520Clin.%2520Microbiol.%26date%3D2008%26volume%3D46%26spage%3D3028%26epage%3D3032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Goldstein, E. J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sears, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babakhani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambol, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerding, D. N.</span><span> </span><span class="NLM_article-title">Comparative Susceptibilities to Fidaxomicin (OPT-80) of Isolates Collected at Baseline, Recurrence, and Failure from Patients in Two Phase III Trials of Fidaxomicin against <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5194</span><span class="NLM_x">–</span> <span class="NLM_lpage">5199</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=5194-5199&author=E.+J.+C.+Goldsteinauthor=D.+M.+Citronauthor=P.+Searsauthor=F.+Babakhaniauthor=S.+P.+Sambolauthor=D.+N.+Gerding&title=Comparative+Susceptibilities+to+Fidaxomicin+%28OPT-80%29+of+Isolates+Collected+at+Baseline%2C+Recurrence%2C+and+Failure+from+Patients+in+Two+Phase+III+Trials+of+Fidaxomicin+against+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DE.%2BJ.%2BC.%26aulast%3DCitron%26aufirst%3DD.%2BM.%26aulast%3DSears%26aufirst%3DP.%26aulast%3DBabakhani%26aufirst%3DF.%26aulast%3DSambol%26aufirst%3DS.%2BP.%26aulast%3DGerding%26aufirst%3DD.%2BN.%26atitle%3DComparative%2520Susceptibilities%2520to%2520Fidaxomicin%2520%2528OPT-80%2529%2520of%2520Isolates%2520Collected%2520at%2520Baseline%252C%2520Recurrence%252C%2520and%2520Failure%2520from%2520Patients%2520in%2520Two%2520Phase%2520III%2520Trials%2520of%2520Fidaxomicin%2520against%2520Clostridium%2520difficile%2520Infection%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2011%26volume%3D55%26spage%3D5194%26epage%3D5199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Grant, E. M.</span><span> </span><span class="NLM_article-title">Fidaxomicin: New Therapy for <i>Clostridium difficile</i>-Associated Diarrhea</span> <span class="citation_source-journal">Formulary</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1eisr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=297-308&author=E.+M.+Grant&title=Fidaxomicin%3A+New+Therapy+for+Clostridium+difficile-Associated+Diarrhea"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Fidaxomicin: new therapy for Clostridium difficile-associated diarrhea</span></div><div class="casAuthors">Grant, Edward M.</div><div class="citationInfo"><span class="NLM_cas:title">Formulary</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">297,298, 302-308</span>CODEN:
                <span class="NLM_cas:coden">FORMF9</span>;
        ISSN:<span class="NLM_cas:issn">1082-801X</span>.
    
            (<span class="NLM_cas:orgname">Advanstar Communications, Inc.</span>)
        </div><div class="casAbstract">A review.  Fidaxomicin is a new oral, nonsystemic macrolide with twice daily dosing that was recently FDA approved to treat Clostridium difficile-assocd. diarrhea (CDAD) in adults (≥18 years of age).  It is a bactericidal agent against C difficile, demonstrates no cross resistance with other classes of antimicrobial agents, and in vitro studies suggest a low frequency of spontaneous resistance of C difficile to fidaxomicin.  In 2 randomized, double-blind clin. studies, clin. response rates to fidaxomicin were shown to be noninferior to those with vancomycin at end of treatment, and fidaxomicin was superior to vancomycin at preventing CDAD recurrences.  For the first time in >30 years, clinicians have a new oral antibiotic to treat C difficile infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6W_3k4kSEi7Vg90H21EOLACvtfcHk0lhdjkG63pLrkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1eisr%252FJ&md5=028cb7457da8b8d136a6b1fd77d514ce</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrant%26aufirst%3DE.%2BM.%26atitle%3DFidaxomicin%253A%2520New%2520Therapy%2520for%2520Clostridium%2520difficile-Associated%2520Diarrhea%26jtitle%3DFormulary%26date%3D2011%26volume%3D46%26spage%3D297%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">O’Connor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galang, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambol, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedantam, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerding, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S.</span><span> </span><span class="NLM_article-title">Rifampin and Rifaximin Resistance in Clinical Isolates of <i>Clostridium difficile</i></span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2813</span><span class="NLM_x">–</span> <span class="NLM_lpage">2817</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=2813-2817&author=J.+R.+O%E2%80%99Connorauthor=M.+A.+Galangauthor=S.+P.+Sambolauthor=D.+W.+Hechtauthor=G.+Vedantamauthor=D.+N.+Gerdingauthor=S.+Johnson&title=Rifampin+and+Rifaximin+Resistance+in+Clinical+Isolates+of+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DJ.%2BR.%26aulast%3DGalang%26aufirst%3DM.%2BA.%26aulast%3DSambol%26aufirst%3DS.%2BP.%26aulast%3DHecht%26aufirst%3DD.%2BW.%26aulast%3DVedantam%26aufirst%3DG.%26aulast%3DGerding%26aufirst%3DD.%2BN.%26aulast%3DJohnson%26aufirst%3DS.%26atitle%3DRifampin%2520and%2520Rifaximin%2520Resistance%2520in%2520Clinical%2520Isolates%2520of%2520Clostridium%2520difficile%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D2813%26epage%3D2817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Johnson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homann, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bettin, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quick, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clabots, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerding, D. N.</span><span> </span><span class="NLM_article-title">Treatment of Asymptomatic <i>Clostridium difficile</i> Carriers (Fecal Excretors) with Vancomycin or Metronidazole. A Randomized, Placebo-Controlled Trial</span> <span class="citation_source-journal">Ann. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.7326%2F0003-4819-117-4-297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=1322075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADyaK38zksVWmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1992&pages=297-302&author=S.+Johnsonauthor=S.+R.+Homannauthor=K.+M.+Bettinauthor=J.+N.+Quickauthor=C.+R.+Clabotsauthor=L.+R.+Petersonauthor=D.+N.+Gerding&title=Treatment+of+Asymptomatic+Clostridium+difficile+Carriers+%28Fecal+Excretors%29+with+Vancomycin+or+Metronidazole.+A+Randomized%2C+Placebo-Controlled+Trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial</span></div><div class="casAuthors">Johnson S; Homann S R; Bettin K M; Quick J N; Clabots C R; Peterson L R; Gerding D N</div><div class="citationInfo"><span class="NLM_cas:title">Annals of internal medicine</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">297-302</span>
        ISSN:<span class="NLM_cas:issn">0003-4819</span>.
    </div><div class="casAbstract">OBJECTIVE:  To compare the efficacy of vancomycin and metronidazole for eradication of asymptomatic Clostridium difficile fecal excretion as a means of controlling nosocomial outbreaks of C. difficile diarrhea.  DESIGN:  Randomized, placebo-controlled, non-blinded trial.  SETTING:  Six hundred-bed regional referral Veterans Affairs Medical Center.  PATIENTS:  Thirty patients excreting C. difficile without diarrhea or abdominal symptoms.  INTERVENTIONS:  All patients were randomized to receive 10 days of oral vancomycin, 125 mg four times daily; metronidazole, 500 mg twice daily; or placebo, three times daily.  MEASUREMENTS:  Stool cultures were obtained during treatment and for 2 months after treatment.  All C. difficile isolates were typed by restriction endonuclease analysis (REA).  RESULTS:  Clostridium difficile organisms were not detected during and immediately after treatment in 9 of 10 patients treated with vancomycin compared with 3 of 10 patients treated with metronidazole (P = 0.02) and 2 of 10 patients in the placebo group (P = 0.005).  The fecal vancomycin concentration was 1406 +/- 1164 micrograms/g feces, but metronidazole was not detectable in 9 of 10 patients.  Eight of the nine evaluable patients who had negative stool cultures after treatment with vancomycin began to excrete C. difficile again 20 +/- 8 days after completing treatment.  Three of these patients received additional antibiotics before C. difficile excretion recurred, and five acquired new C. difficile REA strains.  Four of six patients who received only vancomycin before C. difficile excretion recurred were culture-positive at the end of the study compared with one of nine patients who received only placebo (P = 0.047).  CONCLUSIONS:  Asymptomatic fecal excretion of C. difficile is transient in most patients, and treatment with metronidazole is not effective.  Although treatment with vancomycin is temporarily effective, it is associated with a significantly higher rate of C. difficile carriage 2 months after treatment and is not recommended.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRD-3Sno8N1VaqcneEtCi92fW6udTcc2eYk4nUJ4XBLprntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38zksVWmtA%253D%253D&md5=c023a9331bd8a715ae501c2c7e1195e3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-117-4-297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-117-4-297%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DS.%26aulast%3DHomann%26aufirst%3DS.%2BR.%26aulast%3DBettin%26aufirst%3DK.%2BM.%26aulast%3DQuick%26aufirst%3DJ.%2BN.%26aulast%3DClabots%26aufirst%3DC.%2BR.%26aulast%3DPeterson%26aufirst%3DL.%2BR.%26aulast%3DGerding%26aufirst%3DD.%2BN.%26atitle%3DTreatment%2520of%2520Asymptomatic%2520Clostridium%2520difficile%2520Carriers%2520%2528Fecal%2520Excretors%2529%2520with%2520Vancomycin%2520or%2520Metronidazole.%2520A%2520Randomized%252C%2520Placebo-Controlled%2520Trial%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D1992%26volume%3D117%26spage%3D297%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Sears, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crook, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, K.</span><span> </span><span class="NLM_article-title">Fidaxomicin Attains High Fecal Concentrations with Minimal Plasma Concentrations Following Oral Administration in Patients with <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S116</span><span class="NLM_x">–</span> <span class="NLM_lpage">S120</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=S116-S120&issue=Suppl.+2&author=P.+Searsauthor=D.+W.+Crookauthor=T.+J.+Louieauthor=M.+A.+Millerauthor=K.+Weiss&title=Fidaxomicin+Attains+High+Fecal+Concentrations+with+Minimal+Plasma+Concentrations+Following+Oral+Administration+in+Patients+with+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSears%26aufirst%3DP.%26aulast%3DCrook%26aufirst%3DD.%2BW.%26aulast%3DLouie%26aufirst%3DT.%2BJ.%26aulast%3DMiller%26aufirst%3DM.%2BA.%26aulast%3DWeiss%26aufirst%3DK.%26atitle%3DFidaxomicin%2520Attains%2520High%2520Fecal%2520Concentrations%2520with%2520Minimal%2520Plasma%2520Concentrations%2520Following%2520Oral%2520Administration%2520in%2520Patients%2520with%2520Clostridium%2520difficile%2520Infection%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2012%26volume%3D55%26issue%3DSuppl.%25202%26spage%3DS116%26epage%3DS120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Kelly, C. P.</span><span> </span><span class="NLM_article-title">Fecal Microbiota Transplantation—An Old Therapy Comes of Age</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">474</span><span class="NLM_x">–</span> <span class="NLM_lpage">475</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1056%2FNEJMe1214816" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=23323865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVeltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2013&pages=474-475&author=C.+P.+Kelly&title=Fecal+Microbiota+Transplantation%E2%80%94An+Old+Therapy+Comes+of+Age"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Fecal microbiota transplantation - an old therapy comes of age</span></div><div class="casAuthors">Kelly, Ciaran P.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">474-475</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqABqdif50EO7Vg90H21EOLACvtfcHk0lg-42mGdh6Tjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVeltrw%253D&md5=8f7e32893005cdc4d0025dd66aa917f1</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1056%2FNEJMe1214816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMe1214816%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DC.%2BP.%26atitle%3DFecal%2520Microbiota%2520Transplantation%25E2%2580%2594An%2520Old%2520Therapy%2520Comes%2520of%2520Age%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D368%26spage%3D474%26epage%3D475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Van Nood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrieze, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieuwdorp, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuentes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoetendal, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vos, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuijper, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartelsman, J. F. W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tijssen, J. G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speelman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dijkgraaf, M. G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, J. J.</span><span> </span><span class="NLM_article-title">Duodenal Infusion of Donor Feces for Recurrent <i>Clostridium difficile</i></span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1056%2FNEJMoa1205037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=23323867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVelsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2013&pages=407-415&author=E.+Van+Noodauthor=A.+Vriezeauthor=M.+Nieuwdorpauthor=S.+Fuentesauthor=E.+G.+Zoetendalauthor=W.+M.+de+Vosauthor=C.+E.+Visserauthor=E.+J.+Kuijperauthor=J.+F.+W.+M.+Bartelsmanauthor=J.+G.+P.+Tijssenauthor=P.+Speelmanauthor=M.+G.+W.+Dijkgraafauthor=J.+J.+Keller&title=Duodenal+Infusion+of+Donor+Feces+for+Recurrent+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Duodenal infusion of donor feces for recurrent clostridium difficile</span></div><div class="casAuthors">van Nood, Els; Vrieze, Anne; Nieuwdorp, Max; Fuentes, Susana; Zoetendal, Erwin G.; de Vos, Willem M.; Visser, Caroline E.; Kuijper, Ed J.; Bartelsman, Joep F. W. M.; Tijssen, Jan G. P.; Speelman, Peter; Dijkgraaf, Marcel G. W.; Keller, Josbert J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">407-415</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Recurrent Clostridium difficile infection is difficult to treat, and failure rates for antibiotic therapy are high.  We studied the effect of duodenal infusion of donor feces in patients with recurrent C. difficile infection.  METHODS We randomly assigned patients to receive one of three therapies: an initial vancomycin regimen (500 mg orally four times per day for 4 days), followed by bowel lavage and subsequent infusion of a soln. of donor feces through a nasoduodenal tube; a std. vancomycin regimen (500 mg orally four times per day for 14 days); or a std. vancomycin regimen with bowel lavage.  The primary end point was the resoln. of diarrhea assocd. with C. difficile infection without relapse after 10 wk.  RESULTS The study was stopped after an interim anal.  Of 16 patients in the infusion group, 13 (81%) had resoln. of C. difficile-assocd. diarrhea after the first infusion.  The 3 remaining patients received a second infusion with feces from a different donor, with resoln. in 2 patients.  Resoln. of C. difficile infection occurred in 4 of 13 patients (31%) receiving vancomycin alone and in 3 of 13 patients (23%) receiving vancomycin with bowel lavage (P<0.001 for both comparisons with the infusion group).  No significant differences in adverse events among the three study groups were obsd. except for mild diarrhea and abdominal cramping in the infusion group on the infusion day.  After donor-feces infusion, patients showed increased fecal bacterial diversity, similar to that in healthy donors, with an increase in Bacteroidetes species and clostridium clusters IV and XIVa and a decrease in Proteobacteria species.  CONCLUSIONS The infusion of donor feces was significantly more effective for the treatment of recurrent C. difficile infection than the use of vancomycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0hVsSV2VIDbVg90H21EOLACvtfcHk0lg-42mGdh6Tjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVelsbs%253D&md5=9e739f9ad764896267b832e89666c9fb</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1205037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1205037%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BNood%26aufirst%3DE.%26aulast%3DVrieze%26aufirst%3DA.%26aulast%3DNieuwdorp%26aufirst%3DM.%26aulast%3DFuentes%26aufirst%3DS.%26aulast%3DZoetendal%26aufirst%3DE.%2BG.%26aulast%3Dde%2BVos%26aufirst%3DW.%2BM.%26aulast%3DVisser%26aufirst%3DC.%2BE.%26aulast%3DKuijper%26aufirst%3DE.%2BJ.%26aulast%3DBartelsman%26aufirst%3DJ.%2BF.%2BW.%2BM.%26aulast%3DTijssen%26aufirst%3DJ.%2BG.%2BP.%26aulast%3DSpeelman%26aufirst%3DP.%26aulast%3DDijkgraaf%26aufirst%3DM.%2BG.%2BW.%26aulast%3DKeller%26aufirst%3DJ.%2BJ.%26atitle%3DDuodenal%2520Infusion%2520of%2520Donor%2520Feces%2520for%2520Recurrent%2520Clostridium%2520difficile%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D368%26spage%3D407%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Gough, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaikh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manges, A. R.</span><span> </span><span class="NLM_article-title">Systematic Review of Intestinal Microbiota Transplantation (Fecal Bacteriotherapy) for Recurrent <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">994</span><span class="NLM_x">–</span> <span class="NLM_lpage">1002</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fcid%2Fcir632" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=22002980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADC%252BC3Mbhs1emsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2011&pages=994-1002&author=E.+Goughauthor=H.+Shaikhauthor=A.+R.+Manges&title=Systematic+Review+of+Intestinal+Microbiota+Transplantation+%28Fecal+Bacteriotherapy%29+for+Recurrent+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection</span></div><div class="casAuthors">Gough Ethan; Shaikh Henna; Manges Amee R</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">994-1002</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Clostridium difficile infection (CDI) is a gastrointestinal disease believed to be causally related to perturbations to the intestinal microbiota.  When standard treatment has failed, intestinal microbiota transplantation (IMT) is an alternative therapy for patients with CDI.  IMT involves infusing intestinal microorganisms (in a suspension of healthy donor stool) into the intestine of a sick patient to restore the microbiota.  However, protocols and reported efficacy for IMT vary.  We conducted a systematic literature review of IMT treatment for recurrent CDI and pseudomembranous colitis.  In 317 patients treated across 27 case series and reports, IMT was highly effective, showing disease resolution in 92% of cases.  Effectiveness varied by route of instillation, relationship to stool donor, volume of IMT given, and treatment before infusion.  Death and adverse events were uncommon.  These findings can guide physicians interested in implementing the procedure until better designed studies are conducted to confirm best practices.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnNF5GDChlcJZoeNcnHOQ9fW6udTcc2ebsxpaeM9I5B7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mbhs1emsA%253D%253D&md5=323ed1a1e99f6c06f7c045c917ed5945</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fcir632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fcir632%26sid%3Dliteratum%253Aachs%26aulast%3DGough%26aufirst%3DE.%26aulast%3DShaikh%26aufirst%3DH.%26aulast%3DManges%26aufirst%3DA.%2BR.%26atitle%3DSystematic%2520Review%2520of%2520Intestinal%2520Microbiota%2520Transplantation%2520%2528Fecal%2520Bacteriotherapy%2529%2520for%2520Recurrent%2520Clostridium%2520difficile%2520Infection%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2011%26volume%3D53%26spage%3D994%26epage%3D1002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Zipursky, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidorsky, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidorsky, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkland, K. B.</span><span> </span><span class="NLM_article-title">Patient Attitudes toward the Use of Fecal Microbiota Transplantation in the Treatment of Recurrent <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1652</span><span class="NLM_x">–</span> <span class="NLM_lpage">1658</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fcid%2Fcis809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=22990849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADC%252BC38bot1alug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1652-1658&author=J.+S.+Zipurskyauthor=T.+I.+Sidorskyauthor=C.+A.+Freedmanauthor=M.+N.+Sidorskyauthor=K.+B.+Kirkland&title=Patient+Attitudes+toward+the+Use+of+Fecal+Microbiota+Transplantation+in+the+Treatment+of+Recurrent+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection</span></div><div class="casAuthors">Zipursky Jonathan S; Sidorsky Tivon I; Freedman Carolyn A; Sidorsky Misha N; Kirkland Kathryn B</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1652-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Fecal microbiota transplantation (FMT), a safe, effective alternative therapy for recurrent Clostridium difficile infection (CDI), is infrequently used, in part because of an assumption that patients are unwilling to consider FMT because of its unappealing nature.  METHODS:  Through a structured survey, including hypothetical case scenarios, we assessed patient perceptions of the aesthetics of FMT and their willingness to consider it as a treatment option, when presented with scenarios involving recurrent CDI.  RESULTS:  Four hundred surveys were distributed; 192 (48%) were returned complete.  Seventy percent of respondents were female; 59% were >49 years of age.  When provided efficacy data only, 162 respondents (85%) chose to receive FMT, and 29 (15%) chose antibiotics alone.  When aware of the fecal nature of FMT, 16 respondents changed their choice from FMT to antibiotics alone, but there was no significant change in the total number choosing FMT (154 [81%]; P = .15).  More respondents chose FMT if offered as a pill (90%; P = .002) or if their physician recommended it (94%; P < .001).  Respondents rated all aspects of FMT at least "somewhat unappealing," selecting "the need to handle stool" and "receiving FMT by nasogastric tube" as most unappealing.  Women rated all aspects of FMT more unappealing; older respondents rated all aspects less unappealing.  Most respondents preferred to receive FMT in the hospital (48%) or physician's office (39%); 77% were willing to pay out-of-pocket for FMT.  CONCLUSIONS:  Patients recognize the inherently unappealing nature of FMT, but they are nonetheless open to considering it as a treatment alternative for recurrent CDI, especially when recommended by a physician.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT6291gD3ErOo2y4bB4mnvYfW6udTcc2eYkSSAb1nRui7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bot1alug%253D%253D&md5=80dfac8181c7bdeb354ffccff379c522</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fcis809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fcis809%26sid%3Dliteratum%253Aachs%26aulast%3DZipursky%26aufirst%3DJ.%2BS.%26aulast%3DSidorsky%26aufirst%3DT.%2BI.%26aulast%3DFreedman%26aufirst%3DC.%2BA.%26aulast%3DSidorsky%26aufirst%3DM.%2BN.%26aulast%3DKirkland%26aufirst%3DK.%2BB.%26atitle%3DPatient%2520Attitudes%2520toward%2520the%2520Use%2520of%2520Fecal%2520Microbiota%2520Transplantation%2520in%2520the%2520Treatment%2520of%2520Recurrent%2520Clostridium%2520difficile%2520Infection%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2012%26volume%3D55%26spage%3D1652%26epage%3D1658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Kahn, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorawara Bhat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, D. T.</span><span> </span><span class="NLM_article-title">Fecal Bacteriotherapy for Ulcerative Colitis: Patients Are Ready, Are We?</span> <span class="citation_source-journal">Inflammatory Bowel Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">676</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1002%2Fibd.21775" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=21618362" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=676-684&author=S.+A.+Kahnauthor=R.+Gorawara+Bhatauthor=D.+T.+Rubin&title=Fecal+Bacteriotherapy+for+Ulcerative+Colitis%3A+Patients+Are+Ready%2C+Are+We%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fibd.21775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fibd.21775%26sid%3Dliteratum%253Aachs%26aulast%3DKahn%26aufirst%3DS.%2BA.%26aulast%3DGorawara%2BBhat%26aufirst%3DR.%26aulast%3DRubin%26aufirst%3DD.%2BT.%26atitle%3DFecal%2520Bacteriotherapy%2520for%2520Ulcerative%2520Colitis%253A%2520Patients%2520Are%2520Ready%252C%2520Are%2520We%253F%26jtitle%3DInflammatory%2520Bowel%2520Dis.%26date%3D2011%26volume%3D18%26spage%3D676%26epage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Hong, G.</span> <span class="citation_source-book">Dongjin Dynasty. Zhou Hou Bei Ji Fang</span>; <span class="NLM_publisher-name">Tianjin Science & Technology Press</span>: <span class="NLM_publisher-loc">Tianjin, China</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=G.+Hong&title=Dongjin+Dynasty.+Zhou+Hou+Bei+Ji+Fang"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DG.%26btitle%3DDongjin%2520Dynasty.%2520Zhou%2520Hou%2520Bei%2520Ji%2520Fang%26pub%3DTianjin%2520Science%2520%2526%2520Technology%2520Press%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, G.</span><span> </span><span class="NLM_article-title">Should We Standardize the 1,700-Year-Old Fecal Microbiota Transplantation?</span> <span class="citation_source-journal">Am. J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">1755</span><span class="NLM_x">–</span> <span class="NLM_lpage">1755</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1038%2Fajg.2012.251" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=23160295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADC%252BC3s7kt1Srsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2012&pages=1755-1755&author=F.+Zhangauthor=W.+Luoauthor=Y.+Shiauthor=Z.+Fanauthor=G.+Ji&title=Should+We+Standardize+the+1%2C700-Year-Old+Fecal+Microbiota+Transplantation%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Should we standardize the 1,700-year-old fecal microbiota transplantation?</span></div><div class="casAuthors">Zhang Faming; Luo Wensheng; Shi Yan; Fan Zhining; Ji Guozhong</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of gastroenterology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1755; author reply p.1755-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQeQJrtSRDhIbmQt-ICR3qNfW6udTcc2eYkSSAb1nRui7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s7kt1Srsw%253D%253D&md5=f4f9529f40c384c976f9bd6aaca4fa16</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fajg.2012.251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fajg.2012.251%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DLuo%26aufirst%3DW.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DZ.%26aulast%3DJi%26aufirst%3DG.%26atitle%3DShould%2520We%2520Standardize%2520the%25201%252C700-Year-Old%2520Fecal%2520Microbiota%2520Transplantation%253F%26jtitle%3DAm.%2520J.%2520Gastroenterol.%26date%3D2012%26volume%3D107%26spage%3D1755%26epage%3D1755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Leake, I.</span><span> </span><span class="NLM_article-title"><i>Clostridium difficile</i> Infection: Real or Fake-Faecal Matter Does the Trick for Recurrent CDI</span> <span class="citation_source-journal">Nat. Rev. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1038%2Fnrgastro.2013.16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=23358398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADC%252BC3szjt12gsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=129&author=I.+Leake&title=Clostridium+difficile+Infection%3A+Real+or+Fake-Faecal+Matter+Does+the+Trick+for+Recurrent+CDI"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Clostridium difficile infection: Real or fake--faecal matter does the trick for recurrent CDI</span></div><div class="casAuthors">Leake Isobel</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Gastroenterology & hepatology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">129</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPwiOr3vbNw3y-c-E1v-fmfW6udTcc2eYkSSAb1nRui7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szjt12gsA%253D%253D&md5=47acf0c82cc8a42d47efe641c300e588</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fnrgastro.2013.16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrgastro.2013.16%26sid%3Dliteratum%253Aachs%26aulast%3DLeake%26aufirst%3DI.%26atitle%3DClostridium%2520difficile%2520Infection%253A%2520Real%2520or%2520Fake-Faecal%2520Matter%2520Does%2520the%2520Trick%2520for%2520Recurrent%2520CDI%26jtitle%3DNat.%2520Rev.%2520Gastroenterol.%2520Hepatol.%26date%3D2013%26volume%3D10%26spage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Hamilton, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weingarden, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadowsky, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khoruts, A.</span><span> </span><span class="NLM_article-title">Standardized Frozen Preparation for Transplantation of Fecal Microbiota for Recurrent <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">Am. J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">767</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1038%2Fajg.2011.482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=22290405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADC%252BC38vhsFOgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2012&pages=761-767&author=M.+J.+Hamiltonauthor=A.+R.+Weingardenauthor=M.+J.+Sadowskyauthor=A.+Khoruts&title=Standardized+Frozen+Preparation+for+Transplantation+of+Fecal+Microbiota+for+Recurrent+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection</span></div><div class="casAuthors">Hamilton Matthew J; Weingarden Alexa R; Sadowsky Michael J; Khoruts Alexander</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of gastroenterology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">761-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  While fecal microbiota transplantation (FMT) is historically known to be an effective means to treat recurrent Clostridium difficile infection (CDI) refractory to standard antibiotic therapies, the procedure is rarely performed.  At least some of the reasons for limited availability are those of practicality, including aesthetic concerns and costs of donor screening.  The objective of this study was to overcome these barriers in our clinical FMT program.  METHODS:  We report clinical experience with 43 consecutive patients who were treated with FMT for recurrent CDI since inception of this program at the University of Minnesota.  During this time, we simplified donor identification and screening by moving from patient-identified individual donors to standard volunteer donors.  Material preparation shifted from the endoscopy suite to a standardized process in the laboratory, and ultimately to banking frozen processed fecal material that is ready to use when needed.  RESULTS:  Standardization of material preparation significantly simplified the practical aspects of FMT without loss of apparent efficacy in clearing recurrent CDI.  Approximately 30% of the patients had underlying inflammatory bowel disease, and FMT was equally effective in this group.  CONCLUSIONS:  Several key steps in the standardization of donor material preparation significantly simplified the clinical practice of FMT for recurrent CDI in patients failing antibiotic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2frwdYJiOL5NiNltV31zlfW6udTcc2ebDcWJr5I6vMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vhsFOgug%253D%253D&md5=374660d41abfb3c8f52bfb76d82e0606</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fajg.2011.482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fajg.2011.482%26sid%3Dliteratum%253Aachs%26aulast%3DHamilton%26aufirst%3DM.%2BJ.%26aulast%3DWeingarden%26aufirst%3DA.%2BR.%26aulast%3DSadowsky%26aufirst%3DM.%2BJ.%26aulast%3DKhoruts%26aufirst%3DA.%26atitle%3DStandardized%2520Frozen%2520Preparation%2520for%2520Transplantation%2520of%2520Fecal%2520Microbiota%2520for%2520Recurrent%2520Clostridium%2520difficile%2520Infection%26jtitle%3DAm.%2520J.%2520Gastroenterol.%26date%3D2012%26volume%3D107%26spage%3D761%26epage%3D767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Youngster, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pindar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziv-Baran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohmann, E. L.</span><span> </span><span class="NLM_article-title">Oral, Capsulized, Frozen Fecal Microbiota Transplantation for Relapsing <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">1772</span><span class="NLM_x">–</span> <span class="NLM_lpage">1778</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2014&pages=1772-1778&author=I.+Youngsterauthor=G.+H.+Russellauthor=C.+Pindarauthor=T.+Ziv-Baranauthor=J.+Saukauthor=E.+L.+Hohmann&title=Oral%2C+Capsulized%2C+Frozen+Fecal+Microbiota+Transplantation+for+Relapsing+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoungster%26aufirst%3DI.%26aulast%3DRussell%26aufirst%3DG.%2BH.%26aulast%3DPindar%26aufirst%3DC.%26aulast%3DZiv-Baran%26aufirst%3DT.%26aulast%3DSauk%26aufirst%3DJ.%26aulast%3DHohmann%26aufirst%3DE.%2BL.%26atitle%3DOral%252C%2520Capsulized%252C%2520Frozen%2520Fecal%2520Microbiota%2520Transplantation%2520for%2520Relapsing%2520Clostridium%2520difficile%2520Infection%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2014%26volume%3D312%26spage%3D1772%26epage%3D1778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Lawley, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stares, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connor, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raisen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulding, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rad, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, C.</span><span> </span><span class="NLM_article-title">Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing <i>Clostridium difficile</i> Disease in Mice</span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1002995</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=e1002995&author=T.+D.+Lawleyauthor=S.+Clareauthor=A.+W.+Walkerauthor=M.+D.+Staresauthor=T.+R.+Connorauthor=C.+Raisenauthor=D.+Gouldingauthor=R.+Radauthor=F.+Schreiberauthor=C.+Brandt&title=Targeted+Restoration+of+the+Intestinal+Microbiota+with+a+Simple%2C+Defined+Bacteriotherapy+Resolves+Relapsing+Clostridium+difficile+Disease+in+Mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLawley%26aufirst%3DT.%2BD.%26aulast%3DClare%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DA.%2BW.%26aulast%3DStares%26aufirst%3DM.%2BD.%26aulast%3DConnor%26aufirst%3DT.%2BR.%26aulast%3DRaisen%26aufirst%3DC.%26aulast%3DGoulding%26aufirst%3DD.%26aulast%3DRad%26aufirst%3DR.%26aulast%3DSchreiber%26aufirst%3DF.%26aulast%3DBrandt%26aufirst%3DC.%26atitle%3DTargeted%2520Restoration%2520of%2520the%2520Intestinal%2520Microbiota%2520with%2520a%2520Simple%252C%2520Defined%2520Bacteriotherapy%2520Resolves%2520Relapsing%2520Clostridium%2520difficile%2520Disease%2520in%2520Mice%26jtitle%3DPLoS%2520Pathog.%26date%3D2012%26volume%3D8%26spage%3De1002995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Bakken, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borody, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brill, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demarco, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzos, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khoruts, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surawicz, C.</span><span> </span><span class="NLM_article-title">Treating <i>Clostridium difficile</i> Infection with Fecal Microbiota Transplantation</span> <span class="citation_source-journal">Clin. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1044</span><span class="NLM_x">–</span> <span class="NLM_lpage">1049</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1016%2Fj.cgh.2011.08.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=21871249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADC%252BC38%252FhsFKksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=1044-1049&author=J.+S.+Bakkenauthor=T.+Borodyauthor=L.+J.+Brandtauthor=J.+V.+Brillauthor=D.+C.+Demarcoauthor=M.+A.+Franzosauthor=C.+Kellyauthor=A.+Khorutsauthor=T.+Louieauthor=L.+P.+Martinelliauthor=T.+A.+Mooreauthor=G.+Russellauthor=C.+Surawicz&title=Treating+Clostridium+difficile+Infection+with+Fecal+Microbiota+Transplantation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Treating Clostridium difficile infection with fecal microbiota transplantation</span></div><div class="casAuthors">Bakken Johan S; Borody Thomas; Brandt Lawrence J; Brill Joel V; Demarco Daniel C; Franzos Marc Alaric; Kelly Colleen; Khoruts Alexander; Louie Thomas; Martinelli Lawrence P; Moore Thomas A; Russell George; Surawicz Christina</div><div class="citationInfo"><span class="NLM_cas:title">Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1044-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Clostridium difficile infection is increasing in incidence, severity, and mortality.  Treatment options are limited and appear to be losing efficacy.  Recurrent disease is especially challenging; extended treatment with oral vancomycin is becoming increasingly common but is expensive.  Fecal microbiota transplantation is safe, inexpensive, and effective; according to case and small series reports, about 90% of patients are cured.  We discuss the rationale, methods, and use of fecal microbiota transplantation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSzowxWJ3fGhMSzjBFCN0BJfW6udTcc2ebDcWJr5I6vMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252FhsFKksw%253D%253D&md5=487486ea0718a0be4711b927f761810e</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.cgh.2011.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cgh.2011.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DBakken%26aufirst%3DJ.%2BS.%26aulast%3DBorody%26aufirst%3DT.%26aulast%3DBrandt%26aufirst%3DL.%2BJ.%26aulast%3DBrill%26aufirst%3DJ.%2BV.%26aulast%3DDemarco%26aufirst%3DD.%2BC.%26aulast%3DFranzos%26aufirst%3DM.%2BA.%26aulast%3DKelly%26aufirst%3DC.%26aulast%3DKhoruts%26aufirst%3DA.%26aulast%3DLouie%26aufirst%3DT.%26aulast%3DMartinelli%26aufirst%3DL.%2BP.%26aulast%3DMoore%26aufirst%3DT.%2BA.%26aulast%3DRussell%26aufirst%3DG.%26aulast%3DSurawicz%26aufirst%3DC.%26atitle%3DTreating%2520Clostridium%2520difficile%2520Infection%2520with%2520Fecal%2520Microbiota%2520Transplantation%26jtitle%3DClin.%2520Gastroenterol.%2520Hepatol.%26date%3D2011%26volume%3D9%26spage%3D1044%26epage%3D1049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Kapel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corcos, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayeur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbot-Trystram, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouhnik, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joly, F.</span><span> </span><span class="NLM_article-title">Practical Implementation of Faecal Transplantation</span> <span class="citation_source-journal">Clin. Microbiol. Infect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1098</span><span class="NLM_x">–</span> <span class="NLM_lpage">1105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1111%2F1469-0691.12796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=25273614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADC%252BC2M7mtlKiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=1098-1105&author=N.+Kapelauthor=M.+Thomasauthor=O.+Corcosauthor=C.+Mayeurauthor=L.+Barbot-Trystramauthor=Y.+Bouhnikauthor=F.+Joly&title=Practical+Implementation+of+Faecal+Transplantation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Practical implementation of faecal transplantation</span></div><div class="casAuthors">Kapel N; Thomas M; Corcos O; Mayeur C; Barbot-Trystram L; Bouhnik Y; Joly F</div><div class="citationInfo"><span class="NLM_cas:title">Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1098-105</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Clostridium difficile infection is a leading cause of antibiotic-related and healthcare-related diarrhoea.  In the past decade, faecal microbiota transplantation or transfer has attracted increasing interest as an effective treatment strategy for severe recurrent C. difficile infection, with a global success rate of >80%.  However, experience with this procedure is limited by a lack of randomized trials supporting its efficacy and the lack of standardization of the procedure.  This review will address the practical aspects of the protocol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8etBAhdg0UJPq5LRczm8ffW6udTcc2eaJ9rXF9dksp7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7mtlKiuw%253D%253D&md5=4ac4e8b4969d91a3135a4734c1506a94</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1111%2F1469-0691.12796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252F1469-0691.12796%26sid%3Dliteratum%253Aachs%26aulast%3DKapel%26aufirst%3DN.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DCorcos%26aufirst%3DO.%26aulast%3DMayeur%26aufirst%3DC.%26aulast%3DBarbot-Trystram%26aufirst%3DL.%26aulast%3DBouhnik%26aufirst%3DY.%26aulast%3DJoly%26aufirst%3DF.%26atitle%3DPractical%2520Implementation%2520of%2520Faecal%2520Transplantation%26jtitle%3DClin.%2520Microbiol.%2520Infect.%26date%3D2014%26volume%3D20%26spage%3D1098%26epage%3D1105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span>The Power of Poo: DIY Instructions. <a href="http://thepowerofpoo.blogspot.com.au/p/diy-instructions.html?m=1" class="extLink">http://thepowerofpoo.blogspot.com.au/p/diy-instructions.html?m=1</a> (accessed Aug 18,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+Power+of+Poo%3A+DIY+Instructions.+http%3A%2F%2Fthepowerofpoo.blogspot.com.au%2Fp%2Fdiy-instructions.html%3Fm%3D1+%28accessed+Aug+18%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span>American Gastroenterological Association. AGA Confirms IND Is Required for Fecal Microbiota Transplantation <a href="http://www.gastro.org/advocacy-regulation/regulatory-issues/fecal-microbiota-transplant/aga-confirms-ind-is-required-for-fecal-microbiota-transplantation" class="extLink">http://www.gastro.org/advocacy-regulation/regulatory-issues/fecal-microbiota-transplant/aga-confirms-ind-is-required-for-fecal-microbiota-transplantation</a> (accessed Oct 29,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=American+Gastroenterological+Association.+AGA+Confirms+IND+Is+Required+for+Fecal+Microbiota+Transplantation+http%3A%2F%2Fwww.gastro.org%2Fadvocacy-regulation%2Fregulatory-issues%2Ffecal-microbiota-transplant%2Faga-confirms-ind-is-required-for-fecal-microbiota-transplantation+%28accessed+Oct+29%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span>Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation To Treat <i>Clostridium difficile</i> Infection Not Responsive to Standard Therapies. <a href="http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm361379.htm" class="extLink">http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm361379.htm</a> (accessed Aug 17,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Guidance+for+Industry%3A+Enforcement+Policy+Regarding+Investigational+New+Drug+Requirements+for+Use+of+Fecal+Microbiota+for+Transplantation+To+Treat+Clostridium+difficile+Infection+Not+Responsive+to+Standard+Therapies.+http%3A%2F%2Fwww.fda.gov%2FBiologicsBloodVaccines%2FGuidanceComplianceRegulatoryInformation%2FGuidances%2FVaccines%2Fucm361379.htm+%28accessed+Aug+17%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Ratner, M.</span><span> </span><span class="NLM_article-title">Fecal Transplantation Poses Dilemma for FDA</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=401-402&author=M.+Ratner&title=Fecal+Transplantation+Poses+Dilemma+for+FDA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRatner%26aufirst%3DM.%26atitle%3DFecal%2520Transplantation%2520Poses%2520Dilemma%2520for%2520FDA%26jtitle%3DNat.%2520Biotechnol.%26date%3D2014%26volume%3D32%26spage%3D401%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Smith, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alm, E. J.</span><span> </span><span class="NLM_article-title">Policy: How To Regulate Faecal Transplants</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">506</span><span class="NLM_x">, </span> <span class="NLM_fpage">290</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=506&publication_year=2014&pages=290-291&author=M.+B.+Smithauthor=C.+Kellyauthor=E.+J.+Alm&title=Policy%3A+How+To+Regulate+Faecal+Transplants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DM.%2BB.%26aulast%3DKelly%26aufirst%3DC.%26aulast%3DAlm%26aufirst%3DE.%2BJ.%26atitle%3DPolicy%253A%2520How%2520To%2520Regulate%2520Faecal%2520Transplants%26jtitle%3DNature%26date%3D2014%26volume%3D506%26spage%3D290%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Tsutsumi, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owusu, Y. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurdle, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span> </span><span class="NLM_article-title">Progress in the Discovery of Treatments for <i>C. difficile</i> Infection: A Clinical and Medicinal Chemistry Review</span> <span class="citation_source-journal">Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">152</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.2174%2F1568026613666131113154753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=24236721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlygurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=152-175&author=L.+S.+Tsutsumiauthor=Y.+B.+Owusuauthor=J.+G.+Hurdleauthor=D.+Sun&title=Progress+in+the+Discovery+of+Treatments+for+C.+difficile+Infection%3A+A+Clinical+and+Medicinal+Chemistry+Review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the Discovery of Treatments for C. difficile Infection: A Clinical and Medicinal Chemistry Review</span></div><div class="casAuthors">Tsutsumi, Lissa S.; Owusu, Yaw B.; Hurdle, Julian G.; Sun, Dianqing</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">152-175</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Clostridium difficile is an anaerobic, Gram-pos. pathogen that causes C. difficile infection, which results in significant morbidity and mortality.  The incidence of C. difficile infection in developed countries has become increasingly high due to the emergence of newer epidemic strains, a growing elderly population, extensive use of broad spectrum antibiotics, and limited therapies for this diarrheal disease.  Because treatment options currently available for C. difficile infection have some drawbacks, including cost, promotion of resistance, and selectivity problems, new agents are urgently needed to address these challenges.  This review article focuses on two parts: the first part summarizes current clin. treatment strategies and agents under clin. development for C. difficile infection; the second part reviews newly reported anti-difficile agents that have been evaluated or reevaluated in the last five years and are in the early stages of drug discovery and development.  Antibiotics are divided into natural product inspired and synthetic small mol. compds. that may have the potential to be more efficacious than currently approved treatments.  This includes potency, selectivity, reduced cytotoxicity, and novel modes of action to prevent resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyPZDOO8Im4bVg90H21EOLACvtfcHk0lgaEW4r8anxBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlygurc%253D&md5=d9b3dc0542c138a289588257b0651425</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.2174%2F1568026613666131113154753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026613666131113154753%26sid%3Dliteratum%253Aachs%26aulast%3DTsutsumi%26aufirst%3DL.%2BS.%26aulast%3DOwusu%26aufirst%3DY.%2BB.%26aulast%3DHurdle%26aufirst%3DJ.%2BG.%26aulast%3DSun%26aufirst%3DD.%26atitle%3DProgress%2520in%2520the%2520Discovery%2520of%2520Treatments%2520for%2520C.%2520difficile%2520Infection%253A%2520A%2520Clinical%2520and%2520Medicinal%2520Chemistry%2520Review%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%2520%2528Sharjah%252C%2520United%2520Arab%2520Emirates%2529%26date%3D2014%26volume%3D14%26spage%3D152%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span>Phase I Trial of a Single Dose of CRS3123. Identifier NCT01551004. <a href="http://clinicaltrials.gov/show/NCT01551004" class="extLink">http://clinicaltrials.gov/show/NCT01551004</a> (accessed Mar 21,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Phase+I+Trial+of+a+Single+Dose+of+CRS3123.+Identifier+NCT01551004.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01551004+%28accessed+Mar+21%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span>Novacta Biosystems Limited completes phase I study of NVB302 against <i>C. difficile</i> infection in healthy volunteers. <a href="http://www.novactabio.com/news.php" class="extLink">http://www.novactabio.com/news.php</a> (accessed Mar 18,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Novacta+Biosystems+Limited+completes+phase+I+study+of+NVB302+against+C.+difficile+infection+in+healthy+volunteers.+http%3A%2F%2Fwww.novactabio.com%2Fnews.php+%28accessed+Mar+18%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span>A Study of SMT19969 Compared with Vancomycin for the Treatment of <i>Clostridium difficile</i>-Associated Diarrhoea (CDAD). Identifier NCT02092935. <a href="http://clinicaltrials.gov/show/NCT02092935" class="extLink">http://clinicaltrials.gov/show/NCT02092935</a> (accessed Jan 18,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study+of+SMT19969+Compared+with+Vancomycin+for+the+Treatment+of+Clostridium+difficile-Associated+Diarrhoea+%28CDAD%29.+Identifier+NCT02092935.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT02092935+%28accessed+Jan+18%2C+2015%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">LaMarche, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeds, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaral, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brewer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bushell, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewhurst, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzink-Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamber, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lister, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenney, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palestrant, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patane, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rann, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachdeva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiamfook, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trzasko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitehead, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yifru, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Q.</span><span> </span><span class="NLM_article-title">Discovery of LFF571: An Investigational Agent for <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2376</span><span class="NLM_x">–</span> <span class="NLM_lpage">2387</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201685h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC38XitVektrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2376-2387&author=M.+J.+LaMarcheauthor=J.+A.+Leedsauthor=A.+Amaralauthor=J.+T.+Brewerauthor=S.+M.+Bushellauthor=G.+Dengauthor=J.+M.+Dewhurstauthor=J.+Dingauthor=J.+Dzink-Foxauthor=G.+Gamberauthor=A.+Jainauthor=K.+Leeauthor=L.+Leeauthor=T.+Listerauthor=D.+McKenneyauthor=S.+Mullinauthor=C.+Osborneauthor=D.+Palestrantauthor=M.+A.+Pataneauthor=E.+M.+Rannauthor=M.+Sachdevaauthor=J.+Shaoauthor=S.+Tiamfookauthor=A.+Trzaskoauthor=L.+Whiteheadauthor=A.+Yifruauthor=D.+Yuauthor=W.+Yanauthor=Q.+Zhu&title=Discovery+of+LFF571%3A+An+Investigational+Agent+for+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of LFF571: An Investigational Agent for Clostridium difficile Infection</span></div><div class="casAuthors">LaMarche, Matthew J.; Leeds, Jennifer A.; Amaral, Adam; Brewer, Jason T.; Bushell, Simon M.; Deng, Gejing; Dewhurst, Janetta M.; Ding, Jian; Dzink-Fox, JoAnne; Gamber, Gabriel; Jain, Akash; Lee, Kwangho; Lee, Lac; Lister, Troy; McKenney, David; Mullin, Steve; Osborne, Colin; Palestrant, Deborah; Patane, Michael A.; Rann, Elin M.; Sachdeva, Meena; Shao, Jian; Tiamfook, Stacey; Trzasko, Anna; Whitehead, Lewis; Yifru, Aregahegn; Yu, Donghui; Yan, Wanlin; Zhu, Qingming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2376-2387</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Clostridium difficile (C. difficile) is a Gram pos., anaerobic bacterium that infects the lumen of the large intestine and produces toxins.  This results in a range of syndromes from mild diarrhea to severe toxic megacolon and death.  Alarmingly, the prevalence and severity of C. difficile infection are increasing; thus, assocd. morbidity and mortality rates are rising.  4-Aminothiazolyl analogs of the antibiotic natural product GE2270 A were designed, synthesized, and optimized for the treatment of C. difficile infection.  The medicinal chem. effort focused on enhancing aq. soly. relative to that of the natural product and previous development candidates (2, 3) and improving antibacterial activity.  Structure-activity relationships, cocrystallog. interactions, pharmacokinetics, and efficacy in animal models of infection were characterized.  These studies identified a series of dicarboxylic acid derivs., which enhanced soly./efficacy profile by several orders of magnitude compared to previously studied compds. and led to the selection of LFF571 (I) as an investigational new drug for treating C. difficile infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3mrocvDQFu7Vg90H21EOLACvtfcHk0ljaHZrniemgqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVektrY%253D&md5=c31ff50dd7eedaf633493f784f97193f</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm201685h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201685h%26sid%3Dliteratum%253Aachs%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26aulast%3DLeeds%26aufirst%3DJ.%2BA.%26aulast%3DAmaral%26aufirst%3DA.%26aulast%3DBrewer%26aufirst%3DJ.%2BT.%26aulast%3DBushell%26aufirst%3DS.%2BM.%26aulast%3DDeng%26aufirst%3DG.%26aulast%3DDewhurst%26aufirst%3DJ.%2BM.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DDzink-Fox%26aufirst%3DJ.%26aulast%3DGamber%26aufirst%3DG.%26aulast%3DJain%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLister%26aufirst%3DT.%26aulast%3DMcKenney%26aufirst%3DD.%26aulast%3DMullin%26aufirst%3DS.%26aulast%3DOsborne%26aufirst%3DC.%26aulast%3DPalestrant%26aufirst%3DD.%26aulast%3DPatane%26aufirst%3DM.%2BA.%26aulast%3DRann%26aufirst%3DE.%2BM.%26aulast%3DSachdeva%26aufirst%3DM.%26aulast%3DShao%26aufirst%3DJ.%26aulast%3DTiamfook%26aufirst%3DS.%26aulast%3DTrzasko%26aufirst%3DA.%26aulast%3DWhitehead%26aufirst%3DL.%26aulast%3DYifru%26aufirst%3DA.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DQ.%26atitle%3DDiscovery%2520of%2520LFF571%253A%2520An%2520Investigational%2520Agent%2520for%2520Clostridium%2520difficile%2520Infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2376%26epage%3D2387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span>Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients with Moderate <i>Clostridium difficile</i> Infections. Identifier NCT01232595. <a href="http://www.clinicaltrials.gov/ct2/show/NCT01232595?term=clostridium+difficile&amp;rank=14" class="extLink">http://www.clinicaltrials.gov/ct2/show/NCT01232595?term=clostridium+difficile&rank=14</a> (accessed Mar 20,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Safety+and+Efficacy+of+Multiple+Daily+Dosing+of+Oral+LFF571+in+Patients+with+Moderate+Clostridium+difficile+Infections.+Identifier+NCT01232595.+http%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT01232595%3Fterm%3Dclostridium%2Bdifficile%26rank%3D14+%28accessed+Mar+20%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span>Phase 3 Study with Cadazolid in CDAD. Identifier NCT01987895. <a href="https://clinicaltrials.gov/ct2/show/NCT01987895?term=cadazolid&amp;rank=2" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01987895?term=cadazolid&rank=2</a> (accessed May 21,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Phase+3+Study+with+Cadazolid+in+CDAD.+Identifier+NCT01987895.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01987895%3Fterm%3Dcadazolid%26rank%3D2+%28accessed+May+21%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span>Business Wire. Nanotherapeutics Acquires Two Late Stage Clinical Programs for Alzheimer’s Treatment and CDA Disease. <a href="http://www.businesswire.com/news/home/20091216005124/en/Nanotherapeutics-Acquires-Late-Stage-Clinical-Programs-Alzheimer%E2%80%99s#.UyetsVzoXjI" class="extLink">http://www.businesswire.com/news/home/20091216005124/en/Nanotherapeutics-Acquires-Late-Stage-Clinical-Programs-Alzheimer%E2%80%99s#.UyetsVzoXjI</a> (accessed Mar 18,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Business+Wire.+Nanotherapeutics+Acquires+Two+Late+Stage+Clinical+Programs+for+Alzheimer%E2%80%99s+Treatment+and+CDA+Disease.+http%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20091216005124%2Fen%2FNanotherapeutics-Acquires-Late-Stage-Clinical-Programs-Alzheimer%25E2%2580%2599s%23.UyetsVzoXjI+%28accessed+Mar+18%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span>Nanotherapeutics. NTI-851 (Ramoplanin). <a href="http://www.nanotherapeutics.com/ramoplanin/" class="extLink">http://www.nanotherapeutics.com/ramoplanin/</a> (accessed Oct 29,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Nanotherapeutics.+NTI-851+%28Ramoplanin%29.+http%3A%2F%2Fwww.nanotherapeutics.com%2Framoplanin%2F+%28accessed+Oct+29%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">McLoughlin, F.</span><span> </span><span class="NLM_article-title">CB-315 Fact Sheet</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">3</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=F.+McLoughlin&title=CB-315+Fact+Sheet"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMcLoughlin%26aufirst%3DF.%26atitle%3DCB-315%2520Fact%2520Sheet%26date%3D2013%26spage%3D1%26epage%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Mascio, C. T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortin, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howland, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Praagh, A. D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuong, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, J. A.</span><span> </span><span class="NLM_article-title">In Vitro and In Vivo Characterization of CB-183,315, a Novel Lipopeptide Antibiotic for Treatment of <i>Clostridium difficile</i></span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5023</span><span class="NLM_x">–</span> <span class="NLM_lpage">5030</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=5023-5030&author=C.+T.+M.+Mascioauthor=L.+I.+Mortinauthor=K.+T.+Howlandauthor=A.+D.+G.+Van+Praaghauthor=S.+Zhangauthor=A.+Aryaauthor=C.+L.+Chuongauthor=C.+Kangauthor=T.+Liauthor=J.+A.+Silverman&title=In+Vitro+and+In+Vivo+Characterization+of+CB-183%2C315%2C+a+Novel+Lipopeptide+Antibiotic+for+Treatment+of+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMascio%26aufirst%3DC.%2BT.%2BM.%26aulast%3DMortin%26aufirst%3DL.%2BI.%26aulast%3DHowland%26aufirst%3DK.%2BT.%26aulast%3DVan%2BPraagh%26aufirst%3DA.%2BD.%2BG.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DArya%26aufirst%3DA.%26aulast%3DChuong%26aufirst%3DC.%2BL.%26aulast%3DKang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DSilverman%26aufirst%3DJ.%2BA.%26atitle%3DIn%2520Vitro%2520and%2520In%2520Vivo%2520Characterization%2520of%2520CB-183%252C315%252C%2520a%2520Novel%2520Lipopeptide%2520Antibiotic%2520for%2520Treatment%2520of%2520Clostridium%2520difficile%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D5023%26epage%3D5030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span>Pharmacokinetics and Safety of Tigecycline in the Treatment of <i>C. difficile</i> Associated Diarrhea (CDAD). Identifier NCT01401023. <a href="http://clinicaltrials.gov/ct2/show/NCT01401023" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01401023</a> (accessed Mar 21,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Pharmacokinetics+and+Safety+of+Tigecycline+in+the+Treatment+of+C.+difficile+Associated+Diarrhea+%28CDAD%29.+Identifier+NCT01401023.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01401023+%28accessed+Mar+21%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span>Study of Nitazoxanide in the Treatment of <i>Clostridium difficile</i> Colitis. Identifier NCT00417872. <a href="http://www.clinicaltrials.gov/ct2/show/NCT00417872?term=clostridium+difficile&amp;rank=22" class="extLink">http://www.clinicaltrials.gov/ct2/show/NCT00417872?term=clostridium+difficile&rank=22</a> (accessed Mar 20,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Study+of+Nitazoxanide+in+the+Treatment+of+Clostridium+difficile+Colitis.+Identifier+NCT00417872.+http%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT00417872%3Fterm%3Dclostridium%2Bdifficile%26rank%3D22+%28accessed+Mar+20%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span>Study of a Candidate <i>Clostridium difficile</i> Toxoid Vaccine in Subjects at Risk for <i>C. difficile</i> Infection. Identifier NCT01887912. <a href="http://clinicaltrials.gov/ct2/show/NCT01887912?term=c+difficile+and+vaccine&amp;rank=2" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01887912?term=c+difficile+and+vaccine&rank=2</a> (accessed Oct 23,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Study+of+a+Candidate+Clostridium+difficile+Toxoid+Vaccine+in+Subjects+at+Risk+for+C.+difficile+Infection.+Identifier+NCT01887912.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01887912%3Fterm%3Dc%2Bdifficile%2Band%2Bvaccine%26rank%3D2+%28accessed+Oct+23%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span>An Open-Label Study Assessing Safety, Immunogenicity and Dose Response of IC84. Identifier NCT01296386. <a href="http://clinicaltrials.gov/ct2/show/NCT01296386?term=IC84&amp;rank=1" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01296386?term=IC84&rank=1</a> (accessed Oct 23,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=An+Open-Label+Study+Assessing+Safety%2C+Immunogenicity+and+Dose+Response+of+IC84.+Identifier+NCT01296386.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01296386%3Fterm%3DIC84%26rank%3D1+%28accessed+Oct+23%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Johnson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerding, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornely, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chasan-Taber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitts, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelone, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broom, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, D. M.</span><span> </span><span class="NLM_article-title">Polymer Alternative for CDI Treatment (PACT) investigators. Vancomycin, Metronidazole, or Tolevamer for <i>Clostridium difficile</i> Infection: Results From Two Multinational, Randomized, Controlled Trials</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fcid%2Fciu313" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=24799326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlSrurnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2014&pages=345-354&author=S.+Johnsonauthor=T.+J.+Louieauthor=D.+N.+Gerdingauthor=O.+A.+Cornelyauthor=S.+Chasan-Taberauthor=D.+Fittsauthor=S.+P.+Geloneauthor=C.+Broomauthor=D.+M.+Davidson&title=Polymer+Alternative+for+CDI+Treatment+%28PACT%29+investigators.+Vancomycin%2C+Metronidazole%2C+or+Tolevamer+for+Clostridium+difficile+Infection%3A+Results+From+Two+Multinational%2C+Randomized%2C+Controlled+Trials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials</span></div><div class="casAuthors">Johnson, Stuart; Louie, Thomas J.; Gerding, Dale N.; Cornely, Oliver A.; Chasan-Taber, Scott; Fitts, David; Gelone, Steven P.; Broom, Colin; Davidson, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">345-354</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">In a pooled anal. of data from 2 large, randomized, controlled trials of patients with Clostridium difficile infection, the toxin-binding polymer tolevamer was inferior to both metronidazole and vancomycin with regard to clin. success, and metronidazole was inferior to vancomycin.  Background: Clostridium difficile infection (CDI) is a common complication of antibiotic therapy that is treated with antibiotics, contributing to ongoing disruption of the colonic microbiota and CDI recurrence.  Two multinational trials were conducted to compare the efficacy of tolevamer, a nonantibiotic, toxin-binding polymer, with vancomycin and metronidazole.  Methods: Patients with CDI were randomly assigned in a 2:1:1 ratio to oral tolevamer 9 g (loading dose) followed by 3 g every 8 h for 14 days, vancomycin 125 mg every 6 h for 10 days, or metronidazole 375 mg every 6 h for 10 days.  The primary endpoint was clin. success, defined as resoln. of diarrhea and absence of severe abdominal discomfort for more than 2 consecutive days including day 10.  Results: In a pooled anal., 563 patients received tolevamer, 289 received metronidazole, and 266 received vancomycin.  Clin. success of tolevamer was inferior to both metronidazole and vancomycin (P < .001), and metronidazole was inferior to vancomycin (P = .02; 44.2% [n = 534], 72.7% [n = 278], and 81.1% [n = 259], resp.).  Clin. success in patients with severe CDI who received metronidazole was 66.3% compared with vancomycin, which was 78.5%. (P = .059).  A post-hoc multivariate anal. that excluded tolevamer found 3 factors that were strongly assocd. with clin. success: vancomycin treatment, treatment-naive status, and mild or moderate CDI severity.  Adverse events were similar among the treatment groups.  Conclusions: Tolevamer was inferior to antibiotic treatment of CDI, and metronidazole was inferior to vancomycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8O-PA8pFfqrVg90H21EOLACvtfcHk0lhKDyJQOGSlVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlSrurnL&md5=2844f3620eb00b568b5b37c07c02244d</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fciu313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fciu313%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DS.%26aulast%3DLouie%26aufirst%3DT.%2BJ.%26aulast%3DGerding%26aufirst%3DD.%2BN.%26aulast%3DCornely%26aufirst%3DO.%2BA.%26aulast%3DChasan-Taber%26aufirst%3DS.%26aulast%3DFitts%26aufirst%3DD.%26aulast%3DGelone%26aufirst%3DS.%2BP.%26aulast%3DBroom%26aufirst%3DC.%26aulast%3DDavidson%26aufirst%3DD.%2BM.%26atitle%3DPolymer%2520Alternative%2520for%2520CDI%2520Treatment%2520%2528PACT%2529%2520investigators.%2520Vancomycin%252C%2520Metronidazole%252C%2520or%2520Tolevamer%2520for%2520Clostridium%2520difficile%2520Infection%253A%2520Results%2520From%2520Two%2520Multinational%252C%2520Randomized%252C%2520Controlled%2520Trials%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2014%26volume%3D59%26spage%3D345%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span>A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for <i>Clostridium difficile</i> Infection (MK-3415A-001 AM2). Identifier NCT01241552. <a href="http://www.clinicaltrials.gov/ct2/show/NCT01241552?term=clostridium+difficile&amp;rank=6" class="extLink">http://www.clinicaltrials.gov/ct2/show/NCT01241552?term=clostridium+difficile&rank=6</a> (accessed Mar 20,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study+of+MK-3415%2C+MK-6072%2C+and+MK-3415A+in+Participants+Receiving+Antibiotic+Therapy+for+Clostridium+difficile+Infection+%28MK-3415A-001+AM2%29.+Identifier+NCT01241552.+http%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT01241552%3Fterm%3Dclostridium%2Bdifficile%26rank%3D6+%28accessed+Mar+20%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span>Safety and Efficacy Study of VP20621 for Prevention of Recurrent <i>Clostridium difficile</i> Infection. Identifier NCT01259726. <a href="http://clinicaltrials.gov/ct2/show/NCT01259726?term=VP20621&amp;rank=1" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01259726?term=VP20621&rank=1</a> (accessed Jan 21,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Safety+and+Efficacy+Study+of+VP20621+for+Prevention+of+Recurrent+Clostridium+difficile+Infection.+Identifier+NCT01259726.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01259726%3Fterm%3DVP20621%26rank%3D1+%28accessed+Jan+21%2C+2015%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Brouwer, M. S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullany, P.</span><span> </span><span class="NLM_article-title">Horizontal Gene Transfer Converts Non-Toxigenic <i>Clostridium difficile</i> Strains into Toxin Producers</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1038%2Fncomms3601" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1-6&author=M.+S.+M.+Brouwerauthor=A.+P.+Robertsauthor=H.+Hussainauthor=R.+J.+Williamsauthor=E.+Allanauthor=P.+Mullany&title=Horizontal+Gene+Transfer+Converts+Non-Toxigenic+Clostridium+difficile+Strains+into+Toxin+Producers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1038%2Fncomms3601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms3601%26sid%3Dliteratum%253Aachs%26aulast%3DBrouwer%26aufirst%3DM.%2BS.%2BM.%26aulast%3DRoberts%26aufirst%3DA.%2BP.%26aulast%3DHussain%26aufirst%3DH.%26aulast%3DWilliams%26aufirst%3DR.%2BJ.%26aulast%3DAllan%26aufirst%3DE.%26aulast%3DMullany%26aufirst%3DP.%26atitle%3DHorizontal%2520Gene%2520Transfer%2520Converts%2520Non-Toxigenic%2520Clostridium%2520difficile%2520Strains%2520into%2520Toxin%2520Producers%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Villano, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiberling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatarowicz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monnot-Chase, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerding, D. N.</span><span> </span><span class="NLM_article-title">Evaluation of an Oral Suspension of VP20621, Spores of Nontoxigenic <i>Clostridium difficile</i> Strain M3, in Healthy Subjects</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5224</span><span class="NLM_x">–</span> <span class="NLM_lpage">5229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=5224-5229&author=S.+A.+Villanoauthor=M.+Seiberlingauthor=W.+Tatarowiczauthor=E.+Monnot-Chaseauthor=D.+N.+Gerding&title=Evaluation+of+an+Oral+Suspension+of+VP20621%2C+Spores+of+Nontoxigenic+Clostridium+difficile+Strain+M3%2C+in+Healthy+Subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVillano%26aufirst%3DS.%2BA.%26aulast%3DSeiberling%26aufirst%3DM.%26aulast%3DTatarowicz%26aufirst%3DW.%26aulast%3DMonnot-Chase%26aufirst%3DE.%26aulast%3DGerding%26aufirst%3DD.%2BN.%26atitle%3DEvaluation%2520of%2520an%2520Oral%2520Suspension%2520of%2520VP20621%252C%2520Spores%2520of%2520Nontoxigenic%2520Clostridium%2520difficile%2520Strain%2520M3%252C%2520in%2520Healthy%2520Subjects%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D5224%26epage%3D5229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Buffie, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenney, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobourne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">No, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinnebrew, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Littmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Brink, M. R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenq, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taur, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sander, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toussaint, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xavier, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pamer, E. G.</span><span> </span><span class="NLM_article-title">Precision Microbiome Reconstitution Restores Bile Acid Mediated Resistance to <i>Clostridium difficile</i></span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">517</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=517&publication_year=2015&pages=205-208&author=C.+G.+Buffieauthor=V.+Bucciauthor=R.+R.+Steinauthor=P.+T.+McKenneyauthor=L.+Lingauthor=A.+Gobourneauthor=D.+Noauthor=H.+Liuauthor=M.+Kinnebrewauthor=A.+Vialeauthor=E.+Littmannauthor=M.+R.+M.+van+den+Brinkauthor=R.+R.+Jenqauthor=Y.+Taurauthor=C.+Sanderauthor=J.+Crossauthor=N.+C.+Toussaintauthor=J.+B.+Xavierauthor=E.+G.+Pamer&title=Precision+Microbiome+Reconstitution+Restores+Bile+Acid+Mediated+Resistance+to+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuffie%26aufirst%3DC.%2BG.%26aulast%3DBucci%26aufirst%3DV.%26aulast%3DStein%26aufirst%3DR.%2BR.%26aulast%3DMcKenney%26aufirst%3DP.%2BT.%26aulast%3DLing%26aufirst%3DL.%26aulast%3DGobourne%26aufirst%3DA.%26aulast%3DNo%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DKinnebrew%26aufirst%3DM.%26aulast%3DViale%26aufirst%3DA.%26aulast%3DLittmann%26aufirst%3DE.%26aulast%3Dvan%2Bden%2BBrink%26aufirst%3DM.%2BR.%2BM.%26aulast%3DJenq%26aufirst%3DR.%2BR.%26aulast%3DTaur%26aufirst%3DY.%26aulast%3DSander%26aufirst%3DC.%26aulast%3DCross%26aufirst%3DJ.%26aulast%3DToussaint%26aufirst%3DN.%2BC.%26aulast%3DXavier%26aufirst%3DJ.%2BB.%26aulast%3DPamer%26aufirst%3DE.%2BG.%26atitle%3DPrecision%2520Microbiome%2520Reconstitution%2520Restores%2520Bile%2520Acid%2520Mediated%2520Resistance%2520to%2520Clostridium%2520difficile%26jtitle%3DNature%26date%3D2015%26volume%3D517%26spage%3D205%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Gao, X. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mubasher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reifer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. E.</span><span> </span><span class="NLM_article-title">Dose-Response Efficacy of a Proprietary Probiotic Formula of <i>Lactobacillus acidophilus</i> Cl1285 and <i>Lactobacillus casei</i> Lbc80r for Antibiotic-Associated Diarrhea and <i>Clostridium difficile</i>-Associated Diarrhea Prophylaxis in Adult Patients</span> <span class="citation_source-journal">Am. J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1636</span><span class="NLM_x">–</span> <span class="NLM_lpage">1641</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1038%2Fajg.2010.11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=20145608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADC%252BC3cnkvFWqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2010&pages=1636-1641&author=X.+W.+Gaoauthor=M.+Mubasherauthor=C.+Y.+Fangauthor=C.+Reiferauthor=L.+E.+Miller&title=Dose-Response+Efficacy+of+a+Proprietary+Probiotic+Formula+of+Lactobacillus+acidophilus+Cl1285+and+Lactobacillus+casei+Lbc80r+for+Antibiotic-Associated+Diarrhea+and+Clostridium+difficile-Associated+Diarrhea+Prophylaxis+in+Adult+Patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients</span></div><div class="casAuthors">Gao Xing Wang; Mubasher Mohamed; Fang Chong Yu; Reifer Cheryl; Miller Larry E</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of gastroenterology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1636-41</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  Standard therapies for antibiotic-associated diarrhea (AAD) and Clostridium difficile-associated diarrhea (CDAD) have limited efficacy.  Probiotic prophylaxis is a promising alternative for reduction of AAD and CDAD incidence.  METHODS:  In this single-center, randomized, double-blind, placebo-controlled dose-ranging study, we randomized 255 adult inpatients to one of three groups: two probiotic capsules per day (Pro-2, n=86), one probiotic capsule and one placebo capsule per day (Pro-1, n=85), or two placebo capsules per day (n=84).  Each probiotic capsule contained 50 billion c.f.u. of live organisms (Lactobacillus acidophilus CL1285 +Lactobacillus casei LBC80R Bio-K+ CL1285).  Probiotic prophylaxis began within 36 h of initial antibiotic administration, continued for 5 days after the last antibiotic dose, and patients were followed for an additional 21 days.  RESULTS:  Pro-2 (15.5%) had a lower AAD incidence vs.  Pro-1 (28.2%).  Each probiotic group had a lower AAD incidence vs. placebo (44.1%).  In patients who acquired AAD, Pro-2 (2.8 days) and Pro-1 (4.1 days) had shorter symptom duration vs. placebo (6.4 days).  Similarly, Pro-2 (1.2%) had a lower CDAD incidence vs.  Pro-1 (9.4%).  Each treatment group had a lower CDAD incidence vs. placebo (23.8%).  Gastrointestinal symptoms were less common in the treatment groups vs. placebo and in Pro-2 vs.  Pro-1.  CONCLUSIONS:  The proprietary probiotic blend used in this study was well tolerated and effective for reducing risk of AAD and, in particular, CDAD in hospitalized patients on antibiotics.  A dose-ranging effect was shown with 100 billion c.f.u., yielding superior outcomes and fewer gastrointestinal events compared to 50 billion c.f.u. (ClinicalTrials.gov number NCT00958308).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTepuDTF_5XNysZ1x6zOs0vfW6udTcc2ebFX6PvJQJJ1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cnkvFWqtQ%253D%253D&md5=ee303feb9fc8aac8618e6759cef46630</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1038%2Fajg.2010.11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fajg.2010.11%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DX.%2BW.%26aulast%3DMubasher%26aufirst%3DM.%26aulast%3DFang%26aufirst%3DC.%2BY.%26aulast%3DReifer%26aufirst%3DC.%26aulast%3DMiller%26aufirst%3DL.%2BE.%26atitle%3DDose-Response%2520Efficacy%2520of%2520a%2520Proprietary%2520Probiotic%2520Formula%2520of%2520Lactobacillus%2520acidophilus%2520Cl1285%2520and%2520Lactobacillus%2520casei%2520Lbc80r%2520for%2520Antibiotic-Associated%2520Diarrhea%2520and%2520Clostridium%2520difficile-Associated%2520Diarrhea%2520Prophylaxis%2520in%2520Adult%2520Patients%26jtitle%3DAm.%2520J.%2520Gastroenterol.%26date%3D2010%26volume%3D105%26spage%3D1636%26epage%3D1641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span>Microbiota Restoration Therapy for Recurrent <i>Clostridium difficile</i>-associated Diarrhea. Identifier NCT01925417. <a href="https://clinicaltrials.gov/ct2/show/NCT01925417?term=FMT&amp;phase=1&amp;rank=17" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01925417?term=FMT&phase=1&rank=17</a> (accessed Oct 28,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Microbiota+Restoration+Therapy+for+Recurrent+Clostridium+difficile-associated+Diarrhea.+Identifier+NCT01925417.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01925417%3Fterm%3DFMT%26phase%3D1%26rank%3D17+%28accessed+Oct+28%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span>Monarch Labs. Monarch Labs and BTER Foundation collaborate to develop fecal transplantion products <a href="http://www.monarchlabs.com/Monarch-Labs-and-BTER-Foundation-collaborate-to-develop-fecal-transplantion-products" class="extLink">http://www.monarchlabs.com/Monarch-Labs-and-BTER-Foundation-collaborate-to-develop-fecal-transplantion-products</a> (accessed Aug 18,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Monarch+Labs.+Monarch+Labs+and+BTER+Foundation+collaborate+to+develop+fecal+transplantion+products+http%3A%2F%2Fwww.monarchlabs.com%2FMonarch-Labs-and-BTER-Foundation-collaborate-to-develop-fecal-transplantion-products+%28accessed+Aug+18%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Gaulton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellis, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bento, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Light, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGlinchey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalovich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Lazikani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J. P.</span><span> </span><span class="NLM_article-title">ChEMBL: A Large-Scale Bioactivity Database for Drug Discovery</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">D1100</span><span class="NLM_x">–</span> <span class="NLM_lpage">D1107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fnar%2Fgkr777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=21948594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs12htbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=D1100-D1107&author=A.+Gaultonauthor=L.+J.+Bellisauthor=A.+P.+Bentoauthor=J.+Chambersauthor=M.+Daviesauthor=A.+Herseyauthor=Y.+Lightauthor=S.+McGlincheyauthor=D.+Michalovichauthor=B.+Al-Lazikaniauthor=J.+P.+Overington&title=ChEMBL%3A+A+Large-Scale+Bioactivity+Database+for+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">ChEMBL: a large-scale bioactivity database for drug discovery</span></div><div class="casAuthors">Gaulton, Anna; Bellis, Louisa J.; Bento, A. Patricia; Chambers, Jon; Davies, Mark; Hersey, Anne; Light, Yvonne; McGlinchey, Shaun; Michalovich, David; Al-Lazikani, Bissan; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D1100-D1107</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">ChEMBL is an Open Data database contg. binding, functional and ADMET information for a large no. of drug-like bioactive compds.  These data are manually abstracted from the primary published literature on a regular basis, then further curated and standardized to maximize their quality and utility across a wide range of chem. biol. and drug-discovery research problems.  Currently, the database contains 5.4 million bioactivity measurements for more than 1 million compds. and 5200 protein targets.  Access is available through a web-based interface, data downloads and web services at: https://www.ebi.ac.uk/chembldb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9e9jRENTtubVg90H21EOLACvtfcHk0ljjJ1slqesVRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs12htbjN&md5=aedf7793e1ca54b6a4fa272ea3ef7d0e</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkr777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkr777%26sid%3Dliteratum%253Aachs%26aulast%3DGaulton%26aufirst%3DA.%26aulast%3DBellis%26aufirst%3DL.%2BJ.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DChambers%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DM.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DLight%26aufirst%3DY.%26aulast%3DMcGlinchey%26aufirst%3DS.%26aulast%3DMichalovich%26aufirst%3DD.%26aulast%3DAl-Lazikani%26aufirst%3DB.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DChEMBL%253A%2520A%2520Large-Scale%2520Bioactivity%2520Database%2520for%2520Drug%2520Discovery%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2012%26volume%3D40%26spage%3DD1100%26epage%3DD1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Ballard, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olekhnovich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koerner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. L.</span><span> </span><span class="NLM_article-title">Biological Activity of Modified and Exchanged 2-Amino-5-Nitrothiazole Amide Analogues of Nitazoxanide</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3537</span><span class="NLM_x">–</span> <span class="NLM_lpage">3539</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3537-3539&author=T.+E.+Ballardauthor=X.+Wangauthor=I.+Olekhnovichauthor=T.+Koernerauthor=C.+Seymourauthor=P.+S.+Hoffmanauthor=T.+L.+Macdonald&title=Biological+Activity+of+Modified+and+Exchanged+2-Amino-5-Nitrothiazole+Amide+Analogues+of+Nitazoxanide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBallard%26aufirst%3DT.%2BE.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DOlekhnovich%26aufirst%3DI.%26aulast%3DKoerner%26aufirst%3DT.%26aulast%3DSeymour%26aufirst%3DC.%26aulast%3DHoffman%26aufirst%3DP.%2BS.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DBiological%2520Activity%2520of%2520Modified%2520and%2520Exchanged%25202-Amino-5-Nitrothiazole%2520Amide%2520Analogues%2520of%2520Nitazoxanide%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3537%26epage%3D3539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Ballard, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olekhnovich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koerner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salamoun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warthan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. L.</span><span> </span><span class="NLM_article-title">Synthesis and Antimicrobial Evaluation of Nitazoxanide-Based Analogues: Identification of Selective and Broad Spectrum Activity</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">362</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=362-377&author=T.+E.+Ballardauthor=X.+Wangauthor=I.+Olekhnovichauthor=T.+Koernerauthor=C.+Seymourauthor=J.+Salamounauthor=M.+Warthanauthor=P.+S.+Hoffmanauthor=T.+L.+Macdonald&title=Synthesis+and+Antimicrobial+Evaluation+of+Nitazoxanide-Based+Analogues%3A+Identification+of+Selective+and+Broad+Spectrum+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBallard%26aufirst%3DT.%2BE.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DOlekhnovich%26aufirst%3DI.%26aulast%3DKoerner%26aufirst%3DT.%26aulast%3DSeymour%26aufirst%3DC.%26aulast%3DSalamoun%26aufirst%3DJ.%26aulast%3DWarthan%26aufirst%3DM.%26aulast%3DHoffman%26aufirst%3DP.%2BS.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DSynthesis%2520and%2520Antimicrobial%2520Evaluation%2520of%2520Nitazoxanide-Based%2520Analogues%253A%2520Identification%2520of%2520Selective%2520and%2520Broad%2520Spectrum%2520Activity%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D362%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Katsura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakane, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morinaga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takasugi, H.</span><span> </span><span class="NLM_article-title">Anti-<i>Helicobacter pylori</i> Agents. 3. 2-[(Arylalkyl)Guanidino]-4-furylthiazoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2920</span><span class="NLM_x">–</span> <span class="NLM_lpage">2926</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9900671" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=2920-2926&author=Y.+Katsuraauthor=S.+Nishinoauthor=M.+Ohnoauthor=K.+Sakaneauthor=Y.+Matsumotoauthor=C.+Morinagaauthor=H.+Ishikawaauthor=H.+Takasugi&title=Anti-Helicobacter+pylori+Agents.+3.+2-%5B%28Arylalkyl%29Guanidino%5D-4-furylthiazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fjm9900671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9900671%26sid%3Dliteratum%253Aachs%26aulast%3DKatsura%26aufirst%3DY.%26aulast%3DNishino%26aufirst%3DS.%26aulast%3DOhno%26aufirst%3DM.%26aulast%3DSakane%26aufirst%3DK.%26aulast%3DMatsumoto%26aufirst%3DY.%26aulast%3DMorinaga%26aufirst%3DC.%26aulast%3DIshikawa%26aufirst%3DH.%26aulast%3DTakasugi%26aufirst%3DH.%26atitle%3DAnti-Helicobacter%2520pylori%2520Agents.%25203.%25202-%255B%2528Arylalkyl%2529Guanidino%255D-4-furylthiazoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D2920%26epage%3D2926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Katsura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakane, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takasugi, H.</span><span> </span><span class="NLM_article-title">Anti-<i>Helicobacter pylori</i> Agents. 2. Structure Activity Relationships in a New Series of 2-Alkylguanidino-4-furylthiazoles</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1307</span><span class="NLM_x">–</span> <span class="NLM_lpage">1312</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=1307-1312&author=Y.+Katsuraauthor=S.+Nishinoauthor=T.+Tomishiauthor=K.+Sakaneauthor=Y.+Matsumotoauthor=H.+Ishikawaauthor=H.+Takasugi&title=Anti-Helicobacter+pylori+Agents.+2.+Structure+Activity+Relationships+in+a+New+Series+of+2-Alkylguanidino-4-furylthiazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatsura%26aufirst%3DY.%26aulast%3DNishino%26aufirst%3DS.%26aulast%3DTomishi%26aufirst%3DT.%26aulast%3DSakane%26aufirst%3DK.%26aulast%3DMatsumoto%26aufirst%3DY.%26aulast%3DIshikawa%26aufirst%3DH.%26aulast%3DTakasugi%26aufirst%3DH.%26atitle%3DAnti-Helicobacter%2520pylori%2520Agents.%25202.%2520Structure%2520Activity%2520Relationships%2520in%2520a%2520New%2520Series%2520of%25202-Alkylguanidino-4-furylthiazoles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1998%26volume%3D8%26spage%3D1307%26epage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span>Emerging Drugs for Active Tuberculosis. <a href="http://www.thieme-connect.de/DOI/DOI?10.1055/s-0028-1085706" class="extLink">http://www.thieme-connect.de/DOI/DOI?10.1055/s-0028-1085706</a> (accessed Apr 9,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Emerging+Drugs+for+Active+Tuberculosis.+http%3A%2F%2Fwww.thieme-connect.de%2FDOI%2FDOI%3F10.1055%2Fs-0028-1085706+%28accessed+Apr+9%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Pankuch, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appelbaum, P. C.</span><span> </span><span class="NLM_article-title">Activities of Tizoxanide and Nitazoxanide Compared to Those of Five Other Thiazolides and Three Other Agents against Anaerobic Species</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1112</span><span class="NLM_x">–</span> <span class="NLM_lpage">1117</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=1112-1117&author=G.+A.+Pankuchauthor=P.+C.+Appelbaum&title=Activities+of+Tizoxanide+and+Nitazoxanide+Compared+to+Those+of+Five+Other+Thiazolides+and+Three+Other+Agents+against+Anaerobic+Species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPankuch%26aufirst%3DG.%2BA.%26aulast%3DAppelbaum%26aufirst%3DP.%2BC.%26atitle%3DActivities%2520of%2520Tizoxanide%2520and%2520Nitazoxanide%2520Compared%2520to%2520Those%2520of%2520Five%2520Other%2520Thiazolides%2520and%2520Three%2520Other%2520Agents%2520against%2520Anaerobic%2520Species%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D1112%26epage%3D1117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Costello, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karpanen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathbone, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeldon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worthington, T.</span><span> </span><span class="NLM_article-title">Thiosemicarbazones Active Against <i>Clostridium difficile</i></span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1708</span><span class="NLM_x">–</span> <span class="NLM_lpage">1711</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1708-1711&author=C.+Costelloauthor=T.+Karpanenauthor=P.+A.+Lambertauthor=P.+Mistryauthor=K.+J.+Parkerauthor=D.+L.+Rathboneauthor=J.+Renauthor=L.+Wheeldonauthor=T.+Worthington&title=Thiosemicarbazones+Active+Against+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCostello%26aufirst%3DC.%26aulast%3DKarpanen%26aufirst%3DT.%26aulast%3DLambert%26aufirst%3DP.%2BA.%26aulast%3DMistry%26aufirst%3DP.%26aulast%3DParker%26aufirst%3DK.%2BJ.%26aulast%3DRathbone%26aufirst%3DD.%2BL.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DWheeldon%26aufirst%3DL.%26aulast%3DWorthington%26aufirst%3DT.%26atitle%3DThiosemicarbazones%2520Active%2520Against%2520Clostridium%2520difficile%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1708%26epage%3D1711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Miyamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalisiak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korthals, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauwaet, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobo, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upcroft, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upcroft, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillin, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fokin, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckmann, L.</span><span> </span><span class="NLM_article-title">Expanded Therapeutic Potential in Activity Space of Next-Generation 5-Nitroimidazole Antimicrobials with Broad Structural Diversity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">17564</span><span class="NLM_x">–</span> <span class="NLM_lpage">17569</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=17564-17569&author=Y.+Miyamotoauthor=J.+Kalisiakauthor=K.+Korthalsauthor=T.+Lauwaetauthor=D.+Y.+Cheungauthor=R.+Lozanoauthor=E.+R.+Coboauthor=P.+Upcroftauthor=J.+A.+Upcroftauthor=D.+E.+Bergauthor=F.+D.+Gillinauthor=V.+V.+Fokinauthor=K.+B.+Sharplessauthor=L.+Eckmann&title=Expanded+Therapeutic+Potential+in+Activity+Space+of+Next-Generation+5-Nitroimidazole+Antimicrobials+with+Broad+Structural+Diversity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DY.%26aulast%3DKalisiak%26aufirst%3DJ.%26aulast%3DKorthals%26aufirst%3DK.%26aulast%3DLauwaet%26aufirst%3DT.%26aulast%3DCheung%26aufirst%3DD.%2BY.%26aulast%3DLozano%26aufirst%3DR.%26aulast%3DCobo%26aufirst%3DE.%2BR.%26aulast%3DUpcroft%26aufirst%3DP.%26aulast%3DUpcroft%26aufirst%3DJ.%2BA.%26aulast%3DBerg%26aufirst%3DD.%2BE.%26aulast%3DGillin%26aufirst%3DF.%2BD.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26aulast%3DEckmann%26aufirst%3DL.%26atitle%3DExpanded%2520Therapeutic%2520Potential%2520in%2520Activity%2520Space%2520of%2520Next-Generation%25205-Nitroimidazole%2520Antimicrobials%2520with%2520Broad%2520Structural%2520Diversity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3D17564%26epage%3D17569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Jeong, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukhopadhyay, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akada, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dailidiene, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, D. E.</span><span> </span><span class="NLM_article-title">Roles of FrxA and RdxA Nitroreductases of <i>Helicobacter pylori</i> in Susceptibility and Resistance to Metronidazole</span> <span class="citation_source-journal">J. Bacteriol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">183</span><span class="NLM_x">, </span> <span class="NLM_fpage">5155</span><span class="NLM_x">–</span> <span class="NLM_lpage">5162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1128%2FJB.183.17.5155-5162.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=11489869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtFKrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2001&pages=5155-5162&author=J.+Y.+Jeongauthor=A.+K.+Mukhopadhyayauthor=J.+K.+Akadaauthor=D.+Dailidieneauthor=P.+S.+Hoffmanauthor=D.+E.+Berg&title=Roles+of+FrxA+and+RdxA+Nitroreductases+of+Helicobacter+pylori+in+Susceptibility+and+Resistance+to+Metronidazole"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of FrxA and RdxA nitroreductases of Helicobacter pylori in susceptibility and resistance to metronidazole</span></div><div class="casAuthors">Jeong, Jin-Yong; Mukhopadhyay, Asish K.; Akada, Junko K.; Dailidiene, Daiva; Hoffman, Paul S.; Berg, Douglas E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5155-5162</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The relative importance of the frxA and rdxA nitroreductase genes of Helicobacter pylori in metronidazole (MTZ) susceptibility and resistance has been controversial.  Jeong et al. had interpreted that Mtzs H. pylori were of two types: type I, requiring only inactivation of rdxA to became resistant, and type II, requiring inactivation of both rdxA and frxA to become resistant; frxA inactivation by itself was not sufficient to confer resistance.  In contrast, Kwon et al. had interpreted that resistance resulted from inactivation either of frxA or rdxA.  These two interpretations were tested here.  Resistance was defined as efficient colony formation by single cells from dild. cultures rather than as growth responses of more dense inocula on MTZ-contg. medium.  Tests of three of Kwon's Mtzs strains showed that each was type II, requiring inactivation of both rdxA and frxA to become resistant.  In addnl. tests, derivs. of frxA mutant strains recovered from MTZ-contg. medium were found to contain new mutations in rdxA, and frxA inactivation slowed MTZ-induced killing of Mtzs strains.  Northern blot analyses indicated that frxA mRNA, and perhaps also rdxA mRNA, were more abundant in type II than in type I strains.  We conclude that development of MTZ resistance in H. pylori requires inactivation of rdxA alone or of both rdxA and frxA, depending on bacterial genotype, but rarely, if ever, inactivation of frxA alone, and that H. pylori strains differ in regulation of nitroreductase gene expression.  We suggest that such regulatory differences may be significant functionally during human infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpChB5BXmcFo7Vg90H21EOLACvtfcHk0ljC6ucRiL4OpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtFKrs7c%253D&md5=474bf2670bea9ea195b15d1e02b3d2b7</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1128%2FJB.183.17.5155-5162.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.183.17.5155-5162.2001%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DJ.%2BY.%26aulast%3DMukhopadhyay%26aufirst%3DA.%2BK.%26aulast%3DAkada%26aufirst%3DJ.%2BK.%26aulast%3DDailidiene%26aufirst%3DD.%26aulast%3DHoffman%26aufirst%3DP.%2BS.%26aulast%3DBerg%26aufirst%3DD.%2BE.%26atitle%3DRoles%2520of%2520FrxA%2520and%2520RdxA%2520Nitroreductases%2520of%2520Helicobacter%2520pylori%2520in%2520Susceptibility%2520and%2520Resistance%2520to%2520Metronidazole%26jtitle%3DJ.%2520Bacteriol.%26date%3D2001%26volume%3D183%26spage%3D5155%26epage%3D5162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Segreti, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trenholme, G. M.</span><span> </span><span class="NLM_article-title">In Vitro Activity of New Quinoxaline Compounds against <i>Campylobacter</i> Species and <i>Clostridium difficile</i></span> <span class="citation_source-journal">Diagn. Microbiol. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1016%2F0732-8893%2893%2990031-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=8243041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADyaK2cXitFagtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1993&pages=177-179&author=J.+Segretiauthor=L.+J.+Goodmanauthor=G.+M.+Trenholme&title=In+Vitro+Activity+of+New+Quinoxaline+Compounds+against+Campylobacter+Species+and+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro activity of new quinoxaline compounds against Campylobacter species and Clostridium difficile</span></div><div class="casAuthors">Segreti, John; Goodman, Larry J.; Trenholme, Gordon M.</div><div class="citationInfo"><span class="NLM_cas:title">Diagnostic Microbiology and Infectious Disease</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">177-9</span>CODEN:
                <span class="NLM_cas:coden">DMIDDZ</span>;
        ISSN:<span class="NLM_cas:issn">0732-8893</span>.
    </div><div class="casAbstract">SC-44914 and SC-44942-A are two new quinoxaline compds. with a spectrum of activity similar to that of metronidazole.  The authors studied the activity of SC-44914 and SC-44942-A against 35 Campylobacter jejuni, 30 Campylobacter coli, and 20 Clostridium difficile and compared it with that of metronidazole by utilizing an agar diln. method.  The quinoxalines had little activity against the C. jejuni and C. coli [min. inhibitory concn. (MIC)90 ≥ 64 μg/mL].  SC-44914 and SC-44942-A had excellent activity against Cl. difficile (MIC90 ≤ 0.06 μg/mL for SC 44914, and 0.5 μg/mL for SC-44942A).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrK7FQr7Eub7Vg90H21EOLACvtfcHk0ljC6ucRiL4OpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitFagtbk%253D&md5=e3ccb23317e46ae07f8d7009396fb5d3</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2F0732-8893%2893%2990031-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0732-8893%252893%252990031-2%26sid%3Dliteratum%253Aachs%26aulast%3DSegreti%26aufirst%3DJ.%26aulast%3DGoodman%26aufirst%3DL.%2BJ.%26aulast%3DTrenholme%26aufirst%3DG.%2BM.%26atitle%3DIn%2520Vitro%2520Activity%2520of%2520New%2520Quinoxaline%2520Compounds%2520against%2520Campylobacter%2520Species%2520and%2520Clostridium%2520difficile%26jtitle%3DDiagn.%2520Microbiol.%2520Infect.%2520Dis.%26date%3D1993%26volume%3D17%26spage%3D177%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Zhang, S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span> </span><span class="NLM_article-title">Synthesis and Antibacterial Activity against <i>Clostridium difficile</i> of Novel Demethylvancomycin Derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4942</span><span class="NLM_x">–</span> <span class="NLM_lpage">4945</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4942-4945&author=S.-J.+Zhangauthor=Q.+Yangauthor=L.+Xuauthor=J.+Changauthor=X.+Sun&title=Synthesis+and+Antibacterial+Activity+against+Clostridium+difficile+of+Novel+Demethylvancomycin+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.-J.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DX.%26atitle%3DSynthesis%2520and%2520Antibacterial%2520Activity%2520against%2520Clostridium%2520difficile%2520of%2520Novel%2520Demethylvancomycin%2520Derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D4942%26epage%3D4945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Kirst, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willard, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truedell, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Counter, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felty-Duckworth, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pekarek, R. S.</span><span> </span><span class="NLM_article-title">Synthesis and Evaluation of Tylosin-Related Macrolides Modified at the Aldehyde Function: A New Series of Orally Effective Antibiotics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1631</span><span class="NLM_x">–</span> <span class="NLM_lpage">1641</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00403a025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADyaL1cXksVOrtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=1631-1641&author=H.+A.+Kirstauthor=J.+E.+Tothauthor=M.+Debonoauthor=K.+E.+Willardauthor=B.+A.+Truedellauthor=J.+L.+Ottauthor=F.+T.+Counterauthor=A.+M.+Felty-Duckworthauthor=R.+S.+Pekarek&title=Synthesis+and+Evaluation+of+Tylosin-Related+Macrolides+Modified+at+the+Aldehyde+Function%3A+A+New+Series+of+Orally+Effective+Antibiotics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of tylosin-related macrolides modified at the aldehyde function:  a new series of orally effective antibiotics</span></div><div class="casAuthors">Kirst, Herbert A.; Toth, John E.; Debono, Manuel; Willard, Kevin E.; Truedell, Brenda A.; Ott, John L.; Counter, Fred T.; Felty-Duckworth, Anna M.; Pekarek, Robert S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1631-41</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Modification of the aldehyde group in tylosin (I) and related macrolide antibiotics dramatically enhanced the oral efficacy of the derivs. against exptl. infections caused by susceptible bacteria in lab. animals.  A large no. and wide variety of aldehyde-modified macrolide derivs. were prepd., utilizing the Mitsunobu reaction and other chem. transformations.  Evaluation of in vitro and in vivo antimicrobial activity indicated that derivs. of desmycosin (II) showed the broadest spectrum of antimicrobial activity with the best efficacy and bioavailability after oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo52TYXABepi7Vg90H21EOLACvtfcHk0ljC6ucRiL4OpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXksVOrtb4%253D&md5=eeae47f7c2d09294820a707c6c70f843</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fjm00403a025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00403a025%26sid%3Dliteratum%253Aachs%26aulast%3DKirst%26aufirst%3DH.%2BA.%26aulast%3DToth%26aufirst%3DJ.%2BE.%26aulast%3DDebono%26aufirst%3DM.%26aulast%3DWillard%26aufirst%3DK.%2BE.%26aulast%3DTruedell%26aufirst%3DB.%2BA.%26aulast%3DOtt%26aufirst%3DJ.%2BL.%26aulast%3DCounter%26aufirst%3DF.%2BT.%26aulast%3DFelty-Duckworth%26aufirst%3DA.%2BM.%26aulast%3DPekarek%26aufirst%3DR.%2BS.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Tylosin-Related%2520Macrolides%2520Modified%2520at%2520the%2520Aldehyde%2520Function%253A%2520A%2520New%2520Series%2520of%2520Orally%2520Effective%2520Antibiotics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D1631%26epage%3D1641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Terasawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsuhashi, S.</span><span> </span><span class="NLM_article-title">In Vitro Activity of YM133, a New Semisynthesized Macrolide</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1370</span><span class="NLM_x">–</span> <span class="NLM_lpage">1375</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1991&pages=1370-1375&author=T.+Terasawaauthor=M.+Watanabeauthor=T.+Okuboauthor=S.+Mitsuhashi&title=In+Vitro+Activity+of+YM133%2C+a+New+Semisynthesized+Macrolide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTerasawa%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DOkubo%26aufirst%3DT.%26aulast%3DMitsuhashi%26aufirst%3DS.%26atitle%3DIn%2520Vitro%2520Activity%2520of%2520YM133%252C%2520a%2520New%2520Semisynthesized%2520Macrolide%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1991%26volume%3D35%26spage%3D1370%26epage%3D1375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Sanchez, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogliotti, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domagala, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gracheck, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huband, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sesnie, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, M. A.</span><span> </span><span class="NLM_article-title">The Synthesis, Structure-Activity, and Structure-Side Effect Relationships of a Series of 8-Alkoxy- and 5-Amino-8-alkoxyquinolone Antibacterial Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">4478</span><span class="NLM_x">–</span> <span class="NLM_lpage">4487</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00022a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=4478-4487&author=J.+P.+Sanchezauthor=R.+D.+Gogliottiauthor=J.+M.+Domagalaauthor=S.+J.+Gracheckauthor=M.+D.+Hubandauthor=J.+A.+Sesnieauthor=M.+A.+Cohenauthor=M.+A.+Shapiro&title=The+Synthesis%2C+Structure-Activity%2C+and+Structure-Side+Effect+Relationships+of+a+Series+of+8-Alkoxy-+and+5-Amino-8-alkoxyquinolone+Antibacterial+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Fjm00022a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00022a013%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez%26aufirst%3DJ.%2BP.%26aulast%3DGogliotti%26aufirst%3DR.%2BD.%26aulast%3DDomagala%26aufirst%3DJ.%2BM.%26aulast%3DGracheck%26aufirst%3DS.%2BJ.%26aulast%3DHuband%26aufirst%3DM.%2BD.%26aulast%3DSesnie%26aufirst%3DJ.%2BA.%26aulast%3DCohen%26aufirst%3DM.%2BA.%26aulast%3DShapiro%26aufirst%3DM.%2BA.%26atitle%3DThe%2520Synthesis%252C%2520Structure-Activity%252C%2520and%2520Structure-Side%2520Effect%2520Relationships%2520of%2520a%2520Series%2520of%25208-Alkoxy-%2520and%25205-Amino-8-alkoxyquinolone%2520Antibacterial%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D4478%26epage%3D4487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Rosen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marovich, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pernet, A. G.</span><span> </span><span class="NLM_article-title">Aromatic Dienoyl Tetramic Acids. Novel Antibacterial Agents with Activity against Anaerobes and Staphylococci</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1062</span><span class="NLM_x">–</span> <span class="NLM_lpage">1069</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00125a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=1062-1069&author=T.+Rosenauthor=P.+B.+Fernandesauthor=M.+A.+Marovichauthor=L.+Shenauthor=J.+Maoauthor=A.+G.+Pernet&title=Aromatic+Dienoyl+Tetramic+Acids.+Novel+Antibacterial+Agents+with+Activity+against+Anaerobes+and+Staphylococci"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Fjm00125a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00125a022%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DT.%26aulast%3DFernandes%26aufirst%3DP.%2BB.%26aulast%3DMarovich%26aufirst%3DM.%2BA.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DPernet%26aufirst%3DA.%2BG.%26atitle%3DAromatic%2520Dienoyl%2520Tetramic%2520Acids.%2520Novel%2520Antibacterial%2520Agents%2520with%2520Activity%2520against%2520Anaerobes%2520and%2520Staphylococci%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26spage%3D1062%26epage%3D1069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Ueda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tateda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suematsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiguro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyairi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span> </span><span class="NLM_article-title">Anti-<i>Clostridium difficile</i> Potential of Tetramic Acid Derivatives from <i>Pseudomonas Aeruginosa</i> Quorum-Sensing Autoinducers</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">688</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=683-688&author=C.+Uedaauthor=K.+Tatedaauthor=M.+Horikawaauthor=S.+Kimuraauthor=Y.+Ishiiauthor=K.+Nomuraauthor=K.+Yamadaauthor=T.+Suematsuauthor=Y.+Inoueauthor=M.+Ishiguroauthor=S.+Miyairiauthor=K.+Yamaguchi&title=Anti-Clostridium+difficile+Potential+of+Tetramic+Acid+Derivatives+from+Pseudomonas+Aeruginosa+Quorum-Sensing+Autoinducers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DC.%26aulast%3DTateda%26aufirst%3DK.%26aulast%3DHorikawa%26aufirst%3DM.%26aulast%3DKimura%26aufirst%3DS.%26aulast%3DIshii%26aufirst%3DY.%26aulast%3DNomura%26aufirst%3DK.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DSuematsu%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DY.%26aulast%3DIshiguro%26aufirst%3DM.%26aulast%3DMiyairi%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DK.%26atitle%3DAnti-Clostridium%2520difficile%2520Potential%2520of%2520Tetramic%2520Acid%2520Derivatives%2520from%2520Pseudomonas%2520Aeruginosa%2520Quorum-Sensing%2520Autoinducers%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D683%26epage%3D688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Karwowski, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theriault, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlow, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensey, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, P. E.</span><span> </span><span class="NLM_article-title">Tirandalydigin, a Novel Tetramic Acid of the Tirandamycin-Streptolydigin Type. I. Taxonomy of the Producing Organism, Fermentation and Biological Activity</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1125</span><span class="NLM_x">–</span> <span class="NLM_lpage">1132</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1992&pages=1125-1132&author=J.+P.+Karwowskiauthor=M.+Jacksonauthor=R.+J.+Theriaultauthor=G.+J.+Barlowauthor=L.+Coenauthor=D.+M.+Henseyauthor=P.+E.+Humphrey&title=Tirandalydigin%2C+a+Novel+Tetramic+Acid+of+the+Tirandamycin-Streptolydigin+Type.+I.+Taxonomy+of+the+Producing+Organism%2C+Fermentation+and+Biological+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarwowski%26aufirst%3DJ.%2BP.%26aulast%3DJackson%26aufirst%3DM.%26aulast%3DTheriault%26aufirst%3DR.%2BJ.%26aulast%3DBarlow%26aufirst%3DG.%2BJ.%26aulast%3DCoen%26aufirst%3DL.%26aulast%3DHensey%26aufirst%3DD.%2BM.%26aulast%3DHumphrey%26aufirst%3DP.%2BE.%26atitle%3DTirandalydigin%252C%2520a%2520Novel%2520Tetramic%2520Acid%2520of%2520the%2520Tirandamycin-Streptolydigin%2520Type.%2520I.%2520Taxonomy%2520of%2520the%2520Producing%2520Organism%252C%2520Fermentation%2520and%2520Biological%2520Activity%26jtitle%3DJ.%2520Antibiot.%26date%3D1992%26volume%3D45%26spage%3D1125%26epage%3D1132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Shoji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakazaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uotani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, T.</span><span> </span><span class="NLM_article-title">Isolation and Characterization of Agglomerins A, B, C and D</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1729</span><span class="NLM_x">–</span> <span class="NLM_lpage">1733</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1989&pages=1729-1733&author=J.+Shojiauthor=R.+Sakazakiauthor=T.+Hattoriauthor=K.+Matsumotoauthor=N.+Uotaniauthor=T.+Yoshida&title=Isolation+and+Characterization+of+Agglomerins+A%2C+B%2C+C+and+D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShoji%26aufirst%3DJ.%26aulast%3DSakazaki%26aufirst%3DR.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DUotani%26aufirst%3DN.%26aulast%3DYoshida%26aufirst%3DT.%26atitle%3DIsolation%2520and%2520Characterization%2520of%2520Agglomerins%2520A%252C%2520B%252C%2520C%2520and%2520D%26jtitle%3DJ.%2520Antibiot.%26date%3D1989%26volume%3D42%26spage%3D1729%26epage%3D1733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Terui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakazaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoji, J.</span><span> </span><span class="NLM_article-title">Structures of Agglomerins</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1245</span><span class="NLM_x">–</span> <span class="NLM_lpage">1253</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1990&pages=1245-1253&author=Y.+Teruiauthor=R.+Sakazakiauthor=J.+Shoji&title=Structures+of+Agglomerins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTerui%26aufirst%3DY.%26aulast%3DSakazaki%26aufirst%3DR.%26aulast%3DShoji%26aufirst%3DJ.%26atitle%3DStructures%2520of%2520Agglomerins%26jtitle%3DJ.%2520Antibiot.%26date%3D1990%26volume%3D43%26spage%3D1245%26epage%3D1253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Butler, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peet, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panchal, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bavari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinabarger, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowlin, T. L.</span><span> </span><span class="NLM_article-title">Comparative in Vitro Activity Profiles of Novel Bis-Indole Antibacterials against Gram-Positive and Gram-Negative Clinical Isolates</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3974</span><span class="NLM_x">–</span> <span class="NLM_lpage">3977</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=3974-3977&author=M.+M.+Butlerauthor=J.+D.+Williamsauthor=N.+P.+Peetauthor=D.+T.+Moirauthor=R.+G.+Panchalauthor=S.+Bavariauthor=D.+L.+Shinabargerauthor=T.+L.+Bowlin&title=Comparative+in+Vitro+Activity+Profiles+of+Novel+Bis-Indole+Antibacterials+against+Gram-Positive+and+Gram-Negative+Clinical+Isolates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DM.%2BM.%26aulast%3DWilliams%26aufirst%3DJ.%2BD.%26aulast%3DPeet%26aufirst%3DN.%2BP.%26aulast%3DMoir%26aufirst%3DD.%2BT.%26aulast%3DPanchal%26aufirst%3DR.%2BG.%26aulast%3DBavari%26aufirst%3DS.%26aulast%3DShinabarger%26aufirst%3DD.%2BL.%26aulast%3DBowlin%26aufirst%3DT.%2BL.%26atitle%3DComparative%2520in%2520Vitro%2520Activity%2520Profiles%2520of%2520Novel%2520Bis-Indole%2520Antibacterials%2520against%2520Gram-Positive%2520and%2520Gram-Negative%2520Clinical%2520Isolates%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D3974%26epage%3D3977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Panchal, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houseweart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Opperman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peet, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gussio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowlin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bavari, S.</span><span> </span><span class="NLM_article-title">Novel Broad-Spectrum Bis-(imidazolinylindole) Derivatives with Potent Antibacterial Activities against Antibiotic-Resistant Strains</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4283</span><span class="NLM_x">–</span> <span class="NLM_lpage">4291</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=4283-4291&author=R.+G.+Panchalauthor=R.+L.+Ulrichauthor=D.+Laneauthor=M.+M.+Butlerauthor=C.+Houseweartauthor=T.+Oppermanauthor=J.+D.+Williamsauthor=N.+P.+Peetauthor=D.+T.+Moirauthor=T.+Nguyenauthor=R.+Gussioauthor=T.+Bowlinauthor=S.+Bavari&title=Novel+Broad-Spectrum+Bis-%28imidazolinylindole%29+Derivatives+with+Potent+Antibacterial+Activities+against+Antibiotic-Resistant+Strains"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPanchal%26aufirst%3DR.%2BG.%26aulast%3DUlrich%26aufirst%3DR.%2BL.%26aulast%3DLane%26aufirst%3DD.%26aulast%3DButler%26aufirst%3DM.%2BM.%26aulast%3DHouseweart%26aufirst%3DC.%26aulast%3DOpperman%26aufirst%3DT.%26aulast%3DWilliams%26aufirst%3DJ.%2BD.%26aulast%3DPeet%26aufirst%3DN.%2BP.%26aulast%3DMoir%26aufirst%3DD.%2BT.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DGussio%26aufirst%3DR.%26aulast%3DBowlin%26aufirst%3DT.%26aulast%3DBavari%26aufirst%3DS.%26atitle%3DNovel%2520Broad-Spectrum%2520Bis-%2528imidazolinylindole%2529%2520Derivatives%2520with%2520Potent%2520Antibacterial%2520Activities%2520against%2520Antibiotic-Resistant%2520Strains%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D4283%26epage%3D4291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Ambrus, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelso, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bremner, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casadei, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, K.</span><span> </span><span class="NLM_article-title">Structure-Activity Relationships of 2-Aryl-1<i>H</i>-Indole Inhibitors of the NorA Efflux Pump in <i>Staphylococcus aureus</i></span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4294</span><span class="NLM_x">–</span> <span class="NLM_lpage">4297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1016%2Fj.bmcl.2008.06.093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=18632270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVeqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4294-4297&author=J.+I.+Ambrusauthor=M.+J.+Kelsoauthor=J.+B.+Bremnerauthor=A.+R.+Ballauthor=G.+Casadeiauthor=K.+Lewis&title=Structure-Activity+Relationships+of+2-Aryl-1H-Indole+Inhibitors+of+the+NorA+Efflux+Pump+in+Staphylococcus+aureus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of 2-aryl-1H-indole inhibitors of the NorA efflux pump in Staphylococcus aureus</span></div><div class="casAuthors">Ambrus, Joseph I.; Kelso, Michael J.; Bremner, John B.; Ball, Anthony R.; Casadei, Gabriele; Lewis, Kim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4294-4297</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The synthesis of 22 2-aryl-1H-indoles, e.g. I (R1 = H, NO2, R2 = 2-CO2Me, 3-CO2Me, 4-CO2Me, 2-CH2OH, 3-CH2OH, 4-CH2OH), including 12 new compds., has been achieved via Pd- or Rh-mediated methodologies, or selective electrophilic substitution.  All three methods were based on elaborations from simple indole precursors.  SAR studies on these indoles and 2-phenyl-1H-indole in Staphylococcus aureus as NorA efflux pump inhibitors indicated 5-nitro-2-(3-methoxycarbonyl)phenyl-1H-indole was a slightly more potent inhibitor than the lead INF55 I (R1 = NO2, R2 = H).  A promising new antibacterial lead compd. against S. aureus (2-phenyl-1H-indol-5-yl)-methanol, was also found.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsxs6bHUKlFbVg90H21EOLACvtfcHk0lgwiZiJnQvo6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVeqtLg%253D&md5=d2f7b2a8c6f8e926b4ebf3ba4ac01aa0</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.06.093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.06.093%26sid%3Dliteratum%253Aachs%26aulast%3DAmbrus%26aufirst%3DJ.%2BI.%26aulast%3DKelso%26aufirst%3DM.%2BJ.%26aulast%3DBremner%26aufirst%3DJ.%2BB.%26aulast%3DBall%26aufirst%3DA.%2BR.%26aulast%3DCasadei%26aufirst%3DG.%26aulast%3DLewis%26aufirst%3DK.%26atitle%3DStructure-Activity%2520Relationships%2520of%25202-Aryl-1H-Indole%2520Inhibitors%2520of%2520the%2520NorA%2520Efflux%2520Pump%2520in%2520Staphylococcus%2520aureus%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4294%26epage%3D4297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Ternansky, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eudaly, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasher, J. S.</span><span> </span><span class="NLM_article-title">Synthesis and Anaerobic Activity of Novel 1-Carba-1-dethiacephalosporins</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2332</span><span class="NLM_x">–</span> <span class="NLM_lpage">2334</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00068a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=2332-2334&author=R.+J.+Ternanskyauthor=C.+L.+Jordanauthor=J.+A.+Eudalyauthor=J.+S.+Kasher&title=Synthesis+and+Anaerobic+Activity+of+Novel+1-Carba-1-dethiacephalosporins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fjm00068a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00068a009%26sid%3Dliteratum%253Aachs%26aulast%3DTernansky%26aufirst%3DR.%2BJ.%26aulast%3DJordan%26aufirst%3DC.%2BL.%26aulast%3DEudaly%26aufirst%3DJ.%2BA.%26aulast%3DKasher%26aufirst%3DJ.%2BS.%26atitle%3DSynthesis%2520and%2520Anaerobic%2520Activity%2520of%2520Novel%25201-Carba-1-dethiacephalosporins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D2332%26epage%3D2334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Corraz, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dax, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlap, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgopapadakou, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruess, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossman, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Then, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unowsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, C. C.</span><span> </span><span class="NLM_article-title">Dual-Action Penems and Carbapenems</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1828</span><span class="NLM_x">–</span> <span class="NLM_lpage">1839</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00088a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=1828-1839&author=A.+J.+Corrazauthor=S.+L.+Daxauthor=N.+K.+Dunlapauthor=N.+H.+Georgopapadakouauthor=D.+D.+Keithauthor=D.+L.+Pruessauthor=P.+L.+Rossmanauthor=R.+Thenauthor=J.+Unowskyauthor=C.+C.+Wei&title=Dual-Action+Penems+and+Carbapenems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Fjm00088a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00088a019%26sid%3Dliteratum%253Aachs%26aulast%3DCorraz%26aufirst%3DA.%2BJ.%26aulast%3DDax%26aufirst%3DS.%2BL.%26aulast%3DDunlap%26aufirst%3DN.%2BK.%26aulast%3DGeorgopapadakou%26aufirst%3DN.%2BH.%26aulast%3DKeith%26aufirst%3DD.%2BD.%26aulast%3DPruess%26aufirst%3DD.%2BL.%26aulast%3DRossman%26aufirst%3DP.%2BL.%26aulast%3DThen%26aufirst%3DR.%26aulast%3DUnowsky%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DC.%2BC.%26atitle%3DDual-Action%2520Penems%2520and%2520Carbapenems%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D1828%26epage%3D1839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Mani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanzelka, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillot, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charifson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, T. H.</span><span> </span><span class="NLM_article-title">In Vitro Characterization of the Antibacterial Spectrum of Novel Bacterial Type II Topoisomerase Inhibitors of the Aminobenzimidazole Class</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1228</span><span class="NLM_x">–</span> <span class="NLM_lpage">1237</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=1228-1237&author=N.+Maniauthor=C.+H.+Grossauthor=J.+D.+Parsonsauthor=B.+Hanzelkaauthor=U.+M%C3%BChauthor=S.+Mullinauthor=Y.+Liaoauthor=A.-L.+Grillotauthor=D.+Stamosauthor=P.+S.+Charifsonauthor=T.+H.+Grossman&title=In+Vitro+Characterization+of+the+Antibacterial+Spectrum+of+Novel+Bacterial+Type+II+Topoisomerase+Inhibitors+of+the+Aminobenzimidazole+Class"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMani%26aufirst%3DN.%26aulast%3DGross%26aufirst%3DC.%2BH.%26aulast%3DParsons%26aufirst%3DJ.%2BD.%26aulast%3DHanzelka%26aufirst%3DB.%26aulast%3DM%25C3%25BCh%26aufirst%3DU.%26aulast%3DMullin%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DGrillot%26aufirst%3DA.-L.%26aulast%3DStamos%26aufirst%3DD.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26aulast%3DGrossman%26aufirst%3DT.%2BH.%26atitle%3DIn%2520Vitro%2520Characterization%2520of%2520the%2520Antibacterial%2520Spectrum%2520of%2520Novel%2520Bacterial%2520Type%2520II%2520Topoisomerase%2520Inhibitors%2520of%2520the%2520Aminobenzimidazole%2520Class%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D1228%26epage%3D1237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Charifson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillot, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drumm, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeTiran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolau, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perola, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronkin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenson, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tessier, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trudeau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamos, D.</span><span> </span><span class="NLM_article-title">Novel Dual-Targeting Benzimidazole Urea Inhibitors of DNA Gyrase and Topoisomerase IV Possessing Potent Antibacterial Activity: Intelligent Design and Evolution through the Judicious Use of Structure-Guided Design and Structure-Activity Relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5243</span><span class="NLM_x">–</span> <span class="NLM_lpage">5263</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800318d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1Knsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5243-5263&author=P.+S.+Charifsonauthor=A.-L.+Grillotauthor=T.+H.+Grossmanauthor=J.+D.+Parsonsauthor=M.+Badiaauthor=S.+Bellonauthor=D.+D.+Deiningerauthor=J.+E.+Drummauthor=C.+H.+Grossauthor=A.+LeTiranauthor=Y.+Liaoauthor=N.+Maniauthor=D.+P.+Nicolauauthor=E.+Perolaauthor=S.+Ronkinauthor=D.+Shannonauthor=L.+L.+Swensonauthor=Q.+Tangauthor=P.+R.+Tessierauthor=S.-K.+Tianauthor=M.+Trudeauauthor=T.+Wangauthor=Y.+Weiauthor=H.+Zhangauthor=D.+Stamos&title=Novel+Dual-Targeting+Benzimidazole+Urea+Inhibitors+of+DNA+Gyrase+and+Topoisomerase+IV+Possessing+Potent+Antibacterial+Activity%3A+Intelligent+Design+and+Evolution+through+the+Judicious+Use+of+Structure-Guided+Design+and+Structure-Activity+Relationships"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Dual-Targeting Benzimidazole Urea Inhibitors of DNA Gyrase and Topoisomerase IV Possessing Potent Antibacterial Activity: Intelligent Design and Evolution through the Judicious Use of Structure-Guided Design and Structure-Activity Relationships</span></div><div class="casAuthors">Charifson, Paul S.; Grillot, Anne-Laure; Grossman, Trudy H.; Parsons, Jonathan D.; Badia, Michael; Bellon, Steve; Deininger, David D.; Drumm, Joseph E.; Gross, Christian H.; LeTiran, Arnaud; Liao, Yusheng; Mani, Nagraj; Nicolau, David P.; Perola, Emanuele; Ronkin, Steven; Shannon, Dean; Swenson, Lora L.; Tang, Qing; Tessier, Pamela R.; Tian, Ski-Kai; Trudeau, Martin; Wang, Tiansheng; Wei, Yunyi; Zhang, Hong; Stamos, Dean</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5243-5263</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of new antibacterial agents with novel mechanisms of action is necessary to overcome the problem of bacterial resistance that affects all currently used classes of antibiotics.  Bacterial DNA gyrase and topoisomerase IV are well-characterized clin. validated targets of the fluoroquinolone antibiotics which exert their antibacterial activity through inhibition of the catalytic subunits.  Inhibition of these targets through interaction with their ATP sites has been less clin. successful.  The discovery and characterization of a new class of low mol. wt., synthetic inhibitors of gyrase and topoisomerase IV that bind to the ATP sites are presented.  The benzimidazole ureas are dual targeting inhibitors of both enzymes and possess potent antibacterial activity against a wide spectrum of relevant pathogens responsible for hospital- and community-acquired infections.  The discovery and optimization of this novel class of antibacterials by the use of structure-guided design, modeling, and structure-activity relationships are described.  Data are presented for enzyme inhibition, antibacterial activity, and in vivo efficacy by oral and i.v. administration in two rodent infection models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSg-NiMYqXebVg90H21EOLACvtfcHk0lgYxw7AfrDnZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1Knsb4%253D&md5=284d19912422bcadd38d9c021cd71ef8</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Fjm800318d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800318d%26sid%3Dliteratum%253Aachs%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26aulast%3DGrillot%26aufirst%3DA.-L.%26aulast%3DGrossman%26aufirst%3DT.%2BH.%26aulast%3DParsons%26aufirst%3DJ.%2BD.%26aulast%3DBadia%26aufirst%3DM.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DDeininger%26aufirst%3DD.%2BD.%26aulast%3DDrumm%26aufirst%3DJ.%2BE.%26aulast%3DGross%26aufirst%3DC.%2BH.%26aulast%3DLeTiran%26aufirst%3DA.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DMani%26aufirst%3DN.%26aulast%3DNicolau%26aufirst%3DD.%2BP.%26aulast%3DPerola%26aufirst%3DE.%26aulast%3DRonkin%26aufirst%3DS.%26aulast%3DShannon%26aufirst%3DD.%26aulast%3DSwenson%26aufirst%3DL.%2BL.%26aulast%3DTang%26aufirst%3DQ.%26aulast%3DTessier%26aufirst%3DP.%2BR.%26aulast%3DTian%26aufirst%3DS.-K.%26aulast%3DTrudeau%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DStamos%26aufirst%3DD.%26atitle%3DNovel%2520Dual-Targeting%2520Benzimidazole%2520Urea%2520Inhibitors%2520of%2520DNA%2520Gyrase%2520and%2520Topoisomerase%2520IV%2520Possessing%2520Potent%2520Antibacterial%2520Activity%253A%2520Intelligent%2520Design%2520and%2520Evolution%2520through%2520the%2520Judicious%2520Use%2520of%2520Structure-Guided%2520Design%2520and%2520Structure-Activity%2520Relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5243%26epage%3D5263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Grillot, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiran, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Dowd, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronkin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waal, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauffer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sizensky, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanoury, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perola, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanzelka, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixit, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewing, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charifson, P. S.</span><span> </span><span class="NLM_article-title">Second-Generation Antibacterial Benzimidazole Ureas: Discovery of a Preclinical Candidate with Reduced Metabolic Liability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8792</span><span class="NLM_x">–</span> <span class="NLM_lpage">8816</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500563g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8792-8816&author=A.-L.+Grillotauthor=A.+L.+Tiranauthor=D.+Shannonauthor=E.+Kruegerauthor=Y.+Liaoauthor=H.+O%E2%80%99Dowdauthor=Q.+Tangauthor=S.+Ronkinauthor=T.+Wangauthor=N.+Waalauthor=P.+Liauthor=D.+Laufferauthor=E.+Sizenskyauthor=J.+Tanouryauthor=E.+Perolaauthor=T.+H.+Grossmanauthor=T.+Doyleauthor=B.+Hanzelkaauthor=S.+Jonesauthor=V.+Dixitauthor=N.+Ewingauthor=S.+Liaoauthor=B.+Boucherauthor=M.+Jacobsauthor=Y.+Bennaniauthor=P.+S.+Charifson&title=Second-Generation+Antibacterial+Benzimidazole+Ureas%3A+Discovery+of+a+Preclinical+Candidate+with+Reduced+Metabolic+Liability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Fjm500563g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500563g%26sid%3Dliteratum%253Aachs%26aulast%3DGrillot%26aufirst%3DA.-L.%26aulast%3DTiran%26aufirst%3DA.%2BL.%26aulast%3DShannon%26aufirst%3DD.%26aulast%3DKrueger%26aufirst%3DE.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Dowd%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DQ.%26aulast%3DRonkin%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWaal%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DLauffer%26aufirst%3DD.%26aulast%3DSizensky%26aufirst%3DE.%26aulast%3DTanoury%26aufirst%3DJ.%26aulast%3DPerola%26aufirst%3DE.%26aulast%3DGrossman%26aufirst%3DT.%2BH.%26aulast%3DDoyle%26aufirst%3DT.%26aulast%3DHanzelka%26aufirst%3DB.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DDixit%26aufirst%3DV.%26aulast%3DEwing%26aufirst%3DN.%26aulast%3DLiao%26aufirst%3DS.%26aulast%3DBoucher%26aufirst%3DB.%26aulast%3DJacobs%26aufirst%3DM.%26aulast%3DBennani%26aufirst%3DY.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26atitle%3DSecond-Generation%2520Antibacterial%2520Benzimidazole%2520Ureas%253A%2520Discovery%2520of%2520a%2520Preclinical%2520Candidate%2520with%2520Reduced%2520Metabolic%2520Liability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8792%26epage%3D8816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Perola, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillot, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronkin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeTiran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drumm, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolau, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tessier, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charifson, P. S.</span><span> </span><span class="NLM_article-title">Successful Application of Serum Shift Prediction Models to the Design of Dual Targeting Inhibitors of Bacterial Gyrase B and Topoisomerase IV with Improved in Vivo Efficacy</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2177</span><span class="NLM_x">–</span> <span class="NLM_lpage">2181</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2177-2181&author=E.+Perolaauthor=D.+Stamosauthor=A.-L.+Grillotauthor=S.+Ronkinauthor=T.+Wangauthor=A.+LeTiranauthor=Q.+Tangauthor=D.+D.+Deiningerauthor=Y.+Liaoauthor=S.-K.+Tianauthor=J.+E.+Drummauthor=D.+P.+Nicolauauthor=P.+R.+Tessierauthor=N.+Maniauthor=T.+H.+Grossmanauthor=P.+S.+Charifson&title=Successful+Application+of+Serum+Shift+Prediction+Models+to+the+Design+of+Dual+Targeting+Inhibitors+of+Bacterial+Gyrase+B+and+Topoisomerase+IV+with+Improved+in+Vivo+Efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerola%26aufirst%3DE.%26aulast%3DStamos%26aufirst%3DD.%26aulast%3DGrillot%26aufirst%3DA.-L.%26aulast%3DRonkin%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLeTiran%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DQ.%26aulast%3DDeininger%26aufirst%3DD.%2BD.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DS.-K.%26aulast%3DDrumm%26aufirst%3DJ.%2BE.%26aulast%3DNicolau%26aufirst%3DD.%2BP.%26aulast%3DTessier%26aufirst%3DP.%2BR.%26aulast%3DMani%26aufirst%3DN.%26aulast%3DGrossman%26aufirst%3DT.%2BH.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26atitle%3DSuccessful%2520Application%2520of%2520Serum%2520Shift%2520Prediction%2520Models%2520to%2520the%2520Design%2520of%2520Dual%2520Targeting%2520Inhibitors%2520of%2520Bacterial%2520Gyrase%2520B%2520and%2520Topoisomerase%2520IV%2520with%2520Improved%2520in%2520Vivo%2520Efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2177%26epage%3D2181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Stokes, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomaides-Brears, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czaplewski, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamble, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunniss, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peasley, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haydon, D. J.</span><span> </span><span class="NLM_article-title">Biological Evaluation of Benzothiazole Ethyl Urea Inhibitors of Bacterial Type II Topoisomerases</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5977</span><span class="NLM_x">–</span> <span class="NLM_lpage">5986</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=5977-5986&author=N.+R.+Stokesauthor=H.+B.+Thomaides-Brearsauthor=S.+Barkerauthor=J.+M.+Bennettauthor=J.+Berryauthor=I.+Collinsauthor=L.+G.+Czaplewskiauthor=V.+Gambleauthor=P.+Lancettauthor=A.+Loganauthor=C.+J.+Lunnissauthor=H.+Peasleyauthor=S.+Pommierauthor=D.+Priceauthor=C.+Smeeauthor=D.+J.+Haydon&title=Biological+Evaluation+of+Benzothiazole+Ethyl+Urea+Inhibitors+of+Bacterial+Type+II+Topoisomerases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStokes%26aufirst%3DN.%2BR.%26aulast%3DThomaides-Brears%26aufirst%3DH.%2BB.%26aulast%3DBarker%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DJ.%2BM.%26aulast%3DBerry%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DCzaplewski%26aufirst%3DL.%2BG.%26aulast%3DGamble%26aufirst%3DV.%26aulast%3DLancett%26aufirst%3DP.%26aulast%3DLogan%26aufirst%3DA.%26aulast%3DLunniss%26aufirst%3DC.%2BJ.%26aulast%3DPeasley%26aufirst%3DH.%26aulast%3DPommier%26aufirst%3DS.%26aulast%3DPrice%26aufirst%3DD.%26aulast%3DSmee%26aufirst%3DC.%26aulast%3DHaydon%26aufirst%3DD.%2BJ.%26atitle%3DBiological%2520Evaluation%2520of%2520Benzothiazole%2520Ethyl%2520Urea%2520Inhibitors%2520of%2520Bacterial%2520Type%2520II%2520Topoisomerases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D5977%26epage%3D5986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Miesel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osmolski, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerding, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flattery, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polishook, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. B.</span><span> </span><span class="NLM_article-title">Kibdelomycin Is a Potent and Selective Agent against Toxigenic <i>Clostridium difficile</i></span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2387</span><span class="NLM_x">–</span> <span class="NLM_lpage">2392</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=2387-2392&author=L.+Mieselauthor=D.+W.+Hechtauthor=J.+R.+Osmolskiauthor=D.+Gerdingauthor=A.+Flatteryauthor=F.+Liauthor=J.+Lanauthor=P.+Lipariauthor=J.+D.+Polishookauthor=L.+Liangauthor=J.+Liuauthor=D.+B.+Olsenauthor=S.+B.+Singh&title=Kibdelomycin+Is+a+Potent+and+Selective+Agent+against+Toxigenic+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiesel%26aufirst%3DL.%26aulast%3DHecht%26aufirst%3DD.%2BW.%26aulast%3DOsmolski%26aufirst%3DJ.%2BR.%26aulast%3DGerding%26aufirst%3DD.%26aulast%3DFlattery%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DLipari%26aufirst%3DP.%26aulast%3DPolishook%26aufirst%3DJ.%2BD.%26aulast%3DLiang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26atitle%3DKibdelomycin%2520Is%2520a%2520Potent%2520and%2520Selective%2520Agent%2520against%2520Toxigenic%2520Clostridium%2520difficile%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D2387%26epage%3D2392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span>Dipexium Pharmaceuticals, Inc. Clinical Trials: Mild Infections of Diabetic Foot Ulcers <a href="http://www.dipexiumpharmaceuticals.com/locilex/clinical-trials" class="extLink">http://www.dipexiumpharmaceuticals.com/locilex/clinical-trials</a> (accessed Jan 21,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Dipexium+Pharmaceuticals%2C+Inc.+Clinical+Trials%3A+Mild+Infections+of+Diabetic+Foot+Ulcers+http%3A%2F%2Fwww.dipexiumpharmaceuticals.com%2Flocilex%2Fclinical-trials+%28accessed+Jan+21%2C+2015%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Fuchs, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S. D.</span><span> </span><span class="NLM_article-title">In Vitro Antimicrobial Activity of MSI-78, a Magainin Analog</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1213</span><span class="NLM_x">–</span> <span class="NLM_lpage">1216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1998&pages=1213-1216&author=P.+C.+Fuchsauthor=A.+L.+Barryauthor=S.+D.+Brown&title=In+Vitro+Antimicrobial+Activity+of+MSI-78%2C+a+Magainin+Analog"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFuchs%26aufirst%3DP.%2BC.%26aulast%3DBarry%26aufirst%3DA.%2BL.%26aulast%3DBrown%26aufirst%3DS.%2BD.%26atitle%3DIn%2520Vitro%2520Antimicrobial%2520Activity%2520of%2520MSI-78%252C%2520a%2520Magainin%2520Analog%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1998%26volume%3D42%26spage%3D1213%26epage%3D1216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Ge, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holroyd, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornsberry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zasloff, M.</span><span> </span><span class="NLM_article-title">In Vitro Antibacterial Properties of Pexiganan, an Analog of Magainin</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">782</span><span class="NLM_x">–</span> <span class="NLM_lpage">788</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1128%2FAAC.43.4.782" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=10103181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADyaK1MXisVSgurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1999&pages=782-788&author=Y.+Geauthor=D.+L.+MacDonaldauthor=K.+J.+Holroydauthor=C.+Thornsberryauthor=H.+Wexlerauthor=M.+Zasloff&title=In+Vitro+Antibacterial+Properties+of+Pexiganan%2C+an+Analog+of+Magainin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro antibacterial properties of pexiganan, an analog of magainin</span></div><div class="casAuthors">Ge, Yigong; Macdonald, Dorothy L.; Holroyd, Kenneth J.; Thornsberry, Clyde; Wexler, Hannah; Zasloff, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">782-788</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Pexiganan, a 22-amino-acid antimicrobial peptide, is an analog of the magainin peptides isolated from the skin of the African clawed frog.  Pexiganan exhibited in vitro broad-spectrum antibacterial activity when it was tested against 3,109 clin. isolates of Gram-pos. and Gram-neg., anaerobic and aerobic bacteria.  The pexiganan MIC at which 90% of isolates are inhibited (MIC90) was 32 μg/mL or less for Staphylococcus spp., Streptococcus spp., Enterococcus faecium, Corynebacterium spp., Pseudomonas spp., Acinetobacter spp., Stenotrophomonas spp., certain species of the family Enterobacteriaceae, Bacteroides spp., Peptostreptococcus spp., and Propionibacterium spp.  Comparison of the MICs and min. bactericidal concns. (MBCs) of pexiganan for 143 isolates representing 32 species demonstrated that for 92% of the isolates tested, MBCs were the same or within 1 twofold difference of the MICs, consistent with a bactericidal mechanism of action.  Killing curve anal. showed that pexiganan killed Pseudomonas aeruginosa rapidly, with 106 organisms/mL eliminated within 20 min of treatment with 16 μg of pexiganan per mL.  No evidence of cross-resistance to a no. of other antibiotic classes was obsd., as detd. by the equivalence of the MIC50s and the MIC90s of pexiganan for strains resistant to oxacillin, cefazolin, cefoxitin, imipenem, ofloxacin, ciprofloxacin, gentamicin, and clindamycin vs. those for strains susceptible to these antimicrobial agents.  Attempts to generate resistance in several bacterial species through repeated passage with subinhibitory concns. of pexiganan were unsuccessful.  In conclusion, pexiganan exhibits properties in vitro which make it an attractive candidate for development as a topical antimicrobial agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ55hwXq8EBLVg90H21EOLACvtfcHk0ljzxOWL-nW7Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisVSgurg%253D&md5=da7a25db5f80ae6d9681abc6fdb01f6d</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1128%2FAAC.43.4.782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.43.4.782%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DY.%26aulast%3DMacDonald%26aufirst%3DD.%2BL.%26aulast%3DHolroyd%26aufirst%3DK.%2BJ.%26aulast%3DThornsberry%26aufirst%3DC.%26aulast%3DWexler%26aufirst%3DH.%26aulast%3DZasloff%26aufirst%3DM.%26atitle%3DIn%2520Vitro%2520Antibacterial%2520Properties%2520of%2520Pexiganan%252C%2520an%2520Analog%2520of%2520Magainin%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1999%26volume%3D43%26spage%3D782%26epage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Oh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wade, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, C.</span><span> </span><span class="NLM_article-title">Activities of Synthetic Hybrid Peptides against Anaerobic Bacteria: Aspects of Methodology and Stability</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2000&pages=68-72&author=H.+Ohauthor=M.+Hedbergauthor=D.+Wadeauthor=C.+Edlund&title=Activities+of+Synthetic+Hybrid+Peptides+against+Anaerobic+Bacteria%3A+Aspects+of+Methodology+and+Stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DH.%26aulast%3DHedberg%26aufirst%3DM.%26aulast%3DWade%26aufirst%3DD.%26aulast%3DEdlund%26aufirst%3DC.%26atitle%3DActivities%2520of%2520Synthetic%2520Hybrid%2520Peptides%2520against%2520Anaerobic%2520Bacteria%253A%2520Aspects%2520of%2520Methodology%2520and%2520Stability%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2000%26volume%3D44%26spage%3D68%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suárez, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisblum, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, S. M.</span><span> </span><span class="NLM_article-title">Synthetic Polymers Active against <i>Clostridium difficile</i> Vegetative Cell Growth and Spore Outgrowth</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">14498</span><span class="NLM_x">–</span> <span class="NLM_lpage">14504</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja506798e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=14498-14504&author=R.+Liuauthor=J.+M.+Su%C3%A1rezauthor=B.+Weisblumauthor=S.+H.+Gellmanauthor=S.+M.+McBride&title=Synthetic+Polymers+Active+against+Clostridium+difficile+Vegetative+Cell+Growth+and+Spore+Outgrowth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Fja506798e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja506798e%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DSu%25C3%25A1rez%26aufirst%3DJ.%2BM.%26aulast%3DWeisblum%26aufirst%3DB.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26aulast%3DMcBride%26aufirst%3DS.%2BM.%26atitle%3DSynthetic%2520Polymers%2520Active%2520against%2520Clostridium%2520difficile%2520Vegetative%2520Cell%2520Growth%2520and%2520Spore%2520Outgrowth%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D14498%26epage%3D14504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Nakashio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dun, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanemitsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, J.</span><span> </span><span class="NLM_article-title">Everninomicin, a New Oligosaccharide Antibiotic: Its Antimicrobial Activity, Post-Antibiotic Effect and Synergistic Bactericidal Activity</span> <span class="citation_source-journal">Drugs Exp. Clin. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=7796712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADyaK2MXlslCru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1995&pages=7-16&author=S.+Nakashioauthor=H.+Iwasawaauthor=F.+Y.+Dunauthor=K.+Kanemitsuauthor=J.+Shimada&title=Everninomicin%2C+a+New+Oligosaccharide+Antibiotic%3A+Its+Antimicrobial+Activity%2C+Post-Antibiotic+Effect+and+Synergistic+Bactericidal+Activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Everninomicin, a new oligosaccharide antibiotic: its antimicrobial activity, post-antibiotic effect and synergistic bactericidal activity</span></div><div class="casAuthors">Nakashio, S.; Iwasawa, H.; Dun, F.Y.; Kanemitsu, K.; Shimada, J.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs under Experimental and Clinical Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-16</span>CODEN:
                <span class="NLM_cas:coden">DECRDP</span>;
        ISSN:<span class="NLM_cas:issn">0378-6501</span>.
    
            (<span class="NLM_cas:orgname">Bioscience Ediprint</span>)
        </div><div class="casAbstract">Antimicrobial activity of everninomicin (SCH 27899) in comparison with two glycopeptides (vancomycin, teicoplanin) and six β-lactam agents was evaluated against recent clin. isolates of Gram-pos. bacteria.  Everninomicin showed the highest activity against the species tested and MICs90% of everninomicin against Streptococcus pneumoniae, Streptococcus pyogenes, Enterococcus faecalis, Enterococcus faecium and Clostridium difficile were 0.1, 0.1, 0.2, 0.39, 0.1 μg/mL, resp.  MICs90% of everninomicin against methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus epidermidis (MRSE) were 0.78 μg/mL.  Lab. induced resistance to everninomicin in strains of S. aureus and E. faecalis occurred in a stepwise manner and at a very slow rate.  Post-antibiotic effect against strains of S. aureus and E. faecalis were 1.8 and 2.6 h, resp., and a little longer than that of vancomycin.  Adherence to glass surface of an MRSA strain was strongly repressed by the addn. of sub MIC of everninomicin in combination with fosfomycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_rpljUjr4bLVg90H21EOLACvtfcHk0liV0MC1cR3jmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlslCru70%253D&md5=6e25fc99480d01f3a60c7e69a0b17a98</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakashio%26aufirst%3DS.%26aulast%3DIwasawa%26aufirst%3DH.%26aulast%3DDun%26aufirst%3DF.%2BY.%26aulast%3DKanemitsu%26aufirst%3DK.%26aulast%3DShimada%26aufirst%3DJ.%26atitle%3DEverninomicin%252C%2520a%2520New%2520Oligosaccharide%2520Antibiotic%253A%2520Its%2520Antimicrobial%2520Activity%252C%2520Post-Antibiotic%2520Effect%2520and%2520Synergistic%2520Bactericidal%2520Activity%26jtitle%3DDrugs%2520Exp.%2520Clin.%2520Res.%26date%3D1995%26volume%3D21%26spage%3D7%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Tanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K.</span><span> </span><span class="NLM_article-title">In Vitro Activity of an Evernimicin Derivative, SCH27899, against Anaerobic Bacteria and Propionibacterium Acnes</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fjac%2F46.3.465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=10980176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvV2ktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2000&pages=465-469&author=K.+Tanakaauthor=N.+Katoauthor=K.+Watanabe&title=In+Vitro+Activity+of+an+Evernimicin+Derivative%2C+SCH27899%2C+against+Anaerobic+Bacteria+and+Propionibacterium+Acnes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro activity of an evernimicin derivative, SCH27899, against anaerobic bacteria and Propionibacterium acnes</span></div><div class="casAuthors">Tanaka, Kaori; Kato, Naoki; Watanabe, Kunitomo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">465-469</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The in vitro activity of SCH27899, a novel oligosaccharide antimicrobial agent, was compared with those of representatives of six classes of antimicrobial agents (piperacillin, clarithromycin, clindamycin, vancomycin, sitafloxacin and metronidazole) against clin. isolates of anaerobic bacteria and Propionibacterium acnes.  Against Peptostreptococcus spp. and Clostridium difficile, SCH27899 was the most potent (MIC90 < 0.125 mg/L) of the agents examd.  Besides these Gram-pos. anaerobes, SCH27899 showed a moderate level of activity against Prevotella bivia, Prevotella intermedia and Porphyromonas spp. (MIC90 ≤ 4 mg/L).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2xbbl2RTxyLVg90H21EOLACvtfcHk0liV0MC1cR3jmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvV2ktLo%253D&md5=14e61dcf37cc5d3b64b97ec470abdf14</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1093%2Fjac%2F46.3.465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252F46.3.465%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DN.%26aulast%3DWatanabe%26aufirst%3DK.%26atitle%3DIn%2520Vitro%2520Activity%2520of%2520an%2520Evernimicin%2520Derivative%252C%2520SCH27899%252C%2520against%2520Anaerobic%2520Bacteria%2520and%2520Propionibacterium%2520Acnes%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2000%26volume%3D46%26spage%3D465%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Hanada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oki, T.</span><span> </span><span class="NLM_article-title">Hydramycin, a New Antitumor Antibiotic. Taxonomy, Isolation, Physico-Chemical Properties, Structure and Biological Activity</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">824</span><span class="NLM_x">–</span> <span class="NLM_lpage">831</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1991&pages=824-831&author=M.+Hanadaauthor=K.+Kanetaauthor=Y.+Nishiyamaauthor=Y.+Hoshinoauthor=M.+Konishiauthor=T.+Oki&title=Hydramycin%2C+a+New+Antitumor+Antibiotic.+Taxonomy%2C+Isolation%2C+Physico-Chemical+Properties%2C+Structure+and+Biological+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanada%26aufirst%3DM.%26aulast%3DKaneta%26aufirst%3DK.%26aulast%3DNishiyama%26aufirst%3DY.%26aulast%3DHoshino%26aufirst%3DY.%26aulast%3DKonishi%26aufirst%3DM.%26aulast%3DOki%26aufirst%3DT.%26atitle%3DHydramycin%252C%2520a%2520New%2520Antitumor%2520Antibiotic.%2520Taxonomy%252C%2520Isolation%252C%2520Physico-Chemical%2520Properties%252C%2520Structure%2520and%2520Biological%2520Activity%26jtitle%3DJ.%2520Antibiot.%26date%3D1991%26volume%3D44%26spage%3D824%26epage%3D831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">McCullough, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howells, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Sullivan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summerill, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonner, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, P. B.</span><span> </span><span class="NLM_article-title">Clerocidin, a Terpenoid Antibiotic, Inhibits Bacterial DNA Gyrase</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">526</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1993&pages=526-530&author=J.+E.+McCulloughauthor=M.+T.+Mullerauthor=A.+J.+Howellsauthor=A.+Maxwellauthor=J.+O%E2%80%99Sullivanauthor=R.+S.+Summerillauthor=W.+L.+Parkerauthor=J.+S.+Wellsauthor=D.+P.+Bonnerauthor=P.+B.+Fernandes&title=Clerocidin%2C+a+Terpenoid+Antibiotic%2C+Inhibits+Bacterial+DNA+Gyrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCullough%26aufirst%3DJ.%2BE.%26aulast%3DMuller%26aufirst%3DM.%2BT.%26aulast%3DHowells%26aufirst%3DA.%2BJ.%26aulast%3DMaxwell%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DJ.%26aulast%3DSummerill%26aufirst%3DR.%2BS.%26aulast%3DParker%26aufirst%3DW.%2BL.%26aulast%3DWells%26aufirst%3DJ.%2BS.%26aulast%3DBonner%26aufirst%3DD.%2BP.%26aulast%3DFernandes%26aufirst%3DP.%2BB.%26atitle%3DClerocidin%252C%2520a%2520Terpenoid%2520Antibiotic%252C%2520Inhibits%2520Bacterial%2520DNA%2520Gyrase%26jtitle%3DJ.%2520Antibiot.%26date%3D1993%26volume%3D46%26spage%3D526%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Nadai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palù, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palumbo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, S. N.</span><span> </span><span class="NLM_article-title">Differential Targeting of Unpaired Bases within Duplex DNA by the Natural Compound Clerocidin: A Valuable Tool To Dissect DNA Secondary Structure</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e52994</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e52994&author=M.+Nadaiauthor=G.+Pal%C3%B9author=M.+Palumboauthor=S.+N.+Richter&title=Differential+Targeting+of+Unpaired+Bases+within+Duplex+DNA+by+the+Natural+Compound+Clerocidin%3A+A+Valuable+Tool+To+Dissect+DNA+Secondary+Structure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNadai%26aufirst%3DM.%26aulast%3DPal%25C3%25B9%26aufirst%3DG.%26aulast%3DPalumbo%26aufirst%3DM.%26aulast%3DRichter%26aufirst%3DS.%2BN.%26atitle%3DDifferential%2520Targeting%2520of%2520Unpaired%2520Bases%2520within%2520Duplex%2520DNA%2520by%2520the%2520Natural%2520Compound%2520Clerocidin%253A%2520A%2520Valuable%2520Tool%2520To%2520Dissect%2520DNA%2520Secondary%2520Structure%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De52994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Banskota, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aouidate, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">rensen, D. S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piraee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zazopoulos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alarco, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourdeau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farnet, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falardeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAlpine, J. B.</span><span> </span><span class="NLM_article-title">TLN-05220, TLN-05223, New Echinosporamicin-Type Antibiotics, and Proposed Revision of the Structure of Bravomicins</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2009&pages=565-570&author=A.+H.+Banskotaauthor=M.+Aouidateauthor=D.+S.+O.+rensenauthor=A.+Ibrahimauthor=M.+Piraeeauthor=E.+Zazopoulosauthor=A.-M.+Alarcoauthor=H.+Gourdeauauthor=C.+Mellonauthor=C.+M.+Farnetauthor=P.+Falardeauauthor=J.+B.+McAlpine&title=TLN-05220%2C+TLN-05223%2C+New+Echinosporamicin-Type+Antibiotics%2C+and+Proposed+Revision+of+the+Structure+of+Bravomicins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBanskota%26aufirst%3DA.%2BH.%26aulast%3DAouidate%26aufirst%3DM.%26aulast%3Drensen%26aufirst%3DD.%2BS.%2BO.%26aulast%3DIbrahim%26aufirst%3DA.%26aulast%3DPiraee%26aufirst%3DM.%26aulast%3DZazopoulos%26aufirst%3DE.%26aulast%3DAlarco%26aufirst%3DA.-M.%26aulast%3DGourdeau%26aufirst%3DH.%26aulast%3DMellon%26aufirst%3DC.%26aulast%3DFarnet%26aufirst%3DC.%2BM.%26aulast%3DFalardeau%26aufirst%3DP.%26aulast%3DMcAlpine%26aufirst%3DJ.%2BB.%26atitle%3DTLN-05220%252C%2520TLN-05223%252C%2520New%2520Echinosporamicin-Type%2520Antibiotics%252C%2520and%2520Proposed%2520Revision%2520of%2520the%2520Structure%2520of%2520Bravomicins%26jtitle%3DJ.%2520Antibiot.%26date%3D2009%26volume%3D62%26spage%3D565%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Sakoulas, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loesgen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenical, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensler, M.</span><span> </span><span class="NLM_article-title">Novel Bacterial Metabolite Merochlorin a Demonstrates in Vitro Activity against Multi-Drug Resistant Methicillin-Resistant <i>Staphylococcus aureus</i></span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e29439</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e29439&author=G.+Sakoulasauthor=S.-J.+Namauthor=S.+Loesgenauthor=W.+Fenicalauthor=P.+R.+Jensenauthor=V.+Nizetauthor=M.+Hensler&title=Novel+Bacterial+Metabolite+Merochlorin+a+Demonstrates+in+Vitro+Activity+against+Multi-Drug+Resistant+Methicillin-Resistant+Staphylococcus+aureus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakoulas%26aufirst%3DG.%26aulast%3DNam%26aufirst%3DS.-J.%26aulast%3DLoesgen%26aufirst%3DS.%26aulast%3DFenical%26aufirst%3DW.%26aulast%3DJensen%26aufirst%3DP.%2BR.%26aulast%3DNizet%26aufirst%3DV.%26aulast%3DHensler%26aufirst%3DM.%26atitle%3DNovel%2520Bacterial%2520Metabolite%2520Merochlorin%2520a%2520Demonstrates%2520in%2520Vitro%2520Activity%2520against%2520Multi-Drug%2520Resistant%2520Methicillin-Resistant%2520Staphylococcus%2520aureus%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De29439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Pepper, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, J. H.</span><span> </span><span class="NLM_article-title">Biomimetic Total Synthesis of (±)-Merochlorin A</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">12170</span><span class="NLM_x">–</span> <span class="NLM_lpage">12173</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=12170-12173&author=H.+P.+Pepperauthor=J.+H.+George&title=Biomimetic+Total+Synthesis+of+%28%C2%B1%29-Merochlorin+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPepper%26aufirst%3DH.%2BP.%26aulast%3DGeorge%26aufirst%3DJ.%2BH.%26atitle%3DBiomimetic%2520Total%2520Synthesis%2520of%2520%2528%25C2%25B1%2529-Merochlorin%2520A%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D12170%26epage%3D12173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumi, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurdle, J. G.</span><span> </span><span class="NLM_article-title">Prospects for Flavonoid and Related Phytochemicals as Nature-Inspired Treatments for <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">J. Appl. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1111%2Fjam.12344" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=24479135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFKqtLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2014&pages=23-31&author=X.+Wuauthor=M.+Z.+Alamauthor=L.+Fengauthor=L.+S.+Tsutsumiauthor=D.+Sunauthor=J.+G.+Hurdle&title=Prospects+for+Flavonoid+and+Related+Phytochemicals+as+Nature-Inspired+Treatments+for+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Prospects for flavonoid and related phytochemicals as nature-inspired treatments for Clostridium difficile infection</span></div><div class="casAuthors">Wu, X.; Alam, M. Z.; Feng, L.; Tsutsumi, L. S.; Sun, D.; Hurdle, J. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Microbiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-31</span>CODEN:
                <span class="NLM_cas:coden">JAMIFK</span>;
        ISSN:<span class="NLM_cas:issn">1364-5072</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims : There is a need for novel treatments for Clostridium difficile infection (CDI).  Antibacterial flavonoids are part of a large family of polyphenol phytochems. with a long history of use in ethnomedicine, but are unexamd. against Cl. difficile.  We explored their anti-difficile properties.  Methods and Results : Anti-difficile activities were detd. for several naturally occurring flavonoids, olympicin A and synthetic 4-chromanone and chalcone analogs.  With the exception of olympicin A, most naturally occurring phytochems. tested were poorly active.  Diversified synthetic flavonoids resembling olympicin A retained anti-difficile activity, suggesting olympicin A could act as a pharmacophore to obtain novel agents.  They also demonstrated concn.-dependent killing of logarithmic and stationary phase cultures and reduced sporulation and toxin prodn.  Olympicin A and some synthetic flavonoids dissipated the bacterial transmembrane potential.  Interestingly, mutants could only be selected with the analog 207 at a frequency of 10-9.  Conclusions : Based on the potent anti-difficile properties of olympicin A and modified flavonoids, further exploration of this class of phytochems. is warranted.  Significance and Impact of the Study : Clostridium difficile infection is a major problem in developed countries.  These studies point to there being an avenue for optimizing plant-derived flavonoids, and related antibacterial phytochems., as nature-inspired approaches to treat CDI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozIVKnGSPKxLVg90H21EOLACvtfcHk0ljL0dCpVmcD2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFKqtLvL&md5=d1a0268eb5d9a95dbe5575ff12ca3a70</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1111%2Fjam.12344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjam.12344%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DAlam%26aufirst%3DM.%2BZ.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DTsutsumi%26aufirst%3DL.%2BS.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DHurdle%26aufirst%3DJ.%2BG.%26atitle%3DProspects%2520for%2520Flavonoid%2520and%2520Related%2520Phytochemicals%2520as%2520Nature-Inspired%2520Treatments%2520for%2520Clostridium%2520difficile%2520Infection%26jtitle%3DJ.%2520Appl.%2520Microbiol.%26date%3D2014%26volume%3D116%26spage%3D23%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Feng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddox, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumi, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narula, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruhn, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandhaus, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse-Dinh, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurdle, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span> </span><span class="NLM_article-title">Synthesis, Structure-Activity Relationship Studies, and Antibacterial Evaluation of 4-Chromanones and Chalcones, as Well as Olympicin a and Derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8398</span><span class="NLM_x">–</span> <span class="NLM_lpage">8420</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500853v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8398-8420&author=L.+Fengauthor=M.+M.+Maddoxauthor=M.+Z.+Alamauthor=L.+S.+Tsutsumiauthor=G.+Narulaauthor=D.+F.+Bruhnauthor=X.+Wuauthor=S.+Sandhausauthor=R.+B.+Leeauthor=C.+J.+Simmonsauthor=Y.-C.+Tse-Dinhauthor=J.+G.+Hurdleauthor=R.+E.+Leeauthor=D.+Sun&title=Synthesis%2C+Structure-Activity+Relationship+Studies%2C+and+Antibacterial+Evaluation+of+4-Chromanones+and+Chalcones%2C+as+Well+as+Olympicin+a+and+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Fjm500853v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500853v%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DMaddox%26aufirst%3DM.%2BM.%26aulast%3DAlam%26aufirst%3DM.%2BZ.%26aulast%3DTsutsumi%26aufirst%3DL.%2BS.%26aulast%3DNarula%26aufirst%3DG.%26aulast%3DBruhn%26aufirst%3DD.%2BF.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DSandhaus%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DR.%2BB.%26aulast%3DSimmons%26aufirst%3DC.%2BJ.%26aulast%3DTse-Dinh%26aufirst%3DY.-C.%26aulast%3DHurdle%26aufirst%3DJ.%2BG.%26aulast%3DLee%26aufirst%3DR.%2BE.%26aulast%3DSun%26aufirst%3DD.%26atitle%3DSynthesis%252C%2520Structure-Activity%2520Relationship%2520Studies%252C%2520and%2520Antibacterial%2520Evaluation%2520of%25204-Chromanones%2520and%2520Chalcones%252C%2520as%2520Well%2520as%2520Olympicin%2520a%2520and%2520Derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8398%26epage%3D8420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Pucci, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DenBleyker, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discotto, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fung-Tomc, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, Y.</span><span> </span><span class="NLM_article-title">Antimicrobial Evaluation of Nocathiacins, a Thiazole Peptide Class of Antibiotics</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3697</span><span class="NLM_x">–</span> <span class="NLM_lpage">3701</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=3697-3701&author=M.+J.+Pucciauthor=J.+J.+Bronsonauthor=J.+F.+Barrettauthor=K.+L.+DenBleykerauthor=L.+F.+Discottoauthor=J.+C.+Fung-Tomcauthor=Y.+Ueda&title=Antimicrobial+Evaluation+of+Nocathiacins%2C+a+Thiazole+Peptide+Class+of+Antibiotics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPucci%26aufirst%3DM.%2BJ.%26aulast%3DBronson%26aufirst%3DJ.%2BJ.%26aulast%3DBarrett%26aufirst%3DJ.%2BF.%26aulast%3DDenBleyker%26aufirst%3DK.%2BL.%26aulast%3DDiscotto%26aufirst%3DL.%2BF.%26aulast%3DFung-Tomc%26aufirst%3DJ.%2BC.%26aulast%3DUeda%26aufirst%3DY.%26atitle%3DAntimicrobial%2520Evaluation%2520of%2520Nocathiacins%252C%2520a%2520Thiazole%2520Peptide%2520Class%2520of%2520Antibiotics%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D3697%26epage%3D3701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">LaMarche, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeds, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzink-Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krastel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckermann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palestrant, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patane, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rann, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiamfook, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span> </span><span class="NLM_article-title">Antibiotic Optimization and Chemical Structure Stabilization of Thiomuracin A</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6934</span><span class="NLM_x">–</span> <span class="NLM_lpage">6941</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300783c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6934-6941&author=M.+J.+LaMarcheauthor=J.+A.+Leedsauthor=J.+Dzink-Foxauthor=E.+Ganglauthor=P.+Krastelauthor=G.+Neckermannauthor=D.+Palestrantauthor=M.+A.+Pataneauthor=E.+M.+Rannauthor=S.+Tiamfookauthor=D.+Yu&title=Antibiotic+Optimization+and+Chemical+Structure+Stabilization+of+Thiomuracin+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1021%2Fjm300783c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300783c%26sid%3Dliteratum%253Aachs%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26aulast%3DLeeds%26aufirst%3DJ.%2BA.%26aulast%3DDzink-Fox%26aufirst%3DJ.%26aulast%3DGangl%26aufirst%3DE.%26aulast%3DKrastel%26aufirst%3DP.%26aulast%3DNeckermann%26aufirst%3DG.%26aulast%3DPalestrant%26aufirst%3DD.%26aulast%3DPatane%26aufirst%3DM.%2BA.%26aulast%3DRann%26aufirst%3DE.%2BM.%26aulast%3DTiamfook%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DD.%26atitle%3DAntibiotic%2520Optimization%2520and%2520Chemical%2520Structure%2520Stabilization%2520of%2520Thiomuracin%2520A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6934%26epage%3D6941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Heap, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartman, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minton, N. P.</span><span> </span><span class="NLM_article-title">The ClosTron: A Universal Gene Knock-Out System for the Genus <i>Clostridium</i></span> <span class="citation_source-journal">J. Microbiol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">452</span><span class="NLM_x">–</span> <span class="NLM_lpage">464</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1016%2Fj.mimet.2007.05.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=17658189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFKjsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=452-464&author=J.+T.+Heapauthor=O.+J.+Penningtonauthor=S.+T.+Cartmanauthor=G.+P.+Carterauthor=N.+P.+Minton&title=The+ClosTron%3A+A+Universal+Gene+Knock-Out+System+for+the+Genus+Clostridium"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">The ClosTron: A universal gene knock-out system for the genus Clostridium</span></div><div class="casAuthors">Heap, John T.; Pennington, Oliver J.; Cartman, Stephen T.; Carter, Glen P.; Minton, Nigel P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Microbiological Methods</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">452-464</span>CODEN:
                <span class="NLM_cas:coden">JMIMDQ</span>;
        ISSN:<span class="NLM_cas:issn">0167-7012</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Progress in exploiting clostridial genome information has been severely impeded by a general lack of effective methods for the directed inactivation of specific genes.  Those few mutants that have been generated have been almost exclusively derived by single crossover integration of a replication-deficient or defective plasmid by homologous recombination.  The mutants created are therefore unstable.  Here we have adapted a mutagenesis system based on the mobile group II intron from the ltrB gene of Lactococcus lactis (Ll.ltrB) to function in clostridial hosts.  Integrants are readily selected on the basis of acquisition of resistance to erythromycin, and are generated from start to finish in as little as 10 to 14 days.  Unlike single crossover plasmid integrants, the mutants are extremely stable.  The system has been used to make 6 mutants of Clostridium acetobutylicum and 5 of Clostridium difficile, exceeding the no. of published mutants ever generated in these species.  Genes have also been inactivated for the first time in Clostridium botulinum and Clostridium sporogenes, suggesting the system will be universally applicable to the genus.  The procedure is highly efficient and reproducible, and should revolutionize functional genomic studies in clostridia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquBeAXBVE-YLVg90H21EOLACvtfcHk0lgQNMQYeAFShA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFKjsLk%253D&md5=5ad07920edc8de3b8f622522223016aa</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2Fj.mimet.2007.05.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mimet.2007.05.021%26sid%3Dliteratum%253Aachs%26aulast%3DHeap%26aufirst%3DJ.%2BT.%26aulast%3DPennington%26aufirst%3DO.%2BJ.%26aulast%3DCartman%26aufirst%3DS.%2BT.%26aulast%3DCarter%26aufirst%3DG.%2BP.%26aulast%3DMinton%26aufirst%3DN.%2BP.%26atitle%3DThe%2520ClosTron%253A%2520A%2520Universal%2520Gene%2520Knock-Out%2520System%2520for%2520the%2520Genus%2520Clostridium%26jtitle%3DJ.%2520Microbiol.%2520Methods%26date%3D2007%26volume%3D70%26spage%3D452%26epage%3D464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Jadhav, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezhilarasan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prakash Sharma, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, A.</span><span> </span><span class="NLM_article-title"><i>Clostridium</i>-DTDB: A Comprehensive Database for Potential Drug Targets of <i>Clostridium difficile</i></span> <span class="citation_source-journal">Comput. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">362</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1016%2Fj.compbiomed.2013.01.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=23415847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1OltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2013&pages=362-367&author=A.+Jadhavauthor=V.+Ezhilarasanauthor=O.+Prakash+Sharmaauthor=A.+Pan&title=Clostridium-DTDB%3A+A+Comprehensive+Database+for+Potential+Drug+Targets+of+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Clostridium-DTDB: A comprehensive database for potential drug targets of Clostridium difficile</span></div><div class="casAuthors">Jadhav, Ankush; Ezhilarasan, Vijayalakshmi; Prakash Sharma, Om; Pan, Archana</div><div class="citationInfo"><span class="NLM_cas:title">Computers in Biology and Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">362-367</span>CODEN:
                <span class="NLM_cas:coden">CBMDAW</span>;
        ISSN:<span class="NLM_cas:issn">0010-4825</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Clostridium difficile is considered to be one of the most important causes of health care-assocd. infections currently.  The prevalence and severity of C. difficile infection have increased significantly worldwide in the past decade which led to the increased research interest.  Here, using comparative genomics strategy coupled with bioinformatics tools the authors have identified potential drug targets in C. difficile and detd. their three-dimensional structures to develop a database, named Clostridium-DTDB.  Currently, the database comprises the potential drug targets with their structural information from three strains of C. difficile, namely hypervirulent PCR-ribotype 027 strain R20291, PCR-ribotype 012 strain 630, and PCR-ribotype 027 strain CD196.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLw170fKIcLLVg90H21EOLACvtfcHk0lgQNMQYeAFShA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1OltLg%253D&md5=cf02be1d9141df0dd25d5f32e7db4736</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2Fj.compbiomed.2013.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.compbiomed.2013.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DJadhav%26aufirst%3DA.%26aulast%3DEzhilarasan%26aufirst%3DV.%26aulast%3DPrakash%2BSharma%26aufirst%3DO.%26aulast%3DPan%26aufirst%3DA.%26atitle%3DClostridium-DTDB%253A%2520A%2520Comprehensive%2520Database%2520for%2520Potential%2520Drug%2520Targets%2520of%2520Clostridium%2520difficile%26jtitle%3DComput.%2520Biol.%2520Med.%26date%3D2013%26volume%3D43%26spage%3D362%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Larocque, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chénard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najmanovich, R.</span><span> </span><span class="NLM_article-title">A Curated C. <i>difficile</i> Strain 630 Metabolic Network: Prediction of Essential Targets and Inhibitors</span> <span class="citation_source-journal">BMC Syst. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1186%2Fs12918-014-0117-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=25315994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotFWhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=117&author=M.+Larocqueauthor=T.+Ch%C3%A9nardauthor=R.+Najmanovich&title=A+Curated+C.+difficile+Strain+630+Metabolic+Network%3A+Prediction+of+Essential+Targets+and+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">A curated C. difficile strain 630 metabolic network: prediction of essential targets and inhibitors</span></div><div class="casAuthors">Larocque, Mathieu; Chenard, Thierry; Najmanovich, Rafael</div><div class="citationInfo"><span class="NLM_cas:title">BMC Systems Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">117/1-117/17</span>CODEN:
                <span class="NLM_cas:coden">BSBMCC</span>;
        ISSN:<span class="NLM_cas:issn">1752-0509</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background:Clostridium difficile is the leading cause of hospital-borne infections occurring when the natural intestinal flora is depleted following antibiotic treatment.  Current treatments for Clostridium difficile infections present high relapse rates and new hyper-virulent and multi-resistant strains are emerging, making the study of this nosocomial pathogen necessary to find novel therapeutic targets.  Results: We present iMLTC806cdf, an extensively curated reconstructed metabolic network for the C. difficile pathogenic strain 630. iMLTC806cdf contains 806 genes, 703 metabolites and 769 metabolic, 117 exchange and 145 transport reactions. iMLTC806cdf is the most complete and accurate metabolic reconstruction of a gram-pos. anaerobic bacteria to date.  We validate the model with simulated growth assays in different media and carbon sources and use it to predict essential genes.  We obtain 89.2% accuracy in the prediction of gene essentiality when compared to exptl. data for B. subtilis homologs (the closest organism for which such data exists).  We predict the existence of 76 essential genes and 39 essential gene pairs, a no. of which are unique to C. difficile and have non-existing or predicted non-essential human homologs.  For 29 of these potential therapeutic targets, we find 125 inhibitors of homologous proteins including approved drugs with the potential for drug repositioning, that when validated exptl. could serve as starting points in the development of new antibiotics.  Conclusions: We created a highly curated metabolic network model of C. difficile strain 630 and used it to predict essential genes as potential new therapeutic targets in the fight against Clostridium difficile infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1JjHlRdFNaLVg90H21EOLACvtfcHk0lgQNMQYeAFShA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotFWhsA%253D%253D&md5=83a0d4ccc76523a40ecbcf2399792541</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1186%2Fs12918-014-0117-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12918-014-0117-z%26sid%3Dliteratum%253Aachs%26aulast%3DLarocque%26aufirst%3DM.%26aulast%3DCh%25C3%25A9nard%26aufirst%3DT.%26aulast%3DNajmanovich%26aufirst%3DR.%26atitle%3DA%2520Curated%2520C.%2520difficile%2520Strain%2520630%2520Metabolic%2520Network%253A%2520Prediction%2520of%2520Essential%2520Targets%2520and%2520Inhibitors%26jtitle%3DBMC%2520Syst.%2520Biol.%26date%3D2014%26volume%3D8%26spage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Dang, T. H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Riva, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagan, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storck, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heal, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janoir, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairweather, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, E. W.</span><span> </span><span class="NLM_article-title">Chemical Probes of Surface Layer Biogenesis in <i>Clostridium difficile</i></span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">285</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb9002859" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=279-285&author=T.+H.+T.+Dangauthor=L.+de+la+Rivaauthor=R.+P.+Faganauthor=E.+M.+Storckauthor=W.+P.+Healauthor=C.+Janoirauthor=N.+F.+Fairweatherauthor=E.+W.+Tate&title=Chemical+Probes+of+Surface+Layer+Biogenesis+in+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1021%2Fcb9002859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb9002859%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DT.%2BH.%2BT.%26aulast%3Dde%2Bla%2BRiva%26aufirst%3DL.%26aulast%3DFagan%26aufirst%3DR.%2BP.%26aulast%3DStorck%26aufirst%3DE.%2BM.%26aulast%3DHeal%26aufirst%3DW.%2BP.%26aulast%3DJanoir%26aufirst%3DC.%26aulast%3DFairweather%26aufirst%3DN.%2BF.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DChemical%2520Probes%2520of%2520Surface%2520Layer%2520Biogenesis%2520in%2520Clostridium%2520difficile%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2010%26volume%3D5%26spage%3D279%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Ratia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Light, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antanasijevic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caffrey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavie, A.</span><span> </span><span class="NLM_article-title">Discovery of Selective Inhibitors of the <i>Clostridium difficile</i> Dehydroquinate Dehydratase</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e89356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1371%2Fjournal.pone.0089356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=24586713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGqsrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e89356&author=K.+Ratiaauthor=S.+H.+Lightauthor=A.+Antanasijevicauthor=W.+F.+Andersonauthor=M.+Caffreyauthor=A.+Lavie&title=Discovery+of+Selective+Inhibitors+of+the+Clostridium+difficile+Dehydroquinate+Dehydratase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of selective inhibitors of the Clostridium difficile dehydroquinate dehydratase</span></div><div class="casAuthors">Ratia, Kiira; Light, Samuel H.; Antanasijevic, Aleksandar; Anderson, Wayne F.; Caffrey, Michael; Lavie, Arnon</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e89356/1-e89356/7, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">A vibrant and healthy gut flora is essential for preventing the proliferation of Clostridium difficile, a pathogenic bacterium that causes severe gastrointestinal symptoms.  In fact, most C. difficile infections (CDIs) occur after broad-spectrum antibiotic treatment, which, by eradicating the commensal gut bacteria, allows its spores to proliferate.  Hence, a C. difficile specific antibiotic that spares the gut flora would be highly beneficial in treating CDI.  Towards this goal, we set out to discover small mol. inhibitors of the C. difficile enzyme dehydroquinate dehydratase (DHQD).  DHQD is the 3rd of seven enzymes that compose the shikimate pathway, a metabolic pathway absent in humans, and is present in bacteria as two phylogenetically and mechanistically distinct types.  Using a high-throughput screen we identified three compds. that inhibited the type I C. difficile DHQD but not the type II DHQD from Bacteroides thetaiotaomicron, a highly represented commensal gut bacterial species.  Kinetic anal. revealed that the compds. inhibit the C. difficile enzyme with Ki values ranging from 10 to 20 μM.  Unexpectedly, kinetic and biophys. studies demonstrate that inhibitors also exhibit selectivity between type I DHQDs, inhibiting the C. difficile but not the highly homologous Salmonella enterica DHQD.  Therefore, the three identified compds. seem to be promising lead compds. for the development of C. difficile specific antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4dkh43YIxw7Vg90H21EOLACvtfcHk0lj20Vk2O4Ku2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGqsrjI&md5=4f757a310a535d582663b13fe93d2f53</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0089356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0089356%26sid%3Dliteratum%253Aachs%26aulast%3DRatia%26aufirst%3DK.%26aulast%3DLight%26aufirst%3DS.%2BH.%26aulast%3DAntanasijevic%26aufirst%3DA.%26aulast%3DAnderson%26aufirst%3DW.%2BF.%26aulast%3DCaffrey%26aufirst%3DM.%26aulast%3DLavie%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520Selective%2520Inhibitors%2520of%2520the%2520Clostridium%2520difficile%2520Dehydroquinate%2520Dehydratase%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De89356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Puri, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupardus, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrow, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogyo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, A.</span><span> </span><span class="NLM_article-title">Rational Design of Inhibitors and Activity-Based Probes Targeting <i>Clostridium difficile</i> Virulence Factor TcdB</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1201</span><span class="NLM_x">–</span> <span class="NLM_lpage">1211</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1016%2Fj.chembiol.2010.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=21095570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGntrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=1201-1211&author=A.+W.+Puriauthor=P.+J.+Lupardusauthor=E.+Deuauthor=V.+E.+Albrowauthor=K.+C.+Garciaauthor=M.+Bogyoauthor=A.+Shen&title=Rational+Design+of+Inhibitors+and+Activity-Based+Probes+Targeting+Clostridium+difficile+Virulence+Factor+TcdB"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Inhibitors and Activity-Based Probes Targeting Clostridium difficile Virulence Factor TcdB</span></div><div class="casAuthors">Puri, Aaron W.; Lupardus, Patrick J.; Deu, Edgar; Albrow, Victoria E.; Garcia, K. Christopher; Bogyo, Matthew; Shen, Aimee</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1201-1211</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Clostridium difficile is a leading cause of nosocomial infections.  The major virulence factors of this pathogen are the multi-domain toxins TcdA and TcdB.  These toxins contain a cysteine protease domain (CPD) that autoproteolytically releases a cytotoxic effector domain upon binding intracellular inositol hexakisphosphate.  Currently, there are no known inhibitors of this protease.  Here, we describe the rational design of covalent small mol. inhibitors of TcdB CPD.  We identified compds. that inactivate TcdB holotoxin function in cells and solved the structure of inhibitor-bound protease to 2.0 Å.  This structure reveals the mol. basis of CPD substrate recognition and informed the synthesis of activity-based probes for this enzyme.  The inhibitors presented will guide the development of therapeutics targeting C. difficile, and the probes will serve as tools for studying the unique activation mechanism of bacterial toxin CPDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoktoVIUJMo1LVg90H21EOLACvtfcHk0lj20Vk2O4Ku2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGntrfP&md5=f472b9de20b1379458830e9d4698e820</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DPuri%26aufirst%3DA.%2BW.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DDeu%26aufirst%3DE.%26aulast%3DAlbrow%26aufirst%3DV.%2BE.%26aulast%3DGarcia%26aufirst%3DK.%2BC.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DA.%26atitle%3DRational%2520Design%2520of%2520Inhibitors%2520and%2520Activity-Based%2520Probes%2520Targeting%2520Clostridium%2520difficile%2520Virulence%2520Factor%2520TcdB%26jtitle%3DChem.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D1201%26epage%3D1211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Abdeen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swett, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feig, A. L.</span><span> </span><span class="NLM_article-title">Peptide Inhibitors Targeting <i>Clostridium difficile</i> Toxins A and B</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1097</span><span class="NLM_x">–</span> <span class="NLM_lpage">1103</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb100209b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1097-1103&author=S.+J.+Abdeenauthor=R.+J.+Swettauthor=A.+L.+Feig&title=Peptide+Inhibitors+Targeting+Clostridium+difficile+Toxins+A+and+B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Fcb100209b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb100209b%26sid%3Dliteratum%253Aachs%26aulast%3DAbdeen%26aufirst%3DS.%2BJ.%26aulast%3DSwett%26aufirst%3DR.%2BJ.%26aulast%3DFeig%26aufirst%3DA.%2BL.%26atitle%3DPeptide%2520Inhibitors%2520Targeting%2520Clostridium%2520difficile%2520Toxins%2520A%2520and%2520B%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2010%26volume%3D5%26spage%3D1097%26epage%3D1103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Maurer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathias, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papatheodorou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shekfeh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jank, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aktories, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span> </span><span class="NLM_article-title">From Cosubstrate Similarity to Inhibitor Diversity—Inhibitors of ADP-Ribosyltransferases from Kinase Inhibitor Screening</span> <span class="citation_source-journal">Mol. BioSyst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1039%2FC0MB00151A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=21132207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFemsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=799-808&author=B.+Maurerauthor=U.+Mathiasauthor=P.+Papatheodorouauthor=S.+Shekfehauthor=J.+Orthauthor=T.+Jankauthor=C.+Schwanauthor=W.+Sipplauthor=K.+Aktoriesauthor=M.+Jung&title=From+Cosubstrate+Similarity+to+Inhibitor+Diversity%E2%80%94Inhibitors+of+ADP-Ribosyltransferases+from+Kinase+Inhibitor+Screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">From cosubstrate similarity to inhibitor diversity-inhibitors of ADP-ribosyltransferases from kinase inhibitor screening</span></div><div class="casAuthors">Maurer, Benjamin; Mathias, Ulf; Papatheodorou, Panagiotis; Shekfeh, Suhaib; Orth, Joachim; Jank, Thomas; Schwan, Carsten; Sippl, Wolfgang; Aktories, Klaus; Jung, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">799-808</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-206X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">ADP-ribosyltransferases (ADP-RTs) use NAD+ to transfer an ADP-ribosyl group to target proteins.  Although some ADP-RTs are bacterial toxins only few inhibitors are known.  Here we present the development of fluorescence-based assays and a focussed library screening using kinase inhibitors as a new approach towards inhibitors of ADP-RTs.  Different screening setups were established using surrogate small mol. substrates or the quantitation of the cofactor NAD+.  Proof-of-principle screening expts. were performed using a kinase inhibitor library in order to target the NAD+ binding pockets.  This led to the discovery of structurally different lead inhibitors for the mono-ADP-ribosyltransferases Mosquitocidal toxin (MTX) from Bacillus sphaericus SSII-1, C3bot toxin from Clostridium botulinum and CDTa from Clostridium difficile.  The interaction of the inhibitors with the toxin proteins was analyzed by means of docking and binding free energy calcns.  Binding at the nicotinamide subpocket, which shows a significant difference in the three enzymes, is used to explain the selectivity of the identified inhibitors and offers an opportunity for further development of potent and selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt1oluGyVPbLVg90H21EOLACvtfcHk0lhfSIdPR7CF0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFemsbs%253D&md5=53ba9d27079768d6a80a34e1e39c73e1</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1039%2FC0MB00151A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC0MB00151A%26sid%3Dliteratum%253Aachs%26aulast%3DMaurer%26aufirst%3DB.%26aulast%3DMathias%26aufirst%3DU.%26aulast%3DPapatheodorou%26aufirst%3DP.%26aulast%3DShekfeh%26aufirst%3DS.%26aulast%3DOrth%26aufirst%3DJ.%26aulast%3DJank%26aufirst%3DT.%26aulast%3DSchwan%26aufirst%3DC.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DAktories%26aufirst%3DK.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DFrom%2520Cosubstrate%2520Similarity%2520to%2520Inhibitor%2520Diversity%25E2%2580%2594Inhibitors%2520of%2520ADP-Ribosyltransferases%2520from%2520Kinase%2520Inhibitor%2520Screening%26jtitle%3DMol.%2520BioSyst.%26date%3D2011%26volume%3D7%26spage%3D799%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Nerandzic, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donskey, C. J.</span><span> </span><span class="NLM_article-title">Activate to Eradicate: Inhibition of <i>Clostridium difficile</i> Spore Outgrowth by the Synergistic Effects of Osmotic Activation and Nisin</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e54740</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e54740&author=M.+M.+Nerandzicauthor=C.+J.+Donskey&title=Activate+to+Eradicate%3A+Inhibition+of+Clostridium+difficile+Spore+Outgrowth+by+the+Synergistic+Effects+of+Osmotic+Activation+and+Nisin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNerandzic%26aufirst%3DM.%2BM.%26aulast%3DDonskey%26aufirst%3DC.%2BJ.%26atitle%3DActivate%2520to%2520Eradicate%253A%2520Inhibition%2520of%2520Clostridium%2520difficile%2520Spore%2520Outgrowth%2520by%2520the%2520Synergistic%2520Effects%2520of%2520Osmotic%2520Activation%2520and%2520Nisin%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De54740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Francis, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrestha, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorg, J. A.</span><span> </span><span class="NLM_article-title">Bile Acid Recognition by the <i>Clostridium difficile</i> Germinant Receptor, CspC, Is Important for Establishing Infection</span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1003356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=e1003356&author=M.+B.+Francisauthor=C.+A.+Allenauthor=R.+Shresthaauthor=J.+A.+Sorg&title=Bile+Acid+Recognition+by+the+Clostridium+difficile+Germinant+Receptor%2C+CspC%2C+Is+Important+for+Establishing+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrancis%26aufirst%3DM.%2BB.%26aulast%3DAllen%26aufirst%3DC.%2BA.%26aulast%3DShrestha%26aufirst%3DR.%26aulast%3DSorg%26aufirst%3DJ.%2BA.%26atitle%3DBile%2520Acid%2520Recognition%2520by%2520the%2520Clostridium%2520difficile%2520Germinant%2520Receptor%252C%2520CspC%252C%2520Is%2520Important%2520for%2520Establishing%2520Infection%26jtitle%3DPLoS%2520Pathog.%26date%3D2013%26volume%3D9%26spage%3De1003356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Sorg, J. A.; Dineen, S. S.</span><span> </span><span class="NLM_article-title">Laboratory Maintenance of <i>Clostridium difficile</i></span>.  <span class="citation_source-journal">Curr. Protoc. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span>Chapter 9, Unit 9A.1.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=19235151" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=J.+A.+Sorg&author=S.+S.+Dineen&title=Laboratory+Maintenance+of+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSorg%26aufirst%3DJ.%2BA.%26atitle%3DLaboratory%2520Maintenance%2520of%2520Clostridium%2520difficile%26jtitle%3DCurr.%2520Protoc.%2520Microbiol.%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Edwards, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suárez, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, S. M.</span><span> </span><span class="NLM_article-title">Culturing and Maintaining <i>Clostridium difficile</i> in an Anaerobic Environment</span> <span class="citation_source-journal">J. Visualized Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_fpage">e50787</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=e50787&author=A.+N.+Edwardsauthor=J.+M.+Su%C3%A1rezauthor=S.+M.+McBride&title=Culturing+and+Maintaining+Clostridium+difficile+in+an+Anaerobic+Environment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DA.%2BN.%26aulast%3DSu%25C3%25A1rez%26aufirst%3DJ.%2BM.%26aulast%3DMcBride%26aufirst%3DS.%2BM.%26atitle%3DCulturing%2520and%2520Maintaining%2520Clostridium%2520difficile%2520in%2520an%2520Anaerobic%2520Environment%26jtitle%3DJ.%2520Visualized%2520Exp.%26date%3D2013%26spage%3De50787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span> <span class="citation_source-book">Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria</span>, <span class="NLM_edition">8</span>th ed.; CLSI M11-A8 ; <span class="NLM_publisher-name">Clinical and Laboratory Standards Institute</span>: <span class="NLM_publisher-loc">Wayne, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Methods+for+Antimicrobial+Susceptibility+Testing+of+Anaerobic+Bacteria%2C+8th+ed.%3B+CLSI+M11-A8+%3B+Clinical+and+Laboratory+Standards+Institute%3A+Wayne%2C+PA%2C+2012%3B+pp+1%E2%80%9356."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMethods%2520for%2520Antimicrobial%2520Susceptibility%2520Testing%2520of%2520Anaerobic%2520Bacteria%26pub%3DClinical%2520and%2520Laboratory%2520Standards%2520Institute%26date%3D2012%26spage%3D1%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Dawson, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valiente, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faulds-Pain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donahue, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wren, B. W.</span><span> </span><span class="NLM_article-title">Characterisation of <i>Clostridium difficile</i> Biofilm Formation, a Role for Spo0A</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e50527</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e50527&author=L.+F.+Dawsonauthor=E.+Valienteauthor=A.+Faulds-Painauthor=E.+H.+Donahueauthor=B.+W.+Wren&title=Characterisation+of+Clostridium+difficile+Biofilm+Formation%2C+a+Role+for+Spo0A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DL.%2BF.%26aulast%3DValiente%26aufirst%3DE.%26aulast%3DFaulds-Pain%26aufirst%3DA.%26aulast%3DDonahue%26aufirst%3DE.%2BH.%26aulast%3DWren%26aufirst%3DB.%2BW.%26atitle%3DCharacterisation%2520of%2520Clostridium%2520difficile%2520Biofilm%2520Formation%252C%2520a%2520Role%2520for%2520Spo0A%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De50527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Allen, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babakhani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sears, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorg, J. A.</span><span> </span><span class="NLM_article-title">Both Fidaxomicin and Vancomycin Inhibit Outgrowth of <i>Clostridium difficile</i> Spores</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">667</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=664-667&author=C.+A.+Allenauthor=F.+Babakhaniauthor=P.+Searsauthor=L.+Nguyenauthor=J.+A.+Sorg&title=Both+Fidaxomicin+and+Vancomycin+Inhibit+Outgrowth+of+Clostridium+difficile+Spores"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DC.%2BA.%26aulast%3DBabakhani%26aufirst%3DF.%26aulast%3DSears%26aufirst%3DP.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DSorg%26aufirst%3DJ.%2BA.%26atitle%3DBoth%2520Fidaxomicin%2520and%2520Vancomycin%2520Inhibit%2520Outgrowth%2520of%2520Clostridium%2520difficile%2520Spores%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D664%26epage%3D667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Chilton, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baines, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowther, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. H.</span><span> </span><span class="NLM_article-title">Evaluation of the Effect of Oritavancin on <i>Clostridium difficile</i> Spore Germination, Outgrowth and Recovery</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2078</span><span class="NLM_x">–</span> <span class="NLM_lpage">2082</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fjac%2Fdkt160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=23759507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht12htbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2013&pages=2078-2082&author=C.+H.+Chiltonauthor=J.+Freemanauthor=S.+D.+Bainesauthor=G.+S.+Crowtherauthor=S.+Nicholsonauthor=M.+H.+Wilcox&title=Evaluation+of+the+Effect+of+Oritavancin+on+Clostridium+difficile+Spore+Germination%2C+Outgrowth+and+Recovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the effect of oritavancin on Clostridium difficile spore germination, outgrowth and recovery</span></div><div class="casAuthors">Chilton, C. H.; Freeman, J.; Baines, S. D.; Crowther, G. S.; Nicholson, S.; Wilcox, M. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2078-2082</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Previous work suggests that oritavancin may be inhibitory to Clostridium difficile spores.  The authors have evaluated the effects of oritavancin exposure on C. difficile spore germination, outgrowth and recovery.  Germination and outgrowth of C. difficile spores exposed to different concns. of oritavancin, vancomycin, or metronidazole (0.1-10 mg/L) were monitored at 0, 2, 4, 6, 24 and 48 h using phase-contrast microscopy.  Recovery of antimicrobial-exposed spores was detd. by viable counting on Brazier's modified CCEYL agar.  Persistence of oritavancin activity on spores after washing was detd. by measuring activity against a Staphylococcus aureus lawn.  Oritavancin, vancomycin and metronidazole exposure did not prevent germination of phase-bright spores to phase-dark spores, but did inhibit further outgrowth into vegetative cells.  The inhibitory effect of oritavancin persisted after washing, whereas the inhibitory effects of vancomycin and metronidazole did not.  Oritavancin exposure affected spore recovery; fewer spores were recovered after washing following oritavancin exposure than vancomycin exposure.  The extent of this effect was dependent on PCR ribotype, with recovery of ribotype 078 spores completely prevented, but recovery of ribotype 001 spores only slightly affected.  Spores exposed to oritavancin, but not vancomycin, retained antimicrobial activity after washing, indicating adherence of oritavancin, but not vancomycin, to the spore surface Conclusions Oritavancin may adhere to spores, potentially causing early inhibition of germinated cells, preventing subsequent vegetative outgrowth and spore recovery.  This may prevent some recurrences of symptomatic C. difficile infection that are due to germination of residual spores following antibiotic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdr5tiiPe8oLVg90H21EOLACvtfcHk0li7tbqzLluTUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht12htbfF&md5=f6779d3bf908df11f69d9300c5dad5cc</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkt160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkt160%26sid%3Dliteratum%253Aachs%26aulast%3DChilton%26aufirst%3DC.%2BH.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DBaines%26aufirst%3DS.%2BD.%26aulast%3DCrowther%26aufirst%3DG.%2BS.%26aulast%3DNicholson%26aufirst%3DS.%26aulast%3DWilcox%26aufirst%3DM.%2BH.%26atitle%3DEvaluation%2520of%2520the%2520Effect%2520of%2520Oritavancin%2520on%2520Clostridium%2520difficile%2520Spore%2520Germination%252C%2520Outgrowth%2520and%2520Recovery%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2013%26volume%3D68%26spage%3D2078%26epage%3D2082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Francis, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorg, J. A.</span><span> </span><span class="NLM_article-title">Muricholic Acids Inhibit <i>Clostridium difficile</i> Spore Germination and Growth</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e73653</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e73653&author=M.+B.+Francisauthor=C.+A.+Allenauthor=J.+A.+Sorg&title=Muricholic+Acids+Inhibit+Clostridium+difficile+Spore+Germination+and+Growth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrancis%26aufirst%3DM.%2BB.%26aulast%3DAllen%26aufirst%3DC.%2BA.%26aulast%3DSorg%26aufirst%3DJ.%2BA.%26atitle%3DMuricholic%2520Acids%2520Inhibit%2520Clostridium%2520difficile%2520Spore%2520Germination%2520and%2520Growth%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De73653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Baines, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. H.</span><span> </span><span class="NLM_article-title">Comparison of Oritavancin Versus Vancomycin as Treatments for Clindamycin-Induced <i>Clostridium difficile</i> PCR Ribotype 027 Infection in a Human Gut Model</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1078</span><span class="NLM_x">–</span> <span class="NLM_lpage">1085</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fjac%2Fdkn358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=18772161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1elu7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2008&pages=1078-1085&author=S.+D.+Bainesauthor=R.+O%E2%80%99Connorauthor=K.+Saxtonauthor=J.+Freemanauthor=M.+H.+Wilcox&title=Comparison+of+Oritavancin+Versus+Vancomycin+as+Treatments+for+Clindamycin-Induced+Clostridium+difficile+PCR+Ribotype+027+Infection+in+a+Human+Gut+Model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model</span></div><div class="casAuthors">Baines, Simon D.; O'Connor, Rachael; Saxton, Katie; Freeman, Jane; Wilcox, Mark H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1078-1085</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The aim was to compare the efficacy of oritavancin and vancomycin in the treatment of Clostridium difficile infection (CDI) using an in vitro human gut model.  We induced CDI by instilling clindamycin into an in vitro gut model primed with pooled human faeces and C. difficile ribotype 027 spores.  Oritavancin and vancomycin were instilled in sep. expts. at levels equiv. to those expected in the faeces (vancomycin) of patients or levels limited by the soly. of the drug (oritavancin).  Clindamycin exposure elicited C. difficile proliferation and high-level cytotoxin prodn. in both expts.  Vancomycin instillation reduced vegetative C. difficile nos. within 1 day but did not affect the nos. of C. difficile spores.  Oritavancin instillation markedly reduced C. difficile vegetative nos. and spores to below the limits of detection within 2 days.  Cytotoxin titers in both expts. declined to the limits of detection after instillation with oritavancin or vancomycin, but did so more quickly (within 5 days) in the vancomycin expt.  Cessation of vancomycin instillation was assocd. with further C. difficile proliferation and high-level cytotoxin prodn.  Conversely, toxin recrudescence was not obsd. following cessation of oritavancin.  Both oritavancin and vancomycin were effective in treating clindamycin-induced CDI in a human gut model, but only oritavancin appeared active against spore forms of C. difficile.  Furthermore, recurrence of high-level cytotoxin prodn. was obsd. following vancomycin instillation but not oritavancin.  Oritavancin therapy may be more effective in treating CDI than vancomycin, possibly because it may prevent recrudescence of C. difficile spores.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDul26dz3TPLVg90H21EOLACvtfcHk0liIhKuUG9bELA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1elu7nI&md5=540d271cd519acf20eaa64e7f4de5df1</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkn358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkn358%26sid%3Dliteratum%253Aachs%26aulast%3DBaines%26aufirst%3DS.%2BD.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%26aulast%3DSaxton%26aufirst%3DK.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DWilcox%26aufirst%3DM.%2BH.%26atitle%3DComparison%2520of%2520Oritavancin%2520Versus%2520Vancomycin%2520as%2520Treatments%2520for%2520Clindamycin-Induced%2520Clostridium%2520difficile%2520PCR%2520Ribotype%2520027%2520Infection%2520in%2520a%2520Human%2520Gut%2520Model%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2008%26volume%3D62%26spage%3D1078%26epage%3D1085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Crowther, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baines, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todhunter, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chilton, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. H.</span><span> </span><span class="NLM_article-title">Evaluation of NVB302 Versus Vancomycin Activity in an in Vitro Human Gut Model of <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fjac%2Fdks359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=22966180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVChsbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2013&pages=168-176&author=G.+S.+Crowtherauthor=S.+D.+Bainesauthor=S.+L.+Todhunterauthor=J.+Freemanauthor=C.+H.+Chiltonauthor=M.+H.+Wilcox&title=Evaluation+of+NVB302+Versus+Vancomycin+Activity+in+an+in+Vitro+Human+Gut+Model+of+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection</span></div><div class="casAuthors">Crowther, Grace S.; Baines, Simon D.; Todhunter, Sharie L.; Freeman, Jane; Chilton, Caroline H.; Wilcox, Mark H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">168-176</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives First-line treatment options for Clostridium difficile infection (CDI) are limited.  NVB302 is a novel type B lantibiotic under evaluation for the treatment of CDI.  We compared the responses to NVB302 and vancomycin when used to treat simulated CDI in an in vitro gut model.  Methods We used ceftriaxone to elicit simulated CDI in an in vitro gut model primed with human faeces.  Vancomycin and NVB302 were instilled into sep. gut models and the indigenous gut microbiota and C. difficile total viable counts, spores and toxin levels were monitored throughout.  Results Ceftriaxone instillation promoted C. difficile germination and high-level toxin prodn.  Commencement of NVB302 and vancomycin instillation reduced C. difficile total viable counts rapidly with only C. difficile spores remaining within 3 and 4 days, resp.  Cytotoxin was reduced to undetectable levels 5 and 7 days after vancomycin and NVB302 instillation commenced in vessel 2 and 3, resp., and remained undetectable for the remainder of the expts.  C. difficile spores were unaffected by the presence of vancomycin or NVB302.  NVB302 treatment was assocd. with faster resoln. of Bacteroides fragilis group.  Conclusions Both NVB302 and vancomycin were effective in treating simulated CDI in an in vitro gut model.  C. difficile spore recrudescence was not obsd. following successful treatment with either NVB302 or vancomycin.  NVB302 displayed non-inferiority to vancomycin in the treatment of simulated CDI, and had less deleterious effects against B. fragilis group.  NVB302 warrants further clin. investigation as a potentially novel antimicrobial agent for the treatment of CDI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaGVJxLcodS7Vg90H21EOLACvtfcHk0liIhKuUG9bELA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVChsbfJ&md5=017094dacb83047705cce8b9d6ff4795</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdks359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdks359%26sid%3Dliteratum%253Aachs%26aulast%3DCrowther%26aufirst%3DG.%2BS.%26aulast%3DBaines%26aufirst%3DS.%2BD.%26aulast%3DTodhunter%26aufirst%3DS.%2BL.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DChilton%26aufirst%3DC.%2BH.%26aulast%3DWilcox%26aufirst%3DM.%2BH.%26atitle%3DEvaluation%2520of%2520NVB302%2520Versus%2520Vancomycin%2520Activity%2520in%2520an%2520in%2520Vitro%2520Human%2520Gut%2520Model%2520of%2520Clostridium%2520difficile%2520Infection%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2013%26volume%3D68%26spage%3D168%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Chilton, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowther, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baines, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todhunter, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locher, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Athanasiou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. H.</span><span> </span><span class="NLM_article-title">In Vitro Activity of Cadazolid against Clinically Relevant <i>Clostridium difficile</i> Isolates and in an in Vitro Gut Model of <i>C. difficile</i> Infection</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">697</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fjac%2Fdkt411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=24128668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisF2ltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2014&pages=697-705&author=C.+H.+Chiltonauthor=G.+S.+Crowtherauthor=S.+D.+Bainesauthor=S.+L.+Todhunterauthor=J.+Freemanauthor=H.+H.+Locherauthor=A.+Athanasiouauthor=M.+H.+Wilcox&title=In+Vitro+Activity+of+Cadazolid+against+Clinically+Relevant+Clostridium+difficile+Isolates+and+in+an+in+Vitro+Gut+Model+of+C.+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro activity of cadazolid against clinically relevant Clostridium difficile isolates and in an in vitro gut model of C. difficile infection</span></div><div class="casAuthors">Chilton, C. H.; Crowther, G. S.; Baines, S. D.; Todhunter, S. L.; Freeman, J.; Locher, H. H.; Athanasiou, A.; Wilcox, M. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">697-705</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives We investigated the in vitro activity of cadazolid against 100 Clostridium difficile isolates and its efficacy in a simulated human gut model of C. difficile infection (CDI).  Methods MICs of cadazolid, metronidazole, vancomycin, moxifloxacin and linezolid were detd. using agar incorporation for 100 C. difficile isolates, including 30 epidemic strains (ribotypes 027, 106 and 001) with reduced metronidazole susceptibility, 2 linezolid-resistant isolates and 2 moxifloxacin-resistant isolates.  We evaluated the efficacy of two cadazolid dosing regimens (250 vs. 750 mg/L twice daily for 7 days) to treat simulated CDI.  Microflora populations, C. difficile total viable counts and spores, cytotoxin titers, possible emergence of cadazolid, linezolid or quinolone resistance, and antimicrobial concns. were monitored throughout.  Results Cadazolid was active against all (including linezolid- and moxifloxacin-resistant) C. difficile strains (MIC90 0.125, range 0.03-0.25 mg/L).  The cadazolid geometric mean MIC was 152-fold, 16-fold, 9-fold and 7-fold lower than those of moxifloxacin, linezolid, metronidazole and vancomycin, resp.  Both cadazolid dosing regimens rapidly reduced C. difficile viable counts and cytotoxin with no evidence of recurrence.  Cadazolid levels persisted at 50-100-fold supra-MIC for 14 days post-dosing.  Cadazolid inhibition of enumerated gut microflora was limited, with the exception of bifidobacteria; Bacteroides fragilis group and Lactobacillus spp. counts were unaffected.  There was no evidence for selection of strains resistant to cadazolid, quinolones or linezolid.  Conclusions Cadazolid activity was greater than other tested antimicrobials against 100 C. difficile strains.  Cadazolid effectively treated simulated CDI in a gut model, with limited impact on the enumerated gut microflora and no signs of recurrence or emergence of resistance within the exptl. timeframe.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL-8XP6WYM1LVg90H21EOLACvtfcHk0liIhKuUG9bELA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisF2ltrg%253D&md5=f9fb66ad33f640be6d7bedebd9c5b9d4</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkt411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkt411%26sid%3Dliteratum%253Aachs%26aulast%3DChilton%26aufirst%3DC.%2BH.%26aulast%3DCrowther%26aufirst%3DG.%2BS.%26aulast%3DBaines%26aufirst%3DS.%2BD.%26aulast%3DTodhunter%26aufirst%3DS.%2BL.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DLocher%26aufirst%3DH.%2BH.%26aulast%3DAthanasiou%26aufirst%3DA.%26aulast%3DWilcox%26aufirst%3DM.%2BH.%26atitle%3DIn%2520Vitro%2520Activity%2520of%2520Cadazolid%2520against%2520Clinically%2520Relevant%2520Clostridium%2520difficile%2520Isolates%2520and%2520in%2520an%2520in%2520Vitro%2520Gut%2520Model%2520of%2520C.%2520difficile%2520Infection%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2014%26volume%3D69%26spage%3D697%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Chilton, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowther, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todhunter, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. H.</span><span> </span><span class="NLM_article-title">Effectiveness of a Short (4 Day) Course of Oritavancin in the Treatment of Simulated <i>Clostridium difficile</i> Infection Using a Human Gut Model</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">2434</span><span class="NLM_x">–</span> <span class="NLM_lpage">2437</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fjac%2Fdks243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=22723601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVSntrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2012&pages=2434-2437&author=C.+H.+Chiltonauthor=J.+Freemanauthor=G.+S.+Crowtherauthor=S.+L.+Todhunterauthor=M.+H.+Wilcox&title=Effectiveness+of+a+Short+%284+Day%29+Course+of+Oritavancin+in+the+Treatment+of+Simulated+Clostridium+difficile+Infection+Using+a+Human+Gut+Model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Effectiveness of a short (4 day) course of oritavancin in the treatment of simulated Clostridium difficile infection using a human gut model</span></div><div class="casAuthors">Chilton, C. H.; Freeman, J.; Crowther, G. S.; Todhunter, S. L.; Wilcox, M. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2434-2437</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives: The authors previously demonstrated that 7 days of oritavancin instillation effectively treats Clostridium difficile infection (CDI) in a human gut model.  Oritavancin may be more effective than vancomycin due to apparently increased activity against spores.  The authors compared the efficacy of shortened dosing duration (4 days) of oritavancin and vancomycin for CDI treatment using the gut model.  Methods: Clindamycin induced CDI in two triple-stage chemostat gut models primed with pooled human feces and C. difficile ribotype 027 spores.  Oritavancin (64 mg/L twice daily) or vancomycin (125 mg/L four times daily) was instilled for 4 days and the effects on C. difficile proliferation and toxin prodn., and gut microflora were detd.  Results: Both oritavancin and vancomycin reduced toxin to undetectable levels.  Recurrent C. difficile germination occurred 20 days after vancomycin instillation, with high-level toxin prodn.  Oritavancin reduced C. difficile counts to around the detection limit for the remainder of the expt., with spores undetectable from day 1 of instillation.  Toxin prodn. was reduced to below detectable levels, but was sporadically seen later, despite no evidence of germination.  Both oritavancin and vancomycin instillation led to only modest effects on gut microflora.  Conclusions: Shortened courses of oritavancin and vancomycin effectively treated CDI in a human gut model, but evidence of recurrence was obsd. following vancomycin instillation.  Oritavancin exposure inhibited the recovery of C. difficile spores, as previously described.  Shortened antibiotic exposure minimizes disruption to the gut microflora.  These data indicate the possible value of a 4 day oritavancin dosing regimen for CDI treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfMsxZK2sCtbVg90H21EOLACvtfcHk0lhQJFlaOj3I2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVSntrzM&md5=19a3646d3c280136ddaa1804f0610802</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdks243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdks243%26sid%3Dliteratum%253Aachs%26aulast%3DChilton%26aufirst%3DC.%2BH.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DCrowther%26aufirst%3DG.%2BS.%26aulast%3DTodhunter%26aufirst%3DS.%2BL.%26aulast%3DWilcox%26aufirst%3DM.%2BH.%26atitle%3DEffectiveness%2520of%2520a%2520Short%2520%25284%2520Day%2529%2520Course%2520of%2520Oritavancin%2520in%2520the%2520Treatment%2520of%2520Simulated%2520Clostridium%2520difficile%2520Infection%2520Using%2520a%2520Human%2520Gut%2520Model%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2012%26volume%3D67%26spage%3D2434%26epage%3D2437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Crowther, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chilton, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todhunter, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baines, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. H.</span><span> </span><span class="NLM_article-title">Development and Validation of a Chemostat Gut Model To Study Both Planktonic and Biofilm Modes of Growth of <i>Clostridium difficile</i> and Human Microbiota</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e88396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e88396&author=G.+S.+Crowtherauthor=C.+H.+Chiltonauthor=S.+L.+Todhunterauthor=S.+Nicholsonauthor=J.+Freemanauthor=S.+D.+Bainesauthor=M.+H.+Wilcox&title=Development+and+Validation+of+a+Chemostat+Gut+Model+To+Study+Both+Planktonic+and+Biofilm+Modes+of+Growth+of+Clostridium+difficile+and+Human+Microbiota"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrowther%26aufirst%3DG.%2BS.%26aulast%3DChilton%26aufirst%3DC.%2BH.%26aulast%3DTodhunter%26aufirst%3DS.%2BL.%26aulast%3DNicholson%26aufirst%3DS.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DBaines%26aufirst%3DS.%2BD.%26aulast%3DWilcox%26aufirst%3DM.%2BH.%26atitle%3DDevelopment%2520and%2520Validation%2520of%2520a%2520Chemostat%2520Gut%2520Model%2520To%2520Study%2520Both%2520Planktonic%2520and%2520Biofilm%2520Modes%2520of%2520Growth%2520of%2520Clostridium%2520difficile%2520and%2520Human%2520Microbiota%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De88396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Crowther, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chilton, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todhunter, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baines, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. H.</span><span> </span><span class="NLM_article-title">Comparison of Planktonic and Biofilm-Associated Communities of <i>Clostridium difficile</i> and Indigenous Gut Microbiota in a Triple-Stage Chemostat Gut Model</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">2137</span><span class="NLM_x">–</span> <span class="NLM_lpage">2147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fjac%2Fdku116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=24788662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Sqsb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2014&pages=2137-2147&author=G.+S.+Crowtherauthor=C.+H.+Chiltonauthor=S.+L.+Todhunterauthor=S.+Nicholsonauthor=J.+Freemanauthor=S.+D.+Bainesauthor=M.+H.+Wilcox&title=Comparison+of+Planktonic+and+Biofilm-Associated+Communities+of+Clostridium+difficile+and+Indigenous+Gut+Microbiota+in+a+Triple-Stage+Chemostat+Gut+Model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut model</span></div><div class="casAuthors">Crowther, Grace S.; Chilton, Caroline H.; Todhunter, Sharie L.; Nicholson, Scott; Freeman, Jane; Baines, Simon D.; Wilcox, Mark H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2137-2147</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Biofilms are characteristic of some chronic or recurrent infections and this mode of growth tends to reduce treatment efficacy.  Clostridium difficile infection (CDI) is assocd. with a high rate of recurrent symptomatic disease.  The presence and behavior of C. difficile within intestinal biofilms remains largely unexplored, but may factor in recurrent infection.  A triple-stage chemostat gut model designed to facilitate the formation of intestinal biofilm was inoculated with a pooled human fecal emulsion.  Bacterial populations were allowed to equilibrate before simulated CDI was induced by clindamycin (33.9 mg/L, four times daily, 7 days) and subsequently treated with vancomycin (125 mg/L, four times daily, 7 days).  Indigenous gut microbiota, C. difficile total viable counts, spores, cytotoxin and antimicrobial activity in planktonic and biofilm communities were monitored during the 10 wk exptl. period.  Vancomycin successfully treated the initial episode of simulated CDI, but ∼18 days after therapy cessation, recurrent infection occurred.  Germination, proliferation and toxin prodn. were evident within planktonic communities in both initial and recurrent CDI.  In contrast, sessile C. difficile remained in dormant spore form for the duration of the expt.  The effects of and recovery from clindamycin and vancomycin exposure for sessile populations was delayed compared with responses for planktonic bacteria.  Thus, intestinal biofilms provide a potential reservoir for C. difficile spore persistence, possibly facilitating their dispersal into the gut lumen after therapeutic intervention, leading to recurrent infection.  Therapeutic options for CDI could have increased efficacy if they are more effective against sessile C. difficile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraFnEau80vJbVg90H21EOLACvtfcHk0lhQJFlaOj3I2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Sqsb3P&md5=1a5dece42d7a61ff6645002314b0216e</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdku116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdku116%26sid%3Dliteratum%253Aachs%26aulast%3DCrowther%26aufirst%3DG.%2BS.%26aulast%3DChilton%26aufirst%3DC.%2BH.%26aulast%3DTodhunter%26aufirst%3DS.%2BL.%26aulast%3DNicholson%26aufirst%3DS.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DBaines%26aufirst%3DS.%2BD.%26aulast%3DWilcox%26aufirst%3DM.%2BH.%26atitle%3DComparison%2520of%2520Planktonic%2520and%2520Biofilm-Associated%2520Communities%2520of%2520Clostridium%2520difficile%2520and%2520Indigenous%2520Gut%2520Microbiota%2520in%2520a%2520Triple-Stage%2520Chemostat%2520Gut%2520Model%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2014%26volume%3D69%26spage%3D2137%26epage%3D2147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Best, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. H.</span><span> </span><span class="NLM_article-title">Models for the Study of <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">Gut Microbes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=145-167&author=E.+L.+Bestauthor=J.+Freemanauthor=M.+H.+Wilcox&title=Models+for+the+Study+of+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBest%26aufirst%3DE.%2BL.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DWilcox%26aufirst%3DM.%2BH.%26atitle%3DModels%2520for%2520the%2520Study%2520of%2520Clostridium%2520difficile%2520Infection%26jtitle%3DGut%2520Microbes%26date%3D2012%26volume%3D3%26spage%3D145%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Kokkotou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinoza, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloud, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustafa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pothoulakis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, C. P.</span><span> </span><span class="NLM_article-title">Comparative Efficacies of Rifaximin and Vancomycin for Treatment of <i>Clostridium difficile</i>-Associated Diarrhea and Prevention of Disease Recurrence in Hamsters</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1121</span><span class="NLM_x">–</span> <span class="NLM_lpage">1126</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=1121-1126&author=E.+Kokkotouauthor=A.+C.+Mossauthor=A.+Michosauthor=D.+Espinozaauthor=J.+W.+Cloudauthor=N.+Mustafaauthor=M.+O%E2%80%99Brienauthor=C.+Pothoulakisauthor=C.+P.+Kelly&title=Comparative+Efficacies+of+Rifaximin+and+Vancomycin+for+Treatment+of+Clostridium+difficile-Associated+Diarrhea+and+Prevention+of+Disease+Recurrence+in+Hamsters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKokkotou%26aufirst%3DE.%26aulast%3DMoss%26aufirst%3DA.%2BC.%26aulast%3DMichos%26aufirst%3DA.%26aulast%3DEspinoza%26aufirst%3DD.%26aulast%3DCloud%26aufirst%3DJ.%2BW.%26aulast%3DMustafa%26aufirst%3DN.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%26aulast%3DPothoulakis%26aufirst%3DC.%26aulast%3DKelly%26aufirst%3DC.%2BP.%26atitle%3DComparative%2520Efficacies%2520of%2520Rifaximin%2520and%2520Vancomycin%2520for%2520Treatment%2520of%2520Clostridium%2520difficile-Associated%2520Diarrhea%2520and%2520Prevention%2520of%2520Disease%2520Recurrence%2520in%2520Hamsters%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D1121%26epage%3D1126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Swanson, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipkowitz, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramer, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, J. J.</span><span> </span><span class="NLM_article-title">In Vitro and in Vivo Evaluation of Tiacumicins B and C against <i>Clostridium difficile</i></span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1108</span><span class="NLM_x">–</span> <span class="NLM_lpage">1111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1991&pages=1108-1111&author=R.+N.+Swansonauthor=D.+J.+Hardyauthor=N.+L.+Shipkowitzauthor=C.+W.+Hansonauthor=N.+C.+Ramerauthor=P.+B.+Fernandesauthor=J.+J.+Clement&title=In+Vitro+and+in+Vivo+Evaluation+of+Tiacumicins+B+and+C+against+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwanson%26aufirst%3DR.%2BN.%26aulast%3DHardy%26aufirst%3DD.%2BJ.%26aulast%3DShipkowitz%26aufirst%3DN.%2BL.%26aulast%3DHanson%26aufirst%3DC.%2BW.%26aulast%3DRamer%26aufirst%3DN.%2BC.%26aulast%3DFernandes%26aufirst%3DP.%2BB.%26aulast%3DClement%26aufirst%3DJ.%2BJ.%26atitle%3DIn%2520Vitro%2520and%2520in%2520Vivo%2520Evaluation%2520of%2520Tiacumicins%2520B%2520and%2520C%2520against%2520Clostridium%2520difficile%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1991%26volume%3D35%26spage%3D1108%26epage%3D1111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Ochsner, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Leary, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Critchley, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janjic, N.</span><span> </span><span class="NLM_article-title">Inhibitory Effect of REP3123 on Toxin and Spore Formation in <i>Clostridium difficile</i>, and in Vivo Efficacy in a Hamster Gastrointestinal Infection Model</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">964</span><span class="NLM_x">–</span> <span class="NLM_lpage">971</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fjac%2Fdkp042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=19251726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVaqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2009&pages=964-971&author=U.+A.+Ochsnerauthor=S.+J.+Bellauthor=A.+L.+O%E2%80%99Learyauthor=T.+Hoangauthor=K.+C.+Stoneauthor=C.+L.+Youngauthor=I.+A.+Critchleyauthor=N.+Janjic&title=Inhibitory+Effect+of+REP3123+on+Toxin+and+Spore+Formation+in+Clostridium+difficile%2C+and+in+Vivo+Efficacy+in+a+Hamster+Gastrointestinal+Infection+Model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model</span></div><div class="casAuthors">Ochsner, Urs A.; Bell, Stacie J.; O'Leary, Ann L.; Hoang, Teresa; Stone, Kimberley Clawson; Young, Casey L.; Critchley, Ian A.; Janjic, Nebojsa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">964-971</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">REP3123 is a fully synthetic methionyl-tRNA synthetase inhibitor in pre-clin. development as a novel agent to treat Clostridium difficile infection (CDI).  This novel agent was investigated for its ability to block the prodn. of toxins and spores, and was tested for efficacy in vivo in a hamster model.  Clostridial toxin levels were detd. qual. using monoclonal antibodies and by cytotoxicity assays.  Spores were detected by staining and by quant. diln. plating after ethanol treatment.  Efficacy of REP3123 was tested in a clindamycin-induced C. difficile hamster gastrointestinal (GI) infection model.  REP3123 at concns. as low as 1 mg/L inhibited de novo toxin prodn. in high cell d., stationary phase cultures of C. difficile.  Among comparator agents currently used for CDI therapy, vancomycin required much higher levels of 20 mg/L, and metronidazole had no effect on toxin levels.  REP3123 caused a >10-fold redn. of the sporulation rate in vitro.  Vancomycin and, in particular, metronidazole appeared to promote the formation of spores.  REP3123, at concns. as low as 0.5 mg/kg, demonstrated efficacy in the hamster model of CDI and was superior to vancomycin in the overall survival of the animals at the end of the study (33 days).  REP3123 inhibited growth of C. difficile, affected the prodn. of toxins and spores and demonstrated superior efficacy compared with vancomycin in the hamster GI infection model.  This agent may be a promising candidate for CDI treatment; in particular, the inhibition of toxin prodn. and spore formation may reduce the severity and spread of the disease, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc8dcWSQIzz7Vg90H21EOLACvtfcHk0lge_3-IcoTz7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVaqu7c%253D&md5=9cba5872704bf239698d8d45f2a57e19</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkp042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkp042%26sid%3Dliteratum%253Aachs%26aulast%3DOchsner%26aufirst%3DU.%2BA.%26aulast%3DBell%26aufirst%3DS.%2BJ.%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DA.%2BL.%26aulast%3DHoang%26aufirst%3DT.%26aulast%3DStone%26aufirst%3DK.%2BC.%26aulast%3DYoung%26aufirst%3DC.%2BL.%26aulast%3DCritchley%26aufirst%3DI.%2BA.%26aulast%3DJanjic%26aufirst%3DN.%26atitle%3DInhibitory%2520Effect%2520of%2520REP3123%2520on%2520Toxin%2520and%2520Spore%2520Formation%2520in%2520Clostridium%2520difficile%252C%2520and%2520in%2520Vivo%2520Efficacy%2520in%2520a%2520Hamster%2520Gastrointestinal%2520Infection%2520Model%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2009%26volume%3D63%26spage%3D964%26epage%3D971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Locher, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfaff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enderlin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klenk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fournier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubschwerlen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keck, W.</span><span> </span><span class="NLM_article-title">In Vitro and in Vivo Antibacterial Evaluation of Cadazolid, a New Antibiotic for Treatment of <i>Clostridium difficile</i> Infections</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">900</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=892-900&author=H.+H.+Locherauthor=P.+Seilerauthor=X.+Chenauthor=S.+Schroederauthor=P.+Pfaffauthor=M.+Enderlinauthor=A.+Klenkauthor=E.+Fournierauthor=C.+Hubschwerlenauthor=D.+Ritzauthor=C.+P.+Kellyauthor=W.+Keck&title=In+Vitro+and+in+Vivo+Antibacterial+Evaluation+of+Cadazolid%2C+a+New+Antibiotic+for+Treatment+of+Clostridium+difficile+Infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLocher%26aufirst%3DH.%2BH.%26aulast%3DSeiler%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSchroeder%26aufirst%3DS.%26aulast%3DPfaff%26aufirst%3DP.%26aulast%3DEnderlin%26aufirst%3DM.%26aulast%3DKlenk%26aufirst%3DA.%26aulast%3DFournier%26aufirst%3DE.%26aulast%3DHubschwerlen%26aufirst%3DC.%26aulast%3DRitz%26aufirst%3DD.%26aulast%3DKelly%26aufirst%3DC.%2BP.%26aulast%3DKeck%26aufirst%3DW.%26atitle%3DIn%2520Vitro%2520and%2520in%2520Vivo%2520Antibacterial%2520Evaluation%2520of%2520Cadazolid%252C%2520a%2520New%2520Antibiotic%2520for%2520Treatment%2520of%2520Clostridium%2520difficile%2520Infections%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D892%26epage%3D900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baines, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jabes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. H.</span><span> </span><span class="NLM_article-title">Comparison of the Efficacy of Ramoplanin and Vancomycin in Both in Vitro and in Vivo Models of Clindamycin-Induced <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">725</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fjac%2Fdki321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=16143709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKhsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2005&pages=717-725&author=J.+Freemanauthor=S.+D.+Bainesauthor=D.+Jabesauthor=M.+H.+Wilcox&title=Comparison+of+the+Efficacy+of+Ramoplanin+and+Vancomycin+in+Both+in+Vitro+and+in+Vivo+Models+of+Clindamycin-Induced+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection</span></div><div class="casAuthors">Freeman, Jane; Baines, Simon D.; Jabes, Daniela; Wilcox, Mark H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">717-725</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Treatment of Clostridium difficile infection (CDI) is limited primarily to either metronidazole or vancomycin.  We compared vancomycin and a novel glycolipodepsipeptide, ramoplanin, in both hamster and in vitro gut models of clindamycin-induced CDI.  We used an in vitro triple-stage chemostat model that simulates the human gut, and an in vivo hamster model, both primed with clindamycin.  Clindamycin exposure elicited symptomatic disease in the hamster model, and promoted C. difficile germination and toxin prodn. in the gut model.  C. difficile germination and toxin prodn. were not assocd. with depletion of gut microflora in the gut model, but were temporarily assocd. with subinhibitory concns. of clindamycin.  Both ramoplanin and vancomycin were assocd. with rapid symptom resoln. in the hamster model, and rapid toxin titer decrease in the in vitro gut model.  In both models of CDI, vancomycin was assocd. with greater persistence of C. difficile spores.  C. difficile spores were recovered significantly more often from the caecal contents of vancomycin-treated (n = 19/23) compared with ramoplanin-treated (n = 6/23) hamsters (P < 0.05).  Results from the in vitro gut and hamster models were concordant.  Ramoplanin and vancomycin were similarly effective at reducing cytotoxin prodn. in the gut CDI model and in resolving symptoms in the hamster model.  Ramoplanin may be more effective than vancomycin at killing spores and preventing spore recrudescence.  These findings suggest a potential therapeutic role for ramoplanin in CDI that requires further clin. investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEl9FGqKF4u7Vg90H21EOLACvtfcHk0likCfwtPML3lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKhsr7E&md5=febc4f3ec9555d807ac8e596ced3fb8b</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdki321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdki321%26sid%3Dliteratum%253Aachs%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DBaines%26aufirst%3DS.%2BD.%26aulast%3DJabes%26aufirst%3DD.%26aulast%3DWilcox%26aufirst%3DM.%2BH.%26atitle%3DComparison%2520of%2520the%2520Efficacy%2520of%2520Ramoplanin%2520and%2520Vancomycin%2520in%2520Both%2520in%2520Vitro%2520and%2520in%2520Vivo%2520Models%2520of%2520Clindamycin-Induced%2520Clostridium%2520difficile%2520Infection%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2005%26volume%3D56%26spage%3D717%26epage%3D725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">McVay, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolfe, R. D.</span><span> </span><span class="NLM_article-title">In Vitro and in Vivo Activities of Nitazoxanide against <i>Clostridium difficile</i></span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2254</span><span class="NLM_x">–</span> <span class="NLM_lpage">2258</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2000&pages=2254-2258&author=C.+S.+McVayauthor=R.+D.+Rolfe&title=In+Vitro+and+in+Vivo+Activities+of+Nitazoxanide+against+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcVay%26aufirst%3DC.%2BS.%26aulast%3DRolfe%26aufirst%3DR.%2BD.%26atitle%3DIn%2520Vitro%2520and%2520in%2520Vivo%2520Activities%2520of%2520Nitazoxanide%2520against%2520Clostridium%2520difficile%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2000%26volume%3D44%26spage%3D2254%26epage%3D2258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">Anton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokkotou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenstein, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paraschos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pothoulakis, C.</span><span> </span><span class="NLM_article-title">Rifalazil Treats and Prevents Relapse of <i>Clostridium difficile</i>-Associated Diarrhea in Hamsters</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3975</span><span class="NLM_x">–</span> <span class="NLM_lpage">3979</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=3975-3979&author=P.+M.+Antonauthor=M.+O%E2%80%99Brienauthor=E.+Kokkotouauthor=A.+M.+Eisensteinauthor=D.+M.+Rothsteinauthor=S.+Paraschosauthor=C.+P.+Kellyauthor=C.+Pothoulakis&title=Rifalazil+Treats+and+Prevents+Relapse+of+Clostridium+difficile-Associated+Diarrhea+in+Hamsters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnton%26aufirst%3DP.%2BM.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%26aulast%3DKokkotou%26aufirst%3DE.%26aulast%3DEisenstein%26aufirst%3DA.%2BM.%26aulast%3DRothstein%26aufirst%3DD.%2BM.%26aulast%3DParaschos%26aufirst%3DS.%26aulast%3DKelly%26aufirst%3DC.%2BP.%26aulast%3DPothoulakis%26aufirst%3DC.%26atitle%3DRifalazil%2520Treats%2520and%2520Prevents%2520Relapse%2520of%2520Clostridium%2520difficile-Associated%2520Diarrhea%2520in%2520Hamsters%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D3975%26epage%3D3979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowther, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todhunter, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawley, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chilton, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moeck, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehoux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. H.</span><span> </span><span class="NLM_article-title">Oritavancin Does Not Induce <i>Clostridium difficile</i> Germination and Toxin Production in Hamsters or a Human Gut Model</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">2919</span><span class="NLM_x">–</span> <span class="NLM_lpage">2926</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fjac%2Fdks309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=22899803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Glu73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2012&pages=2919-2926&author=J.+Freemanauthor=M.+Marquisauthor=G.+S.+Crowtherauthor=S.+L.+Todhunterauthor=W.+N.+Fawleyauthor=C.+H.+Chiltonauthor=G.+Moeckauthor=D.+Lehouxauthor=M.+H.+Wilcox&title=Oritavancin+Does+Not+Induce+Clostridium+difficile+Germination+and+Toxin+Production+in+Hamsters+or+a+Human+Gut+Model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model</span></div><div class="casAuthors">Freeman, Jane; Marquis, Miriam; Crowther, Grace S.; Todhunter, Sharie L.; Fawley, Warren N.; Chilton, Caroline H.; Moeck, Gregory; Lehoux, Dario; Wilcox, Mark H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2919-2926</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives: To evaluate the relative propensities of oritavancin and vancomycin to induce Clostridium difficile infection (CDI) in hamster and in vitro human gut models.  Methods: Hamsters received clindamycin (100 mg/kg orally or s.c.), oritavancin (50 mg/kg orally) or vancomycin (50 mg/kg orally).  C. difficile spores were administered orally the next day.  Control hamsters received vehicle only (polyethylene glycol 400) plus spores or clindamycin but no spores.  Hamsters were monitored for clin. signs for 20 days.  Caecal contents were analyzed for C. difficile cells, spores and the presence of (cyto)toxin.  Oritavancin and vancomycin were instilled over 7 days into sep. in vitro gut models primed with pooled human faeces and inoculated with C. difficile ribotype 027 spores.  Gut flora, C. difficile total viable and spore counts, toxin titers and antimicrobial concns. were detd.  Results: All hamsters treated with oritavancin survived up to 20 days, with no evidence of C. difficile spores, vegetative cells or toxin in their caeca.  No hamsters treated with clindamycin or vancomycin survived >6 days after spore administration.  Death was assocd. with high C. difficile counts and toxin in caecal contents.  In the gut model, oritavancin dosing elicited a rapid, marked decrease in total viable C. difficile and spore counts to below the limit of detection.  Vancomycin did not elicit germination or toxin prodn. in the gut model, but C. difficile remained present as spores throughout.  Conclusions: Oritavancin exposure, unlike exposure to vancomycin or clindamycin, did not lead to CDI in hamsters.  In both models, oritavancin reduced C. difficile total counts and spores to below detectable limits.  The data indicate the potential of oritavancin for CDI treatment, since exposure did not induce C. difficile germination and toxin prodn., which are known to exacerbate the disease state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY8iA8HcREcrVg90H21EOLACvtfcHk0liRUvpT36HtiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Glu73L&md5=5bbe75a7f0f471c0e157c0992266eb58</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdks309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdks309%26sid%3Dliteratum%253Aachs%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DMarquis%26aufirst%3DM.%26aulast%3DCrowther%26aufirst%3DG.%2BS.%26aulast%3DTodhunter%26aufirst%3DS.%2BL.%26aulast%3DFawley%26aufirst%3DW.%2BN.%26aulast%3DChilton%26aufirst%3DC.%2BH.%26aulast%3DMoeck%26aufirst%3DG.%26aulast%3DLehoux%26aufirst%3DD.%26aulast%3DWilcox%26aufirst%3DM.%2BH.%26atitle%3DOritavancin%2520Does%2520Not%2520Induce%2520Clostridium%2520difficile%2520Germination%2520and%2520Toxin%2520Production%2520in%2520Hamsters%2520or%2520a%2520Human%2520Gut%2520Model%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2012%26volume%3D67%26spage%3D2919%26epage%3D2926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group">Hutton, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackin, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravorty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyras, D.</span><span> </span><span class="NLM_article-title">Small Animal Models for the Study of <i>Clostridium difficile</i> Disease Pathogenesis</span> <span class="citation_source-journal">FEMS Microbiol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2014&pages=140-149&author=M.+L.+Huttonauthor=K.+E.+Mackinauthor=A.+Chakravortyauthor=D.+Lyras&title=Small+Animal+Models+for+the+Study+of+Clostridium+difficile+Disease+Pathogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHutton%26aufirst%3DM.%2BL.%26aulast%3DMackin%26aufirst%3DK.%2BE.%26aulast%3DChakravorty%26aufirst%3DA.%26aulast%3DLyras%26aufirst%3DD.%26atitle%3DSmall%2520Animal%2520Models%2520for%2520the%2520Study%2520of%2520Clostridium%2520difficile%2520Disease%2520Pathogenesis%26jtitle%3DFEMS%2520Microbiol.%2520Lett.%26date%3D2014%26volume%3D352%26spage%3D140%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group">Deakin, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagan, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wren, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairweather, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawley, T. D.</span><span> </span><span class="NLM_article-title"><i>Clostridium difficile</i> spo0A Gene Is a Persistence and Transmission Factor</span> <span class="citation_source-journal">Infect. Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">2704</span><span class="NLM_x">–</span> <span class="NLM_lpage">2711</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1128%2FIAI.00147-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=22615253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFegsr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2012&pages=2704-2711&author=L.+J.+Deakinauthor=S.+Clareauthor=R.+P.+Faganauthor=L.+F.+Dawsonauthor=D.+J.+Pickardauthor=M.+R.+Westauthor=B.+W.+Wrenauthor=N.+F.+Fairweatherauthor=G.+Douganauthor=T.+D.+Lawley&title=Clostridium+difficile+spo0A+Gene+Is+a+Persistence+and+Transmission+Factor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">The Clostridium difficile spo0A gene is a persistence and transmission factor</span></div><div class="casAuthors">Deakin, Laura J.; Clare, Simon; Fagan, Robert P.; Dawson, Lisa F.; Pickard, Derek J.; West, Michael R.; Wren, Brendan W.; Fairweather, Neil F.; Dougan, Gordon; Lawley, Trevor D.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2704-2711</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Clostridium difficile is a major cause of chronic antibiotic-assocd. diarrhea and a significant health care-assocd. pathogen that forms highly resistant and infectious spores.  Spo0A is a highly conserved transcriptional regulator that plays a key role in initiating sporulation in Bacillus and Clostridium species.  Here, we use a murine model to study the role of the C. difficile spo0A gene during infection and transmission.  We demonstrate that C. difficile spo0A mutant derivs. can cause intestinal disease but are unable to persist within and effectively transmit between mice.  Thus, the C. difficile Spo0A protein plays a key role in persistent infection, including recurrence and host-to-host transmission in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4A5klAQ9VQLVg90H21EOLACvtfcHk0liRUvpT36HtiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFegsr%252FK&md5=1c6b60e49c91ece86bd5610666096711</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1128%2FIAI.00147-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00147-12%26sid%3Dliteratum%253Aachs%26aulast%3DDeakin%26aufirst%3DL.%2BJ.%26aulast%3DClare%26aufirst%3DS.%26aulast%3DFagan%26aufirst%3DR.%2BP.%26aulast%3DDawson%26aufirst%3DL.%2BF.%26aulast%3DPickard%26aufirst%3DD.%2BJ.%26aulast%3DWest%26aufirst%3DM.%2BR.%26aulast%3DWren%26aufirst%3DB.%2BW.%26aulast%3DFairweather%26aufirst%3DN.%2BF.%26aulast%3DDougan%26aufirst%3DG.%26aulast%3DLawley%26aufirst%3DT.%2BD.%26atitle%3DClostridium%2520difficile%2520spo0A%2520Gene%2520Is%2520a%2520Persistence%2520and%2520Transmission%2520Factor%26jtitle%3DInfect.%2520Immun.%26date%3D2012%26volume%3D80%26spage%3D2704%26epage%3D2711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, H.</span><span> </span><span class="NLM_article-title">Mouse Relapse Model of <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">Infect. Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">2856</span><span class="NLM_x">–</span> <span class="NLM_lpage">2864</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1128%2FIAI.01336-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=21576341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3MXot1Kisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=2856-2864&author=X.+Sunauthor=H.+Wangauthor=Y.+Zhangauthor=K.+Chenauthor=B.+Davisauthor=H.+Feng&title=Mouse+Relapse+Model+of+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Mouse relapse model of Clostridium difficile infection</span></div><div class="casAuthors">Sun, Xingmin; Wang, Haiying; Zhang, Yongrong; Chen, Kevin; Davis, Barbara; Feng, Hanping</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2856-2864</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Clostridium difficile is the causative agent of primary and recurrent antibiotic-assocd. diarrhea and colitis in hospitalized patients.  The disease is caused mainly by two exotoxins, TcdA and TcdB, produced by the bacteria.  Recurrent C. difficile infection (CDI) constitutes one of the most significant clin. issues of this disease, occurs in more than 20% of patients after the first episode, and may be increasing in frequency.  However, there is no well-established animal model of CDI relapse currently available for studying disease pathogenesis, prevention, and therapy.  Here we report the establishment of a conventional mouse model of recurrence/relapse CDI.  We found that the primary episode of CDI induced little or no protective antibody response against C. difficile toxins and mice continued shedding C. difficile spores.  Antibiotic treatment of surviving mice induced a second episode of diarrhea, while a simultaneous reexposure of animals to C. difficile bacteria or spores elicited a full spectrum of CDI similar to that of the primary infection.  Moreover, mice treated with immunosuppressive agents were prone to more severe and fulminant recurrent disease.  Finally, utilizing this model, we demonstrated that vancomycin only delayed disease recurrence, whereas neutralizing polyzera against both TcdA and TcdB completely protected mice against CDI relapse.  In conclusion, we have established a mouse relapse CDI model that allows for future investigations of the role of the host immune response in the disease's pathogenesis and permits crit. testing of new therapeutics targeting recurrent disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUX3G_8XqDqbVg90H21EOLACvtfcHk0liRUvpT36HtiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXot1Kisr0%253D&md5=ba9a276ca0ab0180f5b758a7bba473b6</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1128%2FIAI.01336-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.01336-10%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DFeng%26aufirst%3DH.%26atitle%3DMouse%2520Relapse%2520Model%2520of%2520Clostridium%2520difficile%2520Infection%26jtitle%3DInfect.%2520Immun.%26date%3D2011%26volume%3D79%26spage%3D2856%26epage%3D2864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group">Eyre, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cule, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaughan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ip, C. L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golubchik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batty, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finney, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyllie, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Didelot, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piazza, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowden, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingle, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harding, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crook, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peto, T. E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. S.</span><span> </span><span class="NLM_article-title">Diverse Sources of <i>C. difficile</i> Infection Identified on Whole-Genome Sequencing</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x">, </span> <span class="NLM_fpage">1195</span><span class="NLM_x">–</span> <span class="NLM_lpage">1205</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1056%2FNEJMoa1216064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=24066741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFGktLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2013&pages=1195-1205&author=D.+W.+Eyreauthor=M.+L.+Culeauthor=D.+J.+Wilsonauthor=D.+Griffithsauthor=A.+Vaughanauthor=L.+O%E2%80%99Connorauthor=C.+L.+C.+Ipauthor=T.+Golubchikauthor=E.+M.+Battyauthor=J.+M.+Finneyauthor=D.+H.+Wyllieauthor=X.+Didelotauthor=P.+Piazzaauthor=R.+Bowdenauthor=K.+E.+Dingleauthor=R.+M.+Hardingauthor=D.+W.+Crookauthor=M.+H.+Wilcoxauthor=T.+E.+A.+Petoauthor=A.+S.+Walker&title=Diverse+Sources+of+C.+difficile+Infection+Identified+on+Whole-Genome+Sequencing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Diverse sources of C. difficile infection identified on whole-genome sequencing</span></div><div class="casAuthors">Eyre, David W.; Cule, Madeleine L.; Wilson, Daniel J.; Griffiths, David; Vaughan, Alison; O'Connor, Lily; Ip, Camilla L. C.; Golubchik, Tanya; Batty, Elizabeth M.; Finney, John M.; Wyllie, David H.; Didelot, Xavier; Piazza, Paolo; Bowden, Rory; Dingle, Kate E.; Harding, Rosalind M.; Crook, Derrick W.; Wilcox, Mark H.; Peto, Tim E. A.; Walker, A. Sarah</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1195-1205</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">It has been thought that Clostridium difficile infection is transmitted predominantly within health care settings.  However, endemic spread has hampered identification of precise sources of infection and the assessment of the efficacy of interventions.  From Sept. 2007 through March 2011, we performed whole-genome sequencing on isolates obtained from all symptomatic patients with C. difficile infection identified in health care settings or in the community in Oxfordshire, United Kingdom.  We compared single-nucleotide variants (SNVs) between the isolates, using C. difficile evolution rates estd. on the basis of the first and last samples obtained from each of 145 patients, with 0 to 2 SNVs expected between transmitted isolates obtained less than 124 days apart, on the basis of a 95% prediction interval.  We then identified plausible epidemiol. links among genetically related cases from data on hospital admissions and community location.  Of 1250 C. difficile cases that were evaluated, 1223 (98%) were successfully sequenced.  In a comparison of 957 samples obtained from Apr. 2008 through March 2011 with those obtained from Sept. 2007 onward, a total of 333 isolates (35%) had no more than 2 SNVs from at least 1 earlier case, and 428 isolates (45%) had more than 10 SNVs from all previous cases.  Redns. in incidence over time were similar in the two groups, a finding that suggests an effect of interventions targeting the transition from exposure to disease.  Of the 333 patients with no more than 2 SNVs (consistent with transmission), 126 patients (38%) had close hospital contact with another patient, and 120 patients (36%) had no hospital or community contact with another patient.  Distinct subtypes of infection continued to be identified throughout the study, which suggests a considerable reservoir of C. difficile.  Over a 3-yr period, 45% of C. difficile cases in Oxfordshire were genetically distinct from all previous cases.  Genetically diverse sources, in addn. to symptomatic patients, play a major part in C. difficile transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPKI3Qgyeg5rVg90H21EOLACvtfcHk0lit6BWy3PbJXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFGktLjI&md5=1bdafc638cc35d289ca312258cb38087</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1216064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1216064%26sid%3Dliteratum%253Aachs%26aulast%3DEyre%26aufirst%3DD.%2BW.%26aulast%3DCule%26aufirst%3DM.%2BL.%26aulast%3DWilson%26aufirst%3DD.%2BJ.%26aulast%3DGriffiths%26aufirst%3DD.%26aulast%3DVaughan%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DL.%26aulast%3DIp%26aufirst%3DC.%2BL.%2BC.%26aulast%3DGolubchik%26aufirst%3DT.%26aulast%3DBatty%26aufirst%3DE.%2BM.%26aulast%3DFinney%26aufirst%3DJ.%2BM.%26aulast%3DWyllie%26aufirst%3DD.%2BH.%26aulast%3DDidelot%26aufirst%3DX.%26aulast%3DPiazza%26aufirst%3DP.%26aulast%3DBowden%26aufirst%3DR.%26aulast%3DDingle%26aufirst%3DK.%2BE.%26aulast%3DHarding%26aufirst%3DR.%2BM.%26aulast%3DCrook%26aufirst%3DD.%2BW.%26aulast%3DWilcox%26aufirst%3DM.%2BH.%26aulast%3DPeto%26aufirst%3DT.%2BE.%2BA.%26aulast%3DWalker%26aufirst%3DA.%2BS.%26atitle%3DDiverse%2520Sources%2520of%2520C.%2520difficile%2520Infection%2520Identified%2520on%2520Whole-Genome%2520Sequencing%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D369%26spage%3D1195%26epage%3D1205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span>A Trial To Compare Xifaxan to Vancomycin for the Treatment of <i>Clostridium difficile</i>-Associated Diarrhea (CDAD). Identifier NCT00269399. <a href="https://clinicaltrials.gov/ct2/show/NCT00269399?term=NCT00269399&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT00269399?term=NCT00269399&rank=1</a> (accessed Oct 21,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Trial+To+Compare+Xifaxan+to+Vancomycin+for+the+Treatment+of+Clostridium+difficile-Associated+Diarrhea+%28CDAD%29.+Identifier+NCT00269399.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00269399%3Fterm%3DNCT00269399%26rank%3D1+%28accessed+Oct+21%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span>Fecal Microbiota Transplant for Relapsing <i>Clostridium difficile</i> Infection in Adults and Children Using a Frozen Encapsulated Inoculum. Identifier NCT01914731. <a href="http://clinicaltrials.gov/ct2/show/NCT01914731?term=FMT&amp;phase=0&amp;rank=9" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01914731?term=FMT&phase=0&rank=9</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Fecal+Microbiota+Transplant+for+Relapsing+Clostridium+difficile+Infection+in+Adults+and+Children+Using+a+Frozen+Encapsulated+Inoculum.+Identifier+NCT01914731.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01914731%3Fterm%3DFMT%26phase%3D0%26rank%3D9."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group">Youngster, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pindar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alm, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohmann, E. L.</span><span> </span><span class="NLM_article-title">Fecal Microbiota Transplant for Relapsing <i>Clostridium difficile</i> Infection Using a Frozen Inoculum rrom Unrelated Donors: A Randomized, Open-Label, Controlled Pilot Study</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1515</span><span class="NLM_x">–</span> <span class="NLM_lpage">1522</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fcid%2Fciu135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=24762631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADC%252BC2cnmsVKhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=1515-1522&author=I.+Youngsterauthor=J.+Saukauthor=C.+Pindarauthor=R.+G.+Wilsonauthor=J.+L.+Kaplanauthor=M.+B.+Smithauthor=E.+J.+Almauthor=D.+Geversauthor=G.+H.+Russellauthor=E.+L.+Hohmann&title=Fecal+Microbiota+Transplant+for+Relapsing+Clostridium+difficile+Infection+Using+a+Frozen+Inoculum+rrom+Unrelated+Donors%3A+A+Randomized%2C+Open-Label%2C+Controlled+Pilot+Study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study</span></div><div class="casAuthors">Youngster Ilan; Sauk Jenny; Pindar Christina; Wilson Robin G; Kaplan Jess L; Smith Mark B; Alm Eric J; Gevers Dirk; Russell George H; Hohmann Elizabeth L</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1515-22</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Recurrent Clostridium difficile infection (CDI) with poor response to standard antimicrobial therapy is a growing medical concern.  We aimed to investigate the outcomes of fecal microbiota transplant (FMT) for relapsing CDI using a frozen suspension from unrelated donors, comparing colonoscopic and nasogastric tube (NGT) administration.  METHODS:  Healthy volunteer donors were screened and a frozen fecal suspension was generated.  Patients with relapsing/refractory CDI were randomized to receive an infusion of donor stools by colonoscopy or NGT.  The primary endpoint was clinical resolution of diarrhea without relapse after 8 weeks.  The secondary endpoint was self-reported health score using standardized questionnaires.  RESULTS:  A total of 20 patients were enrolled, 10 in each treatment arm.  Patients had a median of 4 (range, 2-16) relapses prior to study enrollment, with 5 (range, 3-15) antibiotic treatment failures.  Resolution of diarrhea was achieved in 14 patients (70%) after a single FMT (8 of 10 in the colonoscopy group and 6 of 10 in the NGT group).  Five patients were retreated, with 4 obtaining cure, resulting in an overall cure rate of 90%.  Daily number of bowel movements changed from a median of 7 (interquartile range [IQR], 5-10) the day prior to FMT to 2 (IQR, 1-2) after the infusion.  Self-ranked health score improved significantly, from a median of 4 (IQR, 2-6) before transplant to 8 (IQR, 5-9) after transplant.  No serious or unexpected adverse events occurred.  CONCLUSIONS:  In our initial feasibility study, FMT using a frozen inoculum from unrelated donors is effective in treating relapsing CDI.  NGT administration appears to be as effective as colonoscopic administration.  CLINICAL TRIALS REGISTRATION:  NCT01704937.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKcK4YrO1pgCO2kE7krGOBfW6udTcc2ebwvz599x5HB7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cnmsVKhsg%253D%253D&md5=6d9ff97a10b7ef08de09fe865bae70ba</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fciu135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fciu135%26sid%3Dliteratum%253Aachs%26aulast%3DYoungster%26aufirst%3DI.%26aulast%3DSauk%26aufirst%3DJ.%26aulast%3DPindar%26aufirst%3DC.%26aulast%3DWilson%26aufirst%3DR.%2BG.%26aulast%3DKaplan%26aufirst%3DJ.%2BL.%26aulast%3DSmith%26aufirst%3DM.%2BB.%26aulast%3DAlm%26aufirst%3DE.%2BJ.%26aulast%3DGevers%26aufirst%3DD.%26aulast%3DRussell%26aufirst%3DG.%2BH.%26aulast%3DHohmann%26aufirst%3DE.%2BL.%26atitle%3DFecal%2520Microbiota%2520Transplant%2520for%2520Relapsing%2520Clostridium%2520difficile%2520Infection%2520Using%2520a%2520Frozen%2520Inoculum%2520rrom%2520Unrelated%2520Donors%253A%2520A%2520Randomized%252C%2520Open-Label%252C%2520Controlled%2520Pilot%2520Study%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2014%26volume%3D58%26spage%3D1515%26epage%3D1522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span>Defined Fecal Microbiota Transplantation for <i>Clostridium difficile</i> Diarrhea. Identifier NCT01868373. <a href="https://clinicaltrials.gov/ct2/show/NCT01868373?term=FMT&amp;phase=0&amp;rank=10" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01868373?term=FMT&phase=0&rank=10</a> (accessed Oct 28,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Defined+Fecal+Microbiota+Transplantation+for+Clostridium+difficile+Diarrhea.+Identifier+NCT01868373.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01868373%3Fterm%3DFMT%26phase%3D0%26rank%3D10+%28accessed+Oct+28%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span>A Study To Investigate a <i>Clostridium difficile</i> Vaccine in Healthy Adults Aged 50 to 85 Years, Who Will Each Receive 3 Doses of Vaccine. Identifier NCT02117570. <a href="http://clinicaltrials.gov/ct2/show/NCT02117570?term=vaccine+difficile&amp;rank=4" class="extLink">http://clinicaltrials.gov/ct2/show/NCT02117570?term=vaccine+difficile&rank=4</a> (accessed Oct 23,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study+To+Investigate+a+Clostridium+difficile+Vaccine+in+Healthy+Adults+Aged+50+to+85+Years%2C+Who+Will+Each+Receive+3+Doses+of+Vaccine.+Identifier+NCT02117570.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02117570%3Fterm%3Dvaccine%2Bdifficile%26rank%3D4+%28accessed+Oct+23%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group">Lowy, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molrine, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leav, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichol, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, W. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrosino, D. M.</span><span> </span><span class="NLM_article-title">Treatment with Monoclonal Antibodies against <i>Clostridium difficile</i> Toxins</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1056%2FNEJMoa0907635" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=20089970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosFShtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=197-205&author=I.+Lowyauthor=D.+C.+Molrineauthor=B.+A.+Leavauthor=B.+M.+Blairauthor=R.+Baxterauthor=G.+Nicholauthor=W.+D.+Thomasauthor=M.+Leneyauthor=S.+Sloanauthor=C.+A.+Hayauthor=D.+M.+Ambrosino&title=Treatment+with+Monoclonal+Antibodies+against+Clostridium+difficile+Toxins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment with monoclonal antibodies against Clostridium difficile toxins</span></div><div class="casAuthors">Lowy, Israel; Molrine, Deborah C.; Leav, Brett A.; Blair, Barbra M.; Baxter, Roger; Gerding, Dale N.; Nichol, Geoffrey; Thomas, William D., Jr.; Leney, Mark; Sloan, Susan; Hay, Catherine A.; Ambrosino, Donna M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">197-205</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">New therapies are needed to manage the increasing incidence, severity, and high rate of recurrence of Clostridium difficile infection.  the authors performed a randomized, double-blind, placebo-controlled study of two neutralizing, fully human monoclonal antibodies against C. difficile toxins A (CDA1) and B (CDB1).  The antibodies were administered together as a single infusion, each at a dose of 10 mg per kg of body wt., in patients with symptomatic C. difficile infection who were receiving either metronidazole or vancomycin.  The primary outcome was lab.-documented recurrence of infection during the 84 days after the administration of monoclonal antibodies or placebo.  Among the 200 patients who were enrolled (101 in the antibody group and 99 in the placebo group), the rate of recurrence of C. difficile infection was lower among patients treated with monoclonal antibodies (7% vs. 25%; 95% confidence interval, 7 to 29).  The recurrence rates among patients with the epidemic BI/NAP1/027 strain were 8% for the antibody group and 32% for the placebo group; among patients with more than one previous episode of C. difficile infection, recurrence rates were 7% and 38%, resp.  The mean duration of the initial hospitalization for inpatients did not differ significantly between the antibody and placebo groups (9.5 and 9.4 days, resp.).  At least one serious adverse event was reported by 18 patients in the antibody group and by 28 patients in the placebo group.  The addn. of monoclonal antibodies against C. difficile toxins to antibiotic agents significantly reduced the recurrence of C. difficile infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu7vAobwaiBLVg90H21EOLACvtfcHk0lj1eSvVQPMknw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosFShtw%253D%253D&md5=f50a149c5afbca55e00f2497905bdf3f</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0907635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0907635%26sid%3Dliteratum%253Aachs%26aulast%3DLowy%26aufirst%3DI.%26aulast%3DMolrine%26aufirst%3DD.%2BC.%26aulast%3DLeav%26aufirst%3DB.%2BA.%26aulast%3DBlair%26aufirst%3DB.%2BM.%26aulast%3DBaxter%26aufirst%3DR.%26aulast%3DNichol%26aufirst%3DG.%26aulast%3DThomas%26aufirst%3DW.%2BD.%26aulast%3DLeney%26aufirst%3DM.%26aulast%3DSloan%26aufirst%3DS.%26aulast%3DHay%26aufirst%3DC.%2BA.%26aulast%3DAmbrosino%26aufirst%3DD.%2BM.%26atitle%3DTreatment%2520with%2520Monoclonal%2520Antibodies%2520against%2520Clostridium%2520difficile%2520Toxins%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26spage%3D197%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span>FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI. Identifier NCT02255305. <a href="https://clinicaltrials.gov/ct2/show/NCT02255305?term=FMT&amp;phase=1&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02255305?term=FMT&phase=1&rank=1</a> (accessed Oct 28,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=FMT+Versus+Antimicrobials+for+Initial+Treatment+of+Recurrent+CDI.+Identifier+NCT02255305.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02255305%3Fterm%3DFMT%26phase%3D1%26rank%3D1+%28accessed+Oct+28%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span>Stool Transplant in Pediatric Patients with Recurring <i>C. difficile</i> Infection. Identifier NCT01972334. <a href="http://clinicaltrials.gov/ct2/show/NCT01972334?term=FMT&amp;phase=1&amp;rank=5" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01972334?term=FMT&phase=1&rank=5</a> (accessed Jan 20,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Stool+Transplant+in+Pediatric+Patients+with+Recurring+C.+difficile+Infection.+Identifier+NCT01972334.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01972334%3Fterm%3DFMT%26phase%3D1%26rank%3D5+%28accessed+Jan+20%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span>Fecal Transplant for Relapsing <i>C. difficile</i> Infection. Identifier NCT01703494. <a href="http://clinicaltrials.gov/ct2/show/NCT01703494" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01703494</a> (accessed Oct 28,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Fecal+Transplant+for+Relapsing+C.+difficile+Infection.+Identifier+NCT01703494.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01703494+%28accessed+Oct+28%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span>Fecal Microbiota Transplantation by Colonoscopy for Recurrent <i>C. difficile</i> Infection. NCT02148601. <a href="https://clinicaltrials.gov/ct2/show/NCT02148601?term=FMT&amp;phase=1&amp;rank=15" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02148601?term=FMT&phase=1&rank=15</a> (accessed Oct 28,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Fecal+Microbiota+Transplantation+by+Colonoscopy+for+Recurrent+C.+difficile+Infection.+NCT02148601.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02148601%3Fterm%3DFMT%26phase%3D1%26rank%3D15+%28accessed+Oct+28%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span>FMT Delivered by Capsule Versus Colonoscopy for Recurrent <i>C. diff</i>. Identifier NCT02254811. <a href="http://clinicaltrials.gov/ct2/show/NCT02254811?term=FMT&amp;phase=2&amp;rank=1" class="extLink">http://clinicaltrials.gov/ct2/show/NCT02254811?term=FMT&phase=2&rank=1</a> (accessed Oct 23,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=FMT+Delivered+by+Capsule+Versus+Colonoscopy+for+Recurrent+C.+diff.+Identifier+NCT02254811.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02254811%3Fterm%3DFMT%26phase%3D2%26rank%3D1+%28accessed+Oct+23%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 50 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Xuwei Shao, Ahmed AbdelKhalek, Nader S. Abutaleb, Uday Kiran Velagapudi, Sabesan Yoganathan, Mohamed N. Seleem, <span class="NLM_string-name hlFld-ContribAuthor">Tanaji T. Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical Space Exploration around Thieno[3,2-d]pyrimidin-4(3H)-one Scaffold Led to a Novel Class of Highly Active Clostridium difficile Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9772-9791. <a href="https://doi.org/10.1021/acs.jmedchem.9b01198" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01198</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01198%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChemical%252BSpace%252BExploration%252Baround%252BThieno%25255B3%25252C2-d%25255Dpyrimidin-4%2525283H%252529-one%252BScaffold%252BLed%252Bto%252Ba%252BNovel%252BClass%252Bof%252BHighly%252BActive%252BClostridium%252Bdifficile%252BInhibitors%26aulast%3DShao%26aufirst%3DXuwei%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D24072019%26date%3D21102019%26date%3D04102019%26volume%3D62%26issue%3D21%26spage%3D9772%26epage%3D9791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ravi K.
R. Marreddy, Xiaoqian Wu, Madhab Sapkota, Allan M. Prior, Jesse A. Jones, Dianqing Sun, Kirk E. Hevener, <span class="NLM_string-name hlFld-ContribAuthor">Julian G. Hurdle</span>. </span><span class="cited-content_cbyCitation_article-title">The Fatty Acid Synthesis Protein Enoyl-ACP Reductase II (FabK) is a Target for Narrow-Spectrum Antibacterials for Clostridium difficile Infection. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2019,</strong> <em>5 </em>
                                    (2)
                                     , 208-217. <a href="https://doi.org/10.1021/acsinfecdis.8b00205" title="DOI URL">https://doi.org/10.1021/acsinfecdis.8b00205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.8b00205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.8b00205%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DThe%252BFatty%252BAcid%252BSynthesis%252BProtein%252BEnoyl-ACP%252BReductase%252BII%252B%252528FabK%252529%252Bis%252Ba%252BTarget%252Bfor%252BNarrow-Spectrum%252BAntibacterials%252Bfor%252BClostridium%252Bdifficile%252BInfection%26aulast%3DMarreddy%26aufirst%3DRavi%2BK.%2BR.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D10082018%26date%3D13122018%26date%3D01122018%26volume%3D5%26issue%3D2%26spage%3D208%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nathan P. Lavey, Tyler Shadid, Jimmy D. Ballard, <span class="NLM_string-name hlFld-ContribAuthor">Adam S. Duerfeldt</span>. </span><span class="cited-content_cbyCitation_article-title">Clostridium difficile ClpP Homologues are Capable of Uncoupled Activity and Exhibit Different Levels of Susceptibility to Acyldepsipeptide Modulation. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2019,</strong> <em>5 </em>
                                    (1)
                                     , 79-89. <a href="https://doi.org/10.1021/acsinfecdis.8b00199" title="DOI URL">https://doi.org/10.1021/acsinfecdis.8b00199</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.8b00199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.8b00199%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DClostridium%252Bdifficile%252BClpP%252BHomologues%252Bare%252BCapable%252Bof%252BUncoupled%252BActivity%252Band%252BExhibit%252BDifferent%252BLevels%252Bof%252BSusceptibility%252Bto%252BAcyldepsipeptide%252BModulation%26aulast%3DLavey%26aufirst%3DNathan%2BP.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D07082018%26date%3D26112018%26date%3D09112018%26volume%3D5%26issue%3D1%26spage%3D79%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katsuhiko  Mitachi</span>, <span class="hlFld-ContribAuthor ">Hyun Gi  Yun</span>, <span class="hlFld-ContribAuthor ">Sara M.  Kurosu</span>, <span class="hlFld-ContribAuthor ">Shakiba  Eslamimehr</span>, <span class="hlFld-ContribAuthor ">Maddie R.  Lemieux</span>, <span class="hlFld-ContribAuthor ">Lada  Klaić</span>, <span class="hlFld-ContribAuthor ">William M.  Clemons, Jr.</span>, and <span class="hlFld-ContribAuthor ">Michio  Kurosu</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel FR-900493 Analogues That Inhibit the Outgrowth of Clostridium difficile Spores. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2018,</strong> <em>3 </em>
                                    (2)
                                     , 1726-1739. <a href="https://doi.org/10.1021/acsomega.7b01740" title="DOI URL">https://doi.org/10.1021/acsomega.7b01740</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.7b01740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.7b01740%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DNovel%252BFR-900493%252BAnalogues%252BThat%252BInhibit%252Bthe%252BOutgrowth%252Bof%252BClostridium%252Bdifficile%252BSpores%26aulast%3DMitachi%26aufirst%3DKatsuhiko%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D07112017%26date%3D26012018%26date%3D28022018%26volume%3D3%26issue%3D2%26spage%3D1726%26epage%3D1739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chee Wei  Ang</span>, <span class="hlFld-ContribAuthor ">Angie M.  Jarrad</span>, <span class="hlFld-ContribAuthor ">Matthew A.  Cooper</span>, and <span class="hlFld-ContribAuthor ">Mark A. T.  Blaskovich</span>  . </span><span class="cited-content_cbyCitation_article-title">Nitroimidazoles: Molecular Fireworks That Combat a Broad Spectrum of Infectious Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (18)
                                     , 7636-7657. <a href="https://doi.org/10.1021/acs.jmedchem.7b00143" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00143</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00143%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNitroimidazoles%25253A%252BMolecular%252BFireworks%252BThat%252BCombat%252Ba%252BBroad%252BSpectrum%252Bof%252BInfectious%252BDiseases%26aulast%3DAng%26aufirst%3DChee%2BWei%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D26012017%26date%3D22052017%26date%3D28092017%26date%3D02052017%26volume%3D60%26issue%3D18%26spage%3D7636%26epage%3D7657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sonam  Mehrotra</span>, <span class="hlFld-ContribAuthor ">Sakthi  Raje</span>, <span class="hlFld-ContribAuthor ">Anant Kumar  Jain</span>, and <span class="hlFld-ContribAuthor ">Raja  Angamuthu</span>  . </span><span class="cited-content_cbyCitation_article-title">Benzimidazolines Convert Sulfur Dioxide to Bisulfate at Room Temperature and Atmospheric Pressure Utilizing Aerial Oxygen. </span><span class="cited-content_cbyCitation_journal-name">ACS Sustainable Chemistry & Engineering</span><span> <strong>2017,</strong> <em>5 </em>
                                    (7)
                                     , 6322-6328. <a href="https://doi.org/10.1021/acssuschemeng.7b01495" title="DOI URL">https://doi.org/10.1021/acssuschemeng.7b01495</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acssuschemeng.7b01495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facssuschemeng.7b01495%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sustainable%2520Chemistry%2520%2526%2520Engineering%26atitle%3DBenzimidazolines%252BConvert%252BSulfur%252BDioxide%252Bto%252BBisulfate%252Bat%252BRoom%252BTemperature%252Band%252BAtmospheric%252BPressure%252BUtilizing%252BAerial%252BOxygen%26aulast%3DMehrotra%26aufirst%3DSonam%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D12052017%26date%3D23052017%26date%3D12062017%26date%3D03072017%26date%3D02062017%26volume%3D5%26issue%3D7%26spage%3D6322%26epage%3D6328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kristen L.  Stoltz</span>, <span class="hlFld-ContribAuthor ">Raymond  Erickson</span>, <span class="hlFld-ContribAuthor ">Christopher  Staley</span>, <span class="hlFld-ContribAuthor ">Alexa R.  Weingarden</span>, <span class="hlFld-ContribAuthor ">Erin  Romens</span>, <span class="hlFld-ContribAuthor ">Clifford J.  Steer</span>, <span class="hlFld-ContribAuthor ">Alexander  Khoruts</span>, <span class="hlFld-ContribAuthor ">Michael J.  Sadowsky</span>, and <span class="hlFld-ContribAuthor ">Peter I.  Dosa</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Bile Acid Analogues Inhibitory to Clostridium difficile Spore Germination. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (8)
                                     , 3451-3471. <a href="https://doi.org/10.1021/acs.jmedchem.7b00295" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00295</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00295%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BBile%252BAcid%252BAnalogues%252BInhibitory%252Bto%252BClostridium%252Bdifficile%252BSpore%252BGermination%26aulast%3DStoltz%26aufirst%3DKristen%2BL.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D21022017%26date%3D12042017%26date%3D27042017%26volume%3D60%26issue%3D8%26spage%3D3451%26epage%3D3471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James  Flynn</span>, <span class="hlFld-ContribAuthor ">Aoibhín  Ryan</span>, <span class="hlFld-ContribAuthor ">Sarah P.  Hudson</span>. </span><span class="cited-content_cbyCitation_article-title">Pre-formulation and delivery strategies for the development of bacteriocins as next generation antibiotics. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutics and Biopharmaceutics</span><span> <strong>2021,</strong> <em>165 </em>, 149-163. <a href="https://doi.org/10.1016/j.ejpb.2021.05.015" title="DOI URL">https://doi.org/10.1016/j.ejpb.2021.05.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejpb.2021.05.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejpb.2021.05.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutics%2520and%2520Biopharmaceutics%26atitle%3DPre-formulation%252Band%252Bdelivery%252Bstrategies%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bbacteriocins%252Bas%252Bnext%252Bgeneration%252Bantibiotics%26aulast%3DFlynn%26aufirst%3DJames%26date%3D2021%26volume%3D165%26spage%3D149%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muni Kumar  Mahadari</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Tague</span>, <span class="hlFld-ContribAuthor ">Papanin  Putsathit</span>, <span class="hlFld-ContribAuthor ">Melanie L.  Hutton</span>, <span class="hlFld-ContribAuthor ">Katherine A.  Hammer</span>, <span class="hlFld-ContribAuthor ">Daniel R.  Knight</span>, <span class="hlFld-ContribAuthor ">Thomas V.  Riley</span>, <span class="hlFld-ContribAuthor ">Dena  Lyras</span>, <span class="hlFld-ContribAuthor ">Paul A.  Keller</span>, <span class="hlFld-ContribAuthor ">Stephen G.  Pyne</span>. </span><span class="cited-content_cbyCitation_article-title">Cationic Peptidomimetic Amphiphiles Having a N-Aryl- or N-Naphthyl-1,2,3-Triazole Core Structure Targeting Clostridioides (Clostridium) difficile: Synthesis, Antibacterial Evaluation, and an In Vivo C. difficile Infection Model. </span><span class="cited-content_cbyCitation_journal-name">Antibiotics</span><span> <strong>2021,</strong> <em>10 </em>
                                    (8)
                                     , 913. <a href="https://doi.org/10.3390/antibiotics10080913" title="DOI URL">https://doi.org/10.3390/antibiotics10080913</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antibiotics10080913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantibiotics10080913%26sid%3Dliteratum%253Aachs%26jtitle%3DAntibiotics%26atitle%3DCationic%252BPeptidomimetic%252BAmphiphiles%252BHaving%252Ba%252BN-Aryl-%252Bor%252BN-Naphthyl-1%25252C2%25252C3-Triazole%252BCore%252BStructure%252BTargeting%252BClostridioides%252B%252528Clostridium%252529%252Bdifficile%25253A%252BSynthesis%25252C%252BAntibacterial%252BEvaluation%25252C%252Band%252Ban%252BIn%252BVivo%252BC.%252Bdifficile%252BInfection%252BModel%26aulast%3DMahadari%26aufirst%3DMuni%2BKumar%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D8%26spage%3D913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael A.  Henson</span>, . </span><span class="cited-content_cbyCitation_article-title">Computational modeling of the gut microbiota reveals putative metabolic mechanisms of recurrent Clostridioides difficile infection. </span><span class="cited-content_cbyCitation_journal-name">PLOS Computational Biology</span><span> <strong>2021,</strong> <em>17 </em>
                                    (2)
                                     , e1008782. <a href="https://doi.org/10.1371/journal.pcbi.1008782" title="DOI URL">https://doi.org/10.1371/journal.pcbi.1008782</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pcbi.1008782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pcbi.1008782%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Computational%2520Biology%26atitle%3DComputational%252Bmodeling%252Bof%252Bthe%252Bgut%252Bmicrobiota%252Breveals%252Bputative%252Bmetabolic%252Bmechanisms%252Bof%252Brecurrent%252BClostridioides%252Bdifficile%252Binfection%26aulast%3DHenson%26aufirst%3DMichael%2BA.%26date%3D2021%26date%3D2021%26volume%3D17%26issue%3D2%26spage%3De1008782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John  Bremner</span>. </span><span class="cited-content_cbyCitation_article-title">Antibacterials. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-20. <a href="https://doi.org/10.1007/978-981-16-0999-2_1" title="DOI URL">https://doi.org/10.1007/978-981-16-0999-2_1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-16-0999-2_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-16-0999-2_1%26sid%3Dliteratum%253Aachs%26atitle%3DAntibacterials%26aulast%3DBremner%26aufirst%3DJohn%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D20%26pub%3DSpringer%2520Singapore%26atitle%3DMultiple%252BAction-Based%252BDesign%252BApproaches%252Bto%252BAntibacterials%26aulast%3DBremner%26aufirst%3DJohn%26date%3D2021%26volume%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdelkader  Chaar</span>, <span class="hlFld-ContribAuthor ">Paul  Feuerstadt</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of clinical guidelines for antimicrobial management of
              Clostridioides difficile
              infection. </span><span class="cited-content_cbyCitation_journal-name">Therapeutic Advances in Gastroenterology</span><span> <strong>2021,</strong> <em>14 </em>, 175628482110119. <a href="https://doi.org/10.1177/17562848211011953" title="DOI URL">https://doi.org/10.1177/17562848211011953</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/17562848211011953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F17562848211011953%26sid%3Dliteratum%253Aachs%26jtitle%3DTherapeutic%2520Advances%2520in%2520Gastroenterology%26atitle%3DEvolution%252Bof%252Bclinical%252Bguidelines%252Bfor%252Bantimicrobial%252Bmanagement%252Bof%252BClostridioides%252Bdifficile%252Binfection%26aulast%3DChaar%26aufirst%3DAbdelkader%26date%3D2021%26date%3D2021%26volume%3D14%26spage%3D175628482110119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kanika  Verma</span>, <span class="hlFld-ContribAuthor ">Panupong  Mahalapbutr</span>, <span class="hlFld-ContribAuthor ">Utid  Suriya</span>, <span class="hlFld-ContribAuthor ">Tuanjai  Somboon</span>, <span class="hlFld-ContribAuthor ">Thitinan  Aiebchun</span>, <span class="hlFld-ContribAuthor ">Liyi  Shi</span>, <span class="hlFld-ContribAuthor ">Phornphimon  Maitarad</span>, <span class="hlFld-ContribAuthor ">Thanyada  Rungrotmongkol</span>. </span><span class="cited-content_cbyCitation_article-title">In Silico Screening of DNA Gyrase B Potent Flavonoids for the Treatment of Clostridium difficile Infection from PhytoHub Database. </span><span class="cited-content_cbyCitation_journal-name">Brazilian Archives of Biology and Technology</span><span> <strong>2021,</strong> <em>64 </em><a href="https://doi.org/10.1590/1678-4324-2021200402" title="DOI URL">https://doi.org/10.1590/1678-4324-2021200402</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1590/1678-4324-2021200402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1590%2F1678-4324-2021200402%26sid%3Dliteratum%253Aachs%26jtitle%3DBrazilian%2520Archives%2520of%2520Biology%2520and%2520Technology%26atitle%3DIn%252BSilico%252BScreening%252Bof%252BDNA%252BGyrase%252BB%252BPotent%252BFlavonoids%252Bfor%252Bthe%252BTreatment%252Bof%252BClostridium%252Bdifficile%252BInfection%252Bfrom%252BPhytoHub%252BDatabase%26aulast%3DVerma%26aufirst%3DKanika%26date%3D2021%26date%3D2021%26volume%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandra T.  Zizzari</span>, <span class="hlFld-ContribAuthor ">Dimanthi  Pliatsika</span>, <span class="hlFld-ContribAuthor ">Flavio M.  Gall</span>, <span class="hlFld-ContribAuthor ">Thomas  Fischer</span>, <span class="hlFld-ContribAuthor ">Rainer  Riedl</span>. </span><span class="cited-content_cbyCitation_article-title">New perspectives in oral peptide delivery. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2021,</strong> <em>3 </em><a href="https://doi.org/10.1016/j.drudis.2021.01.020" title="DOI URL">https://doi.org/10.1016/j.drudis.2021.01.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2021.01.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2021.01.020%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DNew%252Bperspectives%252Bin%252Boral%252Bpeptide%252Bdelivery%26aulast%3DZizzari%26aufirst%3DAlessandra%2BT.%26date%3D2021%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Romero-Rodríguez</span>, <span class="hlFld-ContribAuthor ">S.  Troncoso-Cotal</span>, <span class="hlFld-ContribAuthor ">E.  Guerrero-Araya</span>, <span class="hlFld-ContribAuthor ">D.  Paredes-Sabja</span>, . </span><span class="cited-content_cbyCitation_article-title">The Clostridioides difficile Cysteine-Rich Exosporium Morphogenetic Protein, CdeC, Exhibits Self-Assembly Properties That Lead to Organized Inclusion Bodies in Escherichia coli. </span><span class="cited-content_cbyCitation_journal-name">mSphere</span><span> <strong>2020,</strong> <em>5 </em>
                                    (6)
                                     <a href="https://doi.org/10.1128/mSphere.01065-20" title="DOI URL">https://doi.org/10.1128/mSphere.01065-20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/mSphere.01065-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FmSphere.01065-20%26sid%3Dliteratum%253Aachs%26jtitle%3DmSphere%26atitle%3DThe%252BClostridioides%252Bdifficile%252BCysteine-Rich%252BExosporium%252BMorphogenetic%252BProtein%25252C%252BCdeC%25252C%252BExhibits%252BSelf-Assembly%252BProperties%252BThat%252BLead%252Bto%252BOrganized%252BInclusion%252BBodies%252Bin%252BEscherichia%252Bcoli%26aulast%3DRomero-Rodr%25C3%25ADguez%26aufirst%3DA.%26date%3D2020%26volume%3D5%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chandradhish  Ghosh</span>, <span class="hlFld-ContribAuthor ">Ahmed  AbdelKhalek</span>, <span class="hlFld-ContribAuthor ">Haroon  Mohammad</span>, <span class="hlFld-ContribAuthor ">Mohamed N.  Seleem</span>, <span class="hlFld-ContribAuthor ">Jayanta  Haldar</span>. </span><span class="cited-content_cbyCitation_article-title">Aryl-alkyl-lysines: Novel agents for treatment of C. difficile infection. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-62496-9" title="DOI URL">https://doi.org/10.1038/s41598-020-62496-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-62496-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-62496-9%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DAryl-alkyl-lysines%25253A%252BNovel%252Bagents%252Bfor%252Btreatment%252Bof%252BC.%252Bdifficile%252Binfection%26aulast%3DGhosh%26aufirst%3DChandradhish%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed  AbdelKhalek</span>, <span class="hlFld-ContribAuthor ">Haroon  Mohammad</span>, <span class="hlFld-ContribAuthor ">Abdelrahman S.  Mayhoub</span>, <span class="hlFld-ContribAuthor ">Mohamed N.  Seleem</span>. </span><span class="cited-content_cbyCitation_article-title">Screening for potent and selective anticlostridial leads among FDA-approved drugs. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Antibiotics</span><span> <strong>2020,</strong> <em>73 </em>
                                    (6)
                                     , 392-409. <a href="https://doi.org/10.1038/s41429-020-0288-3" title="DOI URL">https://doi.org/10.1038/s41429-020-0288-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41429-020-0288-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41429-020-0288-3%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Antibiotics%26atitle%3DScreening%252Bfor%252Bpotent%252Band%252Bselective%252Banticlostridial%252Bleads%252Bamong%252BFDA-approved%252Bdrugs%26aulast%3DAbdelKhalek%26aufirst%3DAhmed%26date%3D2020%26date%3D2020%26volume%3D73%26issue%3D6%26spage%3D392%26epage%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dmitrii Y.  Travin</span>, <span class="hlFld-ContribAuthor ">Dmitry  Bikmetov</span>, <span class="hlFld-ContribAuthor ">Konstantin  Severinov</span>. </span><span class="cited-content_cbyCitation_article-title">Translation-Targeting RiPPs and Where to Find Them. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Genetics</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fgene.2020.00226" title="DOI URL">https://doi.org/10.3389/fgene.2020.00226</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fgene.2020.00226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffgene.2020.00226%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Genetics%26atitle%3DTranslation-Targeting%252BRiPPs%252Band%252BWhere%252Bto%252BFind%252BThem%26aulast%3DTravin%26aufirst%3DDmitrii%2BY.%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew I  Hutchings</span>, <span class="hlFld-ContribAuthor ">Andrew W  Truman</span>, <span class="hlFld-ContribAuthor ">Barrie  Wilkinson</span>. </span><span class="cited-content_cbyCitation_article-title">Antibiotics: past, present and future. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Microbiology</span><span> <strong>2019,</strong> <em>51 </em>, 72-80. <a href="https://doi.org/10.1016/j.mib.2019.10.008" title="DOI URL">https://doi.org/10.1016/j.mib.2019.10.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mib.2019.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mib.2019.10.008%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Microbiology%26atitle%3DAntibiotics%25253A%252Bpast%25252C%252Bpresent%252Band%252Bfuture%26aulast%3DHutchings%26aufirst%3DMatthew%2BI%26date%3D2019%26volume%3D51%26spage%3D72%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew J.  Tague</span>, <span class="hlFld-ContribAuthor ">Papanin  Putsathit</span>, <span class="hlFld-ContribAuthor ">Melanie L.  Hutton</span>, <span class="hlFld-ContribAuthor ">Katherine A.  Hammer</span>, <span class="hlFld-ContribAuthor ">Steven M.  Wales</span>, <span class="hlFld-ContribAuthor ">Daniel R.  Knight</span>, <span class="hlFld-ContribAuthor ">Thomas V.  Riley</span>, <span class="hlFld-ContribAuthor ">Dena  Lyras</span>, <span class="hlFld-ContribAuthor ">Paul A.  Keller</span>, <span class="hlFld-ContribAuthor ">Stephen G.  Pyne</span>. </span><span class="cited-content_cbyCitation_article-title">Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles targeting Clostridioides (Clostridium) difficile: Synthesis, antibacterial evaluation and an in vivo C. difficile infection model. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>170 </em>, 203-224. <a href="https://doi.org/10.1016/j.ejmech.2019.02.068" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.02.068</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.02.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.02.068%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCationic%252Bbiaryl%252B1%25252C2%25252C3-triazolyl%252Bpeptidomimetic%252Bamphiphiles%252Btargeting%252BClostridioides%252B%252528Clostridium%252529%252Bdifficile%25253A%252BSynthesis%25252C%252Bantibacterial%252Bevaluation%252Band%252Ban%252Bin%2525C2%2525A0vivo%252BC.%252Bdifficile%252Binfection%252Bmodel%26aulast%3DTague%26aufirst%3DAndrew%2BJ.%26date%3D2019%26volume%3D170%26spage%3D203%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Poonam  Phalak</span>, <span class="hlFld-ContribAuthor ">Michael  Henson</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolic Modeling of Clostridium difficile Associated Dysbiosis of the Gut Microbiota. </span><span class="cited-content_cbyCitation_journal-name">Processes</span><span> <strong>2019,</strong> <em>7 </em>
                                    (2)
                                     , 97. <a href="https://doi.org/10.3390/pr7020097" title="DOI URL">https://doi.org/10.3390/pr7020097</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pr7020097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpr7020097%26sid%3Dliteratum%253Aachs%26jtitle%3DProcesses%26atitle%3DMetabolic%252BModeling%252Bof%252BClostridium%252Bdifficile%252BAssociated%252BDysbiosis%252Bof%252Bthe%252BGut%252BMicrobiota%26aulast%3DPhalak%26aufirst%3DPoonam%26date%3D2019%26date%3D2019%26volume%3D7%26issue%3D2%26spage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeffrey J.  Letourneau</span>, <span class="hlFld-ContribAuthor ">Ilana L.  Stroke</span>, <span class="hlFld-ContribAuthor ">David W.  Hilbert</span>, <span class="hlFld-ContribAuthor ">Andrew G.  Cole</span>, <span class="hlFld-ContribAuthor ">Laurie J.  Sturzenbecker</span>, <span class="hlFld-ContribAuthor ">Brett A.  Marinelli</span>, <span class="hlFld-ContribAuthor ">Jorge G.  Quintero</span>, <span class="hlFld-ContribAuthor ">Joan  Sabalski</span>, <span class="hlFld-ContribAuthor ">Yanfang  Li</span>, <span class="hlFld-ContribAuthor ">Linh  Ma</span>, <span class="hlFld-ContribAuthor ">Igor  Pechik</span>, <span class="hlFld-ContribAuthor ">Philip D.  Stein</span>, <span class="hlFld-ContribAuthor ">Maria L.  Webb</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and SAR studies of novel benzodiazepinedione-based inhibitors of Clostridium difficile (C. difficile) toxin B (TcdB). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (23-24)
                                     , 3601-3605. <a href="https://doi.org/10.1016/j.bmcl.2018.10.047" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.10.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.10.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.10.047%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BSAR%252Bstudies%252Bof%252Bnovel%252Bbenzodiazepinedione-based%252Binhibitors%252Bof%252BClostridium%252Bdifficile%252B%252528C.%252Bdifficile%252529%252Btoxin%252BB%252B%252528TcdB%252529%26aulast%3DLetourneau%26aufirst%3DJeffrey%2BJ.%26date%3D2018%26volume%3D28%26issue%3D23-24%26spage%3D3601%26epage%3D3605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nigel George  Ternan</span>, <span class="hlFld-ContribAuthor ">Nicola Diana  Moore</span>, <span class="hlFld-ContribAuthor ">Deborah  Smyth</span>, <span class="hlFld-ContribAuthor ">Gordon James  McDougall</span>, <span class="hlFld-ContribAuthor ">James William  Allwood</span>, <span class="hlFld-ContribAuthor ">Susan  Verrall</span>, <span class="hlFld-ContribAuthor ">Christopher Ian Richard  Gill</span>, <span class="hlFld-ContribAuthor ">James Stephen Gerard  Dooley</span>, <span class="hlFld-ContribAuthor ">Geoff  McMullan</span>. </span><span class="cited-content_cbyCitation_article-title">Increased sporulation underpins adaptation of Clostridium difficile strain 630 to a biologically–relevant faecal environment, with implications for pathogenicity. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2018,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-018-35050-x" title="DOI URL">https://doi.org/10.1038/s41598-018-35050-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-018-35050-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-018-35050-x%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DIncreased%252Bsporulation%252Bunderpins%252Badaptation%252Bof%252BClostridium%252Bdifficile%252Bstrain%252B630%252Bto%252Ba%252Bbiologically%2525E2%252580%252593relevant%252Bfaecal%252Benvironment%25252C%252Bwith%252Bimplications%252Bfor%252Bpathogenicity%26aulast%3DTernan%26aufirst%3DNigel%2BGeorge%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cindy  Wolfe</span>, <span class="hlFld-ContribAuthor ">Paul  Pagano</span>, <span class="hlFld-ContribAuthor ">Chris M.  Pillar</span>, <span class="hlFld-ContribAuthor ">Dean L.  Shinabarger</span>, <span class="hlFld-ContribAuthor ">Ramiz A.  Boulos</span>. </span><span class="cited-content_cbyCitation_article-title">Comparison of the in vitro antibacterial activity of Ramizol, fidaxomicin, vancomycin, and metronidazole against 100 clinical isolates of Clostridium difficile by broth microdilution. </span><span class="cited-content_cbyCitation_journal-name">Diagnostic Microbiology and Infectious Disease</span><span> <strong>2018,</strong> <em>92 </em>
                                    (3)
                                     , 250-252. <a href="https://doi.org/10.1016/j.diagmicrobio.2018.06.002" title="DOI URL">https://doi.org/10.1016/j.diagmicrobio.2018.06.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.diagmicrobio.2018.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.diagmicrobio.2018.06.002%26sid%3Dliteratum%253Aachs%26jtitle%3DDiagnostic%2520Microbiology%2520and%2520Infectious%2520Disease%26atitle%3DComparison%252Bof%252Bthe%252Bin%252Bvitro%252Bantibacterial%252Bactivity%252Bof%252BRamizol%25252C%252Bfidaxomicin%25252C%252Bvancomycin%25252C%252Band%252Bmetronidazole%252Bagainst%252B100%252Bclinical%252Bisolates%252Bof%252BClostridium%252Bdifficile%252Bby%252Bbroth%252Bmicrodilution%26aulast%3DWolfe%26aufirst%3DCindy%26date%3D2018%26volume%3D92%26issue%3D3%26spage%3D250%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeffrey J.  Letourneau</span>, <span class="hlFld-ContribAuthor ">Ilana L.  Stroke</span>, <span class="hlFld-ContribAuthor ">David W.  Hilbert</span>, <span class="hlFld-ContribAuthor ">Laurie J.  Sturzenbecker</span>, <span class="hlFld-ContribAuthor ">Brett A.  Marinelli</span>, <span class="hlFld-ContribAuthor ">Jorge G.  Quintero</span>, <span class="hlFld-ContribAuthor ">Joan  Sabalski</span>, <span class="hlFld-ContribAuthor ">Linh  Ma</span>, <span class="hlFld-ContribAuthor ">David J.  Diller</span>, <span class="hlFld-ContribAuthor ">Philip D.  Stein</span>, <span class="hlFld-ContribAuthor ">Maria L.  Webb</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and initial optimization of inhibitors of Clostridium difficile (C. difficile) toxin B (TcdB). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (4)
                                     , 756-761. <a href="https://doi.org/10.1016/j.bmcl.2018.01.005" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.01.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.01.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Band%252Binitial%252Boptimization%252Bof%252Binhibitors%252Bof%252BClostridium%252Bdifficile%252B%252528C.%252Bdifficile%252529%252Btoxin%252BB%252B%252528TcdB%252529%26aulast%3DLetourneau%26aufirst%3DJeffrey%2BJ.%26date%3D2018%26volume%3D28%26issue%3D4%26spage%3D756%26epage%3D761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui  Wang</span>, <span class="hlFld-ContribAuthor ">Lin  Suo</span>, <span class="hlFld-ContribAuthor ">Hui Xia  Chen</span>, <span class="hlFld-ContribAuthor ">Lin Jian  Song</span>, <span class="hlFld-ContribAuthor ">Yue Yun  Shen</span>, <span class="hlFld-ContribAuthor ">Yan Ping  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from the Chinese People’s Liberation Army General Hospital in China. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Infectious Diseases</span><span> <strong>2018,</strong> <em>67 </em>, 86-91. <a href="https://doi.org/10.1016/j.ijid.2017.07.010" title="DOI URL">https://doi.org/10.1016/j.ijid.2017.07.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijid.2017.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijid.2017.07.010%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Infectious%2520Diseases%26atitle%3DMolecular%252Bepidemiology%252Band%252Bantimicrobial%252Bsusceptibility%252Bof%252BClostridium%252Bdifficile%252Bisolated%252Bfrom%252Bthe%252BChinese%252BPeople%2525E2%252580%252599s%252BLiberation%252BArmy%252BGeneral%252BHospital%252Bin%252BChina%26aulast%3DWang%26aufirst%3DRui%26date%3D2018%26volume%3D67%26spage%3D86%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patrizia  Spigaglia</span>, <span class="hlFld-ContribAuthor ">Paola  Mastrantonio</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Barbanti</span>. </span><span class="cited-content_cbyCitation_article-title">Antibiotic Resistances of Clostridium difficile. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 137-159. <a href="https://doi.org/10.1007/978-3-319-72799-8_9" title="DOI URL">https://doi.org/10.1007/978-3-319-72799-8_9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-72799-8_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-72799-8_9%26sid%3Dliteratum%253Aachs%26atitle%3DAntibiotic%252BResistances%252Bof%252BClostridium%252Bdifficile%26aulast%3DSpigaglia%26aufirst%3DPatrizia%26date%3D2018%26date%3D2018%26spage%3D137%26epage%3D159%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DUpdates%252Bon%252BClostridium%252Bdifficile%252Bin%252BEurope%26aulast%3DMastrantonio%26aufirst%3DPaola%26date%3D2018%26volume%3D1050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saeed S.  Banawas</span>. </span><span class="cited-content_cbyCitation_article-title">Clostridium difficile
              Infections: A Global Overview of Drug Sensitivity and Resistance Mechanisms. </span><span class="cited-content_cbyCitation_journal-name">BioMed Research International</span><span> <strong>2018,</strong> <em>2018 </em>, 1-9. <a href="https://doi.org/10.1155/2018/8414257" title="DOI URL">https://doi.org/10.1155/2018/8414257</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2018/8414257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2018%2F8414257%26sid%3Dliteratum%253Aachs%26jtitle%3DBioMed%2520Research%2520International%26atitle%3DClostridium%252Bdifficile%252BInfections%25253A%252BA%252BGlobal%252BOverview%252Bof%252BDrug%252BSensitivity%252Band%252BResistance%252BMechanisms%26aulast%3DBanawas%26aufirst%3DSaeed%2BS.%26date%3D2018%26volume%3D2018%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sergio  Álvarez-Pérez</span>, <span class="hlFld-ContribAuthor ">José L.  Blanco</span>, <span class="hlFld-ContribAuthor ">Celine  Harmanus</span>, <span class="hlFld-ContribAuthor ">Ed  Kuijper</span>, <span class="hlFld-ContribAuthor ">Marta E.  García</span>. </span><span class="cited-content_cbyCitation_article-title">Subtyping and antimicrobial susceptibility of Clostridium difficile PCR ribotype 078/126 isolates of human and animal origin. </span><span class="cited-content_cbyCitation_journal-name">Veterinary Microbiology</span><span> <strong>2017,</strong> <em>199 </em>, 15-22. <a href="https://doi.org/10.1016/j.vetmic.2016.12.001" title="DOI URL">https://doi.org/10.1016/j.vetmic.2016.12.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.vetmic.2016.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.vetmic.2016.12.001%26sid%3Dliteratum%253Aachs%26jtitle%3DVeterinary%2520Microbiology%26atitle%3DSubtyping%252Band%252Bantimicrobial%252Bsusceptibility%252Bof%252BClostridium%252Bdifficile%252BPCR%252Bribotype%252B078%25252F126%252Bisolates%252Bof%252Bhuman%252Band%252Banimal%252Borigin%26aulast%3D%25C3%2581lvarez-P%25C3%25A9rez%26aufirst%3DSergio%26date%3D2017%26volume%3D199%26spage%3D15%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy A.  Wencewicz</span>, <span class="hlFld-ContribAuthor ">Marvin J.  Miller</span>. </span><span class="cited-content_cbyCitation_article-title">Sideromycins as Pathogen-Targeted Antibiotics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 151-183. <a href="https://doi.org/10.1007/7355_2017_19" title="DOI URL">https://doi.org/10.1007/7355_2017_19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2017_19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2017_19%26sid%3Dliteratum%253Aachs%26atitle%3DSideromycins%252Bas%252BPathogen-Targeted%252BAntibiotics%26aulast%3DWencewicz%26aufirst%3DTimothy%2BA.%26date%3D2017%26date%3D2017%26spage%3D151%26epage%3D183%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DAntibacterials%26aulast%3DFisher%26aufirst%3DJed%2BF.%26date%3D2018%26volume%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.J.  Pucci</span>, <span class="hlFld-ContribAuthor ">C.  Callebaut</span>, <span class="hlFld-ContribAuthor ">A.  Cathcart</span>, <span class="hlFld-ContribAuthor ">K.  Bush</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Epidemiological Changes in Infectious Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 511-552. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12405-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12405-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12405-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12405-9%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252BEpidemiological%252BChanges%252Bin%252BInfectious%252BDiseases%26aulast%3DPucci%26aufirst%3DM.J.%26date%3D2017%26spage%3D511%26epage%3D552%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingfei  Zheng</span>, <span class="hlFld-ContribAuthor ">Hui  Fang</span>, <span class="hlFld-ContribAuthor ">Wen  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Post-translational modifications involved in the biosynthesis of thiopeptide antibiotics. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2017,</strong> <em>15 </em>
                                    (16)
                                     , 3376-3390. <a href="https://doi.org/10.1039/C7OB00466D" title="DOI URL">https://doi.org/10.1039/C7OB00466D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB00466D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB00466D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DPost-translational%252Bmodifications%252Binvolved%252Bin%252Bthe%252Bbiosynthesis%252Bof%252Bthiopeptide%252Bantibiotics%26aulast%3DZheng%26aufirst%3DQingfei%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D16%26spage%3D3376%26epage%3D3390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed G.  Eissa</span>, <span class="hlFld-ContribAuthor ">James A.  Blaxland</span>, <span class="hlFld-ContribAuthor ">Rhodri O.  Williams</span>, <span class="hlFld-ContribAuthor ">Kamel A.  Metwally</span>, <span class="hlFld-ContribAuthor ">Sobhy M.  El-Adl</span>, <span class="hlFld-ContribAuthor ">El-Sayed M.  Lashine</span>, <span class="hlFld-ContribAuthor ">Leslie W.J.  Baillie</span>, <span class="hlFld-ContribAuthor ">Claire  Simons</span>. </span><span class="cited-content_cbyCitation_article-title">Adenine and benzimidazole-based mimics of REP-3123 as antibacterial agents against Clostridium difficile and Bacillus anthracis: Design, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of Faculty of Pharmacy, Cairo University</span><span> <strong>2016,</strong> <em>54 </em>
                                    (2)
                                     , 197-207. <a href="https://doi.org/10.1016/j.bfopcu.2016.06.002" title="DOI URL">https://doi.org/10.1016/j.bfopcu.2016.06.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bfopcu.2016.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bfopcu.2016.06.002%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520Faculty%2520of%2520Pharmacy%252C%2520Cairo%2520University%26atitle%3DAdenine%252Band%252Bbenzimidazole-based%252Bmimics%252Bof%252BREP-3123%252Bas%252Bantibacterial%252Bagents%252Bagainst%252BClostridium%252Bdifficile%252Band%252BBacillus%252Banthracis%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DEissa%26aufirst%3DAhmed%2BG.%26date%3D2016%26volume%3D54%26issue%3D2%26spage%3D197%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Major  Gooyit</span>, <span class="hlFld-ContribAuthor ">Kim D.  Janda</span>. </span><span class="cited-content_cbyCitation_article-title">Reprofiled anthelmintics abate hypervirulent stationary-phase Clostridium difficile. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep33642" title="DOI URL">https://doi.org/10.1038/srep33642</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep33642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep33642%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DReprofiled%252Banthelmintics%252Babate%252Bhypervirulent%252Bstationary-phase%252BClostridium%252Bdifficile%26aulast%3DGooyit%26aufirst%3DMajor%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.M.  Jarrad</span>, <span class="hlFld-ContribAuthor ">A.  Debnath</span>, <span class="hlFld-ContribAuthor ">Y.  Miyamoto</span>, <span class="hlFld-ContribAuthor ">K.A.  Hansford</span>, <span class="hlFld-ContribAuthor ">R.  Pelingon</span>, <span class="hlFld-ContribAuthor ">M.S.  Butler</span>, <span class="hlFld-ContribAuthor ">T.  Bains</span>, <span class="hlFld-ContribAuthor ">T.  Karoli</span>, <span class="hlFld-ContribAuthor ">M.A.T.  Blaskovich</span>, <span class="hlFld-ContribAuthor ">L.  Eckmann</span>, <span class="hlFld-ContribAuthor ">M.A.  Cooper</span>. </span><span class="cited-content_cbyCitation_article-title">Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>120 </em>, 353-362. <a href="https://doi.org/10.1016/j.ejmech.2016.04.064" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.04.064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.04.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.04.064%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNitroimidazole%252Bcarboxamides%252Bas%252Bantiparasitic%252Bagents%252Btargeting%252BGiardia%252Blamblia%25252C%252BEntamoeba%252Bhistolytica%252Band%252BTrichomonas%252Bvaginalis%26aulast%3DJarrad%26aufirst%3DA.M.%26date%3D2016%26volume%3D120%26spage%3D353%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eamonn  Culligan</span>, <span class="hlFld-ContribAuthor ">Roy  Sleator</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the Microbiome: Applications to Clostridium difficile Infection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Medicine</span><span> <strong>2016,</strong> <em>5 </em>
                                    (9)
                                     , 83. <a href="https://doi.org/10.3390/jcm5090083" title="DOI URL">https://doi.org/10.3390/jcm5090083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/jcm5090083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fjcm5090083%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Medicine%26atitle%3DAdvances%252Bin%252Bthe%252BMicrobiome%25253A%252BApplications%252Bto%252BClostridium%252Bdifficile%252BInfection%26aulast%3DCulligan%26aufirst%3DEamonn%26date%3D2016%26date%3D2016%26volume%3D5%26issue%3D9%26spage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alastair L.  Parkes</span>, <span class="hlFld-ContribAuthor ">Ian A.  Yule</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrid antibiotics – clinical progress and novel designs. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2016,</strong> <em>11 </em>
                                    (7)
                                     , 665-680. <a href="https://doi.org/10.1080/17460441.2016.1187597" title="DOI URL">https://doi.org/10.1080/17460441.2016.1187597</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2016.1187597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2016.1187597%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DHybrid%252Bantibiotics%252B%2525E2%252580%252593%252Bclinical%252Bprogress%252Band%252Bnovel%252Bdesigns%26aulast%3DParkes%26aufirst%3DAlastair%2BL.%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D7%26spage%3D665%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena  Moroz</span>, <span class="hlFld-ContribAuthor ">Simon  Matoori</span>, <span class="hlFld-ContribAuthor ">Jean-Christophe  Leroux</span>. </span><span class="cited-content_cbyCitation_article-title">Oral delivery of macromolecular drugs: Where we are after almost 100 years of attempts. </span><span class="cited-content_cbyCitation_journal-name">Advanced Drug Delivery Reviews</span><span> <strong>2016,</strong> <em>101 </em>, 108-121. <a href="https://doi.org/10.1016/j.addr.2016.01.010" title="DOI URL">https://doi.org/10.1016/j.addr.2016.01.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.addr.2016.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.addr.2016.01.010%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Drug%2520Delivery%2520Reviews%26atitle%3DOral%252Bdelivery%252Bof%252Bmacromolecular%252Bdrugs%25253A%252BWhere%252Bwe%252Bare%252Bafter%252Balmost%252B100%252Byears%252Bof%252Battempts%26aulast%3DMoroz%26aufirst%3DElena%26date%3D2016%26volume%3D101%26spage%3D108%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lynne V.  McFarland</span>. </span><span class="cited-content_cbyCitation_article-title">Therapies on the horizon for
              Clostridium difficile
              infections. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2016,</strong> <em>25 </em>
                                    (5)
                                     , 541-555. <a href="https://doi.org/10.1517/13543784.2016.1161025" title="DOI URL">https://doi.org/10.1517/13543784.2016.1161025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2016.1161025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2016.1161025%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DTherapies%252Bon%252Bthe%252Bhorizon%252Bfor%252BClostridium%252Bdifficile%252Binfections%26aulast%3DMcFarland%26aufirst%3DLynne%2BV.%26date%3D2016%26date%3D2016%26volume%3D25%26issue%3D5%26spage%3D541%26epage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victoria  Knight-Connoni</span>, <span class="hlFld-ContribAuthor ">Carmela  Mascio</span>, <span class="hlFld-ContribAuthor ">Laurent  Chesnel</span>, <span class="hlFld-ContribAuthor ">Jared  Silverman</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and development of surotomycin for the treatment of
              Clostridium difficile. </span><span class="cited-content_cbyCitation_journal-name">Journal of Industrial Microbiology and Biotechnology</span><span> <strong>2016,</strong> <em>43 </em>
                                    (2-3)
                                     , 195-204. <a href="https://doi.org/10.1007/s10295-015-1714-6" title="DOI URL">https://doi.org/10.1007/s10295-015-1714-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10295-015-1714-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10295-015-1714-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Industrial%2520Microbiology%2520and%2520Biotechnology%26atitle%3DDiscovery%252Band%252Bdevelopment%252Bof%252Bsurotomycin%252Bfor%252Bthe%252Btreatment%252Bof%252BClostridium%252Bdifficile%26aulast%3DKnight-Connoni%26aufirst%3DVictoria%26date%3D2016%26date%3D2016%26volume%3D43%26issue%3D2-3%26spage%3D195%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monika  Gaba</span>, <span class="hlFld-ContribAuthor ">Chander  Mohan</span>. </span><span class="cited-content_cbyCitation_article-title">Development of drugs based on imidazole and benzimidazole bioactive heterocycles: recent advances and future directions. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2016,</strong> <em>25 </em>
                                    (2)
                                     , 173-210. <a href="https://doi.org/10.1007/s00044-015-1495-5" title="DOI URL">https://doi.org/10.1007/s00044-015-1495-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-015-1495-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-015-1495-5%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DDevelopment%252Bof%252Bdrugs%252Bbased%252Bon%252Bimidazole%252Band%252Bbenzimidazole%252Bbioactive%252Bheterocycles%25253A%252Brecent%252Badvances%252Band%252Bfuture%252Bdirections%26aulast%3DGaba%26aufirst%3DMonika%26date%3D2016%26date%3D2015%26volume%3D25%26issue%3D2%26spage%3D173%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patrizia  Spigaglia</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the understanding of antibiotic resistance in
              Clostridium difficile
              infection. </span><span class="cited-content_cbyCitation_journal-name">Therapeutic Advances in Infectious Disease</span><span> <strong>2016,</strong> <em>3 </em>
                                    (1)
                                     , 23-42. <a href="https://doi.org/10.1177/2049936115622891" title="DOI URL">https://doi.org/10.1177/2049936115622891</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2049936115622891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2049936115622891%26sid%3Dliteratum%253Aachs%26jtitle%3DTherapeutic%2520Advances%2520in%2520Infectious%2520Disease%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bunderstanding%252Bof%252Bantibiotic%252Bresistance%252Bin%252BClostridium%252Bdifficile%252Binfection%26aulast%3DSpigaglia%26aufirst%3DPatrizia%26date%3D2016%26date%3D2015%26volume%3D3%26issue%3D1%26spage%3D23%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael A.  Henson</span>, <span class="hlFld-ContribAuthor ">Poonam  Phalak</span>. </span><span class="cited-content_cbyCitation_article-title">In silico Analysis of Clostridium difficile Biofilm Metabolism and Treatment * *The authors also wish to acknowledge NIH (Award U01EB019416) and NSF (Award 1511346) for funding this research.. </span><span class="cited-content_cbyCitation_journal-name">IFAC-PapersOnLine</span><span> <strong>2016,</strong> <em>49 </em>
                                    (26)
                                     , 153-158. <a href="https://doi.org/10.1016/j.ifacol.2016.12.118" title="DOI URL">https://doi.org/10.1016/j.ifacol.2016.12.118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ifacol.2016.12.118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ifacol.2016.12.118%26sid%3Dliteratum%253Aachs%26jtitle%3DIFAC-PapersOnLine%26atitle%3DIn%252Bsilico%252BAnalysis%252Bof%252BClostridium%252Bdifficile%252BBiofilm%252BMetabolism%252Band%252BTreatment%252B%252A%252B%252AThe%252Bauthors%252Balso%252Bwish%252Bto%252Backnowledge%252BNIH%252B%252528Award%252BU01EB019416%252529%252Band%252BNSF%252B%252528Award%252B1511346%252529%252Bfor%252Bfunding%252Bthis%252Bresearch.%26aulast%3DHenson%26aufirst%3DMichael%2BA.%26date%3D2016%26volume%3D49%26issue%3D26%26spage%3D153%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shoufeng  Wang</span>, <span class="hlFld-ContribAuthor ">Qingfei  Zheng</span>, <span class="hlFld-ContribAuthor ">Jianfeng  Wang</span>, <span class="hlFld-ContribAuthor ">Dandan  Chen</span>, <span class="hlFld-ContribAuthor ">Yunsong  Yu</span>, <span class="hlFld-ContribAuthor ">Wen  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Concurrent modifications of the C-terminus and side ring of thiostrepton and their synergistic effects with respect to improving antibacterial activities. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2016,</strong> <em>3 </em>
                                    (4)
                                     , 496-500. <a href="https://doi.org/10.1039/C5QO00433K" title="DOI URL">https://doi.org/10.1039/C5QO00433K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5QO00433K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5QO00433K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DConcurrent%252Bmodifications%252Bof%252Bthe%252BC-terminus%252Band%252Bside%252Bring%252Bof%252Bthiostrepton%252Band%252Btheir%252Bsynergistic%252Beffects%252Bwith%252Brespect%252Bto%252Bimproving%252Bantibacterial%252Bactivities%26aulast%3DWang%26aufirst%3DShoufeng%26date%3D2016%26date%3D2016%26volume%3D3%26issue%3D4%26spage%3D496%26epage%3D500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lynne Vernice  McFarland</span>, <span class="hlFld-ContribAuthor ">Metehan  Ozen</span>, <span class="hlFld-ContribAuthor ">Ener Cagri  Dinleyici</span>, <span class="hlFld-ContribAuthor ">Shan  Goh</span>. </span><span class="cited-content_cbyCitation_article-title">Comparison of pediatric and adult antibiotic-associated diarrhea and
              Clostridium difficile
              infections. </span><span class="cited-content_cbyCitation_journal-name">World Journal of Gastroenterology</span><span> <strong>2016,</strong> <em>22 </em>
                                    (11)
                                     , 3078. <a href="https://doi.org/10.3748/wjg.v22.i11.3078" title="DOI URL">https://doi.org/10.3748/wjg.v22.i11.3078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3748/wjg.v22.i11.3078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3748%2Fwjg.v22.i11.3078%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Journal%2520of%2520Gastroenterology%26atitle%3DComparison%252Bof%252Bpediatric%252Band%252Badult%252Bantibiotic-associated%252Bdiarrhea%252Band%252BClostridium%252Bdifficile%252Binfections%26aulast%3DMcFarland%26aufirst%3DLynne%2BVernice%26date%3D2016%26volume%3D22%26issue%3D11%26spage%3D3078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">References. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 421-454. <a href="https://doi.org/10.1128/9781555819316.refs" title="DOI URL">https://doi.org/10.1128/9781555819316.refs</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/9781555819316.refs&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2F9781555819316.refs%26sid%3Dliteratum%253Aachs%26atitle%3DReferences%26date%3D2015%26date%3D2015%26spage%3D421%26epage%3D454%26pub%3DASM%2520Press%26atitle%3DAntibiotics%26aulast%3DWalsh%26aufirst%3DChristopher%26date%3D2016%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angie M.  Jarrad</span>, <span class="hlFld-ContribAuthor ">Mark A. T.  Blaskovich</span>, <span class="hlFld-ContribAuthor ">Dena  Lyras</span>, <span class="hlFld-ContribAuthor ">Matthew A.  Cooper</span>. </span><span class="cited-content_cbyCitation_article-title">Clostridium difficile Infection: Current and Emerging Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Current Treatment Options in Infectious Diseases</span><span> <strong>2015,</strong> <em>7 </em>
                                    (4)
                                     , 317-334. <a href="https://doi.org/10.1007/s40506-015-0062-4" title="DOI URL">https://doi.org/10.1007/s40506-015-0062-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40506-015-0062-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40506-015-0062-4%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Treatment%2520Options%2520in%2520Infectious%2520Diseases%26atitle%3DClostridium%252Bdifficile%252BInfection%25253A%252BCurrent%252Band%252BEmerging%252BTherapeutics%26aulast%3DJarrad%26aufirst%3DAngie%2BM.%26date%3D2015%26date%3D2015%26volume%3D7%26issue%3D4%26spage%3D317%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angie M.  Jarrad</span>, <span class="hlFld-ContribAuthor ">Tomislav  Karoli</span>, <span class="hlFld-ContribAuthor ">Anjan  Debnath</span>, <span class="hlFld-ContribAuthor ">Chin Yen  Tay</span>, <span class="hlFld-ContribAuthor ">Johnny X.  Huang</span>, <span class="hlFld-ContribAuthor ">Geraldine  Kaeslin</span>, <span class="hlFld-ContribAuthor ">Alysha G.  Elliott</span>, <span class="hlFld-ContribAuthor ">Yukiko  Miyamoto</span>, <span class="hlFld-ContribAuthor ">Soumya  Ramu</span>, <span class="hlFld-ContribAuthor ">Angela M.  Kavanagh</span>, <span class="hlFld-ContribAuthor ">Johannes  Zuegg</span>, <span class="hlFld-ContribAuthor ">Lars  Eckmann</span>, <span class="hlFld-ContribAuthor ">Mark A.T.  Blaskovich</span>, <span class="hlFld-ContribAuthor ">Matthew A.  Cooper</span>. </span><span class="cited-content_cbyCitation_article-title">Metronidazole-triazole conjugates: Activity against Clostridium difficile and parasites. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>101 </em>, 96-102. <a href="https://doi.org/10.1016/j.ejmech.2015.06.019" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.06.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.06.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.06.019%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMetronidazole-triazole%252Bconjugates%25253A%252BActivity%252Bagainst%252BClostridium%252Bdifficile%252Band%252Bparasites%26aulast%3DJarrad%26aufirst%3DAngie%2BM.%26date%3D2015%26volume%3D101%26spage%3D96%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric  Wenzler</span>, <span class="hlFld-ContribAuthor ">Surafel  Mulugeta</span>, <span class="hlFld-ContribAuthor ">Larry  Danziger</span>. </span><span class="cited-content_cbyCitation_article-title">The Antimicrobial Stewardship Approach to Combating Clostridium Difficile. </span><span class="cited-content_cbyCitation_journal-name">Antibiotics</span><span> <strong>2015,</strong> <em>4 </em>
                                    (2)
                                     , 198-215. <a href="https://doi.org/10.3390/antibiotics4020198" title="DOI URL">https://doi.org/10.3390/antibiotics4020198</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antibiotics4020198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantibiotics4020198%26sid%3Dliteratum%253Aachs%26jtitle%3DAntibiotics%26atitle%3DThe%252BAntimicrobial%252BStewardship%252BApproach%252Bto%252BCombating%252BClostridium%252BDifficile%26aulast%3DWenzler%26aufirst%3DEric%26date%3D2015%26date%3D2015%26volume%3D4%26issue%3D2%26spage%3D198%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Grant A  Jenkin</span>. </span><span class="cited-content_cbyCitation_article-title">Clostridium difficile infection: an Australian clinical perspective. </span><span class="cited-content_cbyCitation_journal-name">Microbiology Australia</span><span> <strong>2015,</strong> <em>36 </em>
                                    (3)
                                     , 106. <a href="https://doi.org/10.1071/MA15037" title="DOI URL">https://doi.org/10.1071/MA15037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1071/MA15037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1071%2FMA15037%26sid%3Dliteratum%253Aachs%26jtitle%3DMicrobiology%2520Australia%26atitle%3DClostridium%252Bdifficile%252Binfection%25253A%252Ban%252BAustralian%252Bclinical%252Bperspective%26aulast%3DJenkin%26aufirst%3DGrant%2BA%26date%3D2015%26volume%3D36%26issue%3D3%26spage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Current antibiotic treatments primarily used to treat for <i>C. difficile</i> infection: metronidazole <b>1</b>, vancomycin <b>2</b>, rifaximin <b>3</b> (sometimes used as a chaser therapy), and fidaxomicin <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Antibiotics in clinical trials to treat CDI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compounds in early and preclinical drug discovery phase with antimicrobial activity against <i>C. difficile</i> in the scientific literature from the analysis of compounds with antimicrobial activity against <i>C. difficile</i> curated by ChEMBL. Antibiotics on the market and agents in clinical trials were excluded from analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Nitroheterocycles: (A) analogs of nitazoxanide <b>14</b>–<b>16</b>;<a onclick="showRef(event, 'ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref83 ref84">(83, 84)</a> (B) furanyl thiazoles <b>17</b>–<b>20</b> and phenylthiazoles <b>21</b> and <b>22</b> (inactive against <i>C. difficile</i>, MIC > 100 μg/mL);<a onclick="showRef(event, 'ref85 ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref85 ref86 ref87">(85-87)</a> (C) thiazolides with a nitrothiazole ring, similar to nitazoxanide;<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> (D) nitrofuranylsemicarbazone <b>28</b>;<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> (E) the six 5-nitroimidazole scaffolds <b>29</b>–<b>34</b> in the library of metronidazole triazole conjugates (crude, >85% purity);<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> (F) quinoxalines <b>35</b>–<b>36</b>.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Desmethyl vancomycin derivatives <b>37</b>–<b>53</b> with lipophilic variations at R<sub>1</sub> on the vancosamine sugar.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Tylosin derived macrolides <b>54</b>–<b>69</b>.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Fluoroquinolones <b>70</b>–<b>73</b>.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A–C) Tetramic acids <b>74</b>–<b>85</b> investigated for activity against <i>C. difficile</i><a onclick="showRef(event, 'ref87 ref97 ref98'); return false;" href="javascript:void(0);" class="ref ref87 ref97 ref98">(87, 97, 98)</a> and (D) structurally related tetronic acids <b>86</b>–<b>89</b>.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Bis-indoles <b>90</b> and <b>91</b> with potent activity against <i>C. difficile</i> compared to the 2-phenyl-1<i>H</i>-indole <b>92</b> not active at 100 μg/mL.<a onclick="showRef(event, 'ref102 ref104'); return false;" href="javascript:void(0);" class="ref ref102 ref104">(102, 104)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (A) Hybrid 1-carba-3-thiathiazole cephalosporins<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a><b>93</b>–<b>97</b> and (B) hybrid penem and carbapenems linked to quinolones <b>98</b>–<b>101</b>.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Aminobenzimidazole urea inhibitors of bacterial DNA gyrase and topoisomerase IV <b>102</b>–<b>104</b>,<a onclick="showRef(event, 'ref107 ref109'); return false;" href="javascript:void(0);" class="ref ref107 ref109">(107, 109)</a> topoisomerase II ATPase inhibitor kibdelomycin <b>107</b>,<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> and benzothiazole ethyl urea inhibitors of DNA gyrase GyrB and topoisomerase IV ParE ATPase <b>105</b> and <b>106</b>.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Nylon-3 polymers <b>125</b>–<b>127</b>.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Structures of ziracin <b>128</b>,<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> hydramycin <b>129</b>,<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> clerocidin <b>130</b>,<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> echinosporamicin-type antibiotics <b>131</b> and <b>132</b>,<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> merochlorin A <b>133</b>,<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> and olympicin A <b>134</b>,<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> and analogs <b>135</b>–<b>138</b><a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> with activity against <i>C. difficile</i>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Cyclic thiazolyl peptidic antimicrobial compounds <b>139</b> and <b>140</b> similar to <b>8</b>, which is in phase II clinical trials.<a onclick="showRef(event, 'ref128 ref129'); return false;" href="javascript:void(0);" class="ref ref128 ref129">(128, 129)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/medium/jm-2014-016846_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0016.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Inhibitors of type I dehydroquinate dehydratase <b>141</b>–<b>143</b> (IC<sub>50</sub> = 31–35 μM).<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Antimicrobial activity was not reported.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-13/jm5016846/20150702/images/large/jm-2014-016846_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5016846&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14348" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14348" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 176 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span> </span><span class="NLM_article-title">Antibiotic Resistance Threats in the United States, 2013</span>. <span class="NLM_publisher-name">U.S. Department of Health and Human Services, Centers for Disease Control and Prevention</span>: <span class="NLM_publisher-loc">Atlanta, GA</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">114</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Antibiotic+Resistance+Threats+in+the+United+States%2C+2013.+U.S.+Department+of+Health+and+Human+Services%2C+Centers+for+Disease+Control+and+Prevention%3A+Atlanta%2C+GA%2C+2013%3B+pp+1%E2%80%93114."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DAntibiotic%2520Resistance%2520Threats%2520in%2520the%2520United%2520States%252C%25202013%26pub%3DU.S.%2520Department%2520of%2520Health%2520and%2520Human%2520Services%252C%2520Centers%2520for%2520Disease%2520Control%2520and%2520Prevention%26date%3D2013%26spage%3D1%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Carter, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rood, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyras, D.</span><span> </span><span class="NLM_article-title">The Role of Toxin A and Toxin B in the Virulence of <i>Clostridium difficile</i></span> <span class="citation_source-journal">Trends Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=21-29&author=G.+P.+Carterauthor=J.+I.+Roodauthor=D.+Lyras&title=The+Role+of+Toxin+A+and+Toxin+B+in+the+Virulence+of+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DG.%2BP.%26aulast%3DRood%26aufirst%3DJ.%2BI.%26aulast%3DLyras%26aufirst%3DD.%26atitle%3DThe%2520Role%2520of%2520Toxin%2520A%2520and%2520Toxin%2520B%2520in%2520the%2520Virulence%2520of%2520Clostridium%2520difficile%26jtitle%3DTrends%2520Microbiol.%26date%3D2012%26volume%3D20%26spage%3D21%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Gerding, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupnik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aktories, K.</span><span> </span><span class="NLM_article-title"><i>Clostridium difficile</i> Binary Toxin CDT: Mechanism, Epidemiology, and Potential Clinical Importance</span> <span class="citation_source-journal">Gut Microbes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=6-18&author=D.+N.+Gerdingauthor=S.+Johnsonauthor=M.+Rupnikauthor=K.+Aktories&title=Clostridium+difficile+Binary+Toxin+CDT%3A+Mechanism%2C+Epidemiology%2C+and+Potential+Clinical+Importance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGerding%26aufirst%3DD.%2BN.%26aulast%3DJohnson%26aufirst%3DS.%26aulast%3DRupnik%26aufirst%3DM.%26aulast%3DAktories%26aufirst%3DK.%26atitle%3DClostridium%2520difficile%2520Binary%2520Toxin%2520CDT%253A%2520Mechanism%252C%2520Epidemiology%252C%2520and%2520Potential%2520Clinical%2520Importance%26jtitle%3DGut%2520Microbes%26date%3D2014%26volume%3D5%26spage%3D6%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Edmonds, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zapka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasper, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormack, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macinga, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambol, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbogast, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerding, D. N.</span><span> </span><span class="NLM_article-title">Effectiveness of Hand Hygiene for Removal of <i>Clostridium difficile</i> Spores From Hands</span> <span class="citation_source-journal">Infect. Control Hosp. Epidemiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">302</span><span class="NLM_x">–</span> <span class="NLM_lpage">305</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1086%2F669521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=23388366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADC%252BC3szmt1ahsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=302-305&author=S.+L.+Edmondsauthor=C.+Zapkaauthor=D.+Kasperauthor=R.+Gerberauthor=R.+McCormackauthor=D.+Macingaauthor=S.+Johnsonauthor=S.+Sambolauthor=C.+Frickerauthor=J.+Arbogastauthor=D.+N.+Gerding&title=Effectiveness+of+Hand+Hygiene+for+Removal+of+Clostridium+difficile+Spores+From+Hands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Effectiveness of hand hygiene for removal of Clostridium difficile spores from hands</span></div><div class="casAuthors">Edmonds Sarah L; Zapka Carrie; Kasper Douglas; Gerber Robert; McCormack Robert; Macinga David; Johnson Stuart; Sambol Susan; Fricker Christopher; Arbogast James; Gerding Dale N</div><div class="citationInfo"><span class="NLM_cas:title">Infection control and hospital epidemiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">302-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This study determined whether surrogate organisms can predict activity against Clostridium difficile spores and compared the efficacy of hand hygiene preparations against C. difficile.  Our data suggest that surrogate organisms were not predictive of C. difficile spore removal.  Four preparations were significantly more effective than tap water at removing C. difficile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSoXdyRJzxK-fxQvRxYU81tfW6udTcc2eYAXbFlQFKO27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szmt1ahsw%253D%253D&md5=b454d130ea004f9414126bb72aced46f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1086%2F669521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F669521%26sid%3Dliteratum%253Aachs%26aulast%3DEdmonds%26aufirst%3DS.%2BL.%26aulast%3DZapka%26aufirst%3DC.%26aulast%3DKasper%26aufirst%3DD.%26aulast%3DGerber%26aufirst%3DR.%26aulast%3DMcCormack%26aufirst%3DR.%26aulast%3DMacinga%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DS.%26aulast%3DSambol%26aufirst%3DS.%26aulast%3DFricker%26aufirst%3DC.%26aulast%3DArbogast%26aufirst%3DJ.%26aulast%3DGerding%26aufirst%3DD.%2BN.%26atitle%3DEffectiveness%2520of%2520Hand%2520Hygiene%2520for%2520Removal%2520of%2520Clostridium%2520difficile%2520Spores%2520From%2520Hands%26jtitle%3DInfect.%2520Control%2520Hosp.%2520Epidemiol.%26date%3D2013%26volume%3D34%26spage%3D302%26epage%3D305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Sunkesula, V. C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kundrapu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jury, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshpande, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donskey, C. J.</span><span> </span><span class="NLM_article-title">Potential for Transmission of Spores by Patients Awaiting Laboratory Testing To Confirm Suspected <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">Infect. Control Hosp. Epidemiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1086%2F669510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=23388367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADC%252BC3szmt1ahsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=306-308&author=V.+C.+K.+Sunkesulaauthor=S.+Kundrapuauthor=L.+A.+Juryauthor=A.+Deshpandeauthor=A.+K.+Sethiauthor=C.+J.+Donskey&title=Potential+for+Transmission+of+Spores+by+Patients+Awaiting+Laboratory+Testing+To+Confirm+Suspected+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Potential for transmission of spores by patients awaiting laboratory testing to confirm suspected Clostridium difficile infection</span></div><div class="casAuthors">Sunkesula Venkata C K; Kundrapu Sirisha; Jury Lucy A; Deshpande Abhishek; Sethi Ajay K; Donskey Curtis J</div><div class="citationInfo"><span class="NLM_cas:title">Infection control and hospital epidemiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">306-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In a prospective study of inpatients tested for Clostridium difficile infection (CDI), skin and environmental contamination were common at the time of the order for CDI testing, and there were often delays in completion of testing.  Preemptive isolation of patients with suspected CDI may reduce the risk of transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSoXdyRJzxK-e_Q9URG6Dx8fW6udTcc2ebvBWx78hkij7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szmt1ahsA%253D%253D&md5=32bd7eccb7bf5cb8c55de5b8580cada5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1086%2F669510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F669510%26sid%3Dliteratum%253Aachs%26aulast%3DSunkesula%26aufirst%3DV.%2BC.%2BK.%26aulast%3DKundrapu%26aufirst%3DS.%26aulast%3DJury%26aufirst%3DL.%2BA.%26aulast%3DDeshpande%26aufirst%3DA.%26aulast%3DSethi%26aufirst%3DA.%2BK.%26aulast%3DDonskey%26aufirst%3DC.%2BJ.%26atitle%3DPotential%2520for%2520Transmission%2520of%2520Spores%2520by%2520Patients%2520Awaiting%2520Laboratory%2520Testing%2520To%2520Confirm%2520Suspected%2520Clostridium%2520difficile%2520Infection%26jtitle%3DInfect.%2520Control%2520Hosp.%2520Epidemiol.%26date%3D2013%26volume%3D34%26spage%3D306%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Warny, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Killgore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brazier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, L. C.</span><span> </span><span class="NLM_article-title">Toxin Production by an Emerging Strain of <i>Clostridium difficile</i> Associated with Outbreaks of Severe Disease in North America and Europe</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">366</span><span class="NLM_x">, </span> <span class="NLM_fpage">1079</span><span class="NLM_x">–</span> <span class="NLM_lpage">1084</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1016%2FS0140-6736%2805%2967420-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=16182895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVartL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2005&pages=1079-1084&author=M.+Warnyauthor=J.+Pepinauthor=A.+Fangauthor=G.+Killgoreauthor=A.+Thompsonauthor=J.+Brazierauthor=E.+Frostauthor=L.+C.+McDonald&title=Toxin+Production+by+an+Emerging+Strain+of+Clostridium+difficile+Associated+with+Outbreaks+of+Severe+Disease+in+North+America+and+Europe"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe</span></div><div class="casAuthors">Warny, Michel; Pepin, Jacques; Fang, Aiqi; Killgore, George; Thompson, Angela; Brazier, Jon; Frost, Eric; McDonald, L. Clifford</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">9491</span>),
    <span class="NLM_cas:pages">1079-1084</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Toxins A and B are the primary virulence factors of Clostridium difficile.  Since 2002, an epidemic of C difficile-assocd. disease with increased morbidity and mortality has been present in Quebec province, Canada.  We characterized the dominant strain of this epidemic to det. whether it produces higher amts. of toxins A and B than those produced by non-epidemic strains.  We obtained isolates from 124 patients from Center Hospitalier Universitaire de Sherbrooke in Quebec.  Addnl. isolates from the USA, Canada, and the UK were included to increase the genetic diversity of the toxinotypes tested.  Isolate characterization included toxinotyping, pulsed-field gel electrophoresis (PFGE), PCR ribotyping, detection of a binary toxin gene, and detection of deletions in a putative neg. regulator for toxins A and B (tcdC).  By use of an enzyme-linked immunoassay, we measured the in-vitro prodn. of toxins A and B by epidemic strain and non-dominant strain isolates.  Findings: The epidemic strain was characterized as toxinotype III, North American PFGE type 1, and PCR-ribotype 027 (NAP1/027).  This strain carried the binary toxin gene cdtB and an 18-bp deletion in tcdC.  We isolated this strain from 72 patients with C difficile-assocd. disease (58 [67%] of 86 with health-care-assocd. disease; 14 [37%] of 38 with community-acquired disease).  Peak median (IQR) toxin A and toxin B concns. produced in vitro by NAP1/027 were 16 and 23 times higher, resp., than those measured in isolates representing 12 different PFGE types, known as toxinotype 0 (toxin A, median 848 μg/L [IQR 504-1022] vs 54 μg/L [23-203]; toxin B, 180 μg/L [137-210] vs 8 μg/L [5-25]; p<0·0001 for both toxins).  The severity of C difficile-assocd. disease caused by NAP1/027 could result from hyperprodn. of toxins A and B. Dissemination of this strain in North America and Europe could lead to important changes in the epidemiol. of C difficile-assocd. disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOf8zYIbBVarVg90H21EOLACvtfcHk0lhmhBOvgSNB-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVartL3E&md5=2e40f8346690972f4247c7857fcb027a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2805%2967420-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252805%252967420-X%26sid%3Dliteratum%253Aachs%26aulast%3DWarny%26aufirst%3DM.%26aulast%3DPepin%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DA.%26aulast%3DKillgore%26aufirst%3DG.%26aulast%3DThompson%26aufirst%3DA.%26aulast%3DBrazier%26aufirst%3DJ.%26aulast%3DFrost%26aufirst%3DE.%26aulast%3DMcDonald%26aufirst%3DL.%2BC.%26atitle%3DToxin%2520Production%2520by%2520an%2520Emerging%2520Strain%2520of%2520Clostridium%2520difficile%2520Associated%2520with%2520Outbreaks%2520of%2520Severe%2520Disease%2520in%2520North%2520America%2520and%2520Europe%26jtitle%3DLancet%26date%3D2005%26volume%3D366%26spage%3D1079%26epage%3D1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">He, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyajima, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellison, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connor, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamford, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arc, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brazier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douce, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerding, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koh, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senoh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peacock, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Songer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirmohamed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuijper, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wren, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkhill, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawley, T. D.</span><span> </span><span class="NLM_article-title">Emergence and Global Spread of Epidemic Healthcare-Associated <i>Clostridium difficile</i></span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1038%2Fng.2478" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=23222960" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2012&pages=109-113&author=M.+Heauthor=F.+Miyajimaauthor=P.+Robertsauthor=L.+Ellisonauthor=D.+J.+Pickardauthor=M.+J.+Martinauthor=T.+R.+Connorauthor=S.+R.+Harrisauthor=D.+Fairleyauthor=K.+B.+Bamfordauthor=S.+D%E2%80%99Arcauthor=J.+Brazierauthor=D.+Brownauthor=J.+E.+Coiaauthor=G.+Douceauthor=D.+Gerdingauthor=H.+J.+Kimauthor=T.+H.+Kohauthor=H.+Katoauthor=M.+Senohauthor=T.+Louieauthor=S.+Michellauthor=E.+Buttauthor=S.+J.+Peacockauthor=N.+M.+Brownauthor=T.+Rileyauthor=G.+Songerauthor=M.+Wilcoxauthor=M.+Pirmohamedauthor=E.+Kuijperauthor=P.+Hawkeyauthor=B.+W.+Wrenauthor=G.+Douganauthor=J.+Parkhillauthor=T.+D.+Lawley&title=Emergence+and+Global+Spread+of+Epidemic+Healthcare-Associated+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fng.2478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.2478%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DM.%26aulast%3DMiyajima%26aufirst%3DF.%26aulast%3DRoberts%26aufirst%3DP.%26aulast%3DEllison%26aufirst%3DL.%26aulast%3DPickard%26aufirst%3DD.%2BJ.%26aulast%3DMartin%26aufirst%3DM.%2BJ.%26aulast%3DConnor%26aufirst%3DT.%2BR.%26aulast%3DHarris%26aufirst%3DS.%2BR.%26aulast%3DFairley%26aufirst%3DD.%26aulast%3DBamford%26aufirst%3DK.%2BB.%26aulast%3DD%25E2%2580%2599Arc%26aufirst%3DS.%26aulast%3DBrazier%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DCoia%26aufirst%3DJ.%2BE.%26aulast%3DDouce%26aufirst%3DG.%26aulast%3DGerding%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DKoh%26aufirst%3DT.%2BH.%26aulast%3DKato%26aufirst%3DH.%26aulast%3DSenoh%26aufirst%3DM.%26aulast%3DLouie%26aufirst%3DT.%26aulast%3DMichell%26aufirst%3DS.%26aulast%3DButt%26aufirst%3DE.%26aulast%3DPeacock%26aufirst%3DS.%2BJ.%26aulast%3DBrown%26aufirst%3DN.%2BM.%26aulast%3DRiley%26aufirst%3DT.%26aulast%3DSonger%26aufirst%3DG.%26aulast%3DWilcox%26aufirst%3DM.%26aulast%3DPirmohamed%26aufirst%3DM.%26aulast%3DKuijper%26aufirst%3DE.%26aulast%3DHawkey%26aufirst%3DP.%26aulast%3DWren%26aufirst%3DB.%2BW.%26aulast%3DDougan%26aufirst%3DG.%26aulast%3DParkhill%26aufirst%3DJ.%26aulast%3DLawley%26aufirst%3DT.%2BD.%26atitle%3DEmergence%2520and%2520Global%2520Spread%2520of%2520Epidemic%2520Healthcare-Associated%2520Clostridium%2520difficile%26jtitle%3DNat.%2520Genet.%26date%3D2012%26volume%3D45%26spage%3D109%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">McDonald, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Killgore, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, R. C.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakova, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambol, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerding, D. N.</span><span> </span><span class="NLM_article-title">An Epidemic, Toxin Gene–Variant Strain of <i>Clostridium difficile</i></span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">2433</span><span class="NLM_x">–</span> <span class="NLM_lpage">2441</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1056%2FNEJMoa051590" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=16322603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlShurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=2433-2441&author=L.+C.+McDonaldauthor=G.+E.+Killgoreauthor=A.+Thompsonauthor=R.+C.+Owensauthor=S.+V.+Kazakovaauthor=S.+P.+Sambolauthor=S.+Johnsonauthor=D.+N.+Gerding&title=An+Epidemic%2C+Toxin+Gene%E2%80%93Variant+Strain+of+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">An epidemic, toxin gene-variant strain of Clostridium difficile</span></div><div class="casAuthors">McDonald, L. Clifford; Killgore, George E.; Thompson, Angela; Owens, Robert C., Jr.; Kazakova, Sophia V.; Sambol, Susan P.; Johnson, Stuart; Gerding, Dale N.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2433-2441</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Recent reports suggest that the rate and severity of C. difficile-assocd. disease in the United States are increasing and that the increase may be assocd. with the emergence of a new strain of C. difficile with increased virulence, resistance, or both.  A total of 187 C. difficile isolates were collected from 8 health care facilities in 6 states (Georgia, Illinois, Maine, New Jersey, Oregon, and Pennsylvania) in which outbreaks of C. difficile-assocd. disease had occurred between 2000 and 2003.  The isolates were characterized by restriction-endonuclease anal. (REA), pulsed-field gel electrophoresis (PFGE), and toxinotyping, and the results were compared with those from a database of >6000 isolates obtained before 2001.  PCR was used to detect the recently described binary toxin CDT and a deletion in the pathogenicity locus gene, tcdC, that might result in increased prodn. of toxins A and B.  Isolates that belonged to 1 REA group (BI) and had the same PFGE type (NAP1) were identified in specimens collected from patients at all 8 facilities and accounted for at least half of the isolates from 5 facilities.  REA group BI, which was 1st identified in 1984, was uncommon among isolates from the historic database (14 cases).  Both historic and current (obtained since 2001) BI/NAP1 isolates were of toxinotype III, were pos. for the binary toxin CDT, and contained an 18-bp tcdC deletion.  Resistance to gatifloxacin and moxifloxacin was more common in current BI/NAP1 isolates than in non-BI/NAP1 isolates (100% vs. 42%), whereas the rate of resistance to clindamycin was the same in the 2 groups (79%).  All of the current but none of the historic BI/NAP1 isolates were resistant to gatifloxacin and moxifloxacin.  A previously uncommon strain of C. difficile with variations in toxin genes has become more resistant to fluoroquinolones and has emerged as a cause of geog. dispersed outbreaks of C. difficile-assocd. disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9xi0s6sZPxrVg90H21EOLACvtfcHk0liukY65Tfmleg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlShurvP&md5=313fa0e669cc4edc29d63d9892e5ae37</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa051590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa051590%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonald%26aufirst%3DL.%2BC.%26aulast%3DKillgore%26aufirst%3DG.%2BE.%26aulast%3DThompson%26aufirst%3DA.%26aulast%3DOwens%26aufirst%3DR.%2BC.%26aulast%3DKazakova%26aufirst%3DS.%2BV.%26aulast%3DSambol%26aufirst%3DS.%2BP.%26aulast%3DJohnson%26aufirst%3DS.%26aulast%3DGerding%26aufirst%3DD.%2BN.%26atitle%3DAn%2520Epidemic%252C%2520Toxin%2520Gene%25E2%2580%2593Variant%2520Strain%2520of%2520Clostridium%2520difficile%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D353%26spage%3D2433%26epage%3D2441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Loo, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oughton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourgault, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frenette, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, M.</span><span> </span><span class="NLM_article-title">A Predominantly Clonal Multi-Institutional Outbreak of <i>Clostridium difficile</i>-Associated Diarrhea with High Morbidity and Mortality</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">2442</span><span class="NLM_x">–</span> <span class="NLM_lpage">2449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1056%2FNEJMoa051639" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=16322602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlShurvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=2442-2449&author=V.+G.+Looauthor=L.+Poirierauthor=M.+A.+Millerauthor=M.+Oughtonauthor=M.+D.+Libmanauthor=S.+Michaudauthor=A.-M.+Bourgaultauthor=T.+Nguyenauthor=C.+Frenetteauthor=M.+Kelly&title=A+Predominantly+Clonal+Multi-Institutional+Outbreak+of+Clostridium+difficile-Associated+Diarrhea+with+High+Morbidity+and+Mortality"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A predominantly clonal multi-institutional outbreak of clostridium difficile-associated diarrhea with high morbidity and mortality</span></div><div class="casAuthors">Loo, Vivian G.; Poirier, Louise; Miller, Mark A.; Oughton, Matthew; Libman, Michael D.; Michaud, Sophie; Bourgault, Anne-Marie; Nguyen, Tuyen; Frenette, Charles; Kelly, Mirabelle; Vibien, Anne; Brassard, Paul; Fenn, Susan; Dewar, Ken; Hudson, Thomas J.; Horn, Ruth; Rene, Piere; Monczak, Yuryy; Dascal, Andre</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2442-2449</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND In Mar. 2003, several hospitals in Quebec, Canada, noted a marked increase in the incidence of Clostridiumr difficile-assocd. diarrhea.  METHODS In 2004 we conducted a prospective study at 12 Quebec hospitals to det. the incidence of nosocomial C. difficile-assocd. diarrhea and its complications and a case-control study to identify risk factors for the disease.  Isolates of C. difficile were typed by pulsed-field gel electrophoresis and analyzed for binary toxin genes and partial deletions in the toxin A and B repressor gene tcdC.  Antimicrobial susceptibility was evaluated in a subgroup of isolates.  RESULTS A total of 1703 patients with 1719 episodes of nosocomial C. difficile-assocd. diarrhea were identified.  The incidence was 22.5 per 1000 admissions.  The 30-day attributable mortality rate was 6.9 percent.  Case patients were more likely than matched controls to have received fluoroquinolones (odds ratio, 3.9; 95 percent confidence interval, 2.3 to 6.6) or cephalosporins (odds ratio, 3.8; 95 percent confidence interval, 2.2 to 6.6). A predominant strain, resistant to fluoroquinolones, was found in 129 of 157 isolates (82.2 percent), and the binary toxin genes and partial deletions in the tcdC gene were present in 132 isolates (84.1 percent).  CONCLUSIONS A strain of C. difficile that was resistant to fluoroquinolones and had binary toxin and a partial deletion of the tcdC gene was responsible for this outbreak of C. difficile-assocd. diarrhea.  Exposure to fluoroquinolones or cephalosporins was a risk factor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrun2mbufmdVbVg90H21EOLACvtfcHk0liukY65Tfmleg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlShurvK&md5=7913e7008546a811107c1976bc772553</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa051639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa051639%26sid%3Dliteratum%253Aachs%26aulast%3DLoo%26aufirst%3DV.%2BG.%26aulast%3DPoirier%26aufirst%3DL.%26aulast%3DMiller%26aufirst%3DM.%2BA.%26aulast%3DOughton%26aufirst%3DM.%26aulast%3DLibman%26aufirst%3DM.%2BD.%26aulast%3DMichaud%26aufirst%3DS.%26aulast%3DBourgault%26aufirst%3DA.-M.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DFrenette%26aufirst%3DC.%26aulast%3DKelly%26aufirst%3DM.%26atitle%3DA%2520Predominantly%2520Clonal%2520Multi-Institutional%2520Outbreak%2520of%2520Clostridium%2520difficile-Associated%2520Diarrhea%2520with%2520High%2520Morbidity%2520and%2520Mortality%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D353%26spage%3D2442%26epage%3D2449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Khanna, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardi, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aronson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kammer, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baddour, L. M.</span><span> </span><span class="NLM_article-title">Outcomes in Community-Acquired <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">Aliment. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">618</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1111%2Fj.1365-2036.2011.04984.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=22229532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADC%252BC387pvFSlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2012&pages=613-618&author=S.+Khannaauthor=D.+S.+Pardiauthor=S.+L.+Aronsonauthor=P.+P.+Kammerauthor=L.+M.+Baddour&title=Outcomes+in+Community-Acquired+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Outcomes in community-acquired Clostridium difficile infection</span></div><div class="casAuthors">Khanna S; Pardi D S; Aronson S L; Kammer P P; Baddour L M</div><div class="citationInfo"><span class="NLM_cas:title">Alimentary pharmacology & therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">613-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Community-acquired Clostridium difficile infection (CA-CDI) is an increasingly appreciated condition.  It is being described in populations lacking traditional predisposing factors that have been previously considered at low-risk for this infection.  As most studies of CDI are hospital-based, outcomes in these patients are not well known.  AIM:  To examine outcomes and their predictors in patients with CA-CDI.  METHODS:  A sub-group analysis of a population-based epidemiological study of CDI in Olmsted county, Minnesota from 1991-2005 was performed.  Data regarding outcomes, including severity, treatment response, need for hospitalisation and recurrence were analysed.  RESULTS:  Of 157 CA-CDI cases, the median age was 50 years and 75.3% were female.  Among all CA-CDI cases, 40% required hospitalisation, 20% had severe and 4.4% had severe-complicated infection, 20% had treatment failure and 28% had recurrent CDI.  Patients who required hospitalisation were significantly older (64 years vs. 44 years, P < 0.001), more likely to have severe disease (33.3% vs. 11.7%, P = 0.001), and had higher mean Charlson comorbidity index scores (2.06 vs. 0.84, P = 0.001).  They had similar treatment failure and recurrence rates as patients who did not require hospitalisation.  CONCLUSIONS:  Community-acquired Clostridium difficile infection can be associated with complications and poor outcomes, including hospitalisation and severe Clostridium difficile infection.  As the incidence of community-acquired Clostridium difficile infection increases, clinicians should be aware of risk factors (increasing age, comorbid conditions and disease severity) that predict the need for hospitalisation and complications in patients with community-acquired Clostridium difficile infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXsjX1Yu5jIxFwe7cAcrfPfW6udTcc2eYyNnoRC88XZrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC387pvFSlsw%253D%253D&md5=a8ab99baa06f149ee00852fa23aa3976</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2036.2011.04984.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2036.2011.04984.x%26sid%3Dliteratum%253Aachs%26aulast%3DKhanna%26aufirst%3DS.%26aulast%3DPardi%26aufirst%3DD.%2BS.%26aulast%3DAronson%26aufirst%3DS.%2BL.%26aulast%3DKammer%26aufirst%3DP.%2BP.%26aulast%3DBaddour%26aufirst%3DL.%2BM.%26atitle%3DOutcomes%2520in%2520Community-Acquired%2520Clostridium%2520difficile%2520Infection%26jtitle%3DAliment.%2520Pharmacol.%2520Ther.%26date%3D2012%26volume%3D35%26spage%3D613%26epage%3D618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Levine, D. P.</span><span> </span><span class="NLM_article-title">Vancomycin: a History</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">S5</span><span class="NLM_x">–</span> <span class="NLM_lpage">S12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1086%2F491709" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=16323120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsVagtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2006&pages=S5-S12&author=D.+P.+Levine&title=Vancomycin%3A+a+History"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Vancomycin: A history</span></div><div class="casAuthors">Levine, Donald P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S5-S12</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Vancomycin became available for clin. use > 50 years ago but was soon discarded in favor of other antibiotics that were deemed to be more efficacious and less toxic.  The advent of pseudomembranous enterocolitis, coupled with the spread of methicillin-resistant Staphylococcus aureus, led to a resurgence in the use of vancomycin.  Almost immediately, concerns arose with regard to its therapeutic utility.  In addn., resistance to vancomycin developed, first in enterococci and later in staphylococci.  Several types of resistance have now been identified, each with a unique effect on infections treated with vancomycin.  Recent studies have rekindled interest in the best way to administer the antibiotic.  The findings of future studies may result in a return to measuring levels of vancomycin in serum, to assure a successful therapeutic outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2_P2N2zwJHLVg90H21EOLACvtfcHk0lhily_kYwG0JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsVagtw%253D%253D&md5=8b516e40ed39bd3c3ec9e727dbbb048d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1086%2F491709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F491709%26sid%3Dliteratum%253Aachs%26aulast%3DLevine%26aufirst%3DD.%2BP.%26atitle%3DVancomycin%253A%2520a%2520History%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2006%26volume%3D42%26spage%3DS5%26epage%3DS12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Baines, E. J.</span><span> </span><span class="NLM_article-title">Metronidazole: Its Past, Present and Future</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fjac%2F4.suppl_C.97" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=151090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADyaE1MXjtlKhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1978&pages=97-111&author=E.+J.+Baines&title=Metronidazole%3A+Its+Past%2C+Present+and+Future"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Metronidazole:  its past, present and future</span></div><div class="casAuthors">Baines, Eric J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">Suppl. C</span>),
    <span class="NLM_cas:pages">97-111</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    </div><div class="casAbstract">Metronidazole (I)  [443-48-1], introduced in 1960 as the first systemic antitrichomonal agent, was later shown to be effective in other infections caused by anaerobic protozoa; giardiasis (1961), amebiasis (1966) and balantidiasis (1969).  The drug's efficacy in cutaneous leishmaniasis and Chaga's disease is questionable but its widespread use for trichomoniasis led to clin. observations of benefit in other intercurrent conditions.  Some of these were substantiated clin. and can now be explained on the basis of (I)'s anaerobicidal activity.  Its specific action on anaerobic bacteria was not appreciated until 1972 when its clin. efficacy in Bacteroides fragilis infections was reported in the U.S.A.  Its successful uses in dracunculiasis and as a radiosensitizer for anoxic tumor cells were developed on the basis of chem. analogy.  There is substantial clin. evidence of the product's chemotherapeutic activity in the treatment and prevention of anaerobic sepsis, but its full potentialities as an antimicrobial agent and for the further investigation of disorders in which the actions of anaerobic micro-organisms might be involved, have still to be realized.  A review and discussion with many refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZn3BhiatKeLVg90H21EOLACvtfcHk0lhily_kYwG0JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXjtlKhtA%253D%253D&md5=251e0eb150f9e0ea756428d9a45827a7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1093%2Fjac%2F4.suppl_C.97&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252F4.suppl_C.97%26sid%3Dliteratum%253Aachs%26aulast%3DBaines%26aufirst%3DE.%2BJ.%26atitle%3DMetronidazole%253A%2520Its%2520Past%252C%2520Present%2520and%2520Future%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D1978%26volume%3D4%26spage%3D97%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Vardakas, K. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polyzos, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patouni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafailidis, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samonis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falagas, M. E.</span><span> </span><span class="NLM_article-title">Treatment Failure and Recurrence of <i>Clostridium difficile</i> Infection Following Treatment with Vancomycin or Metronidazole: A Systematic Review of the Evidence</span> <span class="citation_source-journal">Int. J. Antimicrob. Agents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1016%2Fj.ijantimicag.2012.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=22398198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtlOgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1-8&author=K.+Z.+Vardakasauthor=K.+A.+Polyzosauthor=K.+Patouniauthor=P.+I.+Rafailidisauthor=G.+Samonisauthor=M.+E.+Falagas&title=Treatment+Failure+and+Recurrence+of+Clostridium+difficile+Infection+Following+Treatment+with+Vancomycin+or+Metronidazole%3A+A+Systematic+Review+of+the+Evidence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence</span></div><div class="casAuthors">Vardakas, Konstantinos Z.; Polyzos, Konstantinos A.; Patouni, Konstantina; Rafailidis, Petros I.; Samonis, George; Falagas, Matthew E.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The objective of this review was to evaluate the frequency of treatment failure and recurrence of Clostridium difficile infection (CDI) following treatment with vancomycin or metronidazole in recently performed studies (last 10 years).  Searches in PubMed and Scopus were performed by two reviewers independently.  Data regarding treatment failure and recurrence following metronidazole and vancomycin treatment were extd. and analyzed.  In total, 39 articles (7005 patients) were selected for inclusion in the systematic review.  The reported treatment failure was 22.4% with metronidazole (16 studies) and 14.2% with vancomycin (8 studies).  Recurrence of CDI occurred in 27.1% of patients following metronidazole treatment (18 studies) and 24.0% of patients following vancomycin treatment (8 studies).  Mean treatment failure and recurrence in the selected studies was 22.3% (24 studies) and 22.1% (37 studies).  The reported outcomes depended on the study design (higher in prospective and retrospective cohort studies than in randomised controlled trials), geog. location of the study (higher in North America than in Europe and Asia), funding (higher in studies funded by non-profit organisations than pharmaceutical companies), mean age of the studied population (higher in older patients) and duration of follow-up (higher in studies with follow-up >1 mo).  In conclusion, infection with C. difficile is assocd. with 22.4% and 14.2% treatment failure and 27.1% and 24.0% recurrence after treatment with metronidazole and vancomycin, resp.  The variation in the reported outcomes amongst studies depends on the study design, location, funding, age and follow-up period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTT4SiLma897Vg90H21EOLACvtfcHk0lj3nAcg3hhjJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtlOgtbk%253D&md5=6addd564a3dce77eb24e4674e3559085</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.ijantimicag.2012.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijantimicag.2012.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DVardakas%26aufirst%3DK.%2BZ.%26aulast%3DPolyzos%26aufirst%3DK.%2BA.%26aulast%3DPatouni%26aufirst%3DK.%26aulast%3DRafailidis%26aufirst%3DP.%2BI.%26aulast%3DSamonis%26aufirst%3DG.%26aulast%3DFalagas%26aufirst%3DM.%2BE.%26atitle%3DTreatment%2520Failure%2520and%2520Recurrence%2520of%2520Clostridium%2520difficile%2520Infection%2520Following%2520Treatment%2520with%2520Vancomycin%2520or%2520Metronidazole%253A%2520A%2520Systematic%2520Review%2520of%2520the%2520Evidence%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2012%26volume%3D40%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Venugopal, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S.</span><span> </span><span class="NLM_article-title">Current State of <i>Clostridium difficile</i> Treatment Options</span> <span class="citation_source-journal">Clinical Infectious Diseases</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S71</span><span class="NLM_x">–</span> <span class="NLM_lpage">S76</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=S71-S76&issue=Suppl.+2&author=A.+A.+Venugopalauthor=S.+Johnson&title=Current+State+of+Clostridium+difficile+Treatment+Options"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVenugopal%26aufirst%3DA.%2BA.%26aulast%3DJohnson%26aufirst%3DS.%26atitle%3DCurrent%2520State%2520of%2520Clostridium%2520difficile%2520Treatment%2520Options%26jtitle%3DClinical%2520Infectious%2520Diseases%26date%3D2012%26volume%3D55%26issue%3DSuppl.%25202%26spage%3DS71%26epage%3DS76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Cornely, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crook, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorbach, S. L.</span><span> </span><span class="NLM_article-title">Treatment of First Recurrence of <i>Clostridium difficile</i> Infection: Fidaxomicin Versus Vancomycin</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S154</span><span class="NLM_x">–</span> <span class="NLM_lpage">S161</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=S154-S161&issue=Suppl.+2&author=O.+A.+Cornelyauthor=M.+A.+Millerauthor=T.+J.+Louieauthor=D.+W.+Crookauthor=S.+L.+Gorbach&title=Treatment+of+First+Recurrence+of+Clostridium+difficile+Infection%3A+Fidaxomicin+Versus+Vancomycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCornely%26aufirst%3DO.%2BA.%26aulast%3DMiller%26aufirst%3DM.%2BA.%26aulast%3DLouie%26aufirst%3DT.%2BJ.%26aulast%3DCrook%26aufirst%3DD.%2BW.%26aulast%3DGorbach%26aufirst%3DS.%2BL.%26atitle%3DTreatment%2520of%2520First%2520Recurrence%2520of%2520Clostridium%2520difficile%2520Infection%253A%2520Fidaxomicin%2520Versus%2520Vancomycin%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2012%26volume%3D55%26issue%3DSuppl.%25202%26spage%3DS154%26epage%3DS161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Louie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrne, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emery, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eyben, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krulicki, W.</span><span> </span><span class="NLM_article-title">Fidaxomicin Preserves the Intestinal Microbiome during and after Treatment of <i>Clostridium difficile</i> Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S132</span><span class="NLM_x">–</span> <span class="NLM_lpage">S142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=S132-S142&issue=Suppl.+2&author=T.+J.+Louieauthor=K.+Cannonauthor=B.+Byrneauthor=J.+Emeryauthor=L.+Wardauthor=M.+Eybenauthor=W.+Krulicki&title=Fidaxomicin+Preserves+the+Intestinal+Microbiome+during+and+after+Treatment+of+Clostridium+difficile+Infection+%28CDI%29+and+Reduces+Both+Toxin+Reexpression+and+Recurrence+of+CDI"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLouie%26aufirst%3DT.%2BJ.%26aulast%3DCannon%26aufirst%3DK.%26aulast%3DByrne%26aufirst%3DB.%26aulast%3DEmery%26aufirst%3DJ.%26aulast%3DWard%26aufirst%3DL.%26aulast%3DEyben%26aufirst%3DM.%26aulast%3DKrulicki%26aufirst%3DW.%26atitle%3DFidaxomicin%2520Preserves%2520the%2520Intestinal%2520Microbiome%2520during%2520and%2520after%2520Treatment%2520of%2520Clostridium%2520difficile%2520Infection%2520%2528CDI%2529%2520and%2520Reduces%2520Both%2520Toxin%2520Reexpression%2520and%2520Recurrence%2520of%2520CDI%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2012%26volume%3D55%26issue%3DSuppl.%25202%26spage%3DS132%26epage%3DS142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Finegold, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molitoris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaisanen, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolanos, M.</span><span> </span><span class="NLM_article-title">In Vitro Activities of OPT-80 and Comparator Drugs against Intestinal Bacteria</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4898</span><span class="NLM_x">–</span> <span class="NLM_lpage">4902</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=4898-4902&author=S.+M.+Finegoldauthor=D.+Molitorisauthor=M.+L.+Vaisanenauthor=Y.+Songauthor=C.+Liuauthor=M.+Bolanos&title=In+Vitro+Activities+of+OPT-80+and+Comparator+Drugs+against+Intestinal+Bacteria"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFinegold%26aufirst%3DS.%2BM.%26aulast%3DMolitoris%26aufirst%3DD.%26aulast%3DVaisanen%26aufirst%3DM.%2BL.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DBolanos%26aufirst%3DM.%26atitle%3DIn%2520Vitro%2520Activities%2520of%2520OPT-80%2520and%2520Comparator%2520Drugs%2520against%2520Intestinal%2520Bacteria%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D4898%26epage%3D4902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Babakhani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillaut, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sears, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonenshein, A. L.</span><span> </span><span class="NLM_article-title">Fidaxomicin Inhibits Spore Production in <i>Clostridium difficile</i></span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S162</span><span class="NLM_x">–</span> <span class="NLM_lpage">S169</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=S162-S169&issue=Suppl.+2&author=F.+Babakhaniauthor=L.+Bouillautauthor=A.+Gomezauthor=P.+Searsauthor=L.+Nguyenauthor=A.+L.+Sonenshein&title=Fidaxomicin+Inhibits+Spore+Production+in+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBabakhani%26aufirst%3DF.%26aulast%3DBouillaut%26aufirst%3DL.%26aulast%3DGomez%26aufirst%3DA.%26aulast%3DSears%26aufirst%3DP.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DSonenshein%26aufirst%3DA.%2BL.%26atitle%3DFidaxomicin%2520Inhibits%2520Spore%2520Production%2520in%2520Clostridium%2520difficile%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2012%26volume%3D55%26issue%3DSuppl.%25202%26spage%3DS162%26epage%3DS169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Müller, M.</span><span> </span><span class="NLM_article-title">Mode of Action of Metronidazole on Anaerobic Bacteria and Protozoa</span> <span class="citation_source-journal">Surgery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=6849201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADyaL3sXksVOgtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1983&pages=165-171&author=M.+M%C3%BCller&title=Mode+of+Action+of+Metronidazole+on+Anaerobic+Bacteria+and+Protozoa"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Mode of action of metronidazole on anaerobic bacteria and protozoa</span></div><div class="casAuthors">Mueller, Miklos</div><div class="citationInfo"><span class="NLM_cas:title">Surgery (St. Louis)</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">1, pt. 2</span>),
    <span class="NLM_cas:pages">165-71</span>CODEN:
                <span class="NLM_cas:coden">SURGAZ</span>;
        ISSN:<span class="NLM_cas:issn">0039-6060</span>.
    </div><div class="casAbstract">A review with 64 refs. of the antibacterial and protozoacidal activities of metronidazole (I)  [443-48-1].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor-3HRUQCoorVg90H21EOLACvtfcHk0lh-lHBCeLpCNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXksVOgtLk%253D&md5=f2ddd052469d34eb6779af4f38e0ff62</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26atitle%3DMode%2520of%2520Action%2520of%2520Metronidazole%2520on%2520Anaerobic%2520Bacteria%2520and%2520Protozoa%26jtitle%3DSurgery%26date%3D1983%26volume%3D93%26spage%3D165%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Edwards, D. I.</span><span> </span><span class="NLM_article-title">Nitroimidazole Drugs—Action and Resistance Mechanisms. II. Mechanisms of Resistance</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fjac%2F31.2.201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=8463167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADyaK3sXks1OgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1993&pages=201-210&author=D.+I.+Edwards&title=Nitroimidazole+Drugs%E2%80%94Action+and+Resistance+Mechanisms.+II.+Mechanisms+of+Resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Nitroimidazole drugs - action and resistance mechanisms. II. Mechanisms of resistance</span></div><div class="casAuthors">Edwards, David I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">201-10</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    </div><div class="casAbstract">A review with 57 refs. on drug resistance of nitroimidazole, esp. metronidazole, in bacteria and Trichomonas species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDufDmfbxSGbVg90H21EOLACvtfcHk0lh-lHBCeLpCNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXks1OgtLo%253D&md5=591df0019db20f5a8061322f1337ab11</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1093%2Fjac%2F31.2.201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252F31.2.201%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DD.%2BI.%26atitle%3DNitroimidazole%2520Drugs%25E2%2580%2594Action%2520and%2520Resistance%2520Mechanisms.%2520II.%2520Mechanisms%2520of%2520Resistance%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D1993%26volume%3D31%26spage%3D201%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Bolton, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culshaw, M. A.</span><span> </span><span class="NLM_article-title">Faecal Metronidazole Concentrations during Oral and Intravenous Therapy for Antibiotic Associated Colitis Due to <i>Clostridium difficile</i></span> <span class="citation_source-journal">Gut</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1169</span><span class="NLM_x">–</span> <span class="NLM_lpage">1172</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1986&pages=1169-1172&author=R.+P.+Boltonauthor=M.+A.+Culshaw&title=Faecal+Metronidazole+Concentrations+during+Oral+and+Intravenous+Therapy+for+Antibiotic+Associated+Colitis+Due+to+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBolton%26aufirst%3DR.%2BP.%26aulast%3DCulshaw%26aufirst%3DM.%2BA.%26atitle%3DFaecal%2520Metronidazole%2520Concentrations%2520during%2520Oral%2520and%2520Intravenous%2520Therapy%2520for%2520Antibiotic%2520Associated%2520Colitis%2520Due%2520to%2520Clostridium%2520difficile%26jtitle%3DGut%26date%3D1986%26volume%3D27%26spage%3D1169%26epage%3D1172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Pepin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alary, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valiquette, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raiche, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulop, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourassa, C.</span><span> </span><span class="NLM_article-title">Increasing Risk of Relapse after Treatment of <i>Clostridium difficile</i> Colitis in Quebec, Canada</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1591</span><span class="NLM_x">–</span> <span class="NLM_lpage">1597</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1086%2F430315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=15889355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlCltLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2005&pages=1591-1597&author=J.+Pepinauthor=M.+E.+Alaryauthor=L.+Valiquetteauthor=E.+Raicheauthor=J.+Ruelauthor=K.+Fulopauthor=D.+Godinauthor=C.+Bourassa&title=Increasing+Risk+of+Relapse+after+Treatment+of+Clostridium+difficile+Colitis+in+Quebec%2C+Canada"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada</span></div><div class="casAuthors">Pepin, Jacques; Alary, Marie-Eve; Valiquette, Louis; Raiche, Evelyne; Ruel, Joannie; Fulop, Katalin; Godin, Dominique; Bourassa, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1591-1597</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Background: Clinicians who treat patients with Clostridium difficile-assocd. diarrhea (CDAD) in Quebec, Canada, have noted an apparent increase in the proportion of patients who experience relapse.  Methods: To det. whether there was an increase in the frequency of treatment failure and of recurrence of CDAD after treatment, we reviewed data on cases that had been diagnosed in a hospital in the province of Quebec during the period 1991-2004.  The frequency of recurrences within 60 days after the initial diagnosis was measured using Kaplan-Meier anal., and Cox regression was used for multivariate anal.  Results: Among patients who had initially been treated with metronidazole, the proportion whose regimens were switched to vancomycin or for whom vancomycin was added because of a disappointing response did not vary between 1991 and 2002 (66 [9.6%] of 688 patients overall) but more than doubled in 2003-2004 (112 [25.7%] of 435; P < .001).  Among 845 patients treated with metronidazole only, the 60-day probability of recurrence increased dramatically in 2003-2004 (47.2%), compared with 1991-2002 (20.8%; P < .001).  During 1991-2002, the probabilities of recurrence were 20.0%, 13.8%, and 28.9% among individuals aged 0-17, 18-64, and ≥65 years, resp.; during 2003-2004, the probabilities were 25.0%, 27.1%, and 58.4%, resp.  Conclusion: In 2003-2004, there was an increase in the proportion of patients with CDAD believed, by their attending physicians, to have experienced metronidazole treatment failure, as well as an increase in the frequency of post-metronidazole therapy recurrences, esp. among elderly persons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreNFxjJULaRLVg90H21EOLACvtfcHk0lh-lHBCeLpCNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlCltLY%253D&md5=5be43d85e2da32190ef94434ac54a330</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1086%2F430315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F430315%26sid%3Dliteratum%253Aachs%26aulast%3DPepin%26aufirst%3DJ.%26aulast%3DAlary%26aufirst%3DM.%2BE.%26aulast%3DValiquette%26aufirst%3DL.%26aulast%3DRaiche%26aufirst%3DE.%26aulast%3DRuel%26aufirst%3DJ.%26aulast%3DFulop%26aufirst%3DK.%26aulast%3DGodin%26aufirst%3DD.%26aulast%3DBourassa%26aufirst%3DC.%26atitle%3DIncreasing%2520Risk%2520of%2520Relapse%2520after%2520Treatment%2520of%2520Clostridium%2520difficile%2520Colitis%2520in%2520Quebec%252C%2520Canada%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2005%26volume%3D40%26spage%3D1591%26epage%3D1597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Loll, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axelsen, P. H.</span><span> </span><span class="NLM_article-title">The Structural Biology of Molecular Recognition by Vancomycin</span> <span class="citation_source-journal">Annu. Rev. Biophys. Biomol. Struct.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2000&pages=265-289&author=P.+J.+Lollauthor=P.+H.+Axelsen&title=The+Structural+Biology+of+Molecular+Recognition+by+Vancomycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLoll%26aufirst%3DP.%2BJ.%26aulast%3DAxelsen%26aufirst%3DP.%2BH.%26atitle%3DThe%2520Structural%2520Biology%2520of%2520Molecular%2520Recognition%2520by%2520Vancomycin%26jtitle%3DAnnu.%2520Rev.%2520Biophys.%2520Biomol.%2520Struct.%26date%3D2000%26volume%3D29%26spage%3D265%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Beauregard, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwynn, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knowles, D. J.</span><span> </span><span class="NLM_article-title">Dimerization and Membrane Anchors in Extracellular Targeting of Vancomycin Group Antibiotics</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">785</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1995&pages=781-785&author=D.+A.+Beauregardauthor=D.+H.+Williamsauthor=M.+N.+Gwynnauthor=D.+J.+Knowles&title=Dimerization+and+Membrane+Anchors+in+Extracellular+Targeting+of+Vancomycin+Group+Antibiotics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeauregard%26aufirst%3DD.%2BA.%26aulast%3DWilliams%26aufirst%3DD.%2BH.%26aulast%3DGwynn%26aufirst%3DM.%2BN.%26aulast%3DKnowles%26aufirst%3DD.%2BJ.%26atitle%3DDimerization%2520and%2520Membrane%2520Anchors%2520in%2520Extracellular%2520Targeting%2520of%2520Vancomycin%2520Group%2520Antibiotics%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1995%26volume%3D39%26spage%3D781%26epage%3D785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Finegold, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molitoris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaisanen, M. L.</span><span> </span><span class="NLM_article-title">Study of the in Vitro Activities of Rifaximin and Comparator Agents against 536 Anaerobic Intestinal Bacteria from the Perspective of Potential Utility in Pathology Involving Bowel Flora</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2008&pages=281-286&author=S.+M.+Finegoldauthor=D.+Molitorisauthor=M.+L.+Vaisanen&title=Study+of+the+in+Vitro+Activities+of+Rifaximin+and+Comparator+Agents+against+536+Anaerobic+Intestinal+Bacteria+from+the+Perspective+of+Potential+Utility+in+Pathology+Involving+Bowel+Flora"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFinegold%26aufirst%3DS.%2BM.%26aulast%3DMolitoris%26aufirst%3DD.%26aulast%3DVaisanen%26aufirst%3DM.%2BL.%26atitle%3DStudy%2520of%2520the%2520in%2520Vitro%2520Activities%2520of%2520Rifaximin%2520and%2520Comparator%2520Agents%2520against%2520536%2520Anaerobic%2520Intestinal%2520Bacteria%2520from%2520the%2520Perspective%2520of%2520Potential%2520Utility%2520in%2520Pathology%2520Involving%2520Bowel%2520Flora%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D53%26spage%3D281%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Jiang, Z. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palazzini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riopel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupont, H.</span><span> </span><span class="NLM_article-title">In Vitro Activity and Fecal Concentration of Rifaximin after Oral Administration</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2205</span><span class="NLM_x">–</span> <span class="NLM_lpage">2206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2000&pages=2205-2206&author=Z.+D.+Jiangauthor=S.+Keauthor=E.+Palazziniauthor=L.+Riopelauthor=H.+Dupont&title=In+Vitro+Activity+and+Fecal+Concentration+of+Rifaximin+after+Oral+Administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%2BD.%26aulast%3DKe%26aufirst%3DS.%26aulast%3DPalazzini%26aufirst%3DE.%26aulast%3DRiopel%26aufirst%3DL.%26aulast%3DDupont%26aufirst%3DH.%26atitle%3DIn%2520Vitro%2520Activity%2520and%2520Fecal%2520Concentration%2520of%2520Rifaximin%2520after%2520Oral%2520Administration%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2000%26volume%3D44%26spage%3D2205%26epage%3D2206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span>New Drug To Fight Hospital Superbug Infection. <a href="http://www.specialisedtherapeutics.com.au/index.php?q=new-drug-to-fight-hospital-superbug-infection.html" class="extLink">http://www.specialisedtherapeutics.com.au/index.php?q=new-drug-to-fight-hospital-superbug-infection.html</a> (accessed Mar 20,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=New+Drug+To+Fight+Hospital+Superbug+Infection.+http%3A%2F%2Fwww.specialisedtherapeutics.com.au%2Findex.php%3Fq%3Dnew-drug-to-fight-hospital-superbug-infection.html+%28accessed+Mar+20%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Crook, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kean, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornely, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoesser, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angus, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorbach, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peto, T. E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Study 003/004 Teams.</span><span> </span><span class="NLM_article-title">Fidaxomicin Versus Vancomycin for <i>Clostridium difficile</i> Infection: Meta-Analysis of Pivotal Randomized Controlled Trials</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">S93</span><span class="NLM_x">–</span> <span class="NLM_lpage">S103</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=S93-S103&author=D.+W.+Crookauthor=A.+S.+Walkerauthor=Y.+Keanauthor=K.+Weissauthor=O.+A.+Cornelyauthor=M.+A.+Millerauthor=R.+Espositoauthor=T.+J.+Louieauthor=N.+E.+Stoesserauthor=B.+C.+Youngauthor=B.+J.+Angusauthor=S.+L.+Gorbachauthor=T.+E.+A.+Petoauthor=Study+003%2F004+Teams.&title=Fidaxomicin+Versus+Vancomycin+for+Clostridium+difficile+Infection%3A+Meta-Analysis+of+Pivotal+Randomized+Controlled+Trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrook%26aufirst%3DD.%2BW.%26aulast%3DWalker%26aufirst%3DA.%2BS.%26aulast%3DKean%26aufirst%3DY.%26aulast%3DWeiss%26aufirst%3DK.%26aulast%3DCornely%26aufirst%3DO.%2BA.%26aulast%3DMiller%26aufirst%3DM.%2BA.%26aulast%3DEsposito%26aufirst%3DR.%26aulast%3DLouie%26aufirst%3DT.%2BJ.%26aulast%3DStoesser%26aufirst%3DN.%2BE.%26aulast%3DYoung%26aufirst%3DB.%2BC.%26aulast%3DAngus%26aufirst%3DB.%2BJ.%26aulast%3DGorbach%26aufirst%3DS.%2BL.%26aulast%3DPeto%26aufirst%3DT.%2BE.%2BA.%26aulast%3D%26atitle%3DFidaxomicin%2520Versus%2520Vancomycin%2520for%2520Clostridium%2520difficile%2520Infection%253A%2520Meta-Analysis%2520of%2520Pivotal%2520Randomized%2520Controlled%2520Trials%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2012%26volume%3D55%26spage%3DS93%26epage%3DS103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Erb, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span> </span><span class="NLM_article-title">From Natural Product to Marketed Drug: the Tiacumicin Odyssey</span> <span class="citation_source-journal">Nat. Prod. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1039%2FC2NP20080E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=23111588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVWhtr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=161-174&author=W.+Erbauthor=J.+Zhu&title=From+Natural+Product+to+Marketed+Drug%3A+the+Tiacumicin+Odyssey"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">From natural product to marketed drug: the tiacumicin odyssey</span></div><div class="casAuthors">Erb, William; Zhu, Jieping</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">161-174</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Covering: 1975 to 2012The first members of the tiacumicin family of antibiotics, encompassing more than 40 compds., were isolated in 1975.  Structurally, the core aglycon is an 18-membered macrolactone having two conjugated diene units, one isolated double bond, 5 stereogenic centers and most often, at least one glycosidic linkage.  Tiacumicin B, a RNA synthesis inhibitor, is a narrow-spectrum antibiotic against clostridia.  For the treatment of Clostridium difficile infection (CDI), it has the same cure rate as vancomycin but with lower relapse rate and was approved by the FDA in May 2011.  The aim of this review is to present an overview of the chem. and biol. of tiacumicins since their discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcFIksUUNzBLVg90H21EOLACvtfcHk0lh2uKkZWj4Tgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVWhtr%252FE&md5=e81d026f6ed1e7534b787fd31eff05c8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2FC2NP20080E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2NP20080E%26sid%3Dliteratum%253Aachs%26aulast%3DErb%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DJ.%26atitle%3DFrom%2520Natural%2520Product%2520to%2520Marketed%2520Drug%253A%2520the%2520Tiacumicin%2520Odyssey%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2013%26volume%3D30%26spage%3D161%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Lynch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hizon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beniac, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kibsey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gravel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvey, M. R.</span><span> </span><span class="NLM_article-title">Canadian Nosocomial Infectious Surveillance Program (CNISP). Characterization of a Stable, Metronidazole-Resistant <i>Clostridium difficile</i> Clinical Isolate</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e53757</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e53757&author=T.+Lynchauthor=P.+Chongauthor=J.+Zhangauthor=R.+Hizonauthor=T.+Duauthor=M.+R.+Grahamauthor=D.+R.+Beniacauthor=T.+F.+Boothauthor=P.+Kibseyauthor=M.+Millerauthor=D.+Gravelauthor=M.+R.+Mulvey&title=Canadian+Nosocomial+Infectious+Surveillance+Program+%28CNISP%29.+Characterization+of+a+Stable%2C+Metronidazole-Resistant+Clostridium+difficile+Clinical+Isolate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DT.%26aulast%3DChong%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DHizon%26aufirst%3DR.%26aulast%3DDu%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DM.%2BR.%26aulast%3DBeniac%26aufirst%3DD.%2BR.%26aulast%3DBooth%26aufirst%3DT.%2BF.%26aulast%3DKibsey%26aufirst%3DP.%26aulast%3DMiller%26aufirst%3DM.%26aulast%3DGravel%26aufirst%3DD.%26aulast%3DMulvey%26aufirst%3DM.%2BR.%26atitle%3DCanadian%2520Nosocomial%2520Infectious%2520Surveillance%2520Program%2520%2528CNISP%2529.%2520Characterization%2520of%2520a%2520Stable%252C%2520Metronidazole-Resistant%2520Clostridium%2520difficile%2520Clinical%2520Isolate%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De53757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Snydman, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobus, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, L. A.</span><span> </span><span class="NLM_article-title">Activity of a Novel Cyclic Lipopeptide, CB-183,315, against Resistant <i>Clostridium difficile</i> and Other Gram-Positive Aerobic and Anaerobic Intestinal Pathogens</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3448</span><span class="NLM_x">–</span> <span class="NLM_lpage">3452</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=3448-3452&author=D.+R.+Snydmanauthor=N.+V.+Jacobusauthor=L.+A.+McDermott&title=Activity+of+a+Novel+Cyclic+Lipopeptide%2C+CB-183%2C315%2C+against+Resistant+Clostridium+difficile+and+Other+Gram-Positive+Aerobic+and+Anaerobic+Intestinal+Pathogens"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSnydman%26aufirst%3DD.%2BR.%26aulast%3DJacobus%26aufirst%3DN.%2BV.%26aulast%3DMcDermott%26aufirst%3DL.%2BA.%26atitle%3DActivity%2520of%2520a%2520Novel%2520Cyclic%2520Lipopeptide%252C%2520CB-183%252C315%252C%2520against%2520Resistant%2520Clostridium%2520difficile%2520and%2520Other%2520Gram-Positive%2520Aerobic%2520and%2520Anaerobic%2520Intestinal%2520Pathogens%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D3448%26epage%3D3452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baines, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corver, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawley, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goorhuis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuijper, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. H.</span><span> </span><span class="NLM_article-title">The Changing Epidemiology of <i>Clostridium difficile</i> Infections</span> <span class="citation_source-journal">Clin. Microbiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">549</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1128%2FCMR.00082-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=20610822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWgtLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=529-549&author=J.+Freemanauthor=M.+P.+Bauerauthor=S.+D.+Bainesauthor=J.+Corverauthor=W.+N.+Fawleyauthor=B.+Goorhuisauthor=E.+J.+Kuijperauthor=M.+H.+Wilcox&title=The+Changing+Epidemiology+of+Clostridium+difficile+Infections"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The changing epidemiology of Clostridium difficile infections</span></div><div class="casAuthors">Freeman, J.; Bauer, M. P.; Baines, S. D.; Corver, J.; Fawley, W. N.; Goorhuis, B.; Kuijper, E. J.; Wilcox, M. H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">529-549</span>CODEN:
                <span class="NLM_cas:coden">CMIREX</span>;
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  The epidemiol. of Clostridium difficile infection (CDI) has changed dramatically during this millennium.  Infection rates have increased markedly in most countries with detailed surveillance data.  There have been clear changes in the clin. presentation, response to treatment, and outcome of CDI.  These changes have been driven to a major degree by the emergence and epidemic spread of a novel strain, known as PCR ribotype 027 (sometimes referred to as BI/NAP1/027).  We review the evidence for the changing epidemiol., clin. virulence and outcome of treatment of CDI, and the similarities and differences between data from various countries and continents.  Community-acquired CDI has also emerged, although the evidence for this as a distinct new entity is less clear.  There are new data on the etiol. of and potential risk factors for CDI; controversial issues include specific antimicrobial agents, gastric acid suppressants, potential animal and food sources of C. difficile, and the effect of the use of alc.-based hand hygiene agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj5gUdmKNzDLVg90H21EOLACvtfcHk0lh2uKkZWj4Tgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWgtLjI&md5=fcfd1a5f5ac00d61e03bcac78f21d84f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1128%2FCMR.00082-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.00082-09%26sid%3Dliteratum%253Aachs%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DBauer%26aufirst%3DM.%2BP.%26aulast%3DBaines%26aufirst%3DS.%2BD.%26aulast%3DCorver%26aufirst%3DJ.%26aulast%3DFawley%26aufirst%3DW.%2BN.%26aulast%3DGoorhuis%26aufirst%3DB.%26aulast%3DKuijper%26aufirst%3DE.%2BJ.%26aulast%3DWilcox%26aufirst%3DM.%2BH.%26atitle%3DThe%2520Changing%2520Epidemiology%2520of%2520Clostridium%2520difficile%2520Infections%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D2010%26volume%3D23%26spage%3D529%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weintraub, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nord, C. E.</span><span> </span><span class="NLM_article-title">Antimicrobial Resistance in <i>Clostridium difficile</i></span> <span class="citation_source-journal">Int. J. Antimicrob. Agents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">516</span><span class="NLM_x">–</span> <span class="NLM_lpage">522</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1016%2Fj.ijantimicag.2009.09.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=19828299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlGhs7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=516-522&author=H.+Huangauthor=A.+Weintraubauthor=H.+Fangauthor=C.+E.+Nord&title=Antimicrobial+Resistance+in+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial resistance in Clostridium difficile</span></div><div class="casAuthors">Huang, Haihui; Weintraub, Andrej; Fang, Hong; Nord, Carl Erik</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">516-522</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Clostridium difficile is the leading cause of hospital-acquired diarrhea, and the no. of outbreaks has risen markedly since 2003.  The emergence and spread of resistance in C. difficile has complicated treatment and prevention.  Most isolates are susceptible to vancomycin and metronidazole (MTZ); however, transient and heteroresistance to MTZ have been reported.  The prevalence of resistance to other antimicrobial agents is highly variable in different populations and in different countries, ranging from 0% to 100%.  Isolates of common PCR ribotypes are more resistant than uncommon ribotypes.  Most of the resistance mechanisms that have been identified in C. difficile are similar to those in other Gram-pos. bacteria, including mutation, selection, and acquisition of the genetic information that encodes resistance.  Better antibiotic stewardship and infection control are needed to prevent further spread of resistance in C. difficile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7gAYS41tNFbVg90H21EOLACvtfcHk0liVC8SKNWbwOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlGhs7vL&md5=f3c925e9c1b6129c26d801a10f2e54d1</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.ijantimicag.2009.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijantimicag.2009.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DWeintraub%26aufirst%3DA.%26aulast%3DFang%26aufirst%3DH.%26aulast%3DNord%26aufirst%3DC.%2BE.%26atitle%3DAntimicrobial%2520Resistance%2520in%2520Clostridium%2520difficile%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2009%26volume%3D34%26spage%3D516%26epage%3D522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Peláez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cercenado, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcalá, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marín, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martín-López, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-Alarcón, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catalán, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez-Somolinos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouza, E.</span><span> </span><span class="NLM_article-title">Metronidazole Resistance in <i>Clostridium difficile</i> Is Heterogeneous</span> <span class="citation_source-journal">J. Clin. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3028</span><span class="NLM_x">–</span> <span class="NLM_lpage">3032</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1128%2FJCM.00524-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=18650353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFOku7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2008&pages=3028-3032&author=T.+Pel%C3%A1ezauthor=E.+Cercenadoauthor=L.+Alcal%C3%A1author=M.+Mar%C3%ADnauthor=A.+Mart%C3%ADn-L%C3%B3pezauthor=J.+Mart%C3%ADnez-Alarc%C3%B3nauthor=P.+Catal%C3%A1nauthor=M.+S%C3%A1nchez-Somolinosauthor=E.+Bouza&title=Metronidazole+Resistance+in+Clostridium+difficile+Is+Heterogeneous"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Metronidazole resistance in Clostridium difficile is heterogeneous</span></div><div class="casAuthors">Pelaez, T.; Cercenado, E.; Alcala, L.; Marin, M.; Martin-Lopez, A.; Martinez-Alarcon, J.; Catalan, P.; Sanchez-Somolinos, M.; Bouza, E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Microbiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3028-3032</span>CODEN:
                <span class="NLM_cas:coden">JCMIDW</span>;
        ISSN:<span class="NLM_cas:issn">0095-1137</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">At our institution, the prevalence of clin. isolates of Clostridium difficile with resistance to metronidazole is 6.3%.  We obsd. that initial metronidazole MICs of 16 to 64 mg/L against toxigenic, primary fresh C. difficile isolates, as detd. by agar diln., decreased to 0.125 mg/L after the isolates were thawed.  In this study, we examd. the possibility of heterogeneous or inducible resistance.  Totals of 14 metronidazole-resistant and 10 metronidazole-susceptible clin. isolates of toxigenic C. difficile were studied.  The isolates were investigated for the presence of nim genes by PCR.  After the isolates were thawed, susceptibility testing was done by agar diln., by disk diffusion using a 5-μg metronidazole disk, and by the Etest method.  An expt. for detg. the effect of prolonged exposure to metronidazole was applied to all resistant isolates and to susceptible control strains.  None of the isolates presented the nim genes.  All initially metronidazole-resistant C. difficile isolates became susceptible after thawing; however, they presented slow-growing subpopulations within the inhibition zones of both the disk and the Etest strip.  All metronidazole-susceptible isolates remained homogeneously susceptible by both methods.  After prolonged exposure in vitro to metronidazole, no zone of inhibition was found around the 5-μg disk in any of the metronidazole-resistant isolates, and the MICs as detd. by the Etest method ranged from 0.125 to >256 mg/L, with colonies growing inside the inhibition zone.  Our results indicate that (i) resistance to metronidazole was not due to the presence of nim genes, (ii) resistance to metronidazole in toxigenic C. difficile isolates is heterogeneous, and (iii) prolonged exposure to metronidazole can select for in vitro resistance.  We recommend routine performance of the disk diffusion method (5-μg metronidazole disk) with primary fresh C. difficile isolates in order to ensure that metronidazole-heteroresistant populations do not go undetected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp33HFIX6NNzrVg90H21EOLACvtfcHk0liVC8SKNWbwOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFOku7vO&md5=2a91c7d8966298827704936bce32639b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1128%2FJCM.00524-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJCM.00524-08%26sid%3Dliteratum%253Aachs%26aulast%3DPel%25C3%25A1ez%26aufirst%3DT.%26aulast%3DCercenado%26aufirst%3DE.%26aulast%3DAlcal%25C3%25A1%26aufirst%3DL.%26aulast%3DMar%25C3%25ADn%26aufirst%3DM.%26aulast%3DMart%25C3%25ADn-L%25C3%25B3pez%26aufirst%3DA.%26aulast%3DMart%25C3%25ADnez-Alarc%25C3%25B3n%26aufirst%3DJ.%26aulast%3DCatal%25C3%25A1n%26aufirst%3DP.%26aulast%3DS%25C3%25A1nchez-Somolinos%26aufirst%3DM.%26aulast%3DBouza%26aufirst%3DE.%26atitle%3DMetronidazole%2520Resistance%2520in%2520Clostridium%2520difficile%2520Is%2520Heterogeneous%26jtitle%3DJ.%2520Clin.%2520Microbiol.%26date%3D2008%26volume%3D46%26spage%3D3028%26epage%3D3032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Goldstein, E. J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sears, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babakhani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambol, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerding, D. N.</span><span> </span><span class="NLM_article-title">Comparative Susceptibilities to Fidaxomicin (OPT-80) of Isolates Collected at Baseline, Recurrence, and Failure from Patients in Two Phase III Trials of Fidaxomicin against <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5194</span><span class="NLM_x">–</span> <span class="NLM_lpage">5199</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=5194-5199&author=E.+J.+C.+Goldsteinauthor=D.+M.+Citronauthor=P.+Searsauthor=F.+Babakhaniauthor=S.+P.+Sambolauthor=D.+N.+Gerding&title=Comparative+Susceptibilities+to+Fidaxomicin+%28OPT-80%29+of+Isolates+Collected+at+Baseline%2C+Recurrence%2C+and+Failure+from+Patients+in+Two+Phase+III+Trials+of+Fidaxomicin+against+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DE.%2BJ.%2BC.%26aulast%3DCitron%26aufirst%3DD.%2BM.%26aulast%3DSears%26aufirst%3DP.%26aulast%3DBabakhani%26aufirst%3DF.%26aulast%3DSambol%26aufirst%3DS.%2BP.%26aulast%3DGerding%26aufirst%3DD.%2BN.%26atitle%3DComparative%2520Susceptibilities%2520to%2520Fidaxomicin%2520%2528OPT-80%2529%2520of%2520Isolates%2520Collected%2520at%2520Baseline%252C%2520Recurrence%252C%2520and%2520Failure%2520from%2520Patients%2520in%2520Two%2520Phase%2520III%2520Trials%2520of%2520Fidaxomicin%2520against%2520Clostridium%2520difficile%2520Infection%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2011%26volume%3D55%26spage%3D5194%26epage%3D5199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Grant, E. M.</span><span> </span><span class="NLM_article-title">Fidaxomicin: New Therapy for <i>Clostridium difficile</i>-Associated Diarrhea</span> <span class="citation_source-journal">Formulary</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1eisr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=297-308&author=E.+M.+Grant&title=Fidaxomicin%3A+New+Therapy+for+Clostridium+difficile-Associated+Diarrhea"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Fidaxomicin: new therapy for Clostridium difficile-associated diarrhea</span></div><div class="casAuthors">Grant, Edward M.</div><div class="citationInfo"><span class="NLM_cas:title">Formulary</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">297,298, 302-308</span>CODEN:
                <span class="NLM_cas:coden">FORMF9</span>;
        ISSN:<span class="NLM_cas:issn">1082-801X</span>.
    
            (<span class="NLM_cas:orgname">Advanstar Communications, Inc.</span>)
        </div><div class="casAbstract">A review.  Fidaxomicin is a new oral, nonsystemic macrolide with twice daily dosing that was recently FDA approved to treat Clostridium difficile-assocd. diarrhea (CDAD) in adults (≥18 years of age).  It is a bactericidal agent against C difficile, demonstrates no cross resistance with other classes of antimicrobial agents, and in vitro studies suggest a low frequency of spontaneous resistance of C difficile to fidaxomicin.  In 2 randomized, double-blind clin. studies, clin. response rates to fidaxomicin were shown to be noninferior to those with vancomycin at end of treatment, and fidaxomicin was superior to vancomycin at preventing CDAD recurrences.  For the first time in >30 years, clinicians have a new oral antibiotic to treat C difficile infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6W_3k4kSEi7Vg90H21EOLACvtfcHk0ljWrwRlnT93bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1eisr%252FJ&md5=028cb7457da8b8d136a6b1fd77d514ce</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrant%26aufirst%3DE.%2BM.%26atitle%3DFidaxomicin%253A%2520New%2520Therapy%2520for%2520Clostridium%2520difficile-Associated%2520Diarrhea%26jtitle%3DFormulary%26date%3D2011%26volume%3D46%26spage%3D297%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">O’Connor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galang, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambol, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedantam, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerding, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S.</span><span> </span><span class="NLM_article-title">Rifampin and Rifaximin Resistance in Clinical Isolates of <i>Clostridium difficile</i></span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2813</span><span class="NLM_x">–</span> <span class="NLM_lpage">2817</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=2813-2817&author=J.+R.+O%E2%80%99Connorauthor=M.+A.+Galangauthor=S.+P.+Sambolauthor=D.+W.+Hechtauthor=G.+Vedantamauthor=D.+N.+Gerdingauthor=S.+Johnson&title=Rifampin+and+Rifaximin+Resistance+in+Clinical+Isolates+of+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DJ.%2BR.%26aulast%3DGalang%26aufirst%3DM.%2BA.%26aulast%3DSambol%26aufirst%3DS.%2BP.%26aulast%3DHecht%26aufirst%3DD.%2BW.%26aulast%3DVedantam%26aufirst%3DG.%26aulast%3DGerding%26aufirst%3DD.%2BN.%26aulast%3DJohnson%26aufirst%3DS.%26atitle%3DRifampin%2520and%2520Rifaximin%2520Resistance%2520in%2520Clinical%2520Isolates%2520of%2520Clostridium%2520difficile%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D2813%26epage%3D2817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Johnson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homann, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bettin, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quick, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clabots, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerding, D. N.</span><span> </span><span class="NLM_article-title">Treatment of Asymptomatic <i>Clostridium difficile</i> Carriers (Fecal Excretors) with Vancomycin or Metronidazole. A Randomized, Placebo-Controlled Trial</span> <span class="citation_source-journal">Ann. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.7326%2F0003-4819-117-4-297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=1322075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADyaK38zksVWmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1992&pages=297-302&author=S.+Johnsonauthor=S.+R.+Homannauthor=K.+M.+Bettinauthor=J.+N.+Quickauthor=C.+R.+Clabotsauthor=L.+R.+Petersonauthor=D.+N.+Gerding&title=Treatment+of+Asymptomatic+Clostridium+difficile+Carriers+%28Fecal+Excretors%29+with+Vancomycin+or+Metronidazole.+A+Randomized%2C+Placebo-Controlled+Trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial</span></div><div class="casAuthors">Johnson S; Homann S R; Bettin K M; Quick J N; Clabots C R; Peterson L R; Gerding D N</div><div class="citationInfo"><span class="NLM_cas:title">Annals of internal medicine</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">297-302</span>
        ISSN:<span class="NLM_cas:issn">0003-4819</span>.
    </div><div class="casAbstract">OBJECTIVE:  To compare the efficacy of vancomycin and metronidazole for eradication of asymptomatic Clostridium difficile fecal excretion as a means of controlling nosocomial outbreaks of C. difficile diarrhea.  DESIGN:  Randomized, placebo-controlled, non-blinded trial.  SETTING:  Six hundred-bed regional referral Veterans Affairs Medical Center.  PATIENTS:  Thirty patients excreting C. difficile without diarrhea or abdominal symptoms.  INTERVENTIONS:  All patients were randomized to receive 10 days of oral vancomycin, 125 mg four times daily; metronidazole, 500 mg twice daily; or placebo, three times daily.  MEASUREMENTS:  Stool cultures were obtained during treatment and for 2 months after treatment.  All C. difficile isolates were typed by restriction endonuclease analysis (REA).  RESULTS:  Clostridium difficile organisms were not detected during and immediately after treatment in 9 of 10 patients treated with vancomycin compared with 3 of 10 patients treated with metronidazole (P = 0.02) and 2 of 10 patients in the placebo group (P = 0.005).  The fecal vancomycin concentration was 1406 +/- 1164 micrograms/g feces, but metronidazole was not detectable in 9 of 10 patients.  Eight of the nine evaluable patients who had negative stool cultures after treatment with vancomycin began to excrete C. difficile again 20 +/- 8 days after completing treatment.  Three of these patients received additional antibiotics before C. difficile excretion recurred, and five acquired new C. difficile REA strains.  Four of six patients who received only vancomycin before C. difficile excretion recurred were culture-positive at the end of the study compared with one of nine patients who received only placebo (P = 0.047).  CONCLUSIONS:  Asymptomatic fecal excretion of C. difficile is transient in most patients, and treatment with metronidazole is not effective.  Although treatment with vancomycin is temporarily effective, it is associated with a significantly higher rate of C. difficile carriage 2 months after treatment and is not recommended.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRD-3Sno8N1VaqcneEtCi92fW6udTcc2eblNYvPOx51b7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38zksVWmtA%253D%253D&md5=c023a9331bd8a715ae501c2c7e1195e3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-117-4-297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-117-4-297%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DS.%26aulast%3DHomann%26aufirst%3DS.%2BR.%26aulast%3DBettin%26aufirst%3DK.%2BM.%26aulast%3DQuick%26aufirst%3DJ.%2BN.%26aulast%3DClabots%26aufirst%3DC.%2BR.%26aulast%3DPeterson%26aufirst%3DL.%2BR.%26aulast%3DGerding%26aufirst%3DD.%2BN.%26atitle%3DTreatment%2520of%2520Asymptomatic%2520Clostridium%2520difficile%2520Carriers%2520%2528Fecal%2520Excretors%2529%2520with%2520Vancomycin%2520or%2520Metronidazole.%2520A%2520Randomized%252C%2520Placebo-Controlled%2520Trial%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D1992%26volume%3D117%26spage%3D297%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Sears, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crook, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, K.</span><span> </span><span class="NLM_article-title">Fidaxomicin Attains High Fecal Concentrations with Minimal Plasma Concentrations Following Oral Administration in Patients with <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S116</span><span class="NLM_x">–</span> <span class="NLM_lpage">S120</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=S116-S120&issue=Suppl.+2&author=P.+Searsauthor=D.+W.+Crookauthor=T.+J.+Louieauthor=M.+A.+Millerauthor=K.+Weiss&title=Fidaxomicin+Attains+High+Fecal+Concentrations+with+Minimal+Plasma+Concentrations+Following+Oral+Administration+in+Patients+with+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSears%26aufirst%3DP.%26aulast%3DCrook%26aufirst%3DD.%2BW.%26aulast%3DLouie%26aufirst%3DT.%2BJ.%26aulast%3DMiller%26aufirst%3DM.%2BA.%26aulast%3DWeiss%26aufirst%3DK.%26atitle%3DFidaxomicin%2520Attains%2520High%2520Fecal%2520Concentrations%2520with%2520Minimal%2520Plasma%2520Concentrations%2520Following%2520Oral%2520Administration%2520in%2520Patients%2520with%2520Clostridium%2520difficile%2520Infection%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2012%26volume%3D55%26issue%3DSuppl.%25202%26spage%3DS116%26epage%3DS120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Kelly, C. P.</span><span> </span><span class="NLM_article-title">Fecal Microbiota Transplantation—An Old Therapy Comes of Age</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">474</span><span class="NLM_x">–</span> <span class="NLM_lpage">475</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1056%2FNEJMe1214816" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=23323865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVeltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2013&pages=474-475&author=C.+P.+Kelly&title=Fecal+Microbiota+Transplantation%E2%80%94An+Old+Therapy+Comes+of+Age"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Fecal microbiota transplantation - an old therapy comes of age</span></div><div class="casAuthors">Kelly, Ciaran P.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">474-475</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqABqdif50EO7Vg90H21EOLACvtfcHk0lj8jWA3U5jToQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVeltrw%253D&md5=8f7e32893005cdc4d0025dd66aa917f1</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1056%2FNEJMe1214816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMe1214816%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DC.%2BP.%26atitle%3DFecal%2520Microbiota%2520Transplantation%25E2%2580%2594An%2520Old%2520Therapy%2520Comes%2520of%2520Age%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D368%26spage%3D474%26epage%3D475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Van Nood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrieze, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieuwdorp, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuentes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoetendal, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vos, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuijper, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartelsman, J. F. W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tijssen, J. G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speelman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dijkgraaf, M. G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, J. J.</span><span> </span><span class="NLM_article-title">Duodenal Infusion of Donor Feces for Recurrent <i>Clostridium difficile</i></span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1056%2FNEJMoa1205037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=23323867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVelsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2013&pages=407-415&author=E.+Van+Noodauthor=A.+Vriezeauthor=M.+Nieuwdorpauthor=S.+Fuentesauthor=E.+G.+Zoetendalauthor=W.+M.+de+Vosauthor=C.+E.+Visserauthor=E.+J.+Kuijperauthor=J.+F.+W.+M.+Bartelsmanauthor=J.+G.+P.+Tijssenauthor=P.+Speelmanauthor=M.+G.+W.+Dijkgraafauthor=J.+J.+Keller&title=Duodenal+Infusion+of+Donor+Feces+for+Recurrent+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Duodenal infusion of donor feces for recurrent clostridium difficile</span></div><div class="casAuthors">van Nood, Els; Vrieze, Anne; Nieuwdorp, Max; Fuentes, Susana; Zoetendal, Erwin G.; de Vos, Willem M.; Visser, Caroline E.; Kuijper, Ed J.; Bartelsman, Joep F. W. M.; Tijssen, Jan G. P.; Speelman, Peter; Dijkgraaf, Marcel G. W.; Keller, Josbert J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">407-415</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Recurrent Clostridium difficile infection is difficult to treat, and failure rates for antibiotic therapy are high.  We studied the effect of duodenal infusion of donor feces in patients with recurrent C. difficile infection.  METHODS We randomly assigned patients to receive one of three therapies: an initial vancomycin regimen (500 mg orally four times per day for 4 days), followed by bowel lavage and subsequent infusion of a soln. of donor feces through a nasoduodenal tube; a std. vancomycin regimen (500 mg orally four times per day for 14 days); or a std. vancomycin regimen with bowel lavage.  The primary end point was the resoln. of diarrhea assocd. with C. difficile infection without relapse after 10 wk.  RESULTS The study was stopped after an interim anal.  Of 16 patients in the infusion group, 13 (81%) had resoln. of C. difficile-assocd. diarrhea after the first infusion.  The 3 remaining patients received a second infusion with feces from a different donor, with resoln. in 2 patients.  Resoln. of C. difficile infection occurred in 4 of 13 patients (31%) receiving vancomycin alone and in 3 of 13 patients (23%) receiving vancomycin with bowel lavage (P<0.001 for both comparisons with the infusion group).  No significant differences in adverse events among the three study groups were obsd. except for mild diarrhea and abdominal cramping in the infusion group on the infusion day.  After donor-feces infusion, patients showed increased fecal bacterial diversity, similar to that in healthy donors, with an increase in Bacteroidetes species and clostridium clusters IV and XIVa and a decrease in Proteobacteria species.  CONCLUSIONS The infusion of donor feces was significantly more effective for the treatment of recurrent C. difficile infection than the use of vancomycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0hVsSV2VIDbVg90H21EOLACvtfcHk0lj8jWA3U5jToQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVelsbs%253D&md5=9e739f9ad764896267b832e89666c9fb</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1205037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1205037%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BNood%26aufirst%3DE.%26aulast%3DVrieze%26aufirst%3DA.%26aulast%3DNieuwdorp%26aufirst%3DM.%26aulast%3DFuentes%26aufirst%3DS.%26aulast%3DZoetendal%26aufirst%3DE.%2BG.%26aulast%3Dde%2BVos%26aufirst%3DW.%2BM.%26aulast%3DVisser%26aufirst%3DC.%2BE.%26aulast%3DKuijper%26aufirst%3DE.%2BJ.%26aulast%3DBartelsman%26aufirst%3DJ.%2BF.%2BW.%2BM.%26aulast%3DTijssen%26aufirst%3DJ.%2BG.%2BP.%26aulast%3DSpeelman%26aufirst%3DP.%26aulast%3DDijkgraaf%26aufirst%3DM.%2BG.%2BW.%26aulast%3DKeller%26aufirst%3DJ.%2BJ.%26atitle%3DDuodenal%2520Infusion%2520of%2520Donor%2520Feces%2520for%2520Recurrent%2520Clostridium%2520difficile%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D368%26spage%3D407%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Gough, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaikh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manges, A. R.</span><span> </span><span class="NLM_article-title">Systematic Review of Intestinal Microbiota Transplantation (Fecal Bacteriotherapy) for Recurrent <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">994</span><span class="NLM_x">–</span> <span class="NLM_lpage">1002</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fcid%2Fcir632" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=22002980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADC%252BC3Mbhs1emsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2011&pages=994-1002&author=E.+Goughauthor=H.+Shaikhauthor=A.+R.+Manges&title=Systematic+Review+of+Intestinal+Microbiota+Transplantation+%28Fecal+Bacteriotherapy%29+for+Recurrent+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection</span></div><div class="casAuthors">Gough Ethan; Shaikh Henna; Manges Amee R</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">994-1002</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Clostridium difficile infection (CDI) is a gastrointestinal disease believed to be causally related to perturbations to the intestinal microbiota.  When standard treatment has failed, intestinal microbiota transplantation (IMT) is an alternative therapy for patients with CDI.  IMT involves infusing intestinal microorganisms (in a suspension of healthy donor stool) into the intestine of a sick patient to restore the microbiota.  However, protocols and reported efficacy for IMT vary.  We conducted a systematic literature review of IMT treatment for recurrent CDI and pseudomembranous colitis.  In 317 patients treated across 27 case series and reports, IMT was highly effective, showing disease resolution in 92% of cases.  Effectiveness varied by route of instillation, relationship to stool donor, volume of IMT given, and treatment before infusion.  Death and adverse events were uncommon.  These findings can guide physicians interested in implementing the procedure until better designed studies are conducted to confirm best practices.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnNF5GDChlcJZoeNcnHOQ9fW6udTcc2eY3r8Uzmk0bGbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mbhs1emsA%253D%253D&md5=323ed1a1e99f6c06f7c045c917ed5945</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fcir632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fcir632%26sid%3Dliteratum%253Aachs%26aulast%3DGough%26aufirst%3DE.%26aulast%3DShaikh%26aufirst%3DH.%26aulast%3DManges%26aufirst%3DA.%2BR.%26atitle%3DSystematic%2520Review%2520of%2520Intestinal%2520Microbiota%2520Transplantation%2520%2528Fecal%2520Bacteriotherapy%2529%2520for%2520Recurrent%2520Clostridium%2520difficile%2520Infection%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2011%26volume%3D53%26spage%3D994%26epage%3D1002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Zipursky, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidorsky, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidorsky, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkland, K. B.</span><span> </span><span class="NLM_article-title">Patient Attitudes toward the Use of Fecal Microbiota Transplantation in the Treatment of Recurrent <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1652</span><span class="NLM_x">–</span> <span class="NLM_lpage">1658</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fcid%2Fcis809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=22990849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADC%252BC38bot1alug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1652-1658&author=J.+S.+Zipurskyauthor=T.+I.+Sidorskyauthor=C.+A.+Freedmanauthor=M.+N.+Sidorskyauthor=K.+B.+Kirkland&title=Patient+Attitudes+toward+the+Use+of+Fecal+Microbiota+Transplantation+in+the+Treatment+of+Recurrent+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection</span></div><div class="casAuthors">Zipursky Jonathan S; Sidorsky Tivon I; Freedman Carolyn A; Sidorsky Misha N; Kirkland Kathryn B</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1652-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Fecal microbiota transplantation (FMT), a safe, effective alternative therapy for recurrent Clostridium difficile infection (CDI), is infrequently used, in part because of an assumption that patients are unwilling to consider FMT because of its unappealing nature.  METHODS:  Through a structured survey, including hypothetical case scenarios, we assessed patient perceptions of the aesthetics of FMT and their willingness to consider it as a treatment option, when presented with scenarios involving recurrent CDI.  RESULTS:  Four hundred surveys were distributed; 192 (48%) were returned complete.  Seventy percent of respondents were female; 59% were >49 years of age.  When provided efficacy data only, 162 respondents (85%) chose to receive FMT, and 29 (15%) chose antibiotics alone.  When aware of the fecal nature of FMT, 16 respondents changed their choice from FMT to antibiotics alone, but there was no significant change in the total number choosing FMT (154 [81%]; P = .15).  More respondents chose FMT if offered as a pill (90%; P = .002) or if their physician recommended it (94%; P < .001).  Respondents rated all aspects of FMT at least "somewhat unappealing," selecting "the need to handle stool" and "receiving FMT by nasogastric tube" as most unappealing.  Women rated all aspects of FMT more unappealing; older respondents rated all aspects less unappealing.  Most respondents preferred to receive FMT in the hospital (48%) or physician's office (39%); 77% were willing to pay out-of-pocket for FMT.  CONCLUSIONS:  Patients recognize the inherently unappealing nature of FMT, but they are nonetheless open to considering it as a treatment alternative for recurrent CDI, especially when recommended by a physician.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT6291gD3ErOo2y4bB4mnvYfW6udTcc2eb0CYMchFrp4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bot1alug%253D%253D&md5=80dfac8181c7bdeb354ffccff379c522</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fcis809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fcis809%26sid%3Dliteratum%253Aachs%26aulast%3DZipursky%26aufirst%3DJ.%2BS.%26aulast%3DSidorsky%26aufirst%3DT.%2BI.%26aulast%3DFreedman%26aufirst%3DC.%2BA.%26aulast%3DSidorsky%26aufirst%3DM.%2BN.%26aulast%3DKirkland%26aufirst%3DK.%2BB.%26atitle%3DPatient%2520Attitudes%2520toward%2520the%2520Use%2520of%2520Fecal%2520Microbiota%2520Transplantation%2520in%2520the%2520Treatment%2520of%2520Recurrent%2520Clostridium%2520difficile%2520Infection%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2012%26volume%3D55%26spage%3D1652%26epage%3D1658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Kahn, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorawara Bhat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, D. T.</span><span> </span><span class="NLM_article-title">Fecal Bacteriotherapy for Ulcerative Colitis: Patients Are Ready, Are We?</span> <span class="citation_source-journal">Inflammatory Bowel Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">676</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1002%2Fibd.21775" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=21618362" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=676-684&author=S.+A.+Kahnauthor=R.+Gorawara+Bhatauthor=D.+T.+Rubin&title=Fecal+Bacteriotherapy+for+Ulcerative+Colitis%3A+Patients+Are+Ready%2C+Are+We%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fibd.21775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fibd.21775%26sid%3Dliteratum%253Aachs%26aulast%3DKahn%26aufirst%3DS.%2BA.%26aulast%3DGorawara%2BBhat%26aufirst%3DR.%26aulast%3DRubin%26aufirst%3DD.%2BT.%26atitle%3DFecal%2520Bacteriotherapy%2520for%2520Ulcerative%2520Colitis%253A%2520Patients%2520Are%2520Ready%252C%2520Are%2520We%253F%26jtitle%3DInflammatory%2520Bowel%2520Dis.%26date%3D2011%26volume%3D18%26spage%3D676%26epage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Hong, G.</span> <span class="citation_source-book">Dongjin Dynasty. Zhou Hou Bei Ji Fang</span>; <span class="NLM_publisher-name">Tianjin Science & Technology Press</span>: <span class="NLM_publisher-loc">Tianjin, China</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=G.+Hong&title=Dongjin+Dynasty.+Zhou+Hou+Bei+Ji+Fang"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DG.%26btitle%3DDongjin%2520Dynasty.%2520Zhou%2520Hou%2520Bei%2520Ji%2520Fang%26pub%3DTianjin%2520Science%2520%2526%2520Technology%2520Press%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, G.</span><span> </span><span class="NLM_article-title">Should We Standardize the 1,700-Year-Old Fecal Microbiota Transplantation?</span> <span class="citation_source-journal">Am. J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">1755</span><span class="NLM_x">–</span> <span class="NLM_lpage">1755</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1038%2Fajg.2012.251" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=23160295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADC%252BC3s7kt1Srsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2012&pages=1755-1755&author=F.+Zhangauthor=W.+Luoauthor=Y.+Shiauthor=Z.+Fanauthor=G.+Ji&title=Should+We+Standardize+the+1%2C700-Year-Old+Fecal+Microbiota+Transplantation%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Should we standardize the 1,700-year-old fecal microbiota transplantation?</span></div><div class="casAuthors">Zhang Faming; Luo Wensheng; Shi Yan; Fan Zhining; Ji Guozhong</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of gastroenterology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1755; author reply p.1755-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQeQJrtSRDhIbmQt-ICR3qNfW6udTcc2eYVv_j6-Y0vNLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s7kt1Srsw%253D%253D&md5=f4f9529f40c384c976f9bd6aaca4fa16</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fajg.2012.251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fajg.2012.251%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DLuo%26aufirst%3DW.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DZ.%26aulast%3DJi%26aufirst%3DG.%26atitle%3DShould%2520We%2520Standardize%2520the%25201%252C700-Year-Old%2520Fecal%2520Microbiota%2520Transplantation%253F%26jtitle%3DAm.%2520J.%2520Gastroenterol.%26date%3D2012%26volume%3D107%26spage%3D1755%26epage%3D1755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Leake, I.</span><span> </span><span class="NLM_article-title"><i>Clostridium difficile</i> Infection: Real or Fake-Faecal Matter Does the Trick for Recurrent CDI</span> <span class="citation_source-journal">Nat. Rev. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1038%2Fnrgastro.2013.16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=23358398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADC%252BC3szjt12gsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=129&author=I.+Leake&title=Clostridium+difficile+Infection%3A+Real+or+Fake-Faecal+Matter+Does+the+Trick+for+Recurrent+CDI"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Clostridium difficile infection: Real or fake--faecal matter does the trick for recurrent CDI</span></div><div class="casAuthors">Leake Isobel</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Gastroenterology & hepatology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">129</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPwiOr3vbNw3y-c-E1v-fmfW6udTcc2eYVv_j6-Y0vNLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szjt12gsA%253D%253D&md5=47acf0c82cc8a42d47efe641c300e588</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fnrgastro.2013.16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrgastro.2013.16%26sid%3Dliteratum%253Aachs%26aulast%3DLeake%26aufirst%3DI.%26atitle%3DClostridium%2520difficile%2520Infection%253A%2520Real%2520or%2520Fake-Faecal%2520Matter%2520Does%2520the%2520Trick%2520for%2520Recurrent%2520CDI%26jtitle%3DNat.%2520Rev.%2520Gastroenterol.%2520Hepatol.%26date%3D2013%26volume%3D10%26spage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Hamilton, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weingarden, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadowsky, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khoruts, A.</span><span> </span><span class="NLM_article-title">Standardized Frozen Preparation for Transplantation of Fecal Microbiota for Recurrent <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">Am. J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">767</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1038%2Fajg.2011.482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=22290405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADC%252BC38vhsFOgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2012&pages=761-767&author=M.+J.+Hamiltonauthor=A.+R.+Weingardenauthor=M.+J.+Sadowskyauthor=A.+Khoruts&title=Standardized+Frozen+Preparation+for+Transplantation+of+Fecal+Microbiota+for+Recurrent+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection</span></div><div class="casAuthors">Hamilton Matthew J; Weingarden Alexa R; Sadowsky Michael J; Khoruts Alexander</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of gastroenterology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">761-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  While fecal microbiota transplantation (FMT) is historically known to be an effective means to treat recurrent Clostridium difficile infection (CDI) refractory to standard antibiotic therapies, the procedure is rarely performed.  At least some of the reasons for limited availability are those of practicality, including aesthetic concerns and costs of donor screening.  The objective of this study was to overcome these barriers in our clinical FMT program.  METHODS:  We report clinical experience with 43 consecutive patients who were treated with FMT for recurrent CDI since inception of this program at the University of Minnesota.  During this time, we simplified donor identification and screening by moving from patient-identified individual donors to standard volunteer donors.  Material preparation shifted from the endoscopy suite to a standardized process in the laboratory, and ultimately to banking frozen processed fecal material that is ready to use when needed.  RESULTS:  Standardization of material preparation significantly simplified the practical aspects of FMT without loss of apparent efficacy in clearing recurrent CDI.  Approximately 30% of the patients had underlying inflammatory bowel disease, and FMT was equally effective in this group.  CONCLUSIONS:  Several key steps in the standardization of donor material preparation significantly simplified the clinical practice of FMT for recurrent CDI in patients failing antibiotic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2frwdYJiOL5NiNltV31zlfW6udTcc2eYVv_j6-Y0vNLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vhsFOgug%253D%253D&md5=374660d41abfb3c8f52bfb76d82e0606</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fajg.2011.482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fajg.2011.482%26sid%3Dliteratum%253Aachs%26aulast%3DHamilton%26aufirst%3DM.%2BJ.%26aulast%3DWeingarden%26aufirst%3DA.%2BR.%26aulast%3DSadowsky%26aufirst%3DM.%2BJ.%26aulast%3DKhoruts%26aufirst%3DA.%26atitle%3DStandardized%2520Frozen%2520Preparation%2520for%2520Transplantation%2520of%2520Fecal%2520Microbiota%2520for%2520Recurrent%2520Clostridium%2520difficile%2520Infection%26jtitle%3DAm.%2520J.%2520Gastroenterol.%26date%3D2012%26volume%3D107%26spage%3D761%26epage%3D767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Youngster, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pindar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziv-Baran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohmann, E. L.</span><span> </span><span class="NLM_article-title">Oral, Capsulized, Frozen Fecal Microbiota Transplantation for Relapsing <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">1772</span><span class="NLM_x">–</span> <span class="NLM_lpage">1778</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2014&pages=1772-1778&author=I.+Youngsterauthor=G.+H.+Russellauthor=C.+Pindarauthor=T.+Ziv-Baranauthor=J.+Saukauthor=E.+L.+Hohmann&title=Oral%2C+Capsulized%2C+Frozen+Fecal+Microbiota+Transplantation+for+Relapsing+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoungster%26aufirst%3DI.%26aulast%3DRussell%26aufirst%3DG.%2BH.%26aulast%3DPindar%26aufirst%3DC.%26aulast%3DZiv-Baran%26aufirst%3DT.%26aulast%3DSauk%26aufirst%3DJ.%26aulast%3DHohmann%26aufirst%3DE.%2BL.%26atitle%3DOral%252C%2520Capsulized%252C%2520Frozen%2520Fecal%2520Microbiota%2520Transplantation%2520for%2520Relapsing%2520Clostridium%2520difficile%2520Infection%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2014%26volume%3D312%26spage%3D1772%26epage%3D1778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Lawley, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stares, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connor, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raisen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulding, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rad, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, C.</span><span> </span><span class="NLM_article-title">Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing <i>Clostridium difficile</i> Disease in Mice</span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1002995</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=e1002995&author=T.+D.+Lawleyauthor=S.+Clareauthor=A.+W.+Walkerauthor=M.+D.+Staresauthor=T.+R.+Connorauthor=C.+Raisenauthor=D.+Gouldingauthor=R.+Radauthor=F.+Schreiberauthor=C.+Brandt&title=Targeted+Restoration+of+the+Intestinal+Microbiota+with+a+Simple%2C+Defined+Bacteriotherapy+Resolves+Relapsing+Clostridium+difficile+Disease+in+Mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLawley%26aufirst%3DT.%2BD.%26aulast%3DClare%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DA.%2BW.%26aulast%3DStares%26aufirst%3DM.%2BD.%26aulast%3DConnor%26aufirst%3DT.%2BR.%26aulast%3DRaisen%26aufirst%3DC.%26aulast%3DGoulding%26aufirst%3DD.%26aulast%3DRad%26aufirst%3DR.%26aulast%3DSchreiber%26aufirst%3DF.%26aulast%3DBrandt%26aufirst%3DC.%26atitle%3DTargeted%2520Restoration%2520of%2520the%2520Intestinal%2520Microbiota%2520with%2520a%2520Simple%252C%2520Defined%2520Bacteriotherapy%2520Resolves%2520Relapsing%2520Clostridium%2520difficile%2520Disease%2520in%2520Mice%26jtitle%3DPLoS%2520Pathog.%26date%3D2012%26volume%3D8%26spage%3De1002995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Bakken, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borody, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brill, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demarco, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzos, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khoruts, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surawicz, C.</span><span> </span><span class="NLM_article-title">Treating <i>Clostridium difficile</i> Infection with Fecal Microbiota Transplantation</span> <span class="citation_source-journal">Clin. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1044</span><span class="NLM_x">–</span> <span class="NLM_lpage">1049</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1016%2Fj.cgh.2011.08.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=21871249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADC%252BC38%252FhsFKksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=1044-1049&author=J.+S.+Bakkenauthor=T.+Borodyauthor=L.+J.+Brandtauthor=J.+V.+Brillauthor=D.+C.+Demarcoauthor=M.+A.+Franzosauthor=C.+Kellyauthor=A.+Khorutsauthor=T.+Louieauthor=L.+P.+Martinelliauthor=T.+A.+Mooreauthor=G.+Russellauthor=C.+Surawicz&title=Treating+Clostridium+difficile+Infection+with+Fecal+Microbiota+Transplantation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Treating Clostridium difficile infection with fecal microbiota transplantation</span></div><div class="casAuthors">Bakken Johan S; Borody Thomas; Brandt Lawrence J; Brill Joel V; Demarco Daniel C; Franzos Marc Alaric; Kelly Colleen; Khoruts Alexander; Louie Thomas; Martinelli Lawrence P; Moore Thomas A; Russell George; Surawicz Christina</div><div class="citationInfo"><span class="NLM_cas:title">Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1044-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Clostridium difficile infection is increasing in incidence, severity, and mortality.  Treatment options are limited and appear to be losing efficacy.  Recurrent disease is especially challenging; extended treatment with oral vancomycin is becoming increasingly common but is expensive.  Fecal microbiota transplantation is safe, inexpensive, and effective; according to case and small series reports, about 90% of patients are cured.  We discuss the rationale, methods, and use of fecal microbiota transplantation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSzowxWJ3fGhMSzjBFCN0BJfW6udTcc2eYDaMi30xfJVLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252FhsFKksw%253D%253D&md5=487486ea0718a0be4711b927f761810e</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.cgh.2011.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cgh.2011.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DBakken%26aufirst%3DJ.%2BS.%26aulast%3DBorody%26aufirst%3DT.%26aulast%3DBrandt%26aufirst%3DL.%2BJ.%26aulast%3DBrill%26aufirst%3DJ.%2BV.%26aulast%3DDemarco%26aufirst%3DD.%2BC.%26aulast%3DFranzos%26aufirst%3DM.%2BA.%26aulast%3DKelly%26aufirst%3DC.%26aulast%3DKhoruts%26aufirst%3DA.%26aulast%3DLouie%26aufirst%3DT.%26aulast%3DMartinelli%26aufirst%3DL.%2BP.%26aulast%3DMoore%26aufirst%3DT.%2BA.%26aulast%3DRussell%26aufirst%3DG.%26aulast%3DSurawicz%26aufirst%3DC.%26atitle%3DTreating%2520Clostridium%2520difficile%2520Infection%2520with%2520Fecal%2520Microbiota%2520Transplantation%26jtitle%3DClin.%2520Gastroenterol.%2520Hepatol.%26date%3D2011%26volume%3D9%26spage%3D1044%26epage%3D1049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Kapel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corcos, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayeur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbot-Trystram, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouhnik, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joly, F.</span><span> </span><span class="NLM_article-title">Practical Implementation of Faecal Transplantation</span> <span class="citation_source-journal">Clin. Microbiol. Infect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1098</span><span class="NLM_x">–</span> <span class="NLM_lpage">1105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1111%2F1469-0691.12796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=25273614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADC%252BC2M7mtlKiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=1098-1105&author=N.+Kapelauthor=M.+Thomasauthor=O.+Corcosauthor=C.+Mayeurauthor=L.+Barbot-Trystramauthor=Y.+Bouhnikauthor=F.+Joly&title=Practical+Implementation+of+Faecal+Transplantation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Practical implementation of faecal transplantation</span></div><div class="casAuthors">Kapel N; Thomas M; Corcos O; Mayeur C; Barbot-Trystram L; Bouhnik Y; Joly F</div><div class="citationInfo"><span class="NLM_cas:title">Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1098-105</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Clostridium difficile infection is a leading cause of antibiotic-related and healthcare-related diarrhoea.  In the past decade, faecal microbiota transplantation or transfer has attracted increasing interest as an effective treatment strategy for severe recurrent C. difficile infection, with a global success rate of >80%.  However, experience with this procedure is limited by a lack of randomized trials supporting its efficacy and the lack of standardization of the procedure.  This review will address the practical aspects of the protocol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8etBAhdg0UJPq5LRczm8ffW6udTcc2eYDaMi30xfJVLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7mtlKiuw%253D%253D&md5=4ac4e8b4969d91a3135a4734c1506a94</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1111%2F1469-0691.12796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252F1469-0691.12796%26sid%3Dliteratum%253Aachs%26aulast%3DKapel%26aufirst%3DN.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DCorcos%26aufirst%3DO.%26aulast%3DMayeur%26aufirst%3DC.%26aulast%3DBarbot-Trystram%26aufirst%3DL.%26aulast%3DBouhnik%26aufirst%3DY.%26aulast%3DJoly%26aufirst%3DF.%26atitle%3DPractical%2520Implementation%2520of%2520Faecal%2520Transplantation%26jtitle%3DClin.%2520Microbiol.%2520Infect.%26date%3D2014%26volume%3D20%26spage%3D1098%26epage%3D1105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span>The Power of Poo: DIY Instructions. <a href="http://thepowerofpoo.blogspot.com.au/p/diy-instructions.html?m=1" class="extLink">http://thepowerofpoo.blogspot.com.au/p/diy-instructions.html?m=1</a> (accessed Aug 18,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+Power+of+Poo%3A+DIY+Instructions.+http%3A%2F%2Fthepowerofpoo.blogspot.com.au%2Fp%2Fdiy-instructions.html%3Fm%3D1+%28accessed+Aug+18%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span>American Gastroenterological Association. AGA Confirms IND Is Required for Fecal Microbiota Transplantation <a href="http://www.gastro.org/advocacy-regulation/regulatory-issues/fecal-microbiota-transplant/aga-confirms-ind-is-required-for-fecal-microbiota-transplantation" class="extLink">http://www.gastro.org/advocacy-regulation/regulatory-issues/fecal-microbiota-transplant/aga-confirms-ind-is-required-for-fecal-microbiota-transplantation</a> (accessed Oct 29,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=American+Gastroenterological+Association.+AGA+Confirms+IND+Is+Required+for+Fecal+Microbiota+Transplantation+http%3A%2F%2Fwww.gastro.org%2Fadvocacy-regulation%2Fregulatory-issues%2Ffecal-microbiota-transplant%2Faga-confirms-ind-is-required-for-fecal-microbiota-transplantation+%28accessed+Oct+29%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span>Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation To Treat <i>Clostridium difficile</i> Infection Not Responsive to Standard Therapies. <a href="http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm361379.htm" class="extLink">http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm361379.htm</a> (accessed Aug 17,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Guidance+for+Industry%3A+Enforcement+Policy+Regarding+Investigational+New+Drug+Requirements+for+Use+of+Fecal+Microbiota+for+Transplantation+To+Treat+Clostridium+difficile+Infection+Not+Responsive+to+Standard+Therapies.+http%3A%2F%2Fwww.fda.gov%2FBiologicsBloodVaccines%2FGuidanceComplianceRegulatoryInformation%2FGuidances%2FVaccines%2Fucm361379.htm+%28accessed+Aug+17%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Ratner, M.</span><span> </span><span class="NLM_article-title">Fecal Transplantation Poses Dilemma for FDA</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=401-402&author=M.+Ratner&title=Fecal+Transplantation+Poses+Dilemma+for+FDA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRatner%26aufirst%3DM.%26atitle%3DFecal%2520Transplantation%2520Poses%2520Dilemma%2520for%2520FDA%26jtitle%3DNat.%2520Biotechnol.%26date%3D2014%26volume%3D32%26spage%3D401%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Smith, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alm, E. J.</span><span> </span><span class="NLM_article-title">Policy: How To Regulate Faecal Transplants</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">506</span><span class="NLM_x">, </span> <span class="NLM_fpage">290</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=506&publication_year=2014&pages=290-291&author=M.+B.+Smithauthor=C.+Kellyauthor=E.+J.+Alm&title=Policy%3A+How+To+Regulate+Faecal+Transplants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DM.%2BB.%26aulast%3DKelly%26aufirst%3DC.%26aulast%3DAlm%26aufirst%3DE.%2BJ.%26atitle%3DPolicy%253A%2520How%2520To%2520Regulate%2520Faecal%2520Transplants%26jtitle%3DNature%26date%3D2014%26volume%3D506%26spage%3D290%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Tsutsumi, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owusu, Y. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurdle, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span> </span><span class="NLM_article-title">Progress in the Discovery of Treatments for <i>C. difficile</i> Infection: A Clinical and Medicinal Chemistry Review</span> <span class="citation_source-journal">Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">152</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.2174%2F1568026613666131113154753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=24236721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlygurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=152-175&author=L.+S.+Tsutsumiauthor=Y.+B.+Owusuauthor=J.+G.+Hurdleauthor=D.+Sun&title=Progress+in+the+Discovery+of+Treatments+for+C.+difficile+Infection%3A+A+Clinical+and+Medicinal+Chemistry+Review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the Discovery of Treatments for C. difficile Infection: A Clinical and Medicinal Chemistry Review</span></div><div class="casAuthors">Tsutsumi, Lissa S.; Owusu, Yaw B.; Hurdle, Julian G.; Sun, Dianqing</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">152-175</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Clostridium difficile is an anaerobic, Gram-pos. pathogen that causes C. difficile infection, which results in significant morbidity and mortality.  The incidence of C. difficile infection in developed countries has become increasingly high due to the emergence of newer epidemic strains, a growing elderly population, extensive use of broad spectrum antibiotics, and limited therapies for this diarrheal disease.  Because treatment options currently available for C. difficile infection have some drawbacks, including cost, promotion of resistance, and selectivity problems, new agents are urgently needed to address these challenges.  This review article focuses on two parts: the first part summarizes current clin. treatment strategies and agents under clin. development for C. difficile infection; the second part reviews newly reported anti-difficile agents that have been evaluated or reevaluated in the last five years and are in the early stages of drug discovery and development.  Antibiotics are divided into natural product inspired and synthetic small mol. compds. that may have the potential to be more efficacious than currently approved treatments.  This includes potency, selectivity, reduced cytotoxicity, and novel modes of action to prevent resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyPZDOO8Im4bVg90H21EOLACvtfcHk0ljXQowBpPKfpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlygurc%253D&md5=d9b3dc0542c138a289588257b0651425</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.2174%2F1568026613666131113154753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026613666131113154753%26sid%3Dliteratum%253Aachs%26aulast%3DTsutsumi%26aufirst%3DL.%2BS.%26aulast%3DOwusu%26aufirst%3DY.%2BB.%26aulast%3DHurdle%26aufirst%3DJ.%2BG.%26aulast%3DSun%26aufirst%3DD.%26atitle%3DProgress%2520in%2520the%2520Discovery%2520of%2520Treatments%2520for%2520C.%2520difficile%2520Infection%253A%2520A%2520Clinical%2520and%2520Medicinal%2520Chemistry%2520Review%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%2520%2528Sharjah%252C%2520United%2520Arab%2520Emirates%2529%26date%3D2014%26volume%3D14%26spage%3D152%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span>Phase I Trial of a Single Dose of CRS3123. Identifier NCT01551004. <a href="http://clinicaltrials.gov/show/NCT01551004" class="extLink">http://clinicaltrials.gov/show/NCT01551004</a> (accessed Mar 21,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Phase+I+Trial+of+a+Single+Dose+of+CRS3123.+Identifier+NCT01551004.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01551004+%28accessed+Mar+21%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span>Novacta Biosystems Limited completes phase I study of NVB302 against <i>C. difficile</i> infection in healthy volunteers. <a href="http://www.novactabio.com/news.php" class="extLink">http://www.novactabio.com/news.php</a> (accessed Mar 18,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Novacta+Biosystems+Limited+completes+phase+I+study+of+NVB302+against+C.+difficile+infection+in+healthy+volunteers.+http%3A%2F%2Fwww.novactabio.com%2Fnews.php+%28accessed+Mar+18%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span>A Study of SMT19969 Compared with Vancomycin for the Treatment of <i>Clostridium difficile</i>-Associated Diarrhoea (CDAD). Identifier NCT02092935. <a href="http://clinicaltrials.gov/show/NCT02092935" class="extLink">http://clinicaltrials.gov/show/NCT02092935</a> (accessed Jan 18,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study+of+SMT19969+Compared+with+Vancomycin+for+the+Treatment+of+Clostridium+difficile-Associated+Diarrhoea+%28CDAD%29.+Identifier+NCT02092935.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT02092935+%28accessed+Jan+18%2C+2015%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">LaMarche, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeds, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaral, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brewer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bushell, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewhurst, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzink-Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamber, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lister, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenney, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palestrant, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patane, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rann, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachdeva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiamfook, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trzasko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitehead, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yifru, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Q.</span><span> </span><span class="NLM_article-title">Discovery of LFF571: An Investigational Agent for <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2376</span><span class="NLM_x">–</span> <span class="NLM_lpage">2387</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201685h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC38XitVektrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2376-2387&author=M.+J.+LaMarcheauthor=J.+A.+Leedsauthor=A.+Amaralauthor=J.+T.+Brewerauthor=S.+M.+Bushellauthor=G.+Dengauthor=J.+M.+Dewhurstauthor=J.+Dingauthor=J.+Dzink-Foxauthor=G.+Gamberauthor=A.+Jainauthor=K.+Leeauthor=L.+Leeauthor=T.+Listerauthor=D.+McKenneyauthor=S.+Mullinauthor=C.+Osborneauthor=D.+Palestrantauthor=M.+A.+Pataneauthor=E.+M.+Rannauthor=M.+Sachdevaauthor=J.+Shaoauthor=S.+Tiamfookauthor=A.+Trzaskoauthor=L.+Whiteheadauthor=A.+Yifruauthor=D.+Yuauthor=W.+Yanauthor=Q.+Zhu&title=Discovery+of+LFF571%3A+An+Investigational+Agent+for+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of LFF571: An Investigational Agent for Clostridium difficile Infection</span></div><div class="casAuthors">LaMarche, Matthew J.; Leeds, Jennifer A.; Amaral, Adam; Brewer, Jason T.; Bushell, Simon M.; Deng, Gejing; Dewhurst, Janetta M.; Ding, Jian; Dzink-Fox, JoAnne; Gamber, Gabriel; Jain, Akash; Lee, Kwangho; Lee, Lac; Lister, Troy; McKenney, David; Mullin, Steve; Osborne, Colin; Palestrant, Deborah; Patane, Michael A.; Rann, Elin M.; Sachdeva, Meena; Shao, Jian; Tiamfook, Stacey; Trzasko, Anna; Whitehead, Lewis; Yifru, Aregahegn; Yu, Donghui; Yan, Wanlin; Zhu, Qingming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2376-2387</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Clostridium difficile (C. difficile) is a Gram pos., anaerobic bacterium that infects the lumen of the large intestine and produces toxins.  This results in a range of syndromes from mild diarrhea to severe toxic megacolon and death.  Alarmingly, the prevalence and severity of C. difficile infection are increasing; thus, assocd. morbidity and mortality rates are rising.  4-Aminothiazolyl analogs of the antibiotic natural product GE2270 A were designed, synthesized, and optimized for the treatment of C. difficile infection.  The medicinal chem. effort focused on enhancing aq. soly. relative to that of the natural product and previous development candidates (2, 3) and improving antibacterial activity.  Structure-activity relationships, cocrystallog. interactions, pharmacokinetics, and efficacy in animal models of infection were characterized.  These studies identified a series of dicarboxylic acid derivs., which enhanced soly./efficacy profile by several orders of magnitude compared to previously studied compds. and led to the selection of LFF571 (I) as an investigational new drug for treating C. difficile infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3mrocvDQFu7Vg90H21EOLACvtfcHk0liJDymXifxhpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVektrY%253D&md5=c31ff50dd7eedaf633493f784f97193f</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm201685h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201685h%26sid%3Dliteratum%253Aachs%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26aulast%3DLeeds%26aufirst%3DJ.%2BA.%26aulast%3DAmaral%26aufirst%3DA.%26aulast%3DBrewer%26aufirst%3DJ.%2BT.%26aulast%3DBushell%26aufirst%3DS.%2BM.%26aulast%3DDeng%26aufirst%3DG.%26aulast%3DDewhurst%26aufirst%3DJ.%2BM.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DDzink-Fox%26aufirst%3DJ.%26aulast%3DGamber%26aufirst%3DG.%26aulast%3DJain%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DLister%26aufirst%3DT.%26aulast%3DMcKenney%26aufirst%3DD.%26aulast%3DMullin%26aufirst%3DS.%26aulast%3DOsborne%26aufirst%3DC.%26aulast%3DPalestrant%26aufirst%3DD.%26aulast%3DPatane%26aufirst%3DM.%2BA.%26aulast%3DRann%26aufirst%3DE.%2BM.%26aulast%3DSachdeva%26aufirst%3DM.%26aulast%3DShao%26aufirst%3DJ.%26aulast%3DTiamfook%26aufirst%3DS.%26aulast%3DTrzasko%26aufirst%3DA.%26aulast%3DWhitehead%26aufirst%3DL.%26aulast%3DYifru%26aufirst%3DA.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DQ.%26atitle%3DDiscovery%2520of%2520LFF571%253A%2520An%2520Investigational%2520Agent%2520for%2520Clostridium%2520difficile%2520Infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2376%26epage%3D2387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span>Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients with Moderate <i>Clostridium difficile</i> Infections. Identifier NCT01232595. <a href="http://www.clinicaltrials.gov/ct2/show/NCT01232595?term=clostridium+difficile&amp;rank=14" class="extLink">http://www.clinicaltrials.gov/ct2/show/NCT01232595?term=clostridium+difficile&rank=14</a> (accessed Mar 20,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Safety+and+Efficacy+of+Multiple+Daily+Dosing+of+Oral+LFF571+in+Patients+with+Moderate+Clostridium+difficile+Infections.+Identifier+NCT01232595.+http%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT01232595%3Fterm%3Dclostridium%2Bdifficile%26rank%3D14+%28accessed+Mar+20%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span>Phase 3 Study with Cadazolid in CDAD. Identifier NCT01987895. <a href="https://clinicaltrials.gov/ct2/show/NCT01987895?term=cadazolid&amp;rank=2" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01987895?term=cadazolid&rank=2</a> (accessed May 21,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Phase+3+Study+with+Cadazolid+in+CDAD.+Identifier+NCT01987895.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01987895%3Fterm%3Dcadazolid%26rank%3D2+%28accessed+May+21%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span>Business Wire. Nanotherapeutics Acquires Two Late Stage Clinical Programs for Alzheimer’s Treatment and CDA Disease. <a href="http://www.businesswire.com/news/home/20091216005124/en/Nanotherapeutics-Acquires-Late-Stage-Clinical-Programs-Alzheimer%E2%80%99s#.UyetsVzoXjI" class="extLink">http://www.businesswire.com/news/home/20091216005124/en/Nanotherapeutics-Acquires-Late-Stage-Clinical-Programs-Alzheimer%E2%80%99s#.UyetsVzoXjI</a> (accessed Mar 18,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Business+Wire.+Nanotherapeutics+Acquires+Two+Late+Stage+Clinical+Programs+for+Alzheimer%E2%80%99s+Treatment+and+CDA+Disease.+http%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20091216005124%2Fen%2FNanotherapeutics-Acquires-Late-Stage-Clinical-Programs-Alzheimer%25E2%2580%2599s%23.UyetsVzoXjI+%28accessed+Mar+18%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span>Nanotherapeutics. NTI-851 (Ramoplanin). <a href="http://www.nanotherapeutics.com/ramoplanin/" class="extLink">http://www.nanotherapeutics.com/ramoplanin/</a> (accessed Oct 29,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Nanotherapeutics.+NTI-851+%28Ramoplanin%29.+http%3A%2F%2Fwww.nanotherapeutics.com%2Framoplanin%2F+%28accessed+Oct+29%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">McLoughlin, F.</span><span> </span><span class="NLM_article-title">CB-315 Fact Sheet</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">3</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=F.+McLoughlin&title=CB-315+Fact+Sheet"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMcLoughlin%26aufirst%3DF.%26atitle%3DCB-315%2520Fact%2520Sheet%26date%3D2013%26spage%3D1%26epage%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Mascio, C. T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortin, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howland, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Praagh, A. D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuong, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, J. A.</span><span> </span><span class="NLM_article-title">In Vitro and In Vivo Characterization of CB-183,315, a Novel Lipopeptide Antibiotic for Treatment of <i>Clostridium difficile</i></span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5023</span><span class="NLM_x">–</span> <span class="NLM_lpage">5030</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=5023-5030&author=C.+T.+M.+Mascioauthor=L.+I.+Mortinauthor=K.+T.+Howlandauthor=A.+D.+G.+Van+Praaghauthor=S.+Zhangauthor=A.+Aryaauthor=C.+L.+Chuongauthor=C.+Kangauthor=T.+Liauthor=J.+A.+Silverman&title=In+Vitro+and+In+Vivo+Characterization+of+CB-183%2C315%2C+a+Novel+Lipopeptide+Antibiotic+for+Treatment+of+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMascio%26aufirst%3DC.%2BT.%2BM.%26aulast%3DMortin%26aufirst%3DL.%2BI.%26aulast%3DHowland%26aufirst%3DK.%2BT.%26aulast%3DVan%2BPraagh%26aufirst%3DA.%2BD.%2BG.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DArya%26aufirst%3DA.%26aulast%3DChuong%26aufirst%3DC.%2BL.%26aulast%3DKang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DSilverman%26aufirst%3DJ.%2BA.%26atitle%3DIn%2520Vitro%2520and%2520In%2520Vivo%2520Characterization%2520of%2520CB-183%252C315%252C%2520a%2520Novel%2520Lipopeptide%2520Antibiotic%2520for%2520Treatment%2520of%2520Clostridium%2520difficile%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D5023%26epage%3D5030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span>Pharmacokinetics and Safety of Tigecycline in the Treatment of <i>C. difficile</i> Associated Diarrhea (CDAD). Identifier NCT01401023. <a href="http://clinicaltrials.gov/ct2/show/NCT01401023" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01401023</a> (accessed Mar 21,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Pharmacokinetics+and+Safety+of+Tigecycline+in+the+Treatment+of+C.+difficile+Associated+Diarrhea+%28CDAD%29.+Identifier+NCT01401023.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01401023+%28accessed+Mar+21%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span>Study of Nitazoxanide in the Treatment of <i>Clostridium difficile</i> Colitis. Identifier NCT00417872. <a href="http://www.clinicaltrials.gov/ct2/show/NCT00417872?term=clostridium+difficile&amp;rank=22" class="extLink">http://www.clinicaltrials.gov/ct2/show/NCT00417872?term=clostridium+difficile&rank=22</a> (accessed Mar 20,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Study+of+Nitazoxanide+in+the+Treatment+of+Clostridium+difficile+Colitis.+Identifier+NCT00417872.+http%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT00417872%3Fterm%3Dclostridium%2Bdifficile%26rank%3D22+%28accessed+Mar+20%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span>Study of a Candidate <i>Clostridium difficile</i> Toxoid Vaccine in Subjects at Risk for <i>C. difficile</i> Infection. Identifier NCT01887912. <a href="http://clinicaltrials.gov/ct2/show/NCT01887912?term=c+difficile+and+vaccine&amp;rank=2" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01887912?term=c+difficile+and+vaccine&rank=2</a> (accessed Oct 23,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Study+of+a+Candidate+Clostridium+difficile+Toxoid+Vaccine+in+Subjects+at+Risk+for+C.+difficile+Infection.+Identifier+NCT01887912.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01887912%3Fterm%3Dc%2Bdifficile%2Band%2Bvaccine%26rank%3D2+%28accessed+Oct+23%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span>An Open-Label Study Assessing Safety, Immunogenicity and Dose Response of IC84. Identifier NCT01296386. <a href="http://clinicaltrials.gov/ct2/show/NCT01296386?term=IC84&amp;rank=1" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01296386?term=IC84&rank=1</a> (accessed Oct 23,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=An+Open-Label+Study+Assessing+Safety%2C+Immunogenicity+and+Dose+Response+of+IC84.+Identifier+NCT01296386.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01296386%3Fterm%3DIC84%26rank%3D1+%28accessed+Oct+23%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Johnson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerding, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornely, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chasan-Taber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitts, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelone, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broom, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, D. M.</span><span> </span><span class="NLM_article-title">Polymer Alternative for CDI Treatment (PACT) investigators. Vancomycin, Metronidazole, or Tolevamer for <i>Clostridium difficile</i> Infection: Results From Two Multinational, Randomized, Controlled Trials</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fcid%2Fciu313" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=24799326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlSrurnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2014&pages=345-354&author=S.+Johnsonauthor=T.+J.+Louieauthor=D.+N.+Gerdingauthor=O.+A.+Cornelyauthor=S.+Chasan-Taberauthor=D.+Fittsauthor=S.+P.+Geloneauthor=C.+Broomauthor=D.+M.+Davidson&title=Polymer+Alternative+for+CDI+Treatment+%28PACT%29+investigators.+Vancomycin%2C+Metronidazole%2C+or+Tolevamer+for+Clostridium+difficile+Infection%3A+Results+From+Two+Multinational%2C+Randomized%2C+Controlled+Trials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials</span></div><div class="casAuthors">Johnson, Stuart; Louie, Thomas J.; Gerding, Dale N.; Cornely, Oliver A.; Chasan-Taber, Scott; Fitts, David; Gelone, Steven P.; Broom, Colin; Davidson, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">345-354</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">In a pooled anal. of data from 2 large, randomized, controlled trials of patients with Clostridium difficile infection, the toxin-binding polymer tolevamer was inferior to both metronidazole and vancomycin with regard to clin. success, and metronidazole was inferior to vancomycin.  Background: Clostridium difficile infection (CDI) is a common complication of antibiotic therapy that is treated with antibiotics, contributing to ongoing disruption of the colonic microbiota and CDI recurrence.  Two multinational trials were conducted to compare the efficacy of tolevamer, a nonantibiotic, toxin-binding polymer, with vancomycin and metronidazole.  Methods: Patients with CDI were randomly assigned in a 2:1:1 ratio to oral tolevamer 9 g (loading dose) followed by 3 g every 8 h for 14 days, vancomycin 125 mg every 6 h for 10 days, or metronidazole 375 mg every 6 h for 10 days.  The primary endpoint was clin. success, defined as resoln. of diarrhea and absence of severe abdominal discomfort for more than 2 consecutive days including day 10.  Results: In a pooled anal., 563 patients received tolevamer, 289 received metronidazole, and 266 received vancomycin.  Clin. success of tolevamer was inferior to both metronidazole and vancomycin (P < .001), and metronidazole was inferior to vancomycin (P = .02; 44.2% [n = 534], 72.7% [n = 278], and 81.1% [n = 259], resp.).  Clin. success in patients with severe CDI who received metronidazole was 66.3% compared with vancomycin, which was 78.5%. (P = .059).  A post-hoc multivariate anal. that excluded tolevamer found 3 factors that were strongly assocd. with clin. success: vancomycin treatment, treatment-naive status, and mild or moderate CDI severity.  Adverse events were similar among the treatment groups.  Conclusions: Tolevamer was inferior to antibiotic treatment of CDI, and metronidazole was inferior to vancomycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8O-PA8pFfqrVg90H21EOLACvtfcHk0lj2k7juOtGisA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlSrurnL&md5=2844f3620eb00b568b5b37c07c02244d</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fciu313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fciu313%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DS.%26aulast%3DLouie%26aufirst%3DT.%2BJ.%26aulast%3DGerding%26aufirst%3DD.%2BN.%26aulast%3DCornely%26aufirst%3DO.%2BA.%26aulast%3DChasan-Taber%26aufirst%3DS.%26aulast%3DFitts%26aufirst%3DD.%26aulast%3DGelone%26aufirst%3DS.%2BP.%26aulast%3DBroom%26aufirst%3DC.%26aulast%3DDavidson%26aufirst%3DD.%2BM.%26atitle%3DPolymer%2520Alternative%2520for%2520CDI%2520Treatment%2520%2528PACT%2529%2520investigators.%2520Vancomycin%252C%2520Metronidazole%252C%2520or%2520Tolevamer%2520for%2520Clostridium%2520difficile%2520Infection%253A%2520Results%2520From%2520Two%2520Multinational%252C%2520Randomized%252C%2520Controlled%2520Trials%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2014%26volume%3D59%26spage%3D345%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span>A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for <i>Clostridium difficile</i> Infection (MK-3415A-001 AM2). Identifier NCT01241552. <a href="http://www.clinicaltrials.gov/ct2/show/NCT01241552?term=clostridium+difficile&amp;rank=6" class="extLink">http://www.clinicaltrials.gov/ct2/show/NCT01241552?term=clostridium+difficile&rank=6</a> (accessed Mar 20,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study+of+MK-3415%2C+MK-6072%2C+and+MK-3415A+in+Participants+Receiving+Antibiotic+Therapy+for+Clostridium+difficile+Infection+%28MK-3415A-001+AM2%29.+Identifier+NCT01241552.+http%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT01241552%3Fterm%3Dclostridium%2Bdifficile%26rank%3D6+%28accessed+Mar+20%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span>Safety and Efficacy Study of VP20621 for Prevention of Recurrent <i>Clostridium difficile</i> Infection. Identifier NCT01259726. <a href="http://clinicaltrials.gov/ct2/show/NCT01259726?term=VP20621&amp;rank=1" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01259726?term=VP20621&rank=1</a> (accessed Jan 21,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Safety+and+Efficacy+Study+of+VP20621+for+Prevention+of+Recurrent+Clostridium+difficile+Infection.+Identifier+NCT01259726.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01259726%3Fterm%3DVP20621%26rank%3D1+%28accessed+Jan+21%2C+2015%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Brouwer, M. S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullany, P.</span><span> </span><span class="NLM_article-title">Horizontal Gene Transfer Converts Non-Toxigenic <i>Clostridium difficile</i> Strains into Toxin Producers</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1038%2Fncomms3601" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1-6&author=M.+S.+M.+Brouwerauthor=A.+P.+Robertsauthor=H.+Hussainauthor=R.+J.+Williamsauthor=E.+Allanauthor=P.+Mullany&title=Horizontal+Gene+Transfer+Converts+Non-Toxigenic+Clostridium+difficile+Strains+into+Toxin+Producers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1038%2Fncomms3601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms3601%26sid%3Dliteratum%253Aachs%26aulast%3DBrouwer%26aufirst%3DM.%2BS.%2BM.%26aulast%3DRoberts%26aufirst%3DA.%2BP.%26aulast%3DHussain%26aufirst%3DH.%26aulast%3DWilliams%26aufirst%3DR.%2BJ.%26aulast%3DAllan%26aufirst%3DE.%26aulast%3DMullany%26aufirst%3DP.%26atitle%3DHorizontal%2520Gene%2520Transfer%2520Converts%2520Non-Toxigenic%2520Clostridium%2520difficile%2520Strains%2520into%2520Toxin%2520Producers%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Villano, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiberling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatarowicz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monnot-Chase, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerding, D. N.</span><span> </span><span class="NLM_article-title">Evaluation of an Oral Suspension of VP20621, Spores of Nontoxigenic <i>Clostridium difficile</i> Strain M3, in Healthy Subjects</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5224</span><span class="NLM_x">–</span> <span class="NLM_lpage">5229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=5224-5229&author=S.+A.+Villanoauthor=M.+Seiberlingauthor=W.+Tatarowiczauthor=E.+Monnot-Chaseauthor=D.+N.+Gerding&title=Evaluation+of+an+Oral+Suspension+of+VP20621%2C+Spores+of+Nontoxigenic+Clostridium+difficile+Strain+M3%2C+in+Healthy+Subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVillano%26aufirst%3DS.%2BA.%26aulast%3DSeiberling%26aufirst%3DM.%26aulast%3DTatarowicz%26aufirst%3DW.%26aulast%3DMonnot-Chase%26aufirst%3DE.%26aulast%3DGerding%26aufirst%3DD.%2BN.%26atitle%3DEvaluation%2520of%2520an%2520Oral%2520Suspension%2520of%2520VP20621%252C%2520Spores%2520of%2520Nontoxigenic%2520Clostridium%2520difficile%2520Strain%2520M3%252C%2520in%2520Healthy%2520Subjects%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26spage%3D5224%26epage%3D5229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Buffie, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenney, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobourne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">No, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinnebrew, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Littmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Brink, M. R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenq, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taur, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sander, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toussaint, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xavier, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pamer, E. G.</span><span> </span><span class="NLM_article-title">Precision Microbiome Reconstitution Restores Bile Acid Mediated Resistance to <i>Clostridium difficile</i></span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">517</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=517&publication_year=2015&pages=205-208&author=C.+G.+Buffieauthor=V.+Bucciauthor=R.+R.+Steinauthor=P.+T.+McKenneyauthor=L.+Lingauthor=A.+Gobourneauthor=D.+Noauthor=H.+Liuauthor=M.+Kinnebrewauthor=A.+Vialeauthor=E.+Littmannauthor=M.+R.+M.+van+den+Brinkauthor=R.+R.+Jenqauthor=Y.+Taurauthor=C.+Sanderauthor=J.+Crossauthor=N.+C.+Toussaintauthor=J.+B.+Xavierauthor=E.+G.+Pamer&title=Precision+Microbiome+Reconstitution+Restores+Bile+Acid+Mediated+Resistance+to+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuffie%26aufirst%3DC.%2BG.%26aulast%3DBucci%26aufirst%3DV.%26aulast%3DStein%26aufirst%3DR.%2BR.%26aulast%3DMcKenney%26aufirst%3DP.%2BT.%26aulast%3DLing%26aufirst%3DL.%26aulast%3DGobourne%26aufirst%3DA.%26aulast%3DNo%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DKinnebrew%26aufirst%3DM.%26aulast%3DViale%26aufirst%3DA.%26aulast%3DLittmann%26aufirst%3DE.%26aulast%3Dvan%2Bden%2BBrink%26aufirst%3DM.%2BR.%2BM.%26aulast%3DJenq%26aufirst%3DR.%2BR.%26aulast%3DTaur%26aufirst%3DY.%26aulast%3DSander%26aufirst%3DC.%26aulast%3DCross%26aufirst%3DJ.%26aulast%3DToussaint%26aufirst%3DN.%2BC.%26aulast%3DXavier%26aufirst%3DJ.%2BB.%26aulast%3DPamer%26aufirst%3DE.%2BG.%26atitle%3DPrecision%2520Microbiome%2520Reconstitution%2520Restores%2520Bile%2520Acid%2520Mediated%2520Resistance%2520to%2520Clostridium%2520difficile%26jtitle%3DNature%26date%3D2015%26volume%3D517%26spage%3D205%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Gao, X. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mubasher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reifer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. E.</span><span> </span><span class="NLM_article-title">Dose-Response Efficacy of a Proprietary Probiotic Formula of <i>Lactobacillus acidophilus</i> Cl1285 and <i>Lactobacillus casei</i> Lbc80r for Antibiotic-Associated Diarrhea and <i>Clostridium difficile</i>-Associated Diarrhea Prophylaxis in Adult Patients</span> <span class="citation_source-journal">Am. J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1636</span><span class="NLM_x">–</span> <span class="NLM_lpage">1641</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1038%2Fajg.2010.11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=20145608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADC%252BC3cnkvFWqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2010&pages=1636-1641&author=X.+W.+Gaoauthor=M.+Mubasherauthor=C.+Y.+Fangauthor=C.+Reiferauthor=L.+E.+Miller&title=Dose-Response+Efficacy+of+a+Proprietary+Probiotic+Formula+of+Lactobacillus+acidophilus+Cl1285+and+Lactobacillus+casei+Lbc80r+for+Antibiotic-Associated+Diarrhea+and+Clostridium+difficile-Associated+Diarrhea+Prophylaxis+in+Adult+Patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients</span></div><div class="casAuthors">Gao Xing Wang; Mubasher Mohamed; Fang Chong Yu; Reifer Cheryl; Miller Larry E</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of gastroenterology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1636-41</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  Standard therapies for antibiotic-associated diarrhea (AAD) and Clostridium difficile-associated diarrhea (CDAD) have limited efficacy.  Probiotic prophylaxis is a promising alternative for reduction of AAD and CDAD incidence.  METHODS:  In this single-center, randomized, double-blind, placebo-controlled dose-ranging study, we randomized 255 adult inpatients to one of three groups: two probiotic capsules per day (Pro-2, n=86), one probiotic capsule and one placebo capsule per day (Pro-1, n=85), or two placebo capsules per day (n=84).  Each probiotic capsule contained 50 billion c.f.u. of live organisms (Lactobacillus acidophilus CL1285 +Lactobacillus casei LBC80R Bio-K+ CL1285).  Probiotic prophylaxis began within 36 h of initial antibiotic administration, continued for 5 days after the last antibiotic dose, and patients were followed for an additional 21 days.  RESULTS:  Pro-2 (15.5%) had a lower AAD incidence vs.  Pro-1 (28.2%).  Each probiotic group had a lower AAD incidence vs. placebo (44.1%).  In patients who acquired AAD, Pro-2 (2.8 days) and Pro-1 (4.1 days) had shorter symptom duration vs. placebo (6.4 days).  Similarly, Pro-2 (1.2%) had a lower CDAD incidence vs.  Pro-1 (9.4%).  Each treatment group had a lower CDAD incidence vs. placebo (23.8%).  Gastrointestinal symptoms were less common in the treatment groups vs. placebo and in Pro-2 vs.  Pro-1.  CONCLUSIONS:  The proprietary probiotic blend used in this study was well tolerated and effective for reducing risk of AAD and, in particular, CDAD in hospitalized patients on antibiotics.  A dose-ranging effect was shown with 100 billion c.f.u., yielding superior outcomes and fewer gastrointestinal events compared to 50 billion c.f.u. (ClinicalTrials.gov number NCT00958308).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTepuDTF_5XNysZ1x6zOs0vfW6udTcc2eaBuz7N_JYSq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cnkvFWqtQ%253D%253D&md5=ee303feb9fc8aac8618e6759cef46630</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1038%2Fajg.2010.11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fajg.2010.11%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DX.%2BW.%26aulast%3DMubasher%26aufirst%3DM.%26aulast%3DFang%26aufirst%3DC.%2BY.%26aulast%3DReifer%26aufirst%3DC.%26aulast%3DMiller%26aufirst%3DL.%2BE.%26atitle%3DDose-Response%2520Efficacy%2520of%2520a%2520Proprietary%2520Probiotic%2520Formula%2520of%2520Lactobacillus%2520acidophilus%2520Cl1285%2520and%2520Lactobacillus%2520casei%2520Lbc80r%2520for%2520Antibiotic-Associated%2520Diarrhea%2520and%2520Clostridium%2520difficile-Associated%2520Diarrhea%2520Prophylaxis%2520in%2520Adult%2520Patients%26jtitle%3DAm.%2520J.%2520Gastroenterol.%26date%3D2010%26volume%3D105%26spage%3D1636%26epage%3D1641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span>Microbiota Restoration Therapy for Recurrent <i>Clostridium difficile</i>-associated Diarrhea. Identifier NCT01925417. <a href="https://clinicaltrials.gov/ct2/show/NCT01925417?term=FMT&amp;phase=1&amp;rank=17" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01925417?term=FMT&phase=1&rank=17</a> (accessed Oct 28,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Microbiota+Restoration+Therapy+for+Recurrent+Clostridium+difficile-associated+Diarrhea.+Identifier+NCT01925417.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01925417%3Fterm%3DFMT%26phase%3D1%26rank%3D17+%28accessed+Oct+28%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span>Monarch Labs. Monarch Labs and BTER Foundation collaborate to develop fecal transplantion products <a href="http://www.monarchlabs.com/Monarch-Labs-and-BTER-Foundation-collaborate-to-develop-fecal-transplantion-products" class="extLink">http://www.monarchlabs.com/Monarch-Labs-and-BTER-Foundation-collaborate-to-develop-fecal-transplantion-products</a> (accessed Aug 18,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Monarch+Labs.+Monarch+Labs+and+BTER+Foundation+collaborate+to+develop+fecal+transplantion+products+http%3A%2F%2Fwww.monarchlabs.com%2FMonarch-Labs-and-BTER-Foundation-collaborate-to-develop-fecal-transplantion-products+%28accessed+Aug+18%2C+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Gaulton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellis, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bento, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Light, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGlinchey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalovich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Lazikani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J. P.</span><span> </span><span class="NLM_article-title">ChEMBL: A Large-Scale Bioactivity Database for Drug Discovery</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">D1100</span><span class="NLM_x">–</span> <span class="NLM_lpage">D1107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fnar%2Fgkr777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=21948594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs12htbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=D1100-D1107&author=A.+Gaultonauthor=L.+J.+Bellisauthor=A.+P.+Bentoauthor=J.+Chambersauthor=M.+Daviesauthor=A.+Herseyauthor=Y.+Lightauthor=S.+McGlincheyauthor=D.+Michalovichauthor=B.+Al-Lazikaniauthor=J.+P.+Overington&title=ChEMBL%3A+A+Large-Scale+Bioactivity+Database+for+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">ChEMBL: a large-scale bioactivity database for drug discovery</span></div><div class="casAuthors">Gaulton, Anna; Bellis, Louisa J.; Bento, A. Patricia; Chambers, Jon; Davies, Mark; Hersey, Anne; Light, Yvonne; McGlinchey, Shaun; Michalovich, David; Al-Lazikani, Bissan; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D1100-D1107</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">ChEMBL is an Open Data database contg. binding, functional and ADMET information for a large no. of drug-like bioactive compds.  These data are manually abstracted from the primary published literature on a regular basis, then further curated and standardized to maximize their quality and utility across a wide range of chem. biol. and drug-discovery research problems.  Currently, the database contains 5.4 million bioactivity measurements for more than 1 million compds. and 5200 protein targets.  Access is available through a web-based interface, data downloads and web services at: https://www.ebi.ac.uk/chembldb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9e9jRENTtubVg90H21EOLACvtfcHk0lhmLW7qJ3odtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs12htbjN&md5=aedf7793e1ca54b6a4fa272ea3ef7d0e</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkr777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkr777%26sid%3Dliteratum%253Aachs%26aulast%3DGaulton%26aufirst%3DA.%26aulast%3DBellis%26aufirst%3DL.%2BJ.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DChambers%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DM.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DLight%26aufirst%3DY.%26aulast%3DMcGlinchey%26aufirst%3DS.%26aulast%3DMichalovich%26aufirst%3DD.%26aulast%3DAl-Lazikani%26aufirst%3DB.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DChEMBL%253A%2520A%2520Large-Scale%2520Bioactivity%2520Database%2520for%2520Drug%2520Discovery%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2012%26volume%3D40%26spage%3DD1100%26epage%3DD1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Ballard, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olekhnovich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koerner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. L.</span><span> </span><span class="NLM_article-title">Biological Activity of Modified and Exchanged 2-Amino-5-Nitrothiazole Amide Analogues of Nitazoxanide</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3537</span><span class="NLM_x">–</span> <span class="NLM_lpage">3539</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3537-3539&author=T.+E.+Ballardauthor=X.+Wangauthor=I.+Olekhnovichauthor=T.+Koernerauthor=C.+Seymourauthor=P.+S.+Hoffmanauthor=T.+L.+Macdonald&title=Biological+Activity+of+Modified+and+Exchanged+2-Amino-5-Nitrothiazole+Amide+Analogues+of+Nitazoxanide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBallard%26aufirst%3DT.%2BE.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DOlekhnovich%26aufirst%3DI.%26aulast%3DKoerner%26aufirst%3DT.%26aulast%3DSeymour%26aufirst%3DC.%26aulast%3DHoffman%26aufirst%3DP.%2BS.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DBiological%2520Activity%2520of%2520Modified%2520and%2520Exchanged%25202-Amino-5-Nitrothiazole%2520Amide%2520Analogues%2520of%2520Nitazoxanide%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3537%26epage%3D3539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Ballard, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olekhnovich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koerner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salamoun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warthan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. L.</span><span> </span><span class="NLM_article-title">Synthesis and Antimicrobial Evaluation of Nitazoxanide-Based Analogues: Identification of Selective and Broad Spectrum Activity</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">362</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=362-377&author=T.+E.+Ballardauthor=X.+Wangauthor=I.+Olekhnovichauthor=T.+Koernerauthor=C.+Seymourauthor=J.+Salamounauthor=M.+Warthanauthor=P.+S.+Hoffmanauthor=T.+L.+Macdonald&title=Synthesis+and+Antimicrobial+Evaluation+of+Nitazoxanide-Based+Analogues%3A+Identification+of+Selective+and+Broad+Spectrum+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBallard%26aufirst%3DT.%2BE.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DOlekhnovich%26aufirst%3DI.%26aulast%3DKoerner%26aufirst%3DT.%26aulast%3DSeymour%26aufirst%3DC.%26aulast%3DSalamoun%26aufirst%3DJ.%26aulast%3DWarthan%26aufirst%3DM.%26aulast%3DHoffman%26aufirst%3DP.%2BS.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DSynthesis%2520and%2520Antimicrobial%2520Evaluation%2520of%2520Nitazoxanide-Based%2520Analogues%253A%2520Identification%2520of%2520Selective%2520and%2520Broad%2520Spectrum%2520Activity%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D362%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Katsura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakane, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morinaga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takasugi, H.</span><span> </span><span class="NLM_article-title">Anti-<i>Helicobacter pylori</i> Agents. 3. 2-[(Arylalkyl)Guanidino]-4-furylthiazoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2920</span><span class="NLM_x">–</span> <span class="NLM_lpage">2926</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9900671" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=2920-2926&author=Y.+Katsuraauthor=S.+Nishinoauthor=M.+Ohnoauthor=K.+Sakaneauthor=Y.+Matsumotoauthor=C.+Morinagaauthor=H.+Ishikawaauthor=H.+Takasugi&title=Anti-Helicobacter+pylori+Agents.+3.+2-%5B%28Arylalkyl%29Guanidino%5D-4-furylthiazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fjm9900671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9900671%26sid%3Dliteratum%253Aachs%26aulast%3DKatsura%26aufirst%3DY.%26aulast%3DNishino%26aufirst%3DS.%26aulast%3DOhno%26aufirst%3DM.%26aulast%3DSakane%26aufirst%3DK.%26aulast%3DMatsumoto%26aufirst%3DY.%26aulast%3DMorinaga%26aufirst%3DC.%26aulast%3DIshikawa%26aufirst%3DH.%26aulast%3DTakasugi%26aufirst%3DH.%26atitle%3DAnti-Helicobacter%2520pylori%2520Agents.%25203.%25202-%255B%2528Arylalkyl%2529Guanidino%255D-4-furylthiazoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D2920%26epage%3D2926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Katsura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakane, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takasugi, H.</span><span> </span><span class="NLM_article-title">Anti-<i>Helicobacter pylori</i> Agents. 2. Structure Activity Relationships in a New Series of 2-Alkylguanidino-4-furylthiazoles</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1307</span><span class="NLM_x">–</span> <span class="NLM_lpage">1312</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=1307-1312&author=Y.+Katsuraauthor=S.+Nishinoauthor=T.+Tomishiauthor=K.+Sakaneauthor=Y.+Matsumotoauthor=H.+Ishikawaauthor=H.+Takasugi&title=Anti-Helicobacter+pylori+Agents.+2.+Structure+Activity+Relationships+in+a+New+Series+of+2-Alkylguanidino-4-furylthiazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatsura%26aufirst%3DY.%26aulast%3DNishino%26aufirst%3DS.%26aulast%3DTomishi%26aufirst%3DT.%26aulast%3DSakane%26aufirst%3DK.%26aulast%3DMatsumoto%26aufirst%3DY.%26aulast%3DIshikawa%26aufirst%3DH.%26aulast%3DTakasugi%26aufirst%3DH.%26atitle%3DAnti-Helicobacter%2520pylori%2520Agents.%25202.%2520Structure%2520Activity%2520Relationships%2520in%2520a%2520New%2520Series%2520of%25202-Alkylguanidino-4-furylthiazoles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1998%26volume%3D8%26spage%3D1307%26epage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span>Emerging Drugs for Active Tuberculosis. <a href="http://www.thieme-connect.de/DOI/DOI?10.1055/s-0028-1085706" class="extLink">http://www.thieme-connect.de/DOI/DOI?10.1055/s-0028-1085706</a> (accessed Apr 9,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Emerging+Drugs+for+Active+Tuberculosis.+http%3A%2F%2Fwww.thieme-connect.de%2FDOI%2FDOI%3F10.1055%2Fs-0028-1085706+%28accessed+Apr+9%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Pankuch, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appelbaum, P. C.</span><span> </span><span class="NLM_article-title">Activities of Tizoxanide and Nitazoxanide Compared to Those of Five Other Thiazolides and Three Other Agents against Anaerobic Species</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1112</span><span class="NLM_x">–</span> <span class="NLM_lpage">1117</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=1112-1117&author=G.+A.+Pankuchauthor=P.+C.+Appelbaum&title=Activities+of+Tizoxanide+and+Nitazoxanide+Compared+to+Those+of+Five+Other+Thiazolides+and+Three+Other+Agents+against+Anaerobic+Species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPankuch%26aufirst%3DG.%2BA.%26aulast%3DAppelbaum%26aufirst%3DP.%2BC.%26atitle%3DActivities%2520of%2520Tizoxanide%2520and%2520Nitazoxanide%2520Compared%2520to%2520Those%2520of%2520Five%2520Other%2520Thiazolides%2520and%2520Three%2520Other%2520Agents%2520against%2520Anaerobic%2520Species%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D1112%26epage%3D1117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Costello, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karpanen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathbone, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeldon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worthington, T.</span><span> </span><span class="NLM_article-title">Thiosemicarbazones Active Against <i>Clostridium difficile</i></span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1708</span><span class="NLM_x">–</span> <span class="NLM_lpage">1711</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1708-1711&author=C.+Costelloauthor=T.+Karpanenauthor=P.+A.+Lambertauthor=P.+Mistryauthor=K.+J.+Parkerauthor=D.+L.+Rathboneauthor=J.+Renauthor=L.+Wheeldonauthor=T.+Worthington&title=Thiosemicarbazones+Active+Against+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCostello%26aufirst%3DC.%26aulast%3DKarpanen%26aufirst%3DT.%26aulast%3DLambert%26aufirst%3DP.%2BA.%26aulast%3DMistry%26aufirst%3DP.%26aulast%3DParker%26aufirst%3DK.%2BJ.%26aulast%3DRathbone%26aufirst%3DD.%2BL.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DWheeldon%26aufirst%3DL.%26aulast%3DWorthington%26aufirst%3DT.%26atitle%3DThiosemicarbazones%2520Active%2520Against%2520Clostridium%2520difficile%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1708%26epage%3D1711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Miyamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalisiak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korthals, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauwaet, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cobo, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upcroft, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upcroft, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillin, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fokin, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckmann, L.</span><span> </span><span class="NLM_article-title">Expanded Therapeutic Potential in Activity Space of Next-Generation 5-Nitroimidazole Antimicrobials with Broad Structural Diversity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">17564</span><span class="NLM_x">–</span> <span class="NLM_lpage">17569</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=17564-17569&author=Y.+Miyamotoauthor=J.+Kalisiakauthor=K.+Korthalsauthor=T.+Lauwaetauthor=D.+Y.+Cheungauthor=R.+Lozanoauthor=E.+R.+Coboauthor=P.+Upcroftauthor=J.+A.+Upcroftauthor=D.+E.+Bergauthor=F.+D.+Gillinauthor=V.+V.+Fokinauthor=K.+B.+Sharplessauthor=L.+Eckmann&title=Expanded+Therapeutic+Potential+in+Activity+Space+of+Next-Generation+5-Nitroimidazole+Antimicrobials+with+Broad+Structural+Diversity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DY.%26aulast%3DKalisiak%26aufirst%3DJ.%26aulast%3DKorthals%26aufirst%3DK.%26aulast%3DLauwaet%26aufirst%3DT.%26aulast%3DCheung%26aufirst%3DD.%2BY.%26aulast%3DLozano%26aufirst%3DR.%26aulast%3DCobo%26aufirst%3DE.%2BR.%26aulast%3DUpcroft%26aufirst%3DP.%26aulast%3DUpcroft%26aufirst%3DJ.%2BA.%26aulast%3DBerg%26aufirst%3DD.%2BE.%26aulast%3DGillin%26aufirst%3DF.%2BD.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26aulast%3DEckmann%26aufirst%3DL.%26atitle%3DExpanded%2520Therapeutic%2520Potential%2520in%2520Activity%2520Space%2520of%2520Next-Generation%25205-Nitroimidazole%2520Antimicrobials%2520with%2520Broad%2520Structural%2520Diversity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3D17564%26epage%3D17569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Jeong, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukhopadhyay, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akada, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dailidiene, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, D. E.</span><span> </span><span class="NLM_article-title">Roles of FrxA and RdxA Nitroreductases of <i>Helicobacter pylori</i> in Susceptibility and Resistance to Metronidazole</span> <span class="citation_source-journal">J. Bacteriol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">183</span><span class="NLM_x">, </span> <span class="NLM_fpage">5155</span><span class="NLM_x">–</span> <span class="NLM_lpage">5162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1128%2FJB.183.17.5155-5162.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=11489869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtFKrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2001&pages=5155-5162&author=J.+Y.+Jeongauthor=A.+K.+Mukhopadhyayauthor=J.+K.+Akadaauthor=D.+Dailidieneauthor=P.+S.+Hoffmanauthor=D.+E.+Berg&title=Roles+of+FrxA+and+RdxA+Nitroreductases+of+Helicobacter+pylori+in+Susceptibility+and+Resistance+to+Metronidazole"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of FrxA and RdxA nitroreductases of Helicobacter pylori in susceptibility and resistance to metronidazole</span></div><div class="casAuthors">Jeong, Jin-Yong; Mukhopadhyay, Asish K.; Akada, Junko K.; Dailidiene, Daiva; Hoffman, Paul S.; Berg, Douglas E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5155-5162</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The relative importance of the frxA and rdxA nitroreductase genes of Helicobacter pylori in metronidazole (MTZ) susceptibility and resistance has been controversial.  Jeong et al. had interpreted that Mtzs H. pylori were of two types: type I, requiring only inactivation of rdxA to became resistant, and type II, requiring inactivation of both rdxA and frxA to become resistant; frxA inactivation by itself was not sufficient to confer resistance.  In contrast, Kwon et al. had interpreted that resistance resulted from inactivation either of frxA or rdxA.  These two interpretations were tested here.  Resistance was defined as efficient colony formation by single cells from dild. cultures rather than as growth responses of more dense inocula on MTZ-contg. medium.  Tests of three of Kwon's Mtzs strains showed that each was type II, requiring inactivation of both rdxA and frxA to become resistant.  In addnl. tests, derivs. of frxA mutant strains recovered from MTZ-contg. medium were found to contain new mutations in rdxA, and frxA inactivation slowed MTZ-induced killing of Mtzs strains.  Northern blot analyses indicated that frxA mRNA, and perhaps also rdxA mRNA, were more abundant in type II than in type I strains.  We conclude that development of MTZ resistance in H. pylori requires inactivation of rdxA alone or of both rdxA and frxA, depending on bacterial genotype, but rarely, if ever, inactivation of frxA alone, and that H. pylori strains differ in regulation of nitroreductase gene expression.  We suggest that such regulatory differences may be significant functionally during human infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpChB5BXmcFo7Vg90H21EOLACvtfcHk0lhsGcUGT2Qw4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtFKrs7c%253D&md5=474bf2670bea9ea195b15d1e02b3d2b7</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1128%2FJB.183.17.5155-5162.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.183.17.5155-5162.2001%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DJ.%2BY.%26aulast%3DMukhopadhyay%26aufirst%3DA.%2BK.%26aulast%3DAkada%26aufirst%3DJ.%2BK.%26aulast%3DDailidiene%26aufirst%3DD.%26aulast%3DHoffman%26aufirst%3DP.%2BS.%26aulast%3DBerg%26aufirst%3DD.%2BE.%26atitle%3DRoles%2520of%2520FrxA%2520and%2520RdxA%2520Nitroreductases%2520of%2520Helicobacter%2520pylori%2520in%2520Susceptibility%2520and%2520Resistance%2520to%2520Metronidazole%26jtitle%3DJ.%2520Bacteriol.%26date%3D2001%26volume%3D183%26spage%3D5155%26epage%3D5162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Segreti, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trenholme, G. M.</span><span> </span><span class="NLM_article-title">In Vitro Activity of New Quinoxaline Compounds against <i>Campylobacter</i> Species and <i>Clostridium difficile</i></span> <span class="citation_source-journal">Diagn. Microbiol. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1016%2F0732-8893%2893%2990031-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=8243041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADyaK2cXitFagtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1993&pages=177-179&author=J.+Segretiauthor=L.+J.+Goodmanauthor=G.+M.+Trenholme&title=In+Vitro+Activity+of+New+Quinoxaline+Compounds+against+Campylobacter+Species+and+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro activity of new quinoxaline compounds against Campylobacter species and Clostridium difficile</span></div><div class="casAuthors">Segreti, John; Goodman, Larry J.; Trenholme, Gordon M.</div><div class="citationInfo"><span class="NLM_cas:title">Diagnostic Microbiology and Infectious Disease</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">177-9</span>CODEN:
                <span class="NLM_cas:coden">DMIDDZ</span>;
        ISSN:<span class="NLM_cas:issn">0732-8893</span>.
    </div><div class="casAbstract">SC-44914 and SC-44942-A are two new quinoxaline compds. with a spectrum of activity similar to that of metronidazole.  The authors studied the activity of SC-44914 and SC-44942-A against 35 Campylobacter jejuni, 30 Campylobacter coli, and 20 Clostridium difficile and compared it with that of metronidazole by utilizing an agar diln. method.  The quinoxalines had little activity against the C. jejuni and C. coli [min. inhibitory concn. (MIC)90 ≥ 64 μg/mL].  SC-44914 and SC-44942-A had excellent activity against Cl. difficile (MIC90 ≤ 0.06 μg/mL for SC 44914, and 0.5 μg/mL for SC-44942A).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrK7FQr7Eub7Vg90H21EOLACvtfcHk0lhsGcUGT2Qw4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitFagtbk%253D&md5=e3ccb23317e46ae07f8d7009396fb5d3</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2F0732-8893%2893%2990031-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0732-8893%252893%252990031-2%26sid%3Dliteratum%253Aachs%26aulast%3DSegreti%26aufirst%3DJ.%26aulast%3DGoodman%26aufirst%3DL.%2BJ.%26aulast%3DTrenholme%26aufirst%3DG.%2BM.%26atitle%3DIn%2520Vitro%2520Activity%2520of%2520New%2520Quinoxaline%2520Compounds%2520against%2520Campylobacter%2520Species%2520and%2520Clostridium%2520difficile%26jtitle%3DDiagn.%2520Microbiol.%2520Infect.%2520Dis.%26date%3D1993%26volume%3D17%26spage%3D177%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Zhang, S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span> </span><span class="NLM_article-title">Synthesis and Antibacterial Activity against <i>Clostridium difficile</i> of Novel Demethylvancomycin Derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4942</span><span class="NLM_x">–</span> <span class="NLM_lpage">4945</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4942-4945&author=S.-J.+Zhangauthor=Q.+Yangauthor=L.+Xuauthor=J.+Changauthor=X.+Sun&title=Synthesis+and+Antibacterial+Activity+against+Clostridium+difficile+of+Novel+Demethylvancomycin+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.-J.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DX.%26atitle%3DSynthesis%2520and%2520Antibacterial%2520Activity%2520against%2520Clostridium%2520difficile%2520of%2520Novel%2520Demethylvancomycin%2520Derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D4942%26epage%3D4945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Kirst, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willard, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truedell, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Counter, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felty-Duckworth, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pekarek, R. S.</span><span> </span><span class="NLM_article-title">Synthesis and Evaluation of Tylosin-Related Macrolides Modified at the Aldehyde Function: A New Series of Orally Effective Antibiotics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1631</span><span class="NLM_x">–</span> <span class="NLM_lpage">1641</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00403a025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADyaL1cXksVOrtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=1631-1641&author=H.+A.+Kirstauthor=J.+E.+Tothauthor=M.+Debonoauthor=K.+E.+Willardauthor=B.+A.+Truedellauthor=J.+L.+Ottauthor=F.+T.+Counterauthor=A.+M.+Felty-Duckworthauthor=R.+S.+Pekarek&title=Synthesis+and+Evaluation+of+Tylosin-Related+Macrolides+Modified+at+the+Aldehyde+Function%3A+A+New+Series+of+Orally+Effective+Antibiotics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of tylosin-related macrolides modified at the aldehyde function:  a new series of orally effective antibiotics</span></div><div class="casAuthors">Kirst, Herbert A.; Toth, John E.; Debono, Manuel; Willard, Kevin E.; Truedell, Brenda A.; Ott, John L.; Counter, Fred T.; Felty-Duckworth, Anna M.; Pekarek, Robert S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1631-41</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Modification of the aldehyde group in tylosin (I) and related macrolide antibiotics dramatically enhanced the oral efficacy of the derivs. against exptl. infections caused by susceptible bacteria in lab. animals.  A large no. and wide variety of aldehyde-modified macrolide derivs. were prepd., utilizing the Mitsunobu reaction and other chem. transformations.  Evaluation of in vitro and in vivo antimicrobial activity indicated that derivs. of desmycosin (II) showed the broadest spectrum of antimicrobial activity with the best efficacy and bioavailability after oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo52TYXABepi7Vg90H21EOLACvtfcHk0lgK2pymdGvVSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXksVOrtb4%253D&md5=eeae47f7c2d09294820a707c6c70f843</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fjm00403a025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00403a025%26sid%3Dliteratum%253Aachs%26aulast%3DKirst%26aufirst%3DH.%2BA.%26aulast%3DToth%26aufirst%3DJ.%2BE.%26aulast%3DDebono%26aufirst%3DM.%26aulast%3DWillard%26aufirst%3DK.%2BE.%26aulast%3DTruedell%26aufirst%3DB.%2BA.%26aulast%3DOtt%26aufirst%3DJ.%2BL.%26aulast%3DCounter%26aufirst%3DF.%2BT.%26aulast%3DFelty-Duckworth%26aufirst%3DA.%2BM.%26aulast%3DPekarek%26aufirst%3DR.%2BS.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Tylosin-Related%2520Macrolides%2520Modified%2520at%2520the%2520Aldehyde%2520Function%253A%2520A%2520New%2520Series%2520of%2520Orally%2520Effective%2520Antibiotics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D1631%26epage%3D1641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Terasawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsuhashi, S.</span><span> </span><span class="NLM_article-title">In Vitro Activity of YM133, a New Semisynthesized Macrolide</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1370</span><span class="NLM_x">–</span> <span class="NLM_lpage">1375</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1991&pages=1370-1375&author=T.+Terasawaauthor=M.+Watanabeauthor=T.+Okuboauthor=S.+Mitsuhashi&title=In+Vitro+Activity+of+YM133%2C+a+New+Semisynthesized+Macrolide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTerasawa%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DOkubo%26aufirst%3DT.%26aulast%3DMitsuhashi%26aufirst%3DS.%26atitle%3DIn%2520Vitro%2520Activity%2520of%2520YM133%252C%2520a%2520New%2520Semisynthesized%2520Macrolide%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1991%26volume%3D35%26spage%3D1370%26epage%3D1375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Sanchez, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogliotti, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domagala, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gracheck, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huband, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sesnie, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, M. A.</span><span> </span><span class="NLM_article-title">The Synthesis, Structure-Activity, and Structure-Side Effect Relationships of a Series of 8-Alkoxy- and 5-Amino-8-alkoxyquinolone Antibacterial Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">4478</span><span class="NLM_x">–</span> <span class="NLM_lpage">4487</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00022a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=4478-4487&author=J.+P.+Sanchezauthor=R.+D.+Gogliottiauthor=J.+M.+Domagalaauthor=S.+J.+Gracheckauthor=M.+D.+Hubandauthor=J.+A.+Sesnieauthor=M.+A.+Cohenauthor=M.+A.+Shapiro&title=The+Synthesis%2C+Structure-Activity%2C+and+Structure-Side+Effect+Relationships+of+a+Series+of+8-Alkoxy-+and+5-Amino-8-alkoxyquinolone+Antibacterial+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Fjm00022a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00022a013%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez%26aufirst%3DJ.%2BP.%26aulast%3DGogliotti%26aufirst%3DR.%2BD.%26aulast%3DDomagala%26aufirst%3DJ.%2BM.%26aulast%3DGracheck%26aufirst%3DS.%2BJ.%26aulast%3DHuband%26aufirst%3DM.%2BD.%26aulast%3DSesnie%26aufirst%3DJ.%2BA.%26aulast%3DCohen%26aufirst%3DM.%2BA.%26aulast%3DShapiro%26aufirst%3DM.%2BA.%26atitle%3DThe%2520Synthesis%252C%2520Structure-Activity%252C%2520and%2520Structure-Side%2520Effect%2520Relationships%2520of%2520a%2520Series%2520of%25208-Alkoxy-%2520and%25205-Amino-8-alkoxyquinolone%2520Antibacterial%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D4478%26epage%3D4487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Rosen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marovich, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pernet, A. G.</span><span> </span><span class="NLM_article-title">Aromatic Dienoyl Tetramic Acids. Novel Antibacterial Agents with Activity against Anaerobes and Staphylococci</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1062</span><span class="NLM_x">–</span> <span class="NLM_lpage">1069</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00125a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=1062-1069&author=T.+Rosenauthor=P.+B.+Fernandesauthor=M.+A.+Marovichauthor=L.+Shenauthor=J.+Maoauthor=A.+G.+Pernet&title=Aromatic+Dienoyl+Tetramic+Acids.+Novel+Antibacterial+Agents+with+Activity+against+Anaerobes+and+Staphylococci"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Fjm00125a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00125a022%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DT.%26aulast%3DFernandes%26aufirst%3DP.%2BB.%26aulast%3DMarovich%26aufirst%3DM.%2BA.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DPernet%26aufirst%3DA.%2BG.%26atitle%3DAromatic%2520Dienoyl%2520Tetramic%2520Acids.%2520Novel%2520Antibacterial%2520Agents%2520with%2520Activity%2520against%2520Anaerobes%2520and%2520Staphylococci%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26spage%3D1062%26epage%3D1069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Ueda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tateda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suematsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiguro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyairi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span> </span><span class="NLM_article-title">Anti-<i>Clostridium difficile</i> Potential of Tetramic Acid Derivatives from <i>Pseudomonas Aeruginosa</i> Quorum-Sensing Autoinducers</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">688</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=683-688&author=C.+Uedaauthor=K.+Tatedaauthor=M.+Horikawaauthor=S.+Kimuraauthor=Y.+Ishiiauthor=K.+Nomuraauthor=K.+Yamadaauthor=T.+Suematsuauthor=Y.+Inoueauthor=M.+Ishiguroauthor=S.+Miyairiauthor=K.+Yamaguchi&title=Anti-Clostridium+difficile+Potential+of+Tetramic+Acid+Derivatives+from+Pseudomonas+Aeruginosa+Quorum-Sensing+Autoinducers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DC.%26aulast%3DTateda%26aufirst%3DK.%26aulast%3DHorikawa%26aufirst%3DM.%26aulast%3DKimura%26aufirst%3DS.%26aulast%3DIshii%26aufirst%3DY.%26aulast%3DNomura%26aufirst%3DK.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DSuematsu%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DY.%26aulast%3DIshiguro%26aufirst%3DM.%26aulast%3DMiyairi%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DK.%26atitle%3DAnti-Clostridium%2520difficile%2520Potential%2520of%2520Tetramic%2520Acid%2520Derivatives%2520from%2520Pseudomonas%2520Aeruginosa%2520Quorum-Sensing%2520Autoinducers%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D683%26epage%3D688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Karwowski, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theriault, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlow, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensey, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, P. E.</span><span> </span><span class="NLM_article-title">Tirandalydigin, a Novel Tetramic Acid of the Tirandamycin-Streptolydigin Type. I. Taxonomy of the Producing Organism, Fermentation and Biological Activity</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1125</span><span class="NLM_x">–</span> <span class="NLM_lpage">1132</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1992&pages=1125-1132&author=J.+P.+Karwowskiauthor=M.+Jacksonauthor=R.+J.+Theriaultauthor=G.+J.+Barlowauthor=L.+Coenauthor=D.+M.+Henseyauthor=P.+E.+Humphrey&title=Tirandalydigin%2C+a+Novel+Tetramic+Acid+of+the+Tirandamycin-Streptolydigin+Type.+I.+Taxonomy+of+the+Producing+Organism%2C+Fermentation+and+Biological+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarwowski%26aufirst%3DJ.%2BP.%26aulast%3DJackson%26aufirst%3DM.%26aulast%3DTheriault%26aufirst%3DR.%2BJ.%26aulast%3DBarlow%26aufirst%3DG.%2BJ.%26aulast%3DCoen%26aufirst%3DL.%26aulast%3DHensey%26aufirst%3DD.%2BM.%26aulast%3DHumphrey%26aufirst%3DP.%2BE.%26atitle%3DTirandalydigin%252C%2520a%2520Novel%2520Tetramic%2520Acid%2520of%2520the%2520Tirandamycin-Streptolydigin%2520Type.%2520I.%2520Taxonomy%2520of%2520the%2520Producing%2520Organism%252C%2520Fermentation%2520and%2520Biological%2520Activity%26jtitle%3DJ.%2520Antibiot.%26date%3D1992%26volume%3D45%26spage%3D1125%26epage%3D1132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Shoji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakazaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uotani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, T.</span><span> </span><span class="NLM_article-title">Isolation and Characterization of Agglomerins A, B, C and D</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1729</span><span class="NLM_x">–</span> <span class="NLM_lpage">1733</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1989&pages=1729-1733&author=J.+Shojiauthor=R.+Sakazakiauthor=T.+Hattoriauthor=K.+Matsumotoauthor=N.+Uotaniauthor=T.+Yoshida&title=Isolation+and+Characterization+of+Agglomerins+A%2C+B%2C+C+and+D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShoji%26aufirst%3DJ.%26aulast%3DSakazaki%26aufirst%3DR.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DUotani%26aufirst%3DN.%26aulast%3DYoshida%26aufirst%3DT.%26atitle%3DIsolation%2520and%2520Characterization%2520of%2520Agglomerins%2520A%252C%2520B%252C%2520C%2520and%2520D%26jtitle%3DJ.%2520Antibiot.%26date%3D1989%26volume%3D42%26spage%3D1729%26epage%3D1733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Terui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakazaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoji, J.</span><span> </span><span class="NLM_article-title">Structures of Agglomerins</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1245</span><span class="NLM_x">–</span> <span class="NLM_lpage">1253</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1990&pages=1245-1253&author=Y.+Teruiauthor=R.+Sakazakiauthor=J.+Shoji&title=Structures+of+Agglomerins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTerui%26aufirst%3DY.%26aulast%3DSakazaki%26aufirst%3DR.%26aulast%3DShoji%26aufirst%3DJ.%26atitle%3DStructures%2520of%2520Agglomerins%26jtitle%3DJ.%2520Antibiot.%26date%3D1990%26volume%3D43%26spage%3D1245%26epage%3D1253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Butler, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peet, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panchal, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bavari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinabarger, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowlin, T. L.</span><span> </span><span class="NLM_article-title">Comparative in Vitro Activity Profiles of Novel Bis-Indole Antibacterials against Gram-Positive and Gram-Negative Clinical Isolates</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3974</span><span class="NLM_x">–</span> <span class="NLM_lpage">3977</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=3974-3977&author=M.+M.+Butlerauthor=J.+D.+Williamsauthor=N.+P.+Peetauthor=D.+T.+Moirauthor=R.+G.+Panchalauthor=S.+Bavariauthor=D.+L.+Shinabargerauthor=T.+L.+Bowlin&title=Comparative+in+Vitro+Activity+Profiles+of+Novel+Bis-Indole+Antibacterials+against+Gram-Positive+and+Gram-Negative+Clinical+Isolates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DM.%2BM.%26aulast%3DWilliams%26aufirst%3DJ.%2BD.%26aulast%3DPeet%26aufirst%3DN.%2BP.%26aulast%3DMoir%26aufirst%3DD.%2BT.%26aulast%3DPanchal%26aufirst%3DR.%2BG.%26aulast%3DBavari%26aufirst%3DS.%26aulast%3DShinabarger%26aufirst%3DD.%2BL.%26aulast%3DBowlin%26aufirst%3DT.%2BL.%26atitle%3DComparative%2520in%2520Vitro%2520Activity%2520Profiles%2520of%2520Novel%2520Bis-Indole%2520Antibacterials%2520against%2520Gram-Positive%2520and%2520Gram-Negative%2520Clinical%2520Isolates%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D3974%26epage%3D3977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Panchal, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houseweart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Opperman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peet, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gussio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowlin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bavari, S.</span><span> </span><span class="NLM_article-title">Novel Broad-Spectrum Bis-(imidazolinylindole) Derivatives with Potent Antibacterial Activities against Antibiotic-Resistant Strains</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4283</span><span class="NLM_x">–</span> <span class="NLM_lpage">4291</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=4283-4291&author=R.+G.+Panchalauthor=R.+L.+Ulrichauthor=D.+Laneauthor=M.+M.+Butlerauthor=C.+Houseweartauthor=T.+Oppermanauthor=J.+D.+Williamsauthor=N.+P.+Peetauthor=D.+T.+Moirauthor=T.+Nguyenauthor=R.+Gussioauthor=T.+Bowlinauthor=S.+Bavari&title=Novel+Broad-Spectrum+Bis-%28imidazolinylindole%29+Derivatives+with+Potent+Antibacterial+Activities+against+Antibiotic-Resistant+Strains"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPanchal%26aufirst%3DR.%2BG.%26aulast%3DUlrich%26aufirst%3DR.%2BL.%26aulast%3DLane%26aufirst%3DD.%26aulast%3DButler%26aufirst%3DM.%2BM.%26aulast%3DHouseweart%26aufirst%3DC.%26aulast%3DOpperman%26aufirst%3DT.%26aulast%3DWilliams%26aufirst%3DJ.%2BD.%26aulast%3DPeet%26aufirst%3DN.%2BP.%26aulast%3DMoir%26aufirst%3DD.%2BT.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DGussio%26aufirst%3DR.%26aulast%3DBowlin%26aufirst%3DT.%26aulast%3DBavari%26aufirst%3DS.%26atitle%3DNovel%2520Broad-Spectrum%2520Bis-%2528imidazolinylindole%2529%2520Derivatives%2520with%2520Potent%2520Antibacterial%2520Activities%2520against%2520Antibiotic-Resistant%2520Strains%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D4283%26epage%3D4291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Ambrus, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelso, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bremner, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casadei, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, K.</span><span> </span><span class="NLM_article-title">Structure-Activity Relationships of 2-Aryl-1<i>H</i>-Indole Inhibitors of the NorA Efflux Pump in <i>Staphylococcus aureus</i></span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4294</span><span class="NLM_x">–</span> <span class="NLM_lpage">4297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1016%2Fj.bmcl.2008.06.093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=18632270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVeqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4294-4297&author=J.+I.+Ambrusauthor=M.+J.+Kelsoauthor=J.+B.+Bremnerauthor=A.+R.+Ballauthor=G.+Casadeiauthor=K.+Lewis&title=Structure-Activity+Relationships+of+2-Aryl-1H-Indole+Inhibitors+of+the+NorA+Efflux+Pump+in+Staphylococcus+aureus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of 2-aryl-1H-indole inhibitors of the NorA efflux pump in Staphylococcus aureus</span></div><div class="casAuthors">Ambrus, Joseph I.; Kelso, Michael J.; Bremner, John B.; Ball, Anthony R.; Casadei, Gabriele; Lewis, Kim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4294-4297</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The synthesis of 22 2-aryl-1H-indoles, e.g. I (R1 = H, NO2, R2 = 2-CO2Me, 3-CO2Me, 4-CO2Me, 2-CH2OH, 3-CH2OH, 4-CH2OH), including 12 new compds., has been achieved via Pd- or Rh-mediated methodologies, or selective electrophilic substitution.  All three methods were based on elaborations from simple indole precursors.  SAR studies on these indoles and 2-phenyl-1H-indole in Staphylococcus aureus as NorA efflux pump inhibitors indicated 5-nitro-2-(3-methoxycarbonyl)phenyl-1H-indole was a slightly more potent inhibitor than the lead INF55 I (R1 = NO2, R2 = H).  A promising new antibacterial lead compd. against S. aureus (2-phenyl-1H-indol-5-yl)-methanol, was also found.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsxs6bHUKlFbVg90H21EOLACvtfcHk0lgyybH5r-4X-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVeqtLg%253D&md5=d2f7b2a8c6f8e926b4ebf3ba4ac01aa0</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.06.093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.06.093%26sid%3Dliteratum%253Aachs%26aulast%3DAmbrus%26aufirst%3DJ.%2BI.%26aulast%3DKelso%26aufirst%3DM.%2BJ.%26aulast%3DBremner%26aufirst%3DJ.%2BB.%26aulast%3DBall%26aufirst%3DA.%2BR.%26aulast%3DCasadei%26aufirst%3DG.%26aulast%3DLewis%26aufirst%3DK.%26atitle%3DStructure-Activity%2520Relationships%2520of%25202-Aryl-1H-Indole%2520Inhibitors%2520of%2520the%2520NorA%2520Efflux%2520Pump%2520in%2520Staphylococcus%2520aureus%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4294%26epage%3D4297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Ternansky, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eudaly, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasher, J. S.</span><span> </span><span class="NLM_article-title">Synthesis and Anaerobic Activity of Novel 1-Carba-1-dethiacephalosporins</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2332</span><span class="NLM_x">–</span> <span class="NLM_lpage">2334</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00068a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=2332-2334&author=R.+J.+Ternanskyauthor=C.+L.+Jordanauthor=J.+A.+Eudalyauthor=J.+S.+Kasher&title=Synthesis+and+Anaerobic+Activity+of+Novel+1-Carba-1-dethiacephalosporins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fjm00068a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00068a009%26sid%3Dliteratum%253Aachs%26aulast%3DTernansky%26aufirst%3DR.%2BJ.%26aulast%3DJordan%26aufirst%3DC.%2BL.%26aulast%3DEudaly%26aufirst%3DJ.%2BA.%26aulast%3DKasher%26aufirst%3DJ.%2BS.%26atitle%3DSynthesis%2520and%2520Anaerobic%2520Activity%2520of%2520Novel%25201-Carba-1-dethiacephalosporins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D2332%26epage%3D2334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Corraz, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dax, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlap, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgopapadakou, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pruess, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossman, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Then, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unowsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, C. C.</span><span> </span><span class="NLM_article-title">Dual-Action Penems and Carbapenems</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1828</span><span class="NLM_x">–</span> <span class="NLM_lpage">1839</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00088a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=1828-1839&author=A.+J.+Corrazauthor=S.+L.+Daxauthor=N.+K.+Dunlapauthor=N.+H.+Georgopapadakouauthor=D.+D.+Keithauthor=D.+L.+Pruessauthor=P.+L.+Rossmanauthor=R.+Thenauthor=J.+Unowskyauthor=C.+C.+Wei&title=Dual-Action+Penems+and+Carbapenems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Fjm00088a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00088a019%26sid%3Dliteratum%253Aachs%26aulast%3DCorraz%26aufirst%3DA.%2BJ.%26aulast%3DDax%26aufirst%3DS.%2BL.%26aulast%3DDunlap%26aufirst%3DN.%2BK.%26aulast%3DGeorgopapadakou%26aufirst%3DN.%2BH.%26aulast%3DKeith%26aufirst%3DD.%2BD.%26aulast%3DPruess%26aufirst%3DD.%2BL.%26aulast%3DRossman%26aufirst%3DP.%2BL.%26aulast%3DThen%26aufirst%3DR.%26aulast%3DUnowsky%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DC.%2BC.%26atitle%3DDual-Action%2520Penems%2520and%2520Carbapenems%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D1828%26epage%3D1839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Mani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanzelka, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillot, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charifson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, T. H.</span><span> </span><span class="NLM_article-title">In Vitro Characterization of the Antibacterial Spectrum of Novel Bacterial Type II Topoisomerase Inhibitors of the Aminobenzimidazole Class</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1228</span><span class="NLM_x">–</span> <span class="NLM_lpage">1237</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=1228-1237&author=N.+Maniauthor=C.+H.+Grossauthor=J.+D.+Parsonsauthor=B.+Hanzelkaauthor=U.+M%C3%BChauthor=S.+Mullinauthor=Y.+Liaoauthor=A.-L.+Grillotauthor=D.+Stamosauthor=P.+S.+Charifsonauthor=T.+H.+Grossman&title=In+Vitro+Characterization+of+the+Antibacterial+Spectrum+of+Novel+Bacterial+Type+II+Topoisomerase+Inhibitors+of+the+Aminobenzimidazole+Class"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMani%26aufirst%3DN.%26aulast%3DGross%26aufirst%3DC.%2BH.%26aulast%3DParsons%26aufirst%3DJ.%2BD.%26aulast%3DHanzelka%26aufirst%3DB.%26aulast%3DM%25C3%25BCh%26aufirst%3DU.%26aulast%3DMullin%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DGrillot%26aufirst%3DA.-L.%26aulast%3DStamos%26aufirst%3DD.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26aulast%3DGrossman%26aufirst%3DT.%2BH.%26atitle%3DIn%2520Vitro%2520Characterization%2520of%2520the%2520Antibacterial%2520Spectrum%2520of%2520Novel%2520Bacterial%2520Type%2520II%2520Topoisomerase%2520Inhibitors%2520of%2520the%2520Aminobenzimidazole%2520Class%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D1228%26epage%3D1237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Charifson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillot, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drumm, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeTiran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolau, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perola, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronkin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swenson, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tessier, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trudeau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamos, D.</span><span> </span><span class="NLM_article-title">Novel Dual-Targeting Benzimidazole Urea Inhibitors of DNA Gyrase and Topoisomerase IV Possessing Potent Antibacterial Activity: Intelligent Design and Evolution through the Judicious Use of Structure-Guided Design and Structure-Activity Relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5243</span><span class="NLM_x">–</span> <span class="NLM_lpage">5263</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800318d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1Knsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5243-5263&author=P.+S.+Charifsonauthor=A.-L.+Grillotauthor=T.+H.+Grossmanauthor=J.+D.+Parsonsauthor=M.+Badiaauthor=S.+Bellonauthor=D.+D.+Deiningerauthor=J.+E.+Drummauthor=C.+H.+Grossauthor=A.+LeTiranauthor=Y.+Liaoauthor=N.+Maniauthor=D.+P.+Nicolauauthor=E.+Perolaauthor=S.+Ronkinauthor=D.+Shannonauthor=L.+L.+Swensonauthor=Q.+Tangauthor=P.+R.+Tessierauthor=S.-K.+Tianauthor=M.+Trudeauauthor=T.+Wangauthor=Y.+Weiauthor=H.+Zhangauthor=D.+Stamos&title=Novel+Dual-Targeting+Benzimidazole+Urea+Inhibitors+of+DNA+Gyrase+and+Topoisomerase+IV+Possessing+Potent+Antibacterial+Activity%3A+Intelligent+Design+and+Evolution+through+the+Judicious+Use+of+Structure-Guided+Design+and+Structure-Activity+Relationships"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Dual-Targeting Benzimidazole Urea Inhibitors of DNA Gyrase and Topoisomerase IV Possessing Potent Antibacterial Activity: Intelligent Design and Evolution through the Judicious Use of Structure-Guided Design and Structure-Activity Relationships</span></div><div class="casAuthors">Charifson, Paul S.; Grillot, Anne-Laure; Grossman, Trudy H.; Parsons, Jonathan D.; Badia, Michael; Bellon, Steve; Deininger, David D.; Drumm, Joseph E.; Gross, Christian H.; LeTiran, Arnaud; Liao, Yusheng; Mani, Nagraj; Nicolau, David P.; Perola, Emanuele; Ronkin, Steven; Shannon, Dean; Swenson, Lora L.; Tang, Qing; Tessier, Pamela R.; Tian, Ski-Kai; Trudeau, Martin; Wang, Tiansheng; Wei, Yunyi; Zhang, Hong; Stamos, Dean</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5243-5263</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of new antibacterial agents with novel mechanisms of action is necessary to overcome the problem of bacterial resistance that affects all currently used classes of antibiotics.  Bacterial DNA gyrase and topoisomerase IV are well-characterized clin. validated targets of the fluoroquinolone antibiotics which exert their antibacterial activity through inhibition of the catalytic subunits.  Inhibition of these targets through interaction with their ATP sites has been less clin. successful.  The discovery and characterization of a new class of low mol. wt., synthetic inhibitors of gyrase and topoisomerase IV that bind to the ATP sites are presented.  The benzimidazole ureas are dual targeting inhibitors of both enzymes and possess potent antibacterial activity against a wide spectrum of relevant pathogens responsible for hospital- and community-acquired infections.  The discovery and optimization of this novel class of antibacterials by the use of structure-guided design, modeling, and structure-activity relationships are described.  Data are presented for enzyme inhibition, antibacterial activity, and in vivo efficacy by oral and i.v. administration in two rodent infection models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSg-NiMYqXebVg90H21EOLACvtfcHk0lip8rIvy-735Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1Knsb4%253D&md5=284d19912422bcadd38d9c021cd71ef8</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Fjm800318d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800318d%26sid%3Dliteratum%253Aachs%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26aulast%3DGrillot%26aufirst%3DA.-L.%26aulast%3DGrossman%26aufirst%3DT.%2BH.%26aulast%3DParsons%26aufirst%3DJ.%2BD.%26aulast%3DBadia%26aufirst%3DM.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DDeininger%26aufirst%3DD.%2BD.%26aulast%3DDrumm%26aufirst%3DJ.%2BE.%26aulast%3DGross%26aufirst%3DC.%2BH.%26aulast%3DLeTiran%26aufirst%3DA.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DMani%26aufirst%3DN.%26aulast%3DNicolau%26aufirst%3DD.%2BP.%26aulast%3DPerola%26aufirst%3DE.%26aulast%3DRonkin%26aufirst%3DS.%26aulast%3DShannon%26aufirst%3DD.%26aulast%3DSwenson%26aufirst%3DL.%2BL.%26aulast%3DTang%26aufirst%3DQ.%26aulast%3DTessier%26aufirst%3DP.%2BR.%26aulast%3DTian%26aufirst%3DS.-K.%26aulast%3DTrudeau%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DStamos%26aufirst%3DD.%26atitle%3DNovel%2520Dual-Targeting%2520Benzimidazole%2520Urea%2520Inhibitors%2520of%2520DNA%2520Gyrase%2520and%2520Topoisomerase%2520IV%2520Possessing%2520Potent%2520Antibacterial%2520Activity%253A%2520Intelligent%2520Design%2520and%2520Evolution%2520through%2520the%2520Judicious%2520Use%2520of%2520Structure-Guided%2520Design%2520and%2520Structure-Activity%2520Relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5243%26epage%3D5263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Grillot, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiran, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Dowd, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronkin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waal, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauffer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sizensky, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanoury, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perola, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanzelka, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixit, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewing, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charifson, P. S.</span><span> </span><span class="NLM_article-title">Second-Generation Antibacterial Benzimidazole Ureas: Discovery of a Preclinical Candidate with Reduced Metabolic Liability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8792</span><span class="NLM_x">–</span> <span class="NLM_lpage">8816</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500563g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8792-8816&author=A.-L.+Grillotauthor=A.+L.+Tiranauthor=D.+Shannonauthor=E.+Kruegerauthor=Y.+Liaoauthor=H.+O%E2%80%99Dowdauthor=Q.+Tangauthor=S.+Ronkinauthor=T.+Wangauthor=N.+Waalauthor=P.+Liauthor=D.+Laufferauthor=E.+Sizenskyauthor=J.+Tanouryauthor=E.+Perolaauthor=T.+H.+Grossmanauthor=T.+Doyleauthor=B.+Hanzelkaauthor=S.+Jonesauthor=V.+Dixitauthor=N.+Ewingauthor=S.+Liaoauthor=B.+Boucherauthor=M.+Jacobsauthor=Y.+Bennaniauthor=P.+S.+Charifson&title=Second-Generation+Antibacterial+Benzimidazole+Ureas%3A+Discovery+of+a+Preclinical+Candidate+with+Reduced+Metabolic+Liability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Fjm500563g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500563g%26sid%3Dliteratum%253Aachs%26aulast%3DGrillot%26aufirst%3DA.-L.%26aulast%3DTiran%26aufirst%3DA.%2BL.%26aulast%3DShannon%26aufirst%3DD.%26aulast%3DKrueger%26aufirst%3DE.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Dowd%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DQ.%26aulast%3DRonkin%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWaal%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DLauffer%26aufirst%3DD.%26aulast%3DSizensky%26aufirst%3DE.%26aulast%3DTanoury%26aufirst%3DJ.%26aulast%3DPerola%26aufirst%3DE.%26aulast%3DGrossman%26aufirst%3DT.%2BH.%26aulast%3DDoyle%26aufirst%3DT.%26aulast%3DHanzelka%26aufirst%3DB.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DDixit%26aufirst%3DV.%26aulast%3DEwing%26aufirst%3DN.%26aulast%3DLiao%26aufirst%3DS.%26aulast%3DBoucher%26aufirst%3DB.%26aulast%3DJacobs%26aufirst%3DM.%26aulast%3DBennani%26aufirst%3DY.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26atitle%3DSecond-Generation%2520Antibacterial%2520Benzimidazole%2520Ureas%253A%2520Discovery%2520of%2520a%2520Preclinical%2520Candidate%2520with%2520Reduced%2520Metabolic%2520Liability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8792%26epage%3D8816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Perola, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillot, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronkin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeTiran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drumm, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolau, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tessier, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charifson, P. S.</span><span> </span><span class="NLM_article-title">Successful Application of Serum Shift Prediction Models to the Design of Dual Targeting Inhibitors of Bacterial Gyrase B and Topoisomerase IV with Improved in Vivo Efficacy</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2177</span><span class="NLM_x">–</span> <span class="NLM_lpage">2181</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2177-2181&author=E.+Perolaauthor=D.+Stamosauthor=A.-L.+Grillotauthor=S.+Ronkinauthor=T.+Wangauthor=A.+LeTiranauthor=Q.+Tangauthor=D.+D.+Deiningerauthor=Y.+Liaoauthor=S.-K.+Tianauthor=J.+E.+Drummauthor=D.+P.+Nicolauauthor=P.+R.+Tessierauthor=N.+Maniauthor=T.+H.+Grossmanauthor=P.+S.+Charifson&title=Successful+Application+of+Serum+Shift+Prediction+Models+to+the+Design+of+Dual+Targeting+Inhibitors+of+Bacterial+Gyrase+B+and+Topoisomerase+IV+with+Improved+in+Vivo+Efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerola%26aufirst%3DE.%26aulast%3DStamos%26aufirst%3DD.%26aulast%3DGrillot%26aufirst%3DA.-L.%26aulast%3DRonkin%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLeTiran%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DQ.%26aulast%3DDeininger%26aufirst%3DD.%2BD.%26aulast%3DLiao%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DS.-K.%26aulast%3DDrumm%26aufirst%3DJ.%2BE.%26aulast%3DNicolau%26aufirst%3DD.%2BP.%26aulast%3DTessier%26aufirst%3DP.%2BR.%26aulast%3DMani%26aufirst%3DN.%26aulast%3DGrossman%26aufirst%3DT.%2BH.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26atitle%3DSuccessful%2520Application%2520of%2520Serum%2520Shift%2520Prediction%2520Models%2520to%2520the%2520Design%2520of%2520Dual%2520Targeting%2520Inhibitors%2520of%2520Bacterial%2520Gyrase%2520B%2520and%2520Topoisomerase%2520IV%2520with%2520Improved%2520in%2520Vivo%2520Efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2177%26epage%3D2181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Stokes, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomaides-Brears, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czaplewski, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamble, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunniss, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peasley, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haydon, D. J.</span><span> </span><span class="NLM_article-title">Biological Evaluation of Benzothiazole Ethyl Urea Inhibitors of Bacterial Type II Topoisomerases</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5977</span><span class="NLM_x">–</span> <span class="NLM_lpage">5986</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=5977-5986&author=N.+R.+Stokesauthor=H.+B.+Thomaides-Brearsauthor=S.+Barkerauthor=J.+M.+Bennettauthor=J.+Berryauthor=I.+Collinsauthor=L.+G.+Czaplewskiauthor=V.+Gambleauthor=P.+Lancettauthor=A.+Loganauthor=C.+J.+Lunnissauthor=H.+Peasleyauthor=S.+Pommierauthor=D.+Priceauthor=C.+Smeeauthor=D.+J.+Haydon&title=Biological+Evaluation+of+Benzothiazole+Ethyl+Urea+Inhibitors+of+Bacterial+Type+II+Topoisomerases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStokes%26aufirst%3DN.%2BR.%26aulast%3DThomaides-Brears%26aufirst%3DH.%2BB.%26aulast%3DBarker%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DJ.%2BM.%26aulast%3DBerry%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DCzaplewski%26aufirst%3DL.%2BG.%26aulast%3DGamble%26aufirst%3DV.%26aulast%3DLancett%26aufirst%3DP.%26aulast%3DLogan%26aufirst%3DA.%26aulast%3DLunniss%26aufirst%3DC.%2BJ.%26aulast%3DPeasley%26aufirst%3DH.%26aulast%3DPommier%26aufirst%3DS.%26aulast%3DPrice%26aufirst%3DD.%26aulast%3DSmee%26aufirst%3DC.%26aulast%3DHaydon%26aufirst%3DD.%2BJ.%26atitle%3DBiological%2520Evaluation%2520of%2520Benzothiazole%2520Ethyl%2520Urea%2520Inhibitors%2520of%2520Bacterial%2520Type%2520II%2520Topoisomerases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D5977%26epage%3D5986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Miesel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osmolski, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerding, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flattery, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polishook, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. B.</span><span> </span><span class="NLM_article-title">Kibdelomycin Is a Potent and Selective Agent against Toxigenic <i>Clostridium difficile</i></span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2387</span><span class="NLM_x">–</span> <span class="NLM_lpage">2392</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=2387-2392&author=L.+Mieselauthor=D.+W.+Hechtauthor=J.+R.+Osmolskiauthor=D.+Gerdingauthor=A.+Flatteryauthor=F.+Liauthor=J.+Lanauthor=P.+Lipariauthor=J.+D.+Polishookauthor=L.+Liangauthor=J.+Liuauthor=D.+B.+Olsenauthor=S.+B.+Singh&title=Kibdelomycin+Is+a+Potent+and+Selective+Agent+against+Toxigenic+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiesel%26aufirst%3DL.%26aulast%3DHecht%26aufirst%3DD.%2BW.%26aulast%3DOsmolski%26aufirst%3DJ.%2BR.%26aulast%3DGerding%26aufirst%3DD.%26aulast%3DFlattery%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DLipari%26aufirst%3DP.%26aulast%3DPolishook%26aufirst%3DJ.%2BD.%26aulast%3DLiang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26atitle%3DKibdelomycin%2520Is%2520a%2520Potent%2520and%2520Selective%2520Agent%2520against%2520Toxigenic%2520Clostridium%2520difficile%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D2387%26epage%3D2392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span>Dipexium Pharmaceuticals, Inc. Clinical Trials: Mild Infections of Diabetic Foot Ulcers <a href="http://www.dipexiumpharmaceuticals.com/locilex/clinical-trials" class="extLink">http://www.dipexiumpharmaceuticals.com/locilex/clinical-trials</a> (accessed Jan 21,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Dipexium+Pharmaceuticals%2C+Inc.+Clinical+Trials%3A+Mild+Infections+of+Diabetic+Foot+Ulcers+http%3A%2F%2Fwww.dipexiumpharmaceuticals.com%2Flocilex%2Fclinical-trials+%28accessed+Jan+21%2C+2015%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Fuchs, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S. D.</span><span> </span><span class="NLM_article-title">In Vitro Antimicrobial Activity of MSI-78, a Magainin Analog</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1213</span><span class="NLM_x">–</span> <span class="NLM_lpage">1216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1998&pages=1213-1216&author=P.+C.+Fuchsauthor=A.+L.+Barryauthor=S.+D.+Brown&title=In+Vitro+Antimicrobial+Activity+of+MSI-78%2C+a+Magainin+Analog"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFuchs%26aufirst%3DP.%2BC.%26aulast%3DBarry%26aufirst%3DA.%2BL.%26aulast%3DBrown%26aufirst%3DS.%2BD.%26atitle%3DIn%2520Vitro%2520Antimicrobial%2520Activity%2520of%2520MSI-78%252C%2520a%2520Magainin%2520Analog%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1998%26volume%3D42%26spage%3D1213%26epage%3D1216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Ge, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holroyd, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornsberry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zasloff, M.</span><span> </span><span class="NLM_article-title">In Vitro Antibacterial Properties of Pexiganan, an Analog of Magainin</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">782</span><span class="NLM_x">–</span> <span class="NLM_lpage">788</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1128%2FAAC.43.4.782" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=10103181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADyaK1MXisVSgurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1999&pages=782-788&author=Y.+Geauthor=D.+L.+MacDonaldauthor=K.+J.+Holroydauthor=C.+Thornsberryauthor=H.+Wexlerauthor=M.+Zasloff&title=In+Vitro+Antibacterial+Properties+of+Pexiganan%2C+an+Analog+of+Magainin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro antibacterial properties of pexiganan, an analog of magainin</span></div><div class="casAuthors">Ge, Yigong; Macdonald, Dorothy L.; Holroyd, Kenneth J.; Thornsberry, Clyde; Wexler, Hannah; Zasloff, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">782-788</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Pexiganan, a 22-amino-acid antimicrobial peptide, is an analog of the magainin peptides isolated from the skin of the African clawed frog.  Pexiganan exhibited in vitro broad-spectrum antibacterial activity when it was tested against 3,109 clin. isolates of Gram-pos. and Gram-neg., anaerobic and aerobic bacteria.  The pexiganan MIC at which 90% of isolates are inhibited (MIC90) was 32 μg/mL or less for Staphylococcus spp., Streptococcus spp., Enterococcus faecium, Corynebacterium spp., Pseudomonas spp., Acinetobacter spp., Stenotrophomonas spp., certain species of the family Enterobacteriaceae, Bacteroides spp., Peptostreptococcus spp., and Propionibacterium spp.  Comparison of the MICs and min. bactericidal concns. (MBCs) of pexiganan for 143 isolates representing 32 species demonstrated that for 92% of the isolates tested, MBCs were the same or within 1 twofold difference of the MICs, consistent with a bactericidal mechanism of action.  Killing curve anal. showed that pexiganan killed Pseudomonas aeruginosa rapidly, with 106 organisms/mL eliminated within 20 min of treatment with 16 μg of pexiganan per mL.  No evidence of cross-resistance to a no. of other antibiotic classes was obsd., as detd. by the equivalence of the MIC50s and the MIC90s of pexiganan for strains resistant to oxacillin, cefazolin, cefoxitin, imipenem, ofloxacin, ciprofloxacin, gentamicin, and clindamycin vs. those for strains susceptible to these antimicrobial agents.  Attempts to generate resistance in several bacterial species through repeated passage with subinhibitory concns. of pexiganan were unsuccessful.  In conclusion, pexiganan exhibits properties in vitro which make it an attractive candidate for development as a topical antimicrobial agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ55hwXq8EBLVg90H21EOLACvtfcHk0liMkn_yK3gAeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisVSgurg%253D&md5=da7a25db5f80ae6d9681abc6fdb01f6d</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1128%2FAAC.43.4.782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.43.4.782%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DY.%26aulast%3DMacDonald%26aufirst%3DD.%2BL.%26aulast%3DHolroyd%26aufirst%3DK.%2BJ.%26aulast%3DThornsberry%26aufirst%3DC.%26aulast%3DWexler%26aufirst%3DH.%26aulast%3DZasloff%26aufirst%3DM.%26atitle%3DIn%2520Vitro%2520Antibacterial%2520Properties%2520of%2520Pexiganan%252C%2520an%2520Analog%2520of%2520Magainin%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1999%26volume%3D43%26spage%3D782%26epage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Oh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wade, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, C.</span><span> </span><span class="NLM_article-title">Activities of Synthetic Hybrid Peptides against Anaerobic Bacteria: Aspects of Methodology and Stability</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2000&pages=68-72&author=H.+Ohauthor=M.+Hedbergauthor=D.+Wadeauthor=C.+Edlund&title=Activities+of+Synthetic+Hybrid+Peptides+against+Anaerobic+Bacteria%3A+Aspects+of+Methodology+and+Stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DH.%26aulast%3DHedberg%26aufirst%3DM.%26aulast%3DWade%26aufirst%3DD.%26aulast%3DEdlund%26aufirst%3DC.%26atitle%3DActivities%2520of%2520Synthetic%2520Hybrid%2520Peptides%2520against%2520Anaerobic%2520Bacteria%253A%2520Aspects%2520of%2520Methodology%2520and%2520Stability%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2000%26volume%3D44%26spage%3D68%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suárez, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisblum, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellman, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, S. M.</span><span> </span><span class="NLM_article-title">Synthetic Polymers Active against <i>Clostridium difficile</i> Vegetative Cell Growth and Spore Outgrowth</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">14498</span><span class="NLM_x">–</span> <span class="NLM_lpage">14504</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja506798e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=14498-14504&author=R.+Liuauthor=J.+M.+Su%C3%A1rezauthor=B.+Weisblumauthor=S.+H.+Gellmanauthor=S.+M.+McBride&title=Synthetic+Polymers+Active+against+Clostridium+difficile+Vegetative+Cell+Growth+and+Spore+Outgrowth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Fja506798e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja506798e%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DSu%25C3%25A1rez%26aufirst%3DJ.%2BM.%26aulast%3DWeisblum%26aufirst%3DB.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26aulast%3DMcBride%26aufirst%3DS.%2BM.%26atitle%3DSynthetic%2520Polymers%2520Active%2520against%2520Clostridium%2520difficile%2520Vegetative%2520Cell%2520Growth%2520and%2520Spore%2520Outgrowth%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D14498%26epage%3D14504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Nakashio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dun, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanemitsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, J.</span><span> </span><span class="NLM_article-title">Everninomicin, a New Oligosaccharide Antibiotic: Its Antimicrobial Activity, Post-Antibiotic Effect and Synergistic Bactericidal Activity</span> <span class="citation_source-journal">Drugs Exp. Clin. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=7796712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADyaK2MXlslCru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1995&pages=7-16&author=S.+Nakashioauthor=H.+Iwasawaauthor=F.+Y.+Dunauthor=K.+Kanemitsuauthor=J.+Shimada&title=Everninomicin%2C+a+New+Oligosaccharide+Antibiotic%3A+Its+Antimicrobial+Activity%2C+Post-Antibiotic+Effect+and+Synergistic+Bactericidal+Activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Everninomicin, a new oligosaccharide antibiotic: its antimicrobial activity, post-antibiotic effect and synergistic bactericidal activity</span></div><div class="casAuthors">Nakashio, S.; Iwasawa, H.; Dun, F.Y.; Kanemitsu, K.; Shimada, J.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs under Experimental and Clinical Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-16</span>CODEN:
                <span class="NLM_cas:coden">DECRDP</span>;
        ISSN:<span class="NLM_cas:issn">0378-6501</span>.
    
            (<span class="NLM_cas:orgname">Bioscience Ediprint</span>)
        </div><div class="casAbstract">Antimicrobial activity of everninomicin (SCH 27899) in comparison with two glycopeptides (vancomycin, teicoplanin) and six β-lactam agents was evaluated against recent clin. isolates of Gram-pos. bacteria.  Everninomicin showed the highest activity against the species tested and MICs90% of everninomicin against Streptococcus pneumoniae, Streptococcus pyogenes, Enterococcus faecalis, Enterococcus faecium and Clostridium difficile were 0.1, 0.1, 0.2, 0.39, 0.1 μg/mL, resp.  MICs90% of everninomicin against methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus epidermidis (MRSE) were 0.78 μg/mL.  Lab. induced resistance to everninomicin in strains of S. aureus and E. faecalis occurred in a stepwise manner and at a very slow rate.  Post-antibiotic effect against strains of S. aureus and E. faecalis were 1.8 and 2.6 h, resp., and a little longer than that of vancomycin.  Adherence to glass surface of an MRSA strain was strongly repressed by the addn. of sub MIC of everninomicin in combination with fosfomycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_rpljUjr4bLVg90H21EOLACvtfcHk0liD2tiMrQy9IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlslCru70%253D&md5=6e25fc99480d01f3a60c7e69a0b17a98</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakashio%26aufirst%3DS.%26aulast%3DIwasawa%26aufirst%3DH.%26aulast%3DDun%26aufirst%3DF.%2BY.%26aulast%3DKanemitsu%26aufirst%3DK.%26aulast%3DShimada%26aufirst%3DJ.%26atitle%3DEverninomicin%252C%2520a%2520New%2520Oligosaccharide%2520Antibiotic%253A%2520Its%2520Antimicrobial%2520Activity%252C%2520Post-Antibiotic%2520Effect%2520and%2520Synergistic%2520Bactericidal%2520Activity%26jtitle%3DDrugs%2520Exp.%2520Clin.%2520Res.%26date%3D1995%26volume%3D21%26spage%3D7%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Tanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K.</span><span> </span><span class="NLM_article-title">In Vitro Activity of an Evernimicin Derivative, SCH27899, against Anaerobic Bacteria and Propionibacterium Acnes</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fjac%2F46.3.465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=10980176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvV2ktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2000&pages=465-469&author=K.+Tanakaauthor=N.+Katoauthor=K.+Watanabe&title=In+Vitro+Activity+of+an+Evernimicin+Derivative%2C+SCH27899%2C+against+Anaerobic+Bacteria+and+Propionibacterium+Acnes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro activity of an evernimicin derivative, SCH27899, against anaerobic bacteria and Propionibacterium acnes</span></div><div class="casAuthors">Tanaka, Kaori; Kato, Naoki; Watanabe, Kunitomo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">465-469</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The in vitro activity of SCH27899, a novel oligosaccharide antimicrobial agent, was compared with those of representatives of six classes of antimicrobial agents (piperacillin, clarithromycin, clindamycin, vancomycin, sitafloxacin and metronidazole) against clin. isolates of anaerobic bacteria and Propionibacterium acnes.  Against Peptostreptococcus spp. and Clostridium difficile, SCH27899 was the most potent (MIC90 < 0.125 mg/L) of the agents examd.  Besides these Gram-pos. anaerobes, SCH27899 showed a moderate level of activity against Prevotella bivia, Prevotella intermedia and Porphyromonas spp. (MIC90 ≤ 4 mg/L).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2xbbl2RTxyLVg90H21EOLACvtfcHk0liD2tiMrQy9IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvV2ktLo%253D&md5=14e61dcf37cc5d3b64b97ec470abdf14</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1093%2Fjac%2F46.3.465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252F46.3.465%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DN.%26aulast%3DWatanabe%26aufirst%3DK.%26atitle%3DIn%2520Vitro%2520Activity%2520of%2520an%2520Evernimicin%2520Derivative%252C%2520SCH27899%252C%2520against%2520Anaerobic%2520Bacteria%2520and%2520Propionibacterium%2520Acnes%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2000%26volume%3D46%26spage%3D465%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Hanada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oki, T.</span><span> </span><span class="NLM_article-title">Hydramycin, a New Antitumor Antibiotic. Taxonomy, Isolation, Physico-Chemical Properties, Structure and Biological Activity</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">824</span><span class="NLM_x">–</span> <span class="NLM_lpage">831</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1991&pages=824-831&author=M.+Hanadaauthor=K.+Kanetaauthor=Y.+Nishiyamaauthor=Y.+Hoshinoauthor=M.+Konishiauthor=T.+Oki&title=Hydramycin%2C+a+New+Antitumor+Antibiotic.+Taxonomy%2C+Isolation%2C+Physico-Chemical+Properties%2C+Structure+and+Biological+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanada%26aufirst%3DM.%26aulast%3DKaneta%26aufirst%3DK.%26aulast%3DNishiyama%26aufirst%3DY.%26aulast%3DHoshino%26aufirst%3DY.%26aulast%3DKonishi%26aufirst%3DM.%26aulast%3DOki%26aufirst%3DT.%26atitle%3DHydramycin%252C%2520a%2520New%2520Antitumor%2520Antibiotic.%2520Taxonomy%252C%2520Isolation%252C%2520Physico-Chemical%2520Properties%252C%2520Structure%2520and%2520Biological%2520Activity%26jtitle%3DJ.%2520Antibiot.%26date%3D1991%26volume%3D44%26spage%3D824%26epage%3D831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">McCullough, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howells, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Sullivan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summerill, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonner, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, P. B.</span><span> </span><span class="NLM_article-title">Clerocidin, a Terpenoid Antibiotic, Inhibits Bacterial DNA Gyrase</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">526</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1993&pages=526-530&author=J.+E.+McCulloughauthor=M.+T.+Mullerauthor=A.+J.+Howellsauthor=A.+Maxwellauthor=J.+O%E2%80%99Sullivanauthor=R.+S.+Summerillauthor=W.+L.+Parkerauthor=J.+S.+Wellsauthor=D.+P.+Bonnerauthor=P.+B.+Fernandes&title=Clerocidin%2C+a+Terpenoid+Antibiotic%2C+Inhibits+Bacterial+DNA+Gyrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCullough%26aufirst%3DJ.%2BE.%26aulast%3DMuller%26aufirst%3DM.%2BT.%26aulast%3DHowells%26aufirst%3DA.%2BJ.%26aulast%3DMaxwell%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DJ.%26aulast%3DSummerill%26aufirst%3DR.%2BS.%26aulast%3DParker%26aufirst%3DW.%2BL.%26aulast%3DWells%26aufirst%3DJ.%2BS.%26aulast%3DBonner%26aufirst%3DD.%2BP.%26aulast%3DFernandes%26aufirst%3DP.%2BB.%26atitle%3DClerocidin%252C%2520a%2520Terpenoid%2520Antibiotic%252C%2520Inhibits%2520Bacterial%2520DNA%2520Gyrase%26jtitle%3DJ.%2520Antibiot.%26date%3D1993%26volume%3D46%26spage%3D526%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Nadai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palù, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palumbo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, S. N.</span><span> </span><span class="NLM_article-title">Differential Targeting of Unpaired Bases within Duplex DNA by the Natural Compound Clerocidin: A Valuable Tool To Dissect DNA Secondary Structure</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e52994</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e52994&author=M.+Nadaiauthor=G.+Pal%C3%B9author=M.+Palumboauthor=S.+N.+Richter&title=Differential+Targeting+of+Unpaired+Bases+within+Duplex+DNA+by+the+Natural+Compound+Clerocidin%3A+A+Valuable+Tool+To+Dissect+DNA+Secondary+Structure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNadai%26aufirst%3DM.%26aulast%3DPal%25C3%25B9%26aufirst%3DG.%26aulast%3DPalumbo%26aufirst%3DM.%26aulast%3DRichter%26aufirst%3DS.%2BN.%26atitle%3DDifferential%2520Targeting%2520of%2520Unpaired%2520Bases%2520within%2520Duplex%2520DNA%2520by%2520the%2520Natural%2520Compound%2520Clerocidin%253A%2520A%2520Valuable%2520Tool%2520To%2520Dissect%2520DNA%2520Secondary%2520Structure%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De52994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Banskota, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aouidate, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">rensen, D. S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piraee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zazopoulos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alarco, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourdeau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farnet, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falardeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAlpine, J. B.</span><span> </span><span class="NLM_article-title">TLN-05220, TLN-05223, New Echinosporamicin-Type Antibiotics, and Proposed Revision of the Structure of Bravomicins</span> <span class="citation_source-journal">J. Antibiot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2009&pages=565-570&author=A.+H.+Banskotaauthor=M.+Aouidateauthor=D.+S.+O.+rensenauthor=A.+Ibrahimauthor=M.+Piraeeauthor=E.+Zazopoulosauthor=A.-M.+Alarcoauthor=H.+Gourdeauauthor=C.+Mellonauthor=C.+M.+Farnetauthor=P.+Falardeauauthor=J.+B.+McAlpine&title=TLN-05220%2C+TLN-05223%2C+New+Echinosporamicin-Type+Antibiotics%2C+and+Proposed+Revision+of+the+Structure+of+Bravomicins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBanskota%26aufirst%3DA.%2BH.%26aulast%3DAouidate%26aufirst%3DM.%26aulast%3Drensen%26aufirst%3DD.%2BS.%2BO.%26aulast%3DIbrahim%26aufirst%3DA.%26aulast%3DPiraee%26aufirst%3DM.%26aulast%3DZazopoulos%26aufirst%3DE.%26aulast%3DAlarco%26aufirst%3DA.-M.%26aulast%3DGourdeau%26aufirst%3DH.%26aulast%3DMellon%26aufirst%3DC.%26aulast%3DFarnet%26aufirst%3DC.%2BM.%26aulast%3DFalardeau%26aufirst%3DP.%26aulast%3DMcAlpine%26aufirst%3DJ.%2BB.%26atitle%3DTLN-05220%252C%2520TLN-05223%252C%2520New%2520Echinosporamicin-Type%2520Antibiotics%252C%2520and%2520Proposed%2520Revision%2520of%2520the%2520Structure%2520of%2520Bravomicins%26jtitle%3DJ.%2520Antibiot.%26date%3D2009%26volume%3D62%26spage%3D565%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Sakoulas, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loesgen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenical, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensler, M.</span><span> </span><span class="NLM_article-title">Novel Bacterial Metabolite Merochlorin a Demonstrates in Vitro Activity against Multi-Drug Resistant Methicillin-Resistant <i>Staphylococcus aureus</i></span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e29439</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e29439&author=G.+Sakoulasauthor=S.-J.+Namauthor=S.+Loesgenauthor=W.+Fenicalauthor=P.+R.+Jensenauthor=V.+Nizetauthor=M.+Hensler&title=Novel+Bacterial+Metabolite+Merochlorin+a+Demonstrates+in+Vitro+Activity+against+Multi-Drug+Resistant+Methicillin-Resistant+Staphylococcus+aureus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakoulas%26aufirst%3DG.%26aulast%3DNam%26aufirst%3DS.-J.%26aulast%3DLoesgen%26aufirst%3DS.%26aulast%3DFenical%26aufirst%3DW.%26aulast%3DJensen%26aufirst%3DP.%2BR.%26aulast%3DNizet%26aufirst%3DV.%26aulast%3DHensler%26aufirst%3DM.%26atitle%3DNovel%2520Bacterial%2520Metabolite%2520Merochlorin%2520a%2520Demonstrates%2520in%2520Vitro%2520Activity%2520against%2520Multi-Drug%2520Resistant%2520Methicillin-Resistant%2520Staphylococcus%2520aureus%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De29439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Pepper, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, J. H.</span><span> </span><span class="NLM_article-title">Biomimetic Total Synthesis of (±)-Merochlorin A</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">12170</span><span class="NLM_x">–</span> <span class="NLM_lpage">12173</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=12170-12173&author=H.+P.+Pepperauthor=J.+H.+George&title=Biomimetic+Total+Synthesis+of+%28%C2%B1%29-Merochlorin+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPepper%26aufirst%3DH.%2BP.%26aulast%3DGeorge%26aufirst%3DJ.%2BH.%26atitle%3DBiomimetic%2520Total%2520Synthesis%2520of%2520%2528%25C2%25B1%2529-Merochlorin%2520A%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D12170%26epage%3D12173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumi, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurdle, J. G.</span><span> </span><span class="NLM_article-title">Prospects for Flavonoid and Related Phytochemicals as Nature-Inspired Treatments for <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">J. Appl. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1111%2Fjam.12344" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=24479135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFKqtLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2014&pages=23-31&author=X.+Wuauthor=M.+Z.+Alamauthor=L.+Fengauthor=L.+S.+Tsutsumiauthor=D.+Sunauthor=J.+G.+Hurdle&title=Prospects+for+Flavonoid+and+Related+Phytochemicals+as+Nature-Inspired+Treatments+for+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Prospects for flavonoid and related phytochemicals as nature-inspired treatments for Clostridium difficile infection</span></div><div class="casAuthors">Wu, X.; Alam, M. Z.; Feng, L.; Tsutsumi, L. S.; Sun, D.; Hurdle, J. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Microbiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-31</span>CODEN:
                <span class="NLM_cas:coden">JAMIFK</span>;
        ISSN:<span class="NLM_cas:issn">1364-5072</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims : There is a need for novel treatments for Clostridium difficile infection (CDI).  Antibacterial flavonoids are part of a large family of polyphenol phytochems. with a long history of use in ethnomedicine, but are unexamd. against Cl. difficile.  We explored their anti-difficile properties.  Methods and Results : Anti-difficile activities were detd. for several naturally occurring flavonoids, olympicin A and synthetic 4-chromanone and chalcone analogs.  With the exception of olympicin A, most naturally occurring phytochems. tested were poorly active.  Diversified synthetic flavonoids resembling olympicin A retained anti-difficile activity, suggesting olympicin A could act as a pharmacophore to obtain novel agents.  They also demonstrated concn.-dependent killing of logarithmic and stationary phase cultures and reduced sporulation and toxin prodn.  Olympicin A and some synthetic flavonoids dissipated the bacterial transmembrane potential.  Interestingly, mutants could only be selected with the analog 207 at a frequency of 10-9.  Conclusions : Based on the potent anti-difficile properties of olympicin A and modified flavonoids, further exploration of this class of phytochems. is warranted.  Significance and Impact of the Study : Clostridium difficile infection is a major problem in developed countries.  These studies point to there being an avenue for optimizing plant-derived flavonoids, and related antibacterial phytochems., as nature-inspired approaches to treat CDI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozIVKnGSPKxLVg90H21EOLACvtfcHk0lhWiieaYbU8zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFKqtLvL&md5=d1a0268eb5d9a95dbe5575ff12ca3a70</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1111%2Fjam.12344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjam.12344%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DAlam%26aufirst%3DM.%2BZ.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DTsutsumi%26aufirst%3DL.%2BS.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DHurdle%26aufirst%3DJ.%2BG.%26atitle%3DProspects%2520for%2520Flavonoid%2520and%2520Related%2520Phytochemicals%2520as%2520Nature-Inspired%2520Treatments%2520for%2520Clostridium%2520difficile%2520Infection%26jtitle%3DJ.%2520Appl.%2520Microbiol.%26date%3D2014%26volume%3D116%26spage%3D23%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Feng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddox, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumi, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narula, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruhn, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandhaus, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse-Dinh, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurdle, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span> </span><span class="NLM_article-title">Synthesis, Structure-Activity Relationship Studies, and Antibacterial Evaluation of 4-Chromanones and Chalcones, as Well as Olympicin a and Derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8398</span><span class="NLM_x">–</span> <span class="NLM_lpage">8420</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500853v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8398-8420&author=L.+Fengauthor=M.+M.+Maddoxauthor=M.+Z.+Alamauthor=L.+S.+Tsutsumiauthor=G.+Narulaauthor=D.+F.+Bruhnauthor=X.+Wuauthor=S.+Sandhausauthor=R.+B.+Leeauthor=C.+J.+Simmonsauthor=Y.-C.+Tse-Dinhauthor=J.+G.+Hurdleauthor=R.+E.+Leeauthor=D.+Sun&title=Synthesis%2C+Structure-Activity+Relationship+Studies%2C+and+Antibacterial+Evaluation+of+4-Chromanones+and+Chalcones%2C+as+Well+as+Olympicin+a+and+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Fjm500853v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500853v%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DMaddox%26aufirst%3DM.%2BM.%26aulast%3DAlam%26aufirst%3DM.%2BZ.%26aulast%3DTsutsumi%26aufirst%3DL.%2BS.%26aulast%3DNarula%26aufirst%3DG.%26aulast%3DBruhn%26aufirst%3DD.%2BF.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DSandhaus%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DR.%2BB.%26aulast%3DSimmons%26aufirst%3DC.%2BJ.%26aulast%3DTse-Dinh%26aufirst%3DY.-C.%26aulast%3DHurdle%26aufirst%3DJ.%2BG.%26aulast%3DLee%26aufirst%3DR.%2BE.%26aulast%3DSun%26aufirst%3DD.%26atitle%3DSynthesis%252C%2520Structure-Activity%2520Relationship%2520Studies%252C%2520and%2520Antibacterial%2520Evaluation%2520of%25204-Chromanones%2520and%2520Chalcones%252C%2520as%2520Well%2520as%2520Olympicin%2520a%2520and%2520Derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8398%26epage%3D8420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Pucci, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DenBleyker, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discotto, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fung-Tomc, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, Y.</span><span> </span><span class="NLM_article-title">Antimicrobial Evaluation of Nocathiacins, a Thiazole Peptide Class of Antibiotics</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3697</span><span class="NLM_x">–</span> <span class="NLM_lpage">3701</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=3697-3701&author=M.+J.+Pucciauthor=J.+J.+Bronsonauthor=J.+F.+Barrettauthor=K.+L.+DenBleykerauthor=L.+F.+Discottoauthor=J.+C.+Fung-Tomcauthor=Y.+Ueda&title=Antimicrobial+Evaluation+of+Nocathiacins%2C+a+Thiazole+Peptide+Class+of+Antibiotics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPucci%26aufirst%3DM.%2BJ.%26aulast%3DBronson%26aufirst%3DJ.%2BJ.%26aulast%3DBarrett%26aufirst%3DJ.%2BF.%26aulast%3DDenBleyker%26aufirst%3DK.%2BL.%26aulast%3DDiscotto%26aufirst%3DL.%2BF.%26aulast%3DFung-Tomc%26aufirst%3DJ.%2BC.%26aulast%3DUeda%26aufirst%3DY.%26atitle%3DAntimicrobial%2520Evaluation%2520of%2520Nocathiacins%252C%2520a%2520Thiazole%2520Peptide%2520Class%2520of%2520Antibiotics%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D3697%26epage%3D3701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">LaMarche, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeds, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzink-Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krastel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckermann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palestrant, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patane, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rann, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiamfook, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span> </span><span class="NLM_article-title">Antibiotic Optimization and Chemical Structure Stabilization of Thiomuracin A</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6934</span><span class="NLM_x">–</span> <span class="NLM_lpage">6941</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300783c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6934-6941&author=M.+J.+LaMarcheauthor=J.+A.+Leedsauthor=J.+Dzink-Foxauthor=E.+Ganglauthor=P.+Krastelauthor=G.+Neckermannauthor=D.+Palestrantauthor=M.+A.+Pataneauthor=E.+M.+Rannauthor=S.+Tiamfookauthor=D.+Yu&title=Antibiotic+Optimization+and+Chemical+Structure+Stabilization+of+Thiomuracin+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1021%2Fjm300783c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300783c%26sid%3Dliteratum%253Aachs%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26aulast%3DLeeds%26aufirst%3DJ.%2BA.%26aulast%3DDzink-Fox%26aufirst%3DJ.%26aulast%3DGangl%26aufirst%3DE.%26aulast%3DKrastel%26aufirst%3DP.%26aulast%3DNeckermann%26aufirst%3DG.%26aulast%3DPalestrant%26aufirst%3DD.%26aulast%3DPatane%26aufirst%3DM.%2BA.%26aulast%3DRann%26aufirst%3DE.%2BM.%26aulast%3DTiamfook%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DD.%26atitle%3DAntibiotic%2520Optimization%2520and%2520Chemical%2520Structure%2520Stabilization%2520of%2520Thiomuracin%2520A%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6934%26epage%3D6941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Heap, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartman, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minton, N. P.</span><span> </span><span class="NLM_article-title">The ClosTron: A Universal Gene Knock-Out System for the Genus <i>Clostridium</i></span> <span class="citation_source-journal">J. Microbiol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">452</span><span class="NLM_x">–</span> <span class="NLM_lpage">464</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1016%2Fj.mimet.2007.05.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=17658189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFKjsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=452-464&author=J.+T.+Heapauthor=O.+J.+Penningtonauthor=S.+T.+Cartmanauthor=G.+P.+Carterauthor=N.+P.+Minton&title=The+ClosTron%3A+A+Universal+Gene+Knock-Out+System+for+the+Genus+Clostridium"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">The ClosTron: A universal gene knock-out system for the genus Clostridium</span></div><div class="casAuthors">Heap, John T.; Pennington, Oliver J.; Cartman, Stephen T.; Carter, Glen P.; Minton, Nigel P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Microbiological Methods</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">452-464</span>CODEN:
                <span class="NLM_cas:coden">JMIMDQ</span>;
        ISSN:<span class="NLM_cas:issn">0167-7012</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Progress in exploiting clostridial genome information has been severely impeded by a general lack of effective methods for the directed inactivation of specific genes.  Those few mutants that have been generated have been almost exclusively derived by single crossover integration of a replication-deficient or defective plasmid by homologous recombination.  The mutants created are therefore unstable.  Here we have adapted a mutagenesis system based on the mobile group II intron from the ltrB gene of Lactococcus lactis (Ll.ltrB) to function in clostridial hosts.  Integrants are readily selected on the basis of acquisition of resistance to erythromycin, and are generated from start to finish in as little as 10 to 14 days.  Unlike single crossover plasmid integrants, the mutants are extremely stable.  The system has been used to make 6 mutants of Clostridium acetobutylicum and 5 of Clostridium difficile, exceeding the no. of published mutants ever generated in these species.  Genes have also been inactivated for the first time in Clostridium botulinum and Clostridium sporogenes, suggesting the system will be universally applicable to the genus.  The procedure is highly efficient and reproducible, and should revolutionize functional genomic studies in clostridia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquBeAXBVE-YLVg90H21EOLACvtfcHk0lhjpEAhY19-Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFKjsLk%253D&md5=5ad07920edc8de3b8f622522223016aa</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2Fj.mimet.2007.05.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mimet.2007.05.021%26sid%3Dliteratum%253Aachs%26aulast%3DHeap%26aufirst%3DJ.%2BT.%26aulast%3DPennington%26aufirst%3DO.%2BJ.%26aulast%3DCartman%26aufirst%3DS.%2BT.%26aulast%3DCarter%26aufirst%3DG.%2BP.%26aulast%3DMinton%26aufirst%3DN.%2BP.%26atitle%3DThe%2520ClosTron%253A%2520A%2520Universal%2520Gene%2520Knock-Out%2520System%2520for%2520the%2520Genus%2520Clostridium%26jtitle%3DJ.%2520Microbiol.%2520Methods%26date%3D2007%26volume%3D70%26spage%3D452%26epage%3D464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Jadhav, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezhilarasan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prakash Sharma, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, A.</span><span> </span><span class="NLM_article-title"><i>Clostridium</i>-DTDB: A Comprehensive Database for Potential Drug Targets of <i>Clostridium difficile</i></span> <span class="citation_source-journal">Comput. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">362</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1016%2Fj.compbiomed.2013.01.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=23415847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1OltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2013&pages=362-367&author=A.+Jadhavauthor=V.+Ezhilarasanauthor=O.+Prakash+Sharmaauthor=A.+Pan&title=Clostridium-DTDB%3A+A+Comprehensive+Database+for+Potential+Drug+Targets+of+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Clostridium-DTDB: A comprehensive database for potential drug targets of Clostridium difficile</span></div><div class="casAuthors">Jadhav, Ankush; Ezhilarasan, Vijayalakshmi; Prakash Sharma, Om; Pan, Archana</div><div class="citationInfo"><span class="NLM_cas:title">Computers in Biology and Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">362-367</span>CODEN:
                <span class="NLM_cas:coden">CBMDAW</span>;
        ISSN:<span class="NLM_cas:issn">0010-4825</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Clostridium difficile is considered to be one of the most important causes of health care-assocd. infections currently.  The prevalence and severity of C. difficile infection have increased significantly worldwide in the past decade which led to the increased research interest.  Here, using comparative genomics strategy coupled with bioinformatics tools the authors have identified potential drug targets in C. difficile and detd. their three-dimensional structures to develop a database, named Clostridium-DTDB.  Currently, the database comprises the potential drug targets with their structural information from three strains of C. difficile, namely hypervirulent PCR-ribotype 027 strain R20291, PCR-ribotype 012 strain 630, and PCR-ribotype 027 strain CD196.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLw170fKIcLLVg90H21EOLACvtfcHk0lhjpEAhY19-Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1OltLg%253D&md5=cf02be1d9141df0dd25d5f32e7db4736</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2Fj.compbiomed.2013.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.compbiomed.2013.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DJadhav%26aufirst%3DA.%26aulast%3DEzhilarasan%26aufirst%3DV.%26aulast%3DPrakash%2BSharma%26aufirst%3DO.%26aulast%3DPan%26aufirst%3DA.%26atitle%3DClostridium-DTDB%253A%2520A%2520Comprehensive%2520Database%2520for%2520Potential%2520Drug%2520Targets%2520of%2520Clostridium%2520difficile%26jtitle%3DComput.%2520Biol.%2520Med.%26date%3D2013%26volume%3D43%26spage%3D362%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Larocque, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chénard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najmanovich, R.</span><span> </span><span class="NLM_article-title">A Curated C. <i>difficile</i> Strain 630 Metabolic Network: Prediction of Essential Targets and Inhibitors</span> <span class="citation_source-journal">BMC Syst. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1186%2Fs12918-014-0117-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=25315994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotFWhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=117&author=M.+Larocqueauthor=T.+Ch%C3%A9nardauthor=R.+Najmanovich&title=A+Curated+C.+difficile+Strain+630+Metabolic+Network%3A+Prediction+of+Essential+Targets+and+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">A curated C. difficile strain 630 metabolic network: prediction of essential targets and inhibitors</span></div><div class="casAuthors">Larocque, Mathieu; Chenard, Thierry; Najmanovich, Rafael</div><div class="citationInfo"><span class="NLM_cas:title">BMC Systems Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">117/1-117/17</span>CODEN:
                <span class="NLM_cas:coden">BSBMCC</span>;
        ISSN:<span class="NLM_cas:issn">1752-0509</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background:Clostridium difficile is the leading cause of hospital-borne infections occurring when the natural intestinal flora is depleted following antibiotic treatment.  Current treatments for Clostridium difficile infections present high relapse rates and new hyper-virulent and multi-resistant strains are emerging, making the study of this nosocomial pathogen necessary to find novel therapeutic targets.  Results: We present iMLTC806cdf, an extensively curated reconstructed metabolic network for the C. difficile pathogenic strain 630. iMLTC806cdf contains 806 genes, 703 metabolites and 769 metabolic, 117 exchange and 145 transport reactions. iMLTC806cdf is the most complete and accurate metabolic reconstruction of a gram-pos. anaerobic bacteria to date.  We validate the model with simulated growth assays in different media and carbon sources and use it to predict essential genes.  We obtain 89.2% accuracy in the prediction of gene essentiality when compared to exptl. data for B. subtilis homologs (the closest organism for which such data exists).  We predict the existence of 76 essential genes and 39 essential gene pairs, a no. of which are unique to C. difficile and have non-existing or predicted non-essential human homologs.  For 29 of these potential therapeutic targets, we find 125 inhibitors of homologous proteins including approved drugs with the potential for drug repositioning, that when validated exptl. could serve as starting points in the development of new antibiotics.  Conclusions: We created a highly curated metabolic network model of C. difficile strain 630 and used it to predict essential genes as potential new therapeutic targets in the fight against Clostridium difficile infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1JjHlRdFNaLVg90H21EOLACvtfcHk0lgsG7qpUG6ynw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotFWhsA%253D%253D&md5=83a0d4ccc76523a40ecbcf2399792541</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1186%2Fs12918-014-0117-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12918-014-0117-z%26sid%3Dliteratum%253Aachs%26aulast%3DLarocque%26aufirst%3DM.%26aulast%3DCh%25C3%25A9nard%26aufirst%3DT.%26aulast%3DNajmanovich%26aufirst%3DR.%26atitle%3DA%2520Curated%2520C.%2520difficile%2520Strain%2520630%2520Metabolic%2520Network%253A%2520Prediction%2520of%2520Essential%2520Targets%2520and%2520Inhibitors%26jtitle%3DBMC%2520Syst.%2520Biol.%26date%3D2014%26volume%3D8%26spage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Dang, T. H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Riva, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagan, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storck, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heal, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janoir, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairweather, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, E. W.</span><span> </span><span class="NLM_article-title">Chemical Probes of Surface Layer Biogenesis in <i>Clostridium difficile</i></span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">285</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb9002859" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=279-285&author=T.+H.+T.+Dangauthor=L.+de+la+Rivaauthor=R.+P.+Faganauthor=E.+M.+Storckauthor=W.+P.+Healauthor=C.+Janoirauthor=N.+F.+Fairweatherauthor=E.+W.+Tate&title=Chemical+Probes+of+Surface+Layer+Biogenesis+in+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1021%2Fcb9002859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb9002859%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DT.%2BH.%2BT.%26aulast%3Dde%2Bla%2BRiva%26aufirst%3DL.%26aulast%3DFagan%26aufirst%3DR.%2BP.%26aulast%3DStorck%26aufirst%3DE.%2BM.%26aulast%3DHeal%26aufirst%3DW.%2BP.%26aulast%3DJanoir%26aufirst%3DC.%26aulast%3DFairweather%26aufirst%3DN.%2BF.%26aulast%3DTate%26aufirst%3DE.%2BW.%26atitle%3DChemical%2520Probes%2520of%2520Surface%2520Layer%2520Biogenesis%2520in%2520Clostridium%2520difficile%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2010%26volume%3D5%26spage%3D279%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Ratia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Light, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antanasijevic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caffrey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavie, A.</span><span> </span><span class="NLM_article-title">Discovery of Selective Inhibitors of the <i>Clostridium difficile</i> Dehydroquinate Dehydratase</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e89356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1371%2Fjournal.pone.0089356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=24586713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGqsrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e89356&author=K.+Ratiaauthor=S.+H.+Lightauthor=A.+Antanasijevicauthor=W.+F.+Andersonauthor=M.+Caffreyauthor=A.+Lavie&title=Discovery+of+Selective+Inhibitors+of+the+Clostridium+difficile+Dehydroquinate+Dehydratase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of selective inhibitors of the Clostridium difficile dehydroquinate dehydratase</span></div><div class="casAuthors">Ratia, Kiira; Light, Samuel H.; Antanasijevic, Aleksandar; Anderson, Wayne F.; Caffrey, Michael; Lavie, Arnon</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e89356/1-e89356/7, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">A vibrant and healthy gut flora is essential for preventing the proliferation of Clostridium difficile, a pathogenic bacterium that causes severe gastrointestinal symptoms.  In fact, most C. difficile infections (CDIs) occur after broad-spectrum antibiotic treatment, which, by eradicating the commensal gut bacteria, allows its spores to proliferate.  Hence, a C. difficile specific antibiotic that spares the gut flora would be highly beneficial in treating CDI.  Towards this goal, we set out to discover small mol. inhibitors of the C. difficile enzyme dehydroquinate dehydratase (DHQD).  DHQD is the 3rd of seven enzymes that compose the shikimate pathway, a metabolic pathway absent in humans, and is present in bacteria as two phylogenetically and mechanistically distinct types.  Using a high-throughput screen we identified three compds. that inhibited the type I C. difficile DHQD but not the type II DHQD from Bacteroides thetaiotaomicron, a highly represented commensal gut bacterial species.  Kinetic anal. revealed that the compds. inhibit the C. difficile enzyme with Ki values ranging from 10 to 20 μM.  Unexpectedly, kinetic and biophys. studies demonstrate that inhibitors also exhibit selectivity between type I DHQDs, inhibiting the C. difficile but not the highly homologous Salmonella enterica DHQD.  Therefore, the three identified compds. seem to be promising lead compds. for the development of C. difficile specific antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4dkh43YIxw7Vg90H21EOLACvtfcHk0lgsG7qpUG6ynw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGqsrjI&md5=4f757a310a535d582663b13fe93d2f53</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0089356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0089356%26sid%3Dliteratum%253Aachs%26aulast%3DRatia%26aufirst%3DK.%26aulast%3DLight%26aufirst%3DS.%2BH.%26aulast%3DAntanasijevic%26aufirst%3DA.%26aulast%3DAnderson%26aufirst%3DW.%2BF.%26aulast%3DCaffrey%26aufirst%3DM.%26aulast%3DLavie%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520Selective%2520Inhibitors%2520of%2520the%2520Clostridium%2520difficile%2520Dehydroquinate%2520Dehydratase%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De89356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Puri, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupardus, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrow, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogyo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, A.</span><span> </span><span class="NLM_article-title">Rational Design of Inhibitors and Activity-Based Probes Targeting <i>Clostridium difficile</i> Virulence Factor TcdB</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1201</span><span class="NLM_x">–</span> <span class="NLM_lpage">1211</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1016%2Fj.chembiol.2010.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=21095570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGntrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=1201-1211&author=A.+W.+Puriauthor=P.+J.+Lupardusauthor=E.+Deuauthor=V.+E.+Albrowauthor=K.+C.+Garciaauthor=M.+Bogyoauthor=A.+Shen&title=Rational+Design+of+Inhibitors+and+Activity-Based+Probes+Targeting+Clostridium+difficile+Virulence+Factor+TcdB"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Inhibitors and Activity-Based Probes Targeting Clostridium difficile Virulence Factor TcdB</span></div><div class="casAuthors">Puri, Aaron W.; Lupardus, Patrick J.; Deu, Edgar; Albrow, Victoria E.; Garcia, K. Christopher; Bogyo, Matthew; Shen, Aimee</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1201-1211</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Clostridium difficile is a leading cause of nosocomial infections.  The major virulence factors of this pathogen are the multi-domain toxins TcdA and TcdB.  These toxins contain a cysteine protease domain (CPD) that autoproteolytically releases a cytotoxic effector domain upon binding intracellular inositol hexakisphosphate.  Currently, there are no known inhibitors of this protease.  Here, we describe the rational design of covalent small mol. inhibitors of TcdB CPD.  We identified compds. that inactivate TcdB holotoxin function in cells and solved the structure of inhibitor-bound protease to 2.0 Å.  This structure reveals the mol. basis of CPD substrate recognition and informed the synthesis of activity-based probes for this enzyme.  The inhibitors presented will guide the development of therapeutics targeting C. difficile, and the probes will serve as tools for studying the unique activation mechanism of bacterial toxin CPDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoktoVIUJMo1LVg90H21EOLACvtfcHk0lgsG7qpUG6ynw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGntrfP&md5=f472b9de20b1379458830e9d4698e820</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DPuri%26aufirst%3DA.%2BW.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DDeu%26aufirst%3DE.%26aulast%3DAlbrow%26aufirst%3DV.%2BE.%26aulast%3DGarcia%26aufirst%3DK.%2BC.%26aulast%3DBogyo%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DA.%26atitle%3DRational%2520Design%2520of%2520Inhibitors%2520and%2520Activity-Based%2520Probes%2520Targeting%2520Clostridium%2520difficile%2520Virulence%2520Factor%2520TcdB%26jtitle%3DChem.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D1201%26epage%3D1211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Abdeen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swett, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feig, A. L.</span><span> </span><span class="NLM_article-title">Peptide Inhibitors Targeting <i>Clostridium difficile</i> Toxins A and B</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1097</span><span class="NLM_x">–</span> <span class="NLM_lpage">1103</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb100209b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1097-1103&author=S.+J.+Abdeenauthor=R.+J.+Swettauthor=A.+L.+Feig&title=Peptide+Inhibitors+Targeting+Clostridium+difficile+Toxins+A+and+B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Fcb100209b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb100209b%26sid%3Dliteratum%253Aachs%26aulast%3DAbdeen%26aufirst%3DS.%2BJ.%26aulast%3DSwett%26aufirst%3DR.%2BJ.%26aulast%3DFeig%26aufirst%3DA.%2BL.%26atitle%3DPeptide%2520Inhibitors%2520Targeting%2520Clostridium%2520difficile%2520Toxins%2520A%2520and%2520B%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2010%26volume%3D5%26spage%3D1097%26epage%3D1103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Maurer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathias, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papatheodorou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shekfeh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jank, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aktories, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span> </span><span class="NLM_article-title">From Cosubstrate Similarity to Inhibitor Diversity—Inhibitors of ADP-Ribosyltransferases from Kinase Inhibitor Screening</span> <span class="citation_source-journal">Mol. BioSyst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1039%2FC0MB00151A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=21132207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFemsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=799-808&author=B.+Maurerauthor=U.+Mathiasauthor=P.+Papatheodorouauthor=S.+Shekfehauthor=J.+Orthauthor=T.+Jankauthor=C.+Schwanauthor=W.+Sipplauthor=K.+Aktoriesauthor=M.+Jung&title=From+Cosubstrate+Similarity+to+Inhibitor+Diversity%E2%80%94Inhibitors+of+ADP-Ribosyltransferases+from+Kinase+Inhibitor+Screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">From cosubstrate similarity to inhibitor diversity-inhibitors of ADP-ribosyltransferases from kinase inhibitor screening</span></div><div class="casAuthors">Maurer, Benjamin; Mathias, Ulf; Papatheodorou, Panagiotis; Shekfeh, Suhaib; Orth, Joachim; Jank, Thomas; Schwan, Carsten; Sippl, Wolfgang; Aktories, Klaus; Jung, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">799-808</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-206X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">ADP-ribosyltransferases (ADP-RTs) use NAD+ to transfer an ADP-ribosyl group to target proteins.  Although some ADP-RTs are bacterial toxins only few inhibitors are known.  Here we present the development of fluorescence-based assays and a focussed library screening using kinase inhibitors as a new approach towards inhibitors of ADP-RTs.  Different screening setups were established using surrogate small mol. substrates or the quantitation of the cofactor NAD+.  Proof-of-principle screening expts. were performed using a kinase inhibitor library in order to target the NAD+ binding pockets.  This led to the discovery of structurally different lead inhibitors for the mono-ADP-ribosyltransferases Mosquitocidal toxin (MTX) from Bacillus sphaericus SSII-1, C3bot toxin from Clostridium botulinum and CDTa from Clostridium difficile.  The interaction of the inhibitors with the toxin proteins was analyzed by means of docking and binding free energy calcns.  Binding at the nicotinamide subpocket, which shows a significant difference in the three enzymes, is used to explain the selectivity of the identified inhibitors and offers an opportunity for further development of potent and selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt1oluGyVPbLVg90H21EOLACvtfcHk0lghN4Lj32UeCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFemsbs%253D&md5=53ba9d27079768d6a80a34e1e39c73e1</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1039%2FC0MB00151A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC0MB00151A%26sid%3Dliteratum%253Aachs%26aulast%3DMaurer%26aufirst%3DB.%26aulast%3DMathias%26aufirst%3DU.%26aulast%3DPapatheodorou%26aufirst%3DP.%26aulast%3DShekfeh%26aufirst%3DS.%26aulast%3DOrth%26aufirst%3DJ.%26aulast%3DJank%26aufirst%3DT.%26aulast%3DSchwan%26aufirst%3DC.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DAktories%26aufirst%3DK.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DFrom%2520Cosubstrate%2520Similarity%2520to%2520Inhibitor%2520Diversity%25E2%2580%2594Inhibitors%2520of%2520ADP-Ribosyltransferases%2520from%2520Kinase%2520Inhibitor%2520Screening%26jtitle%3DMol.%2520BioSyst.%26date%3D2011%26volume%3D7%26spage%3D799%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Nerandzic, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donskey, C. J.</span><span> </span><span class="NLM_article-title">Activate to Eradicate: Inhibition of <i>Clostridium difficile</i> Spore Outgrowth by the Synergistic Effects of Osmotic Activation and Nisin</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e54740</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e54740&author=M.+M.+Nerandzicauthor=C.+J.+Donskey&title=Activate+to+Eradicate%3A+Inhibition+of+Clostridium+difficile+Spore+Outgrowth+by+the+Synergistic+Effects+of+Osmotic+Activation+and+Nisin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNerandzic%26aufirst%3DM.%2BM.%26aulast%3DDonskey%26aufirst%3DC.%2BJ.%26atitle%3DActivate%2520to%2520Eradicate%253A%2520Inhibition%2520of%2520Clostridium%2520difficile%2520Spore%2520Outgrowth%2520by%2520the%2520Synergistic%2520Effects%2520of%2520Osmotic%2520Activation%2520and%2520Nisin%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De54740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Francis, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrestha, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorg, J. A.</span><span> </span><span class="NLM_article-title">Bile Acid Recognition by the <i>Clostridium difficile</i> Germinant Receptor, CspC, Is Important for Establishing Infection</span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1003356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=e1003356&author=M.+B.+Francisauthor=C.+A.+Allenauthor=R.+Shresthaauthor=J.+A.+Sorg&title=Bile+Acid+Recognition+by+the+Clostridium+difficile+Germinant+Receptor%2C+CspC%2C+Is+Important+for+Establishing+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrancis%26aufirst%3DM.%2BB.%26aulast%3DAllen%26aufirst%3DC.%2BA.%26aulast%3DShrestha%26aufirst%3DR.%26aulast%3DSorg%26aufirst%3DJ.%2BA.%26atitle%3DBile%2520Acid%2520Recognition%2520by%2520the%2520Clostridium%2520difficile%2520Germinant%2520Receptor%252C%2520CspC%252C%2520Is%2520Important%2520for%2520Establishing%2520Infection%26jtitle%3DPLoS%2520Pathog.%26date%3D2013%26volume%3D9%26spage%3De1003356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Sorg, J. A.; Dineen, S. S.</span><span> </span><span class="NLM_article-title">Laboratory Maintenance of <i>Clostridium difficile</i></span>.  <span class="citation_source-journal">Curr. Protoc. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span>Chapter 9, Unit 9A.1.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=19235151" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=J.+A.+Sorg&author=S.+S.+Dineen&title=Laboratory+Maintenance+of+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSorg%26aufirst%3DJ.%2BA.%26atitle%3DLaboratory%2520Maintenance%2520of%2520Clostridium%2520difficile%26jtitle%3DCurr.%2520Protoc.%2520Microbiol.%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Edwards, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suárez, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, S. M.</span><span> </span><span class="NLM_article-title">Culturing and Maintaining <i>Clostridium difficile</i> in an Anaerobic Environment</span> <span class="citation_source-journal">J. Visualized Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_fpage">e50787</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=e50787&author=A.+N.+Edwardsauthor=J.+M.+Su%C3%A1rezauthor=S.+M.+McBride&title=Culturing+and+Maintaining+Clostridium+difficile+in+an+Anaerobic+Environment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DA.%2BN.%26aulast%3DSu%25C3%25A1rez%26aufirst%3DJ.%2BM.%26aulast%3DMcBride%26aufirst%3DS.%2BM.%26atitle%3DCulturing%2520and%2520Maintaining%2520Clostridium%2520difficile%2520in%2520an%2520Anaerobic%2520Environment%26jtitle%3DJ.%2520Visualized%2520Exp.%26date%3D2013%26spage%3De50787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span> <span class="citation_source-book">Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria</span>, <span class="NLM_edition">8</span>th ed.; CLSI M11-A8 ; <span class="NLM_publisher-name">Clinical and Laboratory Standards Institute</span>: <span class="NLM_publisher-loc">Wayne, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Methods+for+Antimicrobial+Susceptibility+Testing+of+Anaerobic+Bacteria%2C+8th+ed.%3B+CLSI+M11-A8+%3B+Clinical+and+Laboratory+Standards+Institute%3A+Wayne%2C+PA%2C+2012%3B+pp+1%E2%80%9356."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMethods%2520for%2520Antimicrobial%2520Susceptibility%2520Testing%2520of%2520Anaerobic%2520Bacteria%26pub%3DClinical%2520and%2520Laboratory%2520Standards%2520Institute%26date%3D2012%26spage%3D1%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Dawson, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valiente, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faulds-Pain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donahue, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wren, B. W.</span><span> </span><span class="NLM_article-title">Characterisation of <i>Clostridium difficile</i> Biofilm Formation, a Role for Spo0A</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e50527</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e50527&author=L.+F.+Dawsonauthor=E.+Valienteauthor=A.+Faulds-Painauthor=E.+H.+Donahueauthor=B.+W.+Wren&title=Characterisation+of+Clostridium+difficile+Biofilm+Formation%2C+a+Role+for+Spo0A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DL.%2BF.%26aulast%3DValiente%26aufirst%3DE.%26aulast%3DFaulds-Pain%26aufirst%3DA.%26aulast%3DDonahue%26aufirst%3DE.%2BH.%26aulast%3DWren%26aufirst%3DB.%2BW.%26atitle%3DCharacterisation%2520of%2520Clostridium%2520difficile%2520Biofilm%2520Formation%252C%2520a%2520Role%2520for%2520Spo0A%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De50527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Allen, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babakhani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sears, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorg, J. A.</span><span> </span><span class="NLM_article-title">Both Fidaxomicin and Vancomycin Inhibit Outgrowth of <i>Clostridium difficile</i> Spores</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">667</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=664-667&author=C.+A.+Allenauthor=F.+Babakhaniauthor=P.+Searsauthor=L.+Nguyenauthor=J.+A.+Sorg&title=Both+Fidaxomicin+and+Vancomycin+Inhibit+Outgrowth+of+Clostridium+difficile+Spores"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DC.%2BA.%26aulast%3DBabakhani%26aufirst%3DF.%26aulast%3DSears%26aufirst%3DP.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DSorg%26aufirst%3DJ.%2BA.%26atitle%3DBoth%2520Fidaxomicin%2520and%2520Vancomycin%2520Inhibit%2520Outgrowth%2520of%2520Clostridium%2520difficile%2520Spores%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D664%26epage%3D667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Chilton, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baines, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowther, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. H.</span><span> </span><span class="NLM_article-title">Evaluation of the Effect of Oritavancin on <i>Clostridium difficile</i> Spore Germination, Outgrowth and Recovery</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2078</span><span class="NLM_x">–</span> <span class="NLM_lpage">2082</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fjac%2Fdkt160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=23759507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht12htbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2013&pages=2078-2082&author=C.+H.+Chiltonauthor=J.+Freemanauthor=S.+D.+Bainesauthor=G.+S.+Crowtherauthor=S.+Nicholsonauthor=M.+H.+Wilcox&title=Evaluation+of+the+Effect+of+Oritavancin+on+Clostridium+difficile+Spore+Germination%2C+Outgrowth+and+Recovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the effect of oritavancin on Clostridium difficile spore germination, outgrowth and recovery</span></div><div class="casAuthors">Chilton, C. H.; Freeman, J.; Baines, S. D.; Crowther, G. S.; Nicholson, S.; Wilcox, M. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2078-2082</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Previous work suggests that oritavancin may be inhibitory to Clostridium difficile spores.  The authors have evaluated the effects of oritavancin exposure on C. difficile spore germination, outgrowth and recovery.  Germination and outgrowth of C. difficile spores exposed to different concns. of oritavancin, vancomycin, or metronidazole (0.1-10 mg/L) were monitored at 0, 2, 4, 6, 24 and 48 h using phase-contrast microscopy.  Recovery of antimicrobial-exposed spores was detd. by viable counting on Brazier's modified CCEYL agar.  Persistence of oritavancin activity on spores after washing was detd. by measuring activity against a Staphylococcus aureus lawn.  Oritavancin, vancomycin and metronidazole exposure did not prevent germination of phase-bright spores to phase-dark spores, but did inhibit further outgrowth into vegetative cells.  The inhibitory effect of oritavancin persisted after washing, whereas the inhibitory effects of vancomycin and metronidazole did not.  Oritavancin exposure affected spore recovery; fewer spores were recovered after washing following oritavancin exposure than vancomycin exposure.  The extent of this effect was dependent on PCR ribotype, with recovery of ribotype 078 spores completely prevented, but recovery of ribotype 001 spores only slightly affected.  Spores exposed to oritavancin, but not vancomycin, retained antimicrobial activity after washing, indicating adherence of oritavancin, but not vancomycin, to the spore surface Conclusions Oritavancin may adhere to spores, potentially causing early inhibition of germinated cells, preventing subsequent vegetative outgrowth and spore recovery.  This may prevent some recurrences of symptomatic C. difficile infection that are due to germination of residual spores following antibiotic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdr5tiiPe8oLVg90H21EOLACvtfcHk0lixym1haLsiPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht12htbfF&md5=f6779d3bf908df11f69d9300c5dad5cc</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkt160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkt160%26sid%3Dliteratum%253Aachs%26aulast%3DChilton%26aufirst%3DC.%2BH.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DBaines%26aufirst%3DS.%2BD.%26aulast%3DCrowther%26aufirst%3DG.%2BS.%26aulast%3DNicholson%26aufirst%3DS.%26aulast%3DWilcox%26aufirst%3DM.%2BH.%26atitle%3DEvaluation%2520of%2520the%2520Effect%2520of%2520Oritavancin%2520on%2520Clostridium%2520difficile%2520Spore%2520Germination%252C%2520Outgrowth%2520and%2520Recovery%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2013%26volume%3D68%26spage%3D2078%26epage%3D2082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Francis, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorg, J. A.</span><span> </span><span class="NLM_article-title">Muricholic Acids Inhibit <i>Clostridium difficile</i> Spore Germination and Growth</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e73653</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e73653&author=M.+B.+Francisauthor=C.+A.+Allenauthor=J.+A.+Sorg&title=Muricholic+Acids+Inhibit+Clostridium+difficile+Spore+Germination+and+Growth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrancis%26aufirst%3DM.%2BB.%26aulast%3DAllen%26aufirst%3DC.%2BA.%26aulast%3DSorg%26aufirst%3DJ.%2BA.%26atitle%3DMuricholic%2520Acids%2520Inhibit%2520Clostridium%2520difficile%2520Spore%2520Germination%2520and%2520Growth%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De73653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Baines, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. H.</span><span> </span><span class="NLM_article-title">Comparison of Oritavancin Versus Vancomycin as Treatments for Clindamycin-Induced <i>Clostridium difficile</i> PCR Ribotype 027 Infection in a Human Gut Model</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1078</span><span class="NLM_x">–</span> <span class="NLM_lpage">1085</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fjac%2Fdkn358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=18772161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1elu7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2008&pages=1078-1085&author=S.+D.+Bainesauthor=R.+O%E2%80%99Connorauthor=K.+Saxtonauthor=J.+Freemanauthor=M.+H.+Wilcox&title=Comparison+of+Oritavancin+Versus+Vancomycin+as+Treatments+for+Clindamycin-Induced+Clostridium+difficile+PCR+Ribotype+027+Infection+in+a+Human+Gut+Model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model</span></div><div class="casAuthors">Baines, Simon D.; O'Connor, Rachael; Saxton, Katie; Freeman, Jane; Wilcox, Mark H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1078-1085</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The aim was to compare the efficacy of oritavancin and vancomycin in the treatment of Clostridium difficile infection (CDI) using an in vitro human gut model.  We induced CDI by instilling clindamycin into an in vitro gut model primed with pooled human faeces and C. difficile ribotype 027 spores.  Oritavancin and vancomycin were instilled in sep. expts. at levels equiv. to those expected in the faeces (vancomycin) of patients or levels limited by the soly. of the drug (oritavancin).  Clindamycin exposure elicited C. difficile proliferation and high-level cytotoxin prodn. in both expts.  Vancomycin instillation reduced vegetative C. difficile nos. within 1 day but did not affect the nos. of C. difficile spores.  Oritavancin instillation markedly reduced C. difficile vegetative nos. and spores to below the limits of detection within 2 days.  Cytotoxin titers in both expts. declined to the limits of detection after instillation with oritavancin or vancomycin, but did so more quickly (within 5 days) in the vancomycin expt.  Cessation of vancomycin instillation was assocd. with further C. difficile proliferation and high-level cytotoxin prodn.  Conversely, toxin recrudescence was not obsd. following cessation of oritavancin.  Both oritavancin and vancomycin were effective in treating clindamycin-induced CDI in a human gut model, but only oritavancin appeared active against spore forms of C. difficile.  Furthermore, recurrence of high-level cytotoxin prodn. was obsd. following vancomycin instillation but not oritavancin.  Oritavancin therapy may be more effective in treating CDI than vancomycin, possibly because it may prevent recrudescence of C. difficile spores.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDul26dz3TPLVg90H21EOLACvtfcHk0ljaDygB1CTJ7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1elu7nI&md5=540d271cd519acf20eaa64e7f4de5df1</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkn358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkn358%26sid%3Dliteratum%253Aachs%26aulast%3DBaines%26aufirst%3DS.%2BD.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%26aulast%3DSaxton%26aufirst%3DK.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DWilcox%26aufirst%3DM.%2BH.%26atitle%3DComparison%2520of%2520Oritavancin%2520Versus%2520Vancomycin%2520as%2520Treatments%2520for%2520Clindamycin-Induced%2520Clostridium%2520difficile%2520PCR%2520Ribotype%2520027%2520Infection%2520in%2520a%2520Human%2520Gut%2520Model%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2008%26volume%3D62%26spage%3D1078%26epage%3D1085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Crowther, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baines, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todhunter, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chilton, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. H.</span><span> </span><span class="NLM_article-title">Evaluation of NVB302 Versus Vancomycin Activity in an in Vitro Human Gut Model of <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fjac%2Fdks359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=22966180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVChsbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2013&pages=168-176&author=G.+S.+Crowtherauthor=S.+D.+Bainesauthor=S.+L.+Todhunterauthor=J.+Freemanauthor=C.+H.+Chiltonauthor=M.+H.+Wilcox&title=Evaluation+of+NVB302+Versus+Vancomycin+Activity+in+an+in+Vitro+Human+Gut+Model+of+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection</span></div><div class="casAuthors">Crowther, Grace S.; Baines, Simon D.; Todhunter, Sharie L.; Freeman, Jane; Chilton, Caroline H.; Wilcox, Mark H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">168-176</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives First-line treatment options for Clostridium difficile infection (CDI) are limited.  NVB302 is a novel type B lantibiotic under evaluation for the treatment of CDI.  We compared the responses to NVB302 and vancomycin when used to treat simulated CDI in an in vitro gut model.  Methods We used ceftriaxone to elicit simulated CDI in an in vitro gut model primed with human faeces.  Vancomycin and NVB302 were instilled into sep. gut models and the indigenous gut microbiota and C. difficile total viable counts, spores and toxin levels were monitored throughout.  Results Ceftriaxone instillation promoted C. difficile germination and high-level toxin prodn.  Commencement of NVB302 and vancomycin instillation reduced C. difficile total viable counts rapidly with only C. difficile spores remaining within 3 and 4 days, resp.  Cytotoxin was reduced to undetectable levels 5 and 7 days after vancomycin and NVB302 instillation commenced in vessel 2 and 3, resp., and remained undetectable for the remainder of the expts.  C. difficile spores were unaffected by the presence of vancomycin or NVB302.  NVB302 treatment was assocd. with faster resoln. of Bacteroides fragilis group.  Conclusions Both NVB302 and vancomycin were effective in treating simulated CDI in an in vitro gut model.  C. difficile spore recrudescence was not obsd. following successful treatment with either NVB302 or vancomycin.  NVB302 displayed non-inferiority to vancomycin in the treatment of simulated CDI, and had less deleterious effects against B. fragilis group.  NVB302 warrants further clin. investigation as a potentially novel antimicrobial agent for the treatment of CDI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaGVJxLcodS7Vg90H21EOLACvtfcHk0ljaDygB1CTJ7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVChsbfJ&md5=017094dacb83047705cce8b9d6ff4795</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdks359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdks359%26sid%3Dliteratum%253Aachs%26aulast%3DCrowther%26aufirst%3DG.%2BS.%26aulast%3DBaines%26aufirst%3DS.%2BD.%26aulast%3DTodhunter%26aufirst%3DS.%2BL.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DChilton%26aufirst%3DC.%2BH.%26aulast%3DWilcox%26aufirst%3DM.%2BH.%26atitle%3DEvaluation%2520of%2520NVB302%2520Versus%2520Vancomycin%2520Activity%2520in%2520an%2520in%2520Vitro%2520Human%2520Gut%2520Model%2520of%2520Clostridium%2520difficile%2520Infection%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2013%26volume%3D68%26spage%3D168%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Chilton, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowther, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baines, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todhunter, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locher, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Athanasiou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. H.</span><span> </span><span class="NLM_article-title">In Vitro Activity of Cadazolid against Clinically Relevant <i>Clostridium difficile</i> Isolates and in an in Vitro Gut Model of <i>C. difficile</i> Infection</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">697</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fjac%2Fdkt411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=24128668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisF2ltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2014&pages=697-705&author=C.+H.+Chiltonauthor=G.+S.+Crowtherauthor=S.+D.+Bainesauthor=S.+L.+Todhunterauthor=J.+Freemanauthor=H.+H.+Locherauthor=A.+Athanasiouauthor=M.+H.+Wilcox&title=In+Vitro+Activity+of+Cadazolid+against+Clinically+Relevant+Clostridium+difficile+Isolates+and+in+an+in+Vitro+Gut+Model+of+C.+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro activity of cadazolid against clinically relevant Clostridium difficile isolates and in an in vitro gut model of C. difficile infection</span></div><div class="casAuthors">Chilton, C. H.; Crowther, G. S.; Baines, S. D.; Todhunter, S. L.; Freeman, J.; Locher, H. H.; Athanasiou, A.; Wilcox, M. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">697-705</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives We investigated the in vitro activity of cadazolid against 100 Clostridium difficile isolates and its efficacy in a simulated human gut model of C. difficile infection (CDI).  Methods MICs of cadazolid, metronidazole, vancomycin, moxifloxacin and linezolid were detd. using agar incorporation for 100 C. difficile isolates, including 30 epidemic strains (ribotypes 027, 106 and 001) with reduced metronidazole susceptibility, 2 linezolid-resistant isolates and 2 moxifloxacin-resistant isolates.  We evaluated the efficacy of two cadazolid dosing regimens (250 vs. 750 mg/L twice daily for 7 days) to treat simulated CDI.  Microflora populations, C. difficile total viable counts and spores, cytotoxin titers, possible emergence of cadazolid, linezolid or quinolone resistance, and antimicrobial concns. were monitored throughout.  Results Cadazolid was active against all (including linezolid- and moxifloxacin-resistant) C. difficile strains (MIC90 0.125, range 0.03-0.25 mg/L).  The cadazolid geometric mean MIC was 152-fold, 16-fold, 9-fold and 7-fold lower than those of moxifloxacin, linezolid, metronidazole and vancomycin, resp.  Both cadazolid dosing regimens rapidly reduced C. difficile viable counts and cytotoxin with no evidence of recurrence.  Cadazolid levels persisted at 50-100-fold supra-MIC for 14 days post-dosing.  Cadazolid inhibition of enumerated gut microflora was limited, with the exception of bifidobacteria; Bacteroides fragilis group and Lactobacillus spp. counts were unaffected.  There was no evidence for selection of strains resistant to cadazolid, quinolones or linezolid.  Conclusions Cadazolid activity was greater than other tested antimicrobials against 100 C. difficile strains.  Cadazolid effectively treated simulated CDI in a gut model, with limited impact on the enumerated gut microflora and no signs of recurrence or emergence of resistance within the exptl. timeframe.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL-8XP6WYM1LVg90H21EOLACvtfcHk0liKQTjESDtZRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisF2ltrg%253D&md5=f9fb66ad33f640be6d7bedebd9c5b9d4</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkt411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkt411%26sid%3Dliteratum%253Aachs%26aulast%3DChilton%26aufirst%3DC.%2BH.%26aulast%3DCrowther%26aufirst%3DG.%2BS.%26aulast%3DBaines%26aufirst%3DS.%2BD.%26aulast%3DTodhunter%26aufirst%3DS.%2BL.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DLocher%26aufirst%3DH.%2BH.%26aulast%3DAthanasiou%26aufirst%3DA.%26aulast%3DWilcox%26aufirst%3DM.%2BH.%26atitle%3DIn%2520Vitro%2520Activity%2520of%2520Cadazolid%2520against%2520Clinically%2520Relevant%2520Clostridium%2520difficile%2520Isolates%2520and%2520in%2520an%2520in%2520Vitro%2520Gut%2520Model%2520of%2520C.%2520difficile%2520Infection%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2014%26volume%3D69%26spage%3D697%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Chilton, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowther, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todhunter, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. H.</span><span> </span><span class="NLM_article-title">Effectiveness of a Short (4 Day) Course of Oritavancin in the Treatment of Simulated <i>Clostridium difficile</i> Infection Using a Human Gut Model</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">2434</span><span class="NLM_x">–</span> <span class="NLM_lpage">2437</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fjac%2Fdks243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=22723601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVSntrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2012&pages=2434-2437&author=C.+H.+Chiltonauthor=J.+Freemanauthor=G.+S.+Crowtherauthor=S.+L.+Todhunterauthor=M.+H.+Wilcox&title=Effectiveness+of+a+Short+%284+Day%29+Course+of+Oritavancin+in+the+Treatment+of+Simulated+Clostridium+difficile+Infection+Using+a+Human+Gut+Model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Effectiveness of a short (4 day) course of oritavancin in the treatment of simulated Clostridium difficile infection using a human gut model</span></div><div class="casAuthors">Chilton, C. H.; Freeman, J.; Crowther, G. S.; Todhunter, S. L.; Wilcox, M. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2434-2437</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives: The authors previously demonstrated that 7 days of oritavancin instillation effectively treats Clostridium difficile infection (CDI) in a human gut model.  Oritavancin may be more effective than vancomycin due to apparently increased activity against spores.  The authors compared the efficacy of shortened dosing duration (4 days) of oritavancin and vancomycin for CDI treatment using the gut model.  Methods: Clindamycin induced CDI in two triple-stage chemostat gut models primed with pooled human feces and C. difficile ribotype 027 spores.  Oritavancin (64 mg/L twice daily) or vancomycin (125 mg/L four times daily) was instilled for 4 days and the effects on C. difficile proliferation and toxin prodn., and gut microflora were detd.  Results: Both oritavancin and vancomycin reduced toxin to undetectable levels.  Recurrent C. difficile germination occurred 20 days after vancomycin instillation, with high-level toxin prodn.  Oritavancin reduced C. difficile counts to around the detection limit for the remainder of the expt., with spores undetectable from day 1 of instillation.  Toxin prodn. was reduced to below detectable levels, but was sporadically seen later, despite no evidence of germination.  Both oritavancin and vancomycin instillation led to only modest effects on gut microflora.  Conclusions: Shortened courses of oritavancin and vancomycin effectively treated CDI in a human gut model, but evidence of recurrence was obsd. following vancomycin instillation.  Oritavancin exposure inhibited the recovery of C. difficile spores, as previously described.  Shortened antibiotic exposure minimizes disruption to the gut microflora.  These data indicate the possible value of a 4 day oritavancin dosing regimen for CDI treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfMsxZK2sCtbVg90H21EOLACvtfcHk0liKQTjESDtZRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVSntrzM&md5=19a3646d3c280136ddaa1804f0610802</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdks243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdks243%26sid%3Dliteratum%253Aachs%26aulast%3DChilton%26aufirst%3DC.%2BH.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DCrowther%26aufirst%3DG.%2BS.%26aulast%3DTodhunter%26aufirst%3DS.%2BL.%26aulast%3DWilcox%26aufirst%3DM.%2BH.%26atitle%3DEffectiveness%2520of%2520a%2520Short%2520%25284%2520Day%2529%2520Course%2520of%2520Oritavancin%2520in%2520the%2520Treatment%2520of%2520Simulated%2520Clostridium%2520difficile%2520Infection%2520Using%2520a%2520Human%2520Gut%2520Model%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2012%26volume%3D67%26spage%3D2434%26epage%3D2437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Crowther, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chilton, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todhunter, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baines, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. H.</span><span> </span><span class="NLM_article-title">Development and Validation of a Chemostat Gut Model To Study Both Planktonic and Biofilm Modes of Growth of <i>Clostridium difficile</i> and Human Microbiota</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e88396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e88396&author=G.+S.+Crowtherauthor=C.+H.+Chiltonauthor=S.+L.+Todhunterauthor=S.+Nicholsonauthor=J.+Freemanauthor=S.+D.+Bainesauthor=M.+H.+Wilcox&title=Development+and+Validation+of+a+Chemostat+Gut+Model+To+Study+Both+Planktonic+and+Biofilm+Modes+of+Growth+of+Clostridium+difficile+and+Human+Microbiota"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrowther%26aufirst%3DG.%2BS.%26aulast%3DChilton%26aufirst%3DC.%2BH.%26aulast%3DTodhunter%26aufirst%3DS.%2BL.%26aulast%3DNicholson%26aufirst%3DS.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DBaines%26aufirst%3DS.%2BD.%26aulast%3DWilcox%26aufirst%3DM.%2BH.%26atitle%3DDevelopment%2520and%2520Validation%2520of%2520a%2520Chemostat%2520Gut%2520Model%2520To%2520Study%2520Both%2520Planktonic%2520and%2520Biofilm%2520Modes%2520of%2520Growth%2520of%2520Clostridium%2520difficile%2520and%2520Human%2520Microbiota%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De88396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Crowther, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chilton, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todhunter, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baines, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. H.</span><span> </span><span class="NLM_article-title">Comparison of Planktonic and Biofilm-Associated Communities of <i>Clostridium difficile</i> and Indigenous Gut Microbiota in a Triple-Stage Chemostat Gut Model</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">2137</span><span class="NLM_x">–</span> <span class="NLM_lpage">2147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fjac%2Fdku116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=24788662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Sqsb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2014&pages=2137-2147&author=G.+S.+Crowtherauthor=C.+H.+Chiltonauthor=S.+L.+Todhunterauthor=S.+Nicholsonauthor=J.+Freemanauthor=S.+D.+Bainesauthor=M.+H.+Wilcox&title=Comparison+of+Planktonic+and+Biofilm-Associated+Communities+of+Clostridium+difficile+and+Indigenous+Gut+Microbiota+in+a+Triple-Stage+Chemostat+Gut+Model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut model</span></div><div class="casAuthors">Crowther, Grace S.; Chilton, Caroline H.; Todhunter, Sharie L.; Nicholson, Scott; Freeman, Jane; Baines, Simon D.; Wilcox, Mark H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2137-2147</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Biofilms are characteristic of some chronic or recurrent infections and this mode of growth tends to reduce treatment efficacy.  Clostridium difficile infection (CDI) is assocd. with a high rate of recurrent symptomatic disease.  The presence and behavior of C. difficile within intestinal biofilms remains largely unexplored, but may factor in recurrent infection.  A triple-stage chemostat gut model designed to facilitate the formation of intestinal biofilm was inoculated with a pooled human fecal emulsion.  Bacterial populations were allowed to equilibrate before simulated CDI was induced by clindamycin (33.9 mg/L, four times daily, 7 days) and subsequently treated with vancomycin (125 mg/L, four times daily, 7 days).  Indigenous gut microbiota, C. difficile total viable counts, spores, cytotoxin and antimicrobial activity in planktonic and biofilm communities were monitored during the 10 wk exptl. period.  Vancomycin successfully treated the initial episode of simulated CDI, but ∼18 days after therapy cessation, recurrent infection occurred.  Germination, proliferation and toxin prodn. were evident within planktonic communities in both initial and recurrent CDI.  In contrast, sessile C. difficile remained in dormant spore form for the duration of the expt.  The effects of and recovery from clindamycin and vancomycin exposure for sessile populations was delayed compared with responses for planktonic bacteria.  Thus, intestinal biofilms provide a potential reservoir for C. difficile spore persistence, possibly facilitating their dispersal into the gut lumen after therapeutic intervention, leading to recurrent infection.  Therapeutic options for CDI could have increased efficacy if they are more effective against sessile C. difficile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraFnEau80vJbVg90H21EOLACvtfcHk0lh0gYfadxxgaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Sqsb3P&md5=1a5dece42d7a61ff6645002314b0216e</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdku116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdku116%26sid%3Dliteratum%253Aachs%26aulast%3DCrowther%26aufirst%3DG.%2BS.%26aulast%3DChilton%26aufirst%3DC.%2BH.%26aulast%3DTodhunter%26aufirst%3DS.%2BL.%26aulast%3DNicholson%26aufirst%3DS.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DBaines%26aufirst%3DS.%2BD.%26aulast%3DWilcox%26aufirst%3DM.%2BH.%26atitle%3DComparison%2520of%2520Planktonic%2520and%2520Biofilm-Associated%2520Communities%2520of%2520Clostridium%2520difficile%2520and%2520Indigenous%2520Gut%2520Microbiota%2520in%2520a%2520Triple-Stage%2520Chemostat%2520Gut%2520Model%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2014%26volume%3D69%26spage%3D2137%26epage%3D2147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Best, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. H.</span><span> </span><span class="NLM_article-title">Models for the Study of <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">Gut Microbes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=145-167&author=E.+L.+Bestauthor=J.+Freemanauthor=M.+H.+Wilcox&title=Models+for+the+Study+of+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBest%26aufirst%3DE.%2BL.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DWilcox%26aufirst%3DM.%2BH.%26atitle%3DModels%2520for%2520the%2520Study%2520of%2520Clostridium%2520difficile%2520Infection%26jtitle%3DGut%2520Microbes%26date%3D2012%26volume%3D3%26spage%3D145%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Kokkotou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinoza, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloud, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustafa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pothoulakis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, C. P.</span><span> </span><span class="NLM_article-title">Comparative Efficacies of Rifaximin and Vancomycin for Treatment of <i>Clostridium difficile</i>-Associated Diarrhea and Prevention of Disease Recurrence in Hamsters</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1121</span><span class="NLM_x">–</span> <span class="NLM_lpage">1126</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=1121-1126&author=E.+Kokkotouauthor=A.+C.+Mossauthor=A.+Michosauthor=D.+Espinozaauthor=J.+W.+Cloudauthor=N.+Mustafaauthor=M.+O%E2%80%99Brienauthor=C.+Pothoulakisauthor=C.+P.+Kelly&title=Comparative+Efficacies+of+Rifaximin+and+Vancomycin+for+Treatment+of+Clostridium+difficile-Associated+Diarrhea+and+Prevention+of+Disease+Recurrence+in+Hamsters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKokkotou%26aufirst%3DE.%26aulast%3DMoss%26aufirst%3DA.%2BC.%26aulast%3DMichos%26aufirst%3DA.%26aulast%3DEspinoza%26aufirst%3DD.%26aulast%3DCloud%26aufirst%3DJ.%2BW.%26aulast%3DMustafa%26aufirst%3DN.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%26aulast%3DPothoulakis%26aufirst%3DC.%26aulast%3DKelly%26aufirst%3DC.%2BP.%26atitle%3DComparative%2520Efficacies%2520of%2520Rifaximin%2520and%2520Vancomycin%2520for%2520Treatment%2520of%2520Clostridium%2520difficile-Associated%2520Diarrhea%2520and%2520Prevention%2520of%2520Disease%2520Recurrence%2520in%2520Hamsters%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D1121%26epage%3D1126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Swanson, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipkowitz, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramer, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement, J. J.</span><span> </span><span class="NLM_article-title">In Vitro and in Vivo Evaluation of Tiacumicins B and C against <i>Clostridium difficile</i></span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1108</span><span class="NLM_x">–</span> <span class="NLM_lpage">1111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1991&pages=1108-1111&author=R.+N.+Swansonauthor=D.+J.+Hardyauthor=N.+L.+Shipkowitzauthor=C.+W.+Hansonauthor=N.+C.+Ramerauthor=P.+B.+Fernandesauthor=J.+J.+Clement&title=In+Vitro+and+in+Vivo+Evaluation+of+Tiacumicins+B+and+C+against+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwanson%26aufirst%3DR.%2BN.%26aulast%3DHardy%26aufirst%3DD.%2BJ.%26aulast%3DShipkowitz%26aufirst%3DN.%2BL.%26aulast%3DHanson%26aufirst%3DC.%2BW.%26aulast%3DRamer%26aufirst%3DN.%2BC.%26aulast%3DFernandes%26aufirst%3DP.%2BB.%26aulast%3DClement%26aufirst%3DJ.%2BJ.%26atitle%3DIn%2520Vitro%2520and%2520in%2520Vivo%2520Evaluation%2520of%2520Tiacumicins%2520B%2520and%2520C%2520against%2520Clostridium%2520difficile%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1991%26volume%3D35%26spage%3D1108%26epage%3D1111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Ochsner, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Leary, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Critchley, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janjic, N.</span><span> </span><span class="NLM_article-title">Inhibitory Effect of REP3123 on Toxin and Spore Formation in <i>Clostridium difficile</i>, and in Vivo Efficacy in a Hamster Gastrointestinal Infection Model</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">964</span><span class="NLM_x">–</span> <span class="NLM_lpage">971</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fjac%2Fdkp042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=19251726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVaqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2009&pages=964-971&author=U.+A.+Ochsnerauthor=S.+J.+Bellauthor=A.+L.+O%E2%80%99Learyauthor=T.+Hoangauthor=K.+C.+Stoneauthor=C.+L.+Youngauthor=I.+A.+Critchleyauthor=N.+Janjic&title=Inhibitory+Effect+of+REP3123+on+Toxin+and+Spore+Formation+in+Clostridium+difficile%2C+and+in+Vivo+Efficacy+in+a+Hamster+Gastrointestinal+Infection+Model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model</span></div><div class="casAuthors">Ochsner, Urs A.; Bell, Stacie J.; O'Leary, Ann L.; Hoang, Teresa; Stone, Kimberley Clawson; Young, Casey L.; Critchley, Ian A.; Janjic, Nebojsa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">964-971</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">REP3123 is a fully synthetic methionyl-tRNA synthetase inhibitor in pre-clin. development as a novel agent to treat Clostridium difficile infection (CDI).  This novel agent was investigated for its ability to block the prodn. of toxins and spores, and was tested for efficacy in vivo in a hamster model.  Clostridial toxin levels were detd. qual. using monoclonal antibodies and by cytotoxicity assays.  Spores were detected by staining and by quant. diln. plating after ethanol treatment.  Efficacy of REP3123 was tested in a clindamycin-induced C. difficile hamster gastrointestinal (GI) infection model.  REP3123 at concns. as low as 1 mg/L inhibited de novo toxin prodn. in high cell d., stationary phase cultures of C. difficile.  Among comparator agents currently used for CDI therapy, vancomycin required much higher levels of 20 mg/L, and metronidazole had no effect on toxin levels.  REP3123 caused a >10-fold redn. of the sporulation rate in vitro.  Vancomycin and, in particular, metronidazole appeared to promote the formation of spores.  REP3123, at concns. as low as 0.5 mg/kg, demonstrated efficacy in the hamster model of CDI and was superior to vancomycin in the overall survival of the animals at the end of the study (33 days).  REP3123 inhibited growth of C. difficile, affected the prodn. of toxins and spores and demonstrated superior efficacy compared with vancomycin in the hamster GI infection model.  This agent may be a promising candidate for CDI treatment; in particular, the inhibition of toxin prodn. and spore formation may reduce the severity and spread of the disease, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc8dcWSQIzz7Vg90H21EOLACvtfcHk0lh0gYfadxxgaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVaqu7c%253D&md5=9cba5872704bf239698d8d45f2a57e19</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkp042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkp042%26sid%3Dliteratum%253Aachs%26aulast%3DOchsner%26aufirst%3DU.%2BA.%26aulast%3DBell%26aufirst%3DS.%2BJ.%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DA.%2BL.%26aulast%3DHoang%26aufirst%3DT.%26aulast%3DStone%26aufirst%3DK.%2BC.%26aulast%3DYoung%26aufirst%3DC.%2BL.%26aulast%3DCritchley%26aufirst%3DI.%2BA.%26aulast%3DJanjic%26aufirst%3DN.%26atitle%3DInhibitory%2520Effect%2520of%2520REP3123%2520on%2520Toxin%2520and%2520Spore%2520Formation%2520in%2520Clostridium%2520difficile%252C%2520and%2520in%2520Vivo%2520Efficacy%2520in%2520a%2520Hamster%2520Gastrointestinal%2520Infection%2520Model%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2009%26volume%3D63%26spage%3D964%26epage%3D971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Locher, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfaff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enderlin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klenk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fournier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubschwerlen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keck, W.</span><span> </span><span class="NLM_article-title">In Vitro and in Vivo Antibacterial Evaluation of Cadazolid, a New Antibiotic for Treatment of <i>Clostridium difficile</i> Infections</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">900</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=892-900&author=H.+H.+Locherauthor=P.+Seilerauthor=X.+Chenauthor=S.+Schroederauthor=P.+Pfaffauthor=M.+Enderlinauthor=A.+Klenkauthor=E.+Fournierauthor=C.+Hubschwerlenauthor=D.+Ritzauthor=C.+P.+Kellyauthor=W.+Keck&title=In+Vitro+and+in+Vivo+Antibacterial+Evaluation+of+Cadazolid%2C+a+New+Antibiotic+for+Treatment+of+Clostridium+difficile+Infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLocher%26aufirst%3DH.%2BH.%26aulast%3DSeiler%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSchroeder%26aufirst%3DS.%26aulast%3DPfaff%26aufirst%3DP.%26aulast%3DEnderlin%26aufirst%3DM.%26aulast%3DKlenk%26aufirst%3DA.%26aulast%3DFournier%26aufirst%3DE.%26aulast%3DHubschwerlen%26aufirst%3DC.%26aulast%3DRitz%26aufirst%3DD.%26aulast%3DKelly%26aufirst%3DC.%2BP.%26aulast%3DKeck%26aufirst%3DW.%26atitle%3DIn%2520Vitro%2520and%2520in%2520Vivo%2520Antibacterial%2520Evaluation%2520of%2520Cadazolid%252C%2520a%2520New%2520Antibiotic%2520for%2520Treatment%2520of%2520Clostridium%2520difficile%2520Infections%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D892%26epage%3D900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baines, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jabes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. H.</span><span> </span><span class="NLM_article-title">Comparison of the Efficacy of Ramoplanin and Vancomycin in Both in Vitro and in Vivo Models of Clindamycin-Induced <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">725</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fjac%2Fdki321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=16143709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKhsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2005&pages=717-725&author=J.+Freemanauthor=S.+D.+Bainesauthor=D.+Jabesauthor=M.+H.+Wilcox&title=Comparison+of+the+Efficacy+of+Ramoplanin+and+Vancomycin+in+Both+in+Vitro+and+in+Vivo+Models+of+Clindamycin-Induced+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection</span></div><div class="casAuthors">Freeman, Jane; Baines, Simon D.; Jabes, Daniela; Wilcox, Mark H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">717-725</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Treatment of Clostridium difficile infection (CDI) is limited primarily to either metronidazole or vancomycin.  We compared vancomycin and a novel glycolipodepsipeptide, ramoplanin, in both hamster and in vitro gut models of clindamycin-induced CDI.  We used an in vitro triple-stage chemostat model that simulates the human gut, and an in vivo hamster model, both primed with clindamycin.  Clindamycin exposure elicited symptomatic disease in the hamster model, and promoted C. difficile germination and toxin prodn. in the gut model.  C. difficile germination and toxin prodn. were not assocd. with depletion of gut microflora in the gut model, but were temporarily assocd. with subinhibitory concns. of clindamycin.  Both ramoplanin and vancomycin were assocd. with rapid symptom resoln. in the hamster model, and rapid toxin titer decrease in the in vitro gut model.  In both models of CDI, vancomycin was assocd. with greater persistence of C. difficile spores.  C. difficile spores were recovered significantly more often from the caecal contents of vancomycin-treated (n = 19/23) compared with ramoplanin-treated (n = 6/23) hamsters (P < 0.05).  Results from the in vitro gut and hamster models were concordant.  Ramoplanin and vancomycin were similarly effective at reducing cytotoxin prodn. in the gut CDI model and in resolving symptoms in the hamster model.  Ramoplanin may be more effective than vancomycin at killing spores and preventing spore recrudescence.  These findings suggest a potential therapeutic role for ramoplanin in CDI that requires further clin. investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEl9FGqKF4u7Vg90H21EOLACvtfcHk0liGiGRUv2A_8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKhsr7E&md5=febc4f3ec9555d807ac8e596ced3fb8b</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdki321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdki321%26sid%3Dliteratum%253Aachs%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DBaines%26aufirst%3DS.%2BD.%26aulast%3DJabes%26aufirst%3DD.%26aulast%3DWilcox%26aufirst%3DM.%2BH.%26atitle%3DComparison%2520of%2520the%2520Efficacy%2520of%2520Ramoplanin%2520and%2520Vancomycin%2520in%2520Both%2520in%2520Vitro%2520and%2520in%2520Vivo%2520Models%2520of%2520Clindamycin-Induced%2520Clostridium%2520difficile%2520Infection%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2005%26volume%3D56%26spage%3D717%26epage%3D725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">McVay, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolfe, R. D.</span><span> </span><span class="NLM_article-title">In Vitro and in Vivo Activities of Nitazoxanide against <i>Clostridium difficile</i></span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2254</span><span class="NLM_x">–</span> <span class="NLM_lpage">2258</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2000&pages=2254-2258&author=C.+S.+McVayauthor=R.+D.+Rolfe&title=In+Vitro+and+in+Vivo+Activities+of+Nitazoxanide+against+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcVay%26aufirst%3DC.%2BS.%26aulast%3DRolfe%26aufirst%3DR.%2BD.%26atitle%3DIn%2520Vitro%2520and%2520in%2520Vivo%2520Activities%2520of%2520Nitazoxanide%2520against%2520Clostridium%2520difficile%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2000%26volume%3D44%26spage%3D2254%26epage%3D2258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">Anton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokkotou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenstein, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paraschos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pothoulakis, C.</span><span> </span><span class="NLM_article-title">Rifalazil Treats and Prevents Relapse of <i>Clostridium difficile</i>-Associated Diarrhea in Hamsters</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3975</span><span class="NLM_x">–</span> <span class="NLM_lpage">3979</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=3975-3979&author=P.+M.+Antonauthor=M.+O%E2%80%99Brienauthor=E.+Kokkotouauthor=A.+M.+Eisensteinauthor=D.+M.+Rothsteinauthor=S.+Paraschosauthor=C.+P.+Kellyauthor=C.+Pothoulakis&title=Rifalazil+Treats+and+Prevents+Relapse+of+Clostridium+difficile-Associated+Diarrhea+in+Hamsters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnton%26aufirst%3DP.%2BM.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%26aulast%3DKokkotou%26aufirst%3DE.%26aulast%3DEisenstein%26aufirst%3DA.%2BM.%26aulast%3DRothstein%26aufirst%3DD.%2BM.%26aulast%3DParaschos%26aufirst%3DS.%26aulast%3DKelly%26aufirst%3DC.%2BP.%26aulast%3DPothoulakis%26aufirst%3DC.%26atitle%3DRifalazil%2520Treats%2520and%2520Prevents%2520Relapse%2520of%2520Clostridium%2520difficile-Associated%2520Diarrhea%2520in%2520Hamsters%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D3975%26epage%3D3979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowther, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todhunter, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawley, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chilton, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moeck, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehoux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. H.</span><span> </span><span class="NLM_article-title">Oritavancin Does Not Induce <i>Clostridium difficile</i> Germination and Toxin Production in Hamsters or a Human Gut Model</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">2919</span><span class="NLM_x">–</span> <span class="NLM_lpage">2926</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fjac%2Fdks309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=22899803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Glu73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2012&pages=2919-2926&author=J.+Freemanauthor=M.+Marquisauthor=G.+S.+Crowtherauthor=S.+L.+Todhunterauthor=W.+N.+Fawleyauthor=C.+H.+Chiltonauthor=G.+Moeckauthor=D.+Lehouxauthor=M.+H.+Wilcox&title=Oritavancin+Does+Not+Induce+Clostridium+difficile+Germination+and+Toxin+Production+in+Hamsters+or+a+Human+Gut+Model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model</span></div><div class="casAuthors">Freeman, Jane; Marquis, Miriam; Crowther, Grace S.; Todhunter, Sharie L.; Fawley, Warren N.; Chilton, Caroline H.; Moeck, Gregory; Lehoux, Dario; Wilcox, Mark H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2919-2926</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives: To evaluate the relative propensities of oritavancin and vancomycin to induce Clostridium difficile infection (CDI) in hamster and in vitro human gut models.  Methods: Hamsters received clindamycin (100 mg/kg orally or s.c.), oritavancin (50 mg/kg orally) or vancomycin (50 mg/kg orally).  C. difficile spores were administered orally the next day.  Control hamsters received vehicle only (polyethylene glycol 400) plus spores or clindamycin but no spores.  Hamsters were monitored for clin. signs for 20 days.  Caecal contents were analyzed for C. difficile cells, spores and the presence of (cyto)toxin.  Oritavancin and vancomycin were instilled over 7 days into sep. in vitro gut models primed with pooled human faeces and inoculated with C. difficile ribotype 027 spores.  Gut flora, C. difficile total viable and spore counts, toxin titers and antimicrobial concns. were detd.  Results: All hamsters treated with oritavancin survived up to 20 days, with no evidence of C. difficile spores, vegetative cells or toxin in their caeca.  No hamsters treated with clindamycin or vancomycin survived >6 days after spore administration.  Death was assocd. with high C. difficile counts and toxin in caecal contents.  In the gut model, oritavancin dosing elicited a rapid, marked decrease in total viable C. difficile and spore counts to below the limit of detection.  Vancomycin did not elicit germination or toxin prodn. in the gut model, but C. difficile remained present as spores throughout.  Conclusions: Oritavancin exposure, unlike exposure to vancomycin or clindamycin, did not lead to CDI in hamsters.  In both models, oritavancin reduced C. difficile total counts and spores to below detectable limits.  The data indicate the potential of oritavancin for CDI treatment, since exposure did not induce C. difficile germination and toxin prodn., which are known to exacerbate the disease state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY8iA8HcREcrVg90H21EOLACvtfcHk0li0SAyKVtq3GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Glu73L&md5=5bbe75a7f0f471c0e157c0992266eb58</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdks309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdks309%26sid%3Dliteratum%253Aachs%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DMarquis%26aufirst%3DM.%26aulast%3DCrowther%26aufirst%3DG.%2BS.%26aulast%3DTodhunter%26aufirst%3DS.%2BL.%26aulast%3DFawley%26aufirst%3DW.%2BN.%26aulast%3DChilton%26aufirst%3DC.%2BH.%26aulast%3DMoeck%26aufirst%3DG.%26aulast%3DLehoux%26aufirst%3DD.%26aulast%3DWilcox%26aufirst%3DM.%2BH.%26atitle%3DOritavancin%2520Does%2520Not%2520Induce%2520Clostridium%2520difficile%2520Germination%2520and%2520Toxin%2520Production%2520in%2520Hamsters%2520or%2520a%2520Human%2520Gut%2520Model%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2012%26volume%3D67%26spage%3D2919%26epage%3D2926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group">Hutton, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackin, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravorty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyras, D.</span><span> </span><span class="NLM_article-title">Small Animal Models for the Study of <i>Clostridium difficile</i> Disease Pathogenesis</span> <span class="citation_source-journal">FEMS Microbiol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2014&pages=140-149&author=M.+L.+Huttonauthor=K.+E.+Mackinauthor=A.+Chakravortyauthor=D.+Lyras&title=Small+Animal+Models+for+the+Study+of+Clostridium+difficile+Disease+Pathogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHutton%26aufirst%3DM.%2BL.%26aulast%3DMackin%26aufirst%3DK.%2BE.%26aulast%3DChakravorty%26aufirst%3DA.%26aulast%3DLyras%26aufirst%3DD.%26atitle%3DSmall%2520Animal%2520Models%2520for%2520the%2520Study%2520of%2520Clostridium%2520difficile%2520Disease%2520Pathogenesis%26jtitle%3DFEMS%2520Microbiol.%2520Lett.%26date%3D2014%26volume%3D352%26spage%3D140%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group">Deakin, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagan, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wren, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairweather, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawley, T. D.</span><span> </span><span class="NLM_article-title"><i>Clostridium difficile</i> spo0A Gene Is a Persistence and Transmission Factor</span> <span class="citation_source-journal">Infect. Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">2704</span><span class="NLM_x">–</span> <span class="NLM_lpage">2711</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1128%2FIAI.00147-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=22615253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFegsr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2012&pages=2704-2711&author=L.+J.+Deakinauthor=S.+Clareauthor=R.+P.+Faganauthor=L.+F.+Dawsonauthor=D.+J.+Pickardauthor=M.+R.+Westauthor=B.+W.+Wrenauthor=N.+F.+Fairweatherauthor=G.+Douganauthor=T.+D.+Lawley&title=Clostridium+difficile+spo0A+Gene+Is+a+Persistence+and+Transmission+Factor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">The Clostridium difficile spo0A gene is a persistence and transmission factor</span></div><div class="casAuthors">Deakin, Laura J.; Clare, Simon; Fagan, Robert P.; Dawson, Lisa F.; Pickard, Derek J.; West, Michael R.; Wren, Brendan W.; Fairweather, Neil F.; Dougan, Gordon; Lawley, Trevor D.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2704-2711</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Clostridium difficile is a major cause of chronic antibiotic-assocd. diarrhea and a significant health care-assocd. pathogen that forms highly resistant and infectious spores.  Spo0A is a highly conserved transcriptional regulator that plays a key role in initiating sporulation in Bacillus and Clostridium species.  Here, we use a murine model to study the role of the C. difficile spo0A gene during infection and transmission.  We demonstrate that C. difficile spo0A mutant derivs. can cause intestinal disease but are unable to persist within and effectively transmit between mice.  Thus, the C. difficile Spo0A protein plays a key role in persistent infection, including recurrence and host-to-host transmission in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4A5klAQ9VQLVg90H21EOLACvtfcHk0li0SAyKVtq3GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFegsr%252FK&md5=1c6b60e49c91ece86bd5610666096711</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1128%2FIAI.00147-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00147-12%26sid%3Dliteratum%253Aachs%26aulast%3DDeakin%26aufirst%3DL.%2BJ.%26aulast%3DClare%26aufirst%3DS.%26aulast%3DFagan%26aufirst%3DR.%2BP.%26aulast%3DDawson%26aufirst%3DL.%2BF.%26aulast%3DPickard%26aufirst%3DD.%2BJ.%26aulast%3DWest%26aufirst%3DM.%2BR.%26aulast%3DWren%26aufirst%3DB.%2BW.%26aulast%3DFairweather%26aufirst%3DN.%2BF.%26aulast%3DDougan%26aufirst%3DG.%26aulast%3DLawley%26aufirst%3DT.%2BD.%26atitle%3DClostridium%2520difficile%2520spo0A%2520Gene%2520Is%2520a%2520Persistence%2520and%2520Transmission%2520Factor%26jtitle%3DInfect.%2520Immun.%26date%3D2012%26volume%3D80%26spage%3D2704%26epage%3D2711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, H.</span><span> </span><span class="NLM_article-title">Mouse Relapse Model of <i>Clostridium difficile</i> Infection</span> <span class="citation_source-journal">Infect. Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">2856</span><span class="NLM_x">–</span> <span class="NLM_lpage">2864</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1128%2FIAI.01336-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=21576341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3MXot1Kisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=2856-2864&author=X.+Sunauthor=H.+Wangauthor=Y.+Zhangauthor=K.+Chenauthor=B.+Davisauthor=H.+Feng&title=Mouse+Relapse+Model+of+Clostridium+difficile+Infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Mouse relapse model of Clostridium difficile infection</span></div><div class="casAuthors">Sun, Xingmin; Wang, Haiying; Zhang, Yongrong; Chen, Kevin; Davis, Barbara; Feng, Hanping</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2856-2864</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Clostridium difficile is the causative agent of primary and recurrent antibiotic-assocd. diarrhea and colitis in hospitalized patients.  The disease is caused mainly by two exotoxins, TcdA and TcdB, produced by the bacteria.  Recurrent C. difficile infection (CDI) constitutes one of the most significant clin. issues of this disease, occurs in more than 20% of patients after the first episode, and may be increasing in frequency.  However, there is no well-established animal model of CDI relapse currently available for studying disease pathogenesis, prevention, and therapy.  Here we report the establishment of a conventional mouse model of recurrence/relapse CDI.  We found that the primary episode of CDI induced little or no protective antibody response against C. difficile toxins and mice continued shedding C. difficile spores.  Antibiotic treatment of surviving mice induced a second episode of diarrhea, while a simultaneous reexposure of animals to C. difficile bacteria or spores elicited a full spectrum of CDI similar to that of the primary infection.  Moreover, mice treated with immunosuppressive agents were prone to more severe and fulminant recurrent disease.  Finally, utilizing this model, we demonstrated that vancomycin only delayed disease recurrence, whereas neutralizing polyzera against both TcdA and TcdB completely protected mice against CDI relapse.  In conclusion, we have established a mouse relapse CDI model that allows for future investigations of the role of the host immune response in the disease's pathogenesis and permits crit. testing of new therapeutics targeting recurrent disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUX3G_8XqDqbVg90H21EOLACvtfcHk0lgdjqtN32_OoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXot1Kisr0%253D&md5=ba9a276ca0ab0180f5b758a7bba473b6</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1128%2FIAI.01336-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.01336-10%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DFeng%26aufirst%3DH.%26atitle%3DMouse%2520Relapse%2520Model%2520of%2520Clostridium%2520difficile%2520Infection%26jtitle%3DInfect.%2520Immun.%26date%3D2011%26volume%3D79%26spage%3D2856%26epage%3D2864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group">Eyre, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cule, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaughan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ip, C. L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golubchik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batty, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finney, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyllie, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Didelot, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piazza, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowden, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingle, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harding, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crook, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peto, T. E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. S.</span><span> </span><span class="NLM_article-title">Diverse Sources of <i>C. difficile</i> Infection Identified on Whole-Genome Sequencing</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x">, </span> <span class="NLM_fpage">1195</span><span class="NLM_x">–</span> <span class="NLM_lpage">1205</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1056%2FNEJMoa1216064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=24066741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFGktLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2013&pages=1195-1205&author=D.+W.+Eyreauthor=M.+L.+Culeauthor=D.+J.+Wilsonauthor=D.+Griffithsauthor=A.+Vaughanauthor=L.+O%E2%80%99Connorauthor=C.+L.+C.+Ipauthor=T.+Golubchikauthor=E.+M.+Battyauthor=J.+M.+Finneyauthor=D.+H.+Wyllieauthor=X.+Didelotauthor=P.+Piazzaauthor=R.+Bowdenauthor=K.+E.+Dingleauthor=R.+M.+Hardingauthor=D.+W.+Crookauthor=M.+H.+Wilcoxauthor=T.+E.+A.+Petoauthor=A.+S.+Walker&title=Diverse+Sources+of+C.+difficile+Infection+Identified+on+Whole-Genome+Sequencing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Diverse sources of C. difficile infection identified on whole-genome sequencing</span></div><div class="casAuthors">Eyre, David W.; Cule, Madeleine L.; Wilson, Daniel J.; Griffiths, David; Vaughan, Alison; O'Connor, Lily; Ip, Camilla L. C.; Golubchik, Tanya; Batty, Elizabeth M.; Finney, John M.; Wyllie, David H.; Didelot, Xavier; Piazza, Paolo; Bowden, Rory; Dingle, Kate E.; Harding, Rosalind M.; Crook, Derrick W.; Wilcox, Mark H.; Peto, Tim E. A.; Walker, A. Sarah</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1195-1205</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">It has been thought that Clostridium difficile infection is transmitted predominantly within health care settings.  However, endemic spread has hampered identification of precise sources of infection and the assessment of the efficacy of interventions.  From Sept. 2007 through March 2011, we performed whole-genome sequencing on isolates obtained from all symptomatic patients with C. difficile infection identified in health care settings or in the community in Oxfordshire, United Kingdom.  We compared single-nucleotide variants (SNVs) between the isolates, using C. difficile evolution rates estd. on the basis of the first and last samples obtained from each of 145 patients, with 0 to 2 SNVs expected between transmitted isolates obtained less than 124 days apart, on the basis of a 95% prediction interval.  We then identified plausible epidemiol. links among genetically related cases from data on hospital admissions and community location.  Of 1250 C. difficile cases that were evaluated, 1223 (98%) were successfully sequenced.  In a comparison of 957 samples obtained from Apr. 2008 through March 2011 with those obtained from Sept. 2007 onward, a total of 333 isolates (35%) had no more than 2 SNVs from at least 1 earlier case, and 428 isolates (45%) had more than 10 SNVs from all previous cases.  Redns. in incidence over time were similar in the two groups, a finding that suggests an effect of interventions targeting the transition from exposure to disease.  Of the 333 patients with no more than 2 SNVs (consistent with transmission), 126 patients (38%) had close hospital contact with another patient, and 120 patients (36%) had no hospital or community contact with another patient.  Distinct subtypes of infection continued to be identified throughout the study, which suggests a considerable reservoir of C. difficile.  Over a 3-yr period, 45% of C. difficile cases in Oxfordshire were genetically distinct from all previous cases.  Genetically diverse sources, in addn. to symptomatic patients, play a major part in C. difficile transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPKI3Qgyeg5rVg90H21EOLACvtfcHk0lgdjqtN32_OoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFGktLjI&md5=1bdafc638cc35d289ca312258cb38087</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1216064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1216064%26sid%3Dliteratum%253Aachs%26aulast%3DEyre%26aufirst%3DD.%2BW.%26aulast%3DCule%26aufirst%3DM.%2BL.%26aulast%3DWilson%26aufirst%3DD.%2BJ.%26aulast%3DGriffiths%26aufirst%3DD.%26aulast%3DVaughan%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DL.%26aulast%3DIp%26aufirst%3DC.%2BL.%2BC.%26aulast%3DGolubchik%26aufirst%3DT.%26aulast%3DBatty%26aufirst%3DE.%2BM.%26aulast%3DFinney%26aufirst%3DJ.%2BM.%26aulast%3DWyllie%26aufirst%3DD.%2BH.%26aulast%3DDidelot%26aufirst%3DX.%26aulast%3DPiazza%26aufirst%3DP.%26aulast%3DBowden%26aufirst%3DR.%26aulast%3DDingle%26aufirst%3DK.%2BE.%26aulast%3DHarding%26aufirst%3DR.%2BM.%26aulast%3DCrook%26aufirst%3DD.%2BW.%26aulast%3DWilcox%26aufirst%3DM.%2BH.%26aulast%3DPeto%26aufirst%3DT.%2BE.%2BA.%26aulast%3DWalker%26aufirst%3DA.%2BS.%26atitle%3DDiverse%2520Sources%2520of%2520C.%2520difficile%2520Infection%2520Identified%2520on%2520Whole-Genome%2520Sequencing%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D369%26spage%3D1195%26epage%3D1205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span>A Trial To Compare Xifaxan to Vancomycin for the Treatment of <i>Clostridium difficile</i>-Associated Diarrhea (CDAD). Identifier NCT00269399. <a href="https://clinicaltrials.gov/ct2/show/NCT00269399?term=NCT00269399&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT00269399?term=NCT00269399&rank=1</a> (accessed Oct 21,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Trial+To+Compare+Xifaxan+to+Vancomycin+for+the+Treatment+of+Clostridium+difficile-Associated+Diarrhea+%28CDAD%29.+Identifier+NCT00269399.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00269399%3Fterm%3DNCT00269399%26rank%3D1+%28accessed+Oct+21%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span>Fecal Microbiota Transplant for Relapsing <i>Clostridium difficile</i> Infection in Adults and Children Using a Frozen Encapsulated Inoculum. Identifier NCT01914731. <a href="http://clinicaltrials.gov/ct2/show/NCT01914731?term=FMT&amp;phase=0&amp;rank=9" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01914731?term=FMT&phase=0&rank=9</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Fecal+Microbiota+Transplant+for+Relapsing+Clostridium+difficile+Infection+in+Adults+and+Children+Using+a+Frozen+Encapsulated+Inoculum.+Identifier+NCT01914731.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01914731%3Fterm%3DFMT%26phase%3D0%26rank%3D9."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group">Youngster, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pindar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alm, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohmann, E. L.</span><span> </span><span class="NLM_article-title">Fecal Microbiota Transplant for Relapsing <i>Clostridium difficile</i> Infection Using a Frozen Inoculum rrom Unrelated Donors: A Randomized, Open-Label, Controlled Pilot Study</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1515</span><span class="NLM_x">–</span> <span class="NLM_lpage">1522</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1093%2Fcid%2Fciu135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=24762631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A280%3ADC%252BC2cnmsVKhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=1515-1522&author=I.+Youngsterauthor=J.+Saukauthor=C.+Pindarauthor=R.+G.+Wilsonauthor=J.+L.+Kaplanauthor=M.+B.+Smithauthor=E.+J.+Almauthor=D.+Geversauthor=G.+H.+Russellauthor=E.+L.+Hohmann&title=Fecal+Microbiota+Transplant+for+Relapsing+Clostridium+difficile+Infection+Using+a+Frozen+Inoculum+rrom+Unrelated+Donors%3A+A+Randomized%2C+Open-Label%2C+Controlled+Pilot+Study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study</span></div><div class="casAuthors">Youngster Ilan; Sauk Jenny; Pindar Christina; Wilson Robin G; Kaplan Jess L; Smith Mark B; Alm Eric J; Gevers Dirk; Russell George H; Hohmann Elizabeth L</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1515-22</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Recurrent Clostridium difficile infection (CDI) with poor response to standard antimicrobial therapy is a growing medical concern.  We aimed to investigate the outcomes of fecal microbiota transplant (FMT) for relapsing CDI using a frozen suspension from unrelated donors, comparing colonoscopic and nasogastric tube (NGT) administration.  METHODS:  Healthy volunteer donors were screened and a frozen fecal suspension was generated.  Patients with relapsing/refractory CDI were randomized to receive an infusion of donor stools by colonoscopy or NGT.  The primary endpoint was clinical resolution of diarrhea without relapse after 8 weeks.  The secondary endpoint was self-reported health score using standardized questionnaires.  RESULTS:  A total of 20 patients were enrolled, 10 in each treatment arm.  Patients had a median of 4 (range, 2-16) relapses prior to study enrollment, with 5 (range, 3-15) antibiotic treatment failures.  Resolution of diarrhea was achieved in 14 patients (70%) after a single FMT (8 of 10 in the colonoscopy group and 6 of 10 in the NGT group).  Five patients were retreated, with 4 obtaining cure, resulting in an overall cure rate of 90%.  Daily number of bowel movements changed from a median of 7 (interquartile range [IQR], 5-10) the day prior to FMT to 2 (IQR, 1-2) after the infusion.  Self-ranked health score improved significantly, from a median of 4 (IQR, 2-6) before transplant to 8 (IQR, 5-9) after transplant.  No serious or unexpected adverse events occurred.  CONCLUSIONS:  In our initial feasibility study, FMT using a frozen inoculum from unrelated donors is effective in treating relapsing CDI.  NGT administration appears to be as effective as colonoscopic administration.  CLINICAL TRIALS REGISTRATION:  NCT01704937.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKcK4YrO1pgCO2kE7krGOBfW6udTcc2eanSiX1ofzmu7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cnmsVKhsg%253D%253D&md5=6d9ff97a10b7ef08de09fe865bae70ba</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fciu135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fciu135%26sid%3Dliteratum%253Aachs%26aulast%3DYoungster%26aufirst%3DI.%26aulast%3DSauk%26aufirst%3DJ.%26aulast%3DPindar%26aufirst%3DC.%26aulast%3DWilson%26aufirst%3DR.%2BG.%26aulast%3DKaplan%26aufirst%3DJ.%2BL.%26aulast%3DSmith%26aufirst%3DM.%2BB.%26aulast%3DAlm%26aufirst%3DE.%2BJ.%26aulast%3DGevers%26aufirst%3DD.%26aulast%3DRussell%26aufirst%3DG.%2BH.%26aulast%3DHohmann%26aufirst%3DE.%2BL.%26atitle%3DFecal%2520Microbiota%2520Transplant%2520for%2520Relapsing%2520Clostridium%2520difficile%2520Infection%2520Using%2520a%2520Frozen%2520Inoculum%2520rrom%2520Unrelated%2520Donors%253A%2520A%2520Randomized%252C%2520Open-Label%252C%2520Controlled%2520Pilot%2520Study%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2014%26volume%3D58%26spage%3D1515%26epage%3D1522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span>Defined Fecal Microbiota Transplantation for <i>Clostridium difficile</i> Diarrhea. Identifier NCT01868373. <a href="https://clinicaltrials.gov/ct2/show/NCT01868373?term=FMT&amp;phase=0&amp;rank=10" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01868373?term=FMT&phase=0&rank=10</a> (accessed Oct 28,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Defined+Fecal+Microbiota+Transplantation+for+Clostridium+difficile+Diarrhea.+Identifier+NCT01868373.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01868373%3Fterm%3DFMT%26phase%3D0%26rank%3D10+%28accessed+Oct+28%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span>A Study To Investigate a <i>Clostridium difficile</i> Vaccine in Healthy Adults Aged 50 to 85 Years, Who Will Each Receive 3 Doses of Vaccine. Identifier NCT02117570. <a href="http://clinicaltrials.gov/ct2/show/NCT02117570?term=vaccine+difficile&amp;rank=4" class="extLink">http://clinicaltrials.gov/ct2/show/NCT02117570?term=vaccine+difficile&rank=4</a> (accessed Oct 23,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study+To+Investigate+a+Clostridium+difficile+Vaccine+in+Healthy+Adults+Aged+50+to+85+Years%2C+Who+Will+Each+Receive+3+Doses+of+Vaccine.+Identifier+NCT02117570.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02117570%3Fterm%3Dvaccine%2Bdifficile%26rank%3D4+%28accessed+Oct+23%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group">Lowy, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molrine, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leav, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichol, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, W. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrosino, D. M.</span><span> </span><span class="NLM_article-title">Treatment with Monoclonal Antibodies against <i>Clostridium difficile</i> Toxins</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Fjm5016846&amp;key=10.1056%2FNEJMoa0907635" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Fjm5016846&amp;key=20089970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Fjm5016846&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosFShtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=197-205&author=I.+Lowyauthor=D.+C.+Molrineauthor=B.+A.+Leavauthor=B.+M.+Blairauthor=R.+Baxterauthor=G.+Nicholauthor=W.+D.+Thomasauthor=M.+Leneyauthor=S.+Sloanauthor=C.+A.+Hayauthor=D.+M.+Ambrosino&title=Treatment+with+Monoclonal+Antibodies+against+Clostridium+difficile+Toxins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment with monoclonal antibodies against Clostridium difficile toxins</span></div><div class="casAuthors">Lowy, Israel; Molrine, Deborah C.; Leav, Brett A.; Blair, Barbra M.; Baxter, Roger; Gerding, Dale N.; Nichol, Geoffrey; Thomas, William D., Jr.; Leney, Mark; Sloan, Susan; Hay, Catherine A.; Ambrosino, Donna M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">197-205</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">New therapies are needed to manage the increasing incidence, severity, and high rate of recurrence of Clostridium difficile infection.  the authors performed a randomized, double-blind, placebo-controlled study of two neutralizing, fully human monoclonal antibodies against C. difficile toxins A (CDA1) and B (CDB1).  The antibodies were administered together as a single infusion, each at a dose of 10 mg per kg of body wt., in patients with symptomatic C. difficile infection who were receiving either metronidazole or vancomycin.  The primary outcome was lab.-documented recurrence of infection during the 84 days after the administration of monoclonal antibodies or placebo.  Among the 200 patients who were enrolled (101 in the antibody group and 99 in the placebo group), the rate of recurrence of C. difficile infection was lower among patients treated with monoclonal antibodies (7% vs. 25%; 95% confidence interval, 7 to 29).  The recurrence rates among patients with the epidemic BI/NAP1/027 strain were 8% for the antibody group and 32% for the placebo group; among patients with more than one previous episode of C. difficile infection, recurrence rates were 7% and 38%, resp.  The mean duration of the initial hospitalization for inpatients did not differ significantly between the antibody and placebo groups (9.5 and 9.4 days, resp.).  At least one serious adverse event was reported by 18 patients in the antibody group and by 28 patients in the placebo group.  The addn. of monoclonal antibodies against C. difficile toxins to antibiotic agents significantly reduced the recurrence of C. difficile infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu7vAobwaiBLVg90H21EOLACvtfcHk0lgneHLTwc_8QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosFShtw%253D%253D&md5=f50a149c5afbca55e00f2497905bdf3f</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0907635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0907635%26sid%3Dliteratum%253Aachs%26aulast%3DLowy%26aufirst%3DI.%26aulast%3DMolrine%26aufirst%3DD.%2BC.%26aulast%3DLeav%26aufirst%3DB.%2BA.%26aulast%3DBlair%26aufirst%3DB.%2BM.%26aulast%3DBaxter%26aufirst%3DR.%26aulast%3DNichol%26aufirst%3DG.%26aulast%3DThomas%26aufirst%3DW.%2BD.%26aulast%3DLeney%26aufirst%3DM.%26aulast%3DSloan%26aufirst%3DS.%26aulast%3DHay%26aufirst%3DC.%2BA.%26aulast%3DAmbrosino%26aufirst%3DD.%2BM.%26atitle%3DTreatment%2520with%2520Monoclonal%2520Antibodies%2520against%2520Clostridium%2520difficile%2520Toxins%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26spage%3D197%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span>FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI. Identifier NCT02255305. <a href="https://clinicaltrials.gov/ct2/show/NCT02255305?term=FMT&amp;phase=1&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02255305?term=FMT&phase=1&rank=1</a> (accessed Oct 28,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=FMT+Versus+Antimicrobials+for+Initial+Treatment+of+Recurrent+CDI.+Identifier+NCT02255305.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02255305%3Fterm%3DFMT%26phase%3D1%26rank%3D1+%28accessed+Oct+28%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span>Stool Transplant in Pediatric Patients with Recurring <i>C. difficile</i> Infection. Identifier NCT01972334. <a href="http://clinicaltrials.gov/ct2/show/NCT01972334?term=FMT&amp;phase=1&amp;rank=5" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01972334?term=FMT&phase=1&rank=5</a> (accessed Jan 20,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Stool+Transplant+in+Pediatric+Patients+with+Recurring+C.+difficile+Infection.+Identifier+NCT01972334.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01972334%3Fterm%3DFMT%26phase%3D1%26rank%3D5+%28accessed+Jan+20%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span>Fecal Transplant for Relapsing <i>C. difficile</i> Infection. Identifier NCT01703494. <a href="http://clinicaltrials.gov/ct2/show/NCT01703494" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01703494</a> (accessed Oct 28,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Fecal+Transplant+for+Relapsing+C.+difficile+Infection.+Identifier+NCT01703494.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01703494+%28accessed+Oct+28%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span>Fecal Microbiota Transplantation by Colonoscopy for Recurrent <i>C. difficile</i> Infection. NCT02148601. <a href="https://clinicaltrials.gov/ct2/show/NCT02148601?term=FMT&amp;phase=1&amp;rank=15" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02148601?term=FMT&phase=1&rank=15</a> (accessed Oct 28,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Fecal+Microbiota+Transplantation+by+Colonoscopy+for+Recurrent+C.+difficile+Infection.+NCT02148601.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02148601%3Fterm%3DFMT%26phase%3D1%26rank%3D15+%28accessed+Oct+28%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span>FMT Delivered by Capsule Versus Colonoscopy for Recurrent <i>C. diff</i>. Identifier NCT02254811. <a href="http://clinicaltrials.gov/ct2/show/NCT02254811?term=FMT&amp;phase=2&amp;rank=1" class="extLink">http://clinicaltrials.gov/ct2/show/NCT02254811?term=FMT&phase=2&rank=1</a> (accessed Oct 23,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=FMT+Delivered+by+Capsule+Versus+Colonoscopy+for+Recurrent+C.+diff.+Identifier+NCT02254811.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02254811%3Fterm%3DFMT%26phase%3D2%26rank%3D1+%28accessed+Oct+23%2C+2014%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i32"><a href="/doi/suppl/10.1021/jm5016846">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_48724"></div></div></div></div></div><hr /></hr><p class="last">Methods for clustering ChEMBL data and Table 1 listing summary of single drug candidates tested against <i>C. difficile</i>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5016846/suppl_file/jm5016846_si_001.pdf">jm5016846_si_001.pdf (217.69 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm5016846&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm5016846%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-13%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm5016846" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a57a24b4cd95a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
